Form 10-Q

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

0001193125-15-354886.txt : 20151027 0001193125-15-354886.hdr.sgml : 20151027 20151027171757 ACCESSION NUMBER: 0001193125-15-354886 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151027 DATE AS OF CHANGE: 20151027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 151178531 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 10-Q 1 d87082d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-15317

ResMed Inc.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation or organization)

98-0152841

(I.R.S. Employer Identification No.)

9001 Spectrum Center Blvd.

San Diego, CA 92123

United States of America

(Address of principal executive offices)

(858) 836-5000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

At October 20, 2015, there were 139,649,869 shares of Common Stock ($0.004 par value) outstanding. This number excludes 40,386,234 shares held by the registrant as treasury shares.

RESMED INC. AND SUBSIDIARIES

INDEX


Part I	Financial Information	3

Item 1	Financial Statements	3

	Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2015 and June 30, 2015	3

	Condensed Consolidated Statements of Income (Unaudited) for the Three Months Ended September 30, 2015 and 2014	4

	Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the Three Months Ended September 30, 2015 and 2014	5

	Condensed Consolidated Statements of Cash Flows (Unaudited) for the Three months Ended September 30, 2015 and 2014	6

	Notes to the Condensed Consolidated Financial Statements (Unaudited)	7

Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16

Item 3	Quantitative and Qualitative Disclosures About Market Risk	23

Item 4	Controls and Procedures	25

Part II	Other Information	26

Item 1	Legal Proceedings	26

Item 1A	Risk Factors	26

Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	26

Item 3	Defaults Upon Senior Securities	27

Item 4	Mine Safety Disclosures	27

Item 5	Other Information	27

Item 6	Exhibits	28

	Signatures	29


PART I – FINANCIAL INFORMATION		Item 1

Item 1. Financial Statements

RESMED INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(In US$ thousands, except share and per share data)


	September 30, 2015			June 30, 2015
Assets
Current assets:
Cash and cash equivalents	$	822,053		$	717,249
Accounts receivable, net of allowance for doubtful accounts of $13,394 and $12,276 at September 30, 2015 and June 30, 2015, respectively		327,168			362,568
Inventories (note 3)		258,609			246,859
Deferred income taxes		41,494			36,338
Prepaid expenses and other current assets		83,476			81,168

Total current assets		1,532,800			1,444,182
Non-current assets:
Property, plant and equipment, net (note 4)		368,984			387,758
Goodwill and other intangible assets, net (note 6)		305,418			311,403
Deferred income taxes		11,990			12,528
Other assets		35,487			28,389

Total non-current assets		721,879			740,078

Total assets	$	2,254,679		$	2,184,260

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable		77,482			81,112
Accrued expenses		117,651			132,976
Deferred revenue		34,848			36,097
Income taxes payable		26,550			16,278
Deferred income taxes		776			796

Total current liabilities		257,307			267,259
Non-current liabilities:
Deferred income taxes		7,968			8,062
Deferred revenue		23,446			19,284
Long-term debt (note 7)		500,587			300,594
Other long-term liabilities		2,804			-
Income taxes payable		1,754			1,754

Total non-current liabilities		536,559			329,694

Total liabilities		793,866			596,953

Commitments and contingencies (note 12)
Stockholders’ equity: (note 10)
Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued		-			-
Common stock, $0.004 par value, 350,000,000 shares authorized; 179,925,750 issued and 139,539,516 outstanding at September 30, 2015 and 179,660,939 issued and 140,474,705 outstanding at June 30, 2015		558			562
Additional paid-in capital		1,248,077			1,228,795
Retained earnings		2,014,344			1,976,020
Treasury stock, at cost, 40,386,234 shares at September 30, 2015, and 39,186,234 shares at June 30, 2015		(1,506,542	)		(1,444,554	)
Accumulated other comprehensive (loss) income		(295,624	)		(173,516	)

Total stockholders’ equity		1,460,813			1,587,307

Total liabilities and stockholders’ equity	$	2,254,679		$	2,184,260

See the accompanying notes to the unaudited condensed consolidated financial statements.


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income (Unaudited)

(In US$ thousands, except per share data)


	Three Months Ended September 30,
	2015			2014
Net revenue	$	411,647		$	380,399
Cost of sales (excluding amortization of acquired intangible assets)		173,028			143,086

Gross profit		238,619			237,313

Operating expenses:
Selling, general and administrative		111,095			110,520
Research and development		27,192			30,024
Amortization of acquired intangible assets		2,307			2,094

Total operating expenses		140,594			142,638

Income from operations		98,025			94,675

Other income, net:
Interest income, net		3,422			5,584
Other, net		(2,003	)		1,671

Total other income, net		1,419			7,255

Income before income taxes		99,444			101,930
Income taxes		19,041			18,670

Net income	$	80,403		$	83,260

Basic earnings per share	$	0.57		$	0.59
Diluted earnings per share (note 2)	$	0.57		$	0.58
Dividend declared per share	$	0.30		$	0.28
Basic shares outstanding (000’s)		140,309			140,127
Diluted shares outstanding (000’s)		141,946			142,683

See the accompanying notes to the unaudited condensed consolidated financial statements.


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income (Unaudited)

(In US$ thousands)


	Three Months Ended September 30,
	2015			2014
Net income	$	80,403		$	83,260
Other comprehensive income:
Foreign currency translation (loss) gain adjustments		(122,108	)		(125,108	)

Comprehensive (loss) income	$	(41,705	)	$	(41,848	)

See the accompanying notes to the unaudited condensed consolidated financial statements.


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (Unaudited)

(In US$ thousands)


	Three Months Ended September 30,
	2015			2014
Cash flows from operating activities:
Net income	$	80,403		$	83,260
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		18,403			18,582
Gain on divestment of business		-			(709	)
Stock-based compensation costs		12,383			11,367
Excess tax benefit from stock-based compensation arrangements		(2,536	)		(2,575	)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net		30,498			20,804
Inventories, net		(17,194	)		(37,897	)
Prepaid expenses, net deferred income taxes and other current assets		(3,526	)		(15,168	)
Accounts payable, accrued expenses and other liabilities		3,641			8,872

Net cash provided by operating activities		122,072			86,536

Cash flows from investing activities:
Purchases of property, plant and equipment		(16,403	)		(20,681	)
Patent registration costs		(2,423	)		(2,366	)
Business acquisitions, net of cash acquired		-			(7,318	)
Investments in cost-method investments		(4,582	)		(500	)
Proceeds from divestiture of business		-			468
Payments on maturity of foreign currency contracts		(39,341	)		(11,206	)

Net cash provided by (used in) investing activities		(62,749	)		(41,603	)

Cash flows from financing activities:
Proceeds from issuance of common stock, net		4,352			4,930
Excess tax benefit from stock-based compensation arrangements		2,536			2,575
Purchases of treasury stock		(57,857	)		(46,803	)
Payment of business combination contingent consideration		-			(458	)
Proceeds from borrowings, net of borrowing costs		200,000			75,000
Repayment of borrowings		(8	)		(10	)
Dividend paid		(42,079	)		(39,199	)

Net cash provided by (used in) financing activities		106,944			(3,965	)

Effect of exchange rate changes on cash		(61,463	)		(65,004	)

Net (decrease)/increase in cash and cash equivalents		104,804			(24,036	)
Cash and cash equivalents at beginning of period		717,249			905,730

Cash and cash equivalents at end of period	$	822,053		$	881,694

Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds	$	18,118		$	14,373
Interest paid	$	1,247		$	1,233

Fair value of assets acquired, excluding cash	$	-		$	7,342
Liabilities assumed		-			(3,168	)
Goodwill on acquisition		-			6,454
Deferred payments		-			(2,405	)
Fair value of contingent consideration		-			(905	)

Total purchase price, excluding contingent consideration	$	-		$	7,318

See the accompanying notes to the unaudited condensed consolidated financial statements.


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(1)	Summary of Significant Accounting Policies

Organization and Basis of Presentation

ResMed Inc. (referred to herein as “we”, “us”, “our” or the “Company”) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group. Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. Our manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States. Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the year ending June 30, 2016.

The condensed consolidated financial statements for the three months ended September 30, 2015 and 2014 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Form 10-K for the year ended June 30, 2015.

New Accounting Pronouncements

In May, 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers”, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company beginning in the first quarter of fiscal year 2019. Early application is not permitted. We are currently assessing the impact of the adoption of ASU 2014-09 on our financial condition, results of operations and cash flows.

In April, 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs”. ASU 2015-03 will more closely align the presentation of debt issuance costs under U.S. GAAP with the presentation under comparable International Financial Reporting Standards (IFRS) by requiring that debt issuance costs be presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. The new standard is effective for us beginning in the first quarter of fiscal 2017. We do not expect this updated standard to have a material impact on our consolidated financial statements and related disclosures.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory” which requires an entity to measure inventory within the scope of this ASU at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The amendments in this guidance more closely align the measurement of inventory in GAAP with the measurement of inventory in IFRS. The new standard is effective for us beginning in the first quarter of fiscal 2018. We do not expect this updated standard to have a material impact on our consolidated financial statements and related disclosures.


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(2)	Earnings Per Share

Basic earnings per share is computed by dividing the net income available to common stockholders by the weighted average number of shares of common stock outstanding. For purposes of calculating diluted earnings per share, the denominator includes both the weighted average number of shares of common stock outstanding and the number of dilutive common stock equivalents such as stock options and restricted stock units.

Stock options and restricted stock units of 98,697 and 154,551, for the three months ended September 30, 2015 and 2014, respectively, were not included in the computation of diluted earnings per share as the effect would have been anti-dilutive.

Basic and diluted earnings per share for the three months ended September 30, 2015 and 2014 are calculated as follows (in thousands except per share data):


	Three Months Ended September 30,
	2015		2014
Numerator:
Net Income	$	80,403	$	83,260
Denominator:
Basic weighted-average common shares outstanding		140,309		140,127
Effect of dilutive securities:
Stock options and restricted stock units		1,637		2,556
Diluted weighted average shares		141,946		142,683
Basic earnings per share	$	0.57	$	0.59
Diluted earnings per share	$	0.57	$	0.58

(3)	Inventories

Inventories were comprised of the following at September 30, 2015 and June 30, 2015 (in thousands):


	September 30, 2015		June 30, 2015
Raw materials	$	75,490	$	74,416
Work in progress		2,215		2,550
Finished goods		180,904		169,893
Total inventories	$	258,609	$	246,859

(4)	Property, Plant and Equipment

Property, plant and equipment were comprised of the following as of September 30, 2015 and June 30, 2015 (in thousands):


	September 30, 2015			June 30, 2015
Machinery and equipment	$	188,059		$	198,047
Computer equipment		126,928			125,423
Furniture and fixtures		37,396			38,511
Vehicles		5,680			5,371
Clinical, demonstration and rental equipment		81,174			80,911
Leasehold improvements		30,915			31,553
Land		51,905			54,915
Buildings		223,423			235,515
		745,480			770,246
Accumulated depreciation and amortization		(376,496	)		(382,488	)
Property, plant and equipment, net	$	368,984		$	387,758


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(5)	Cost-Method Investments

The aggregate carrying amount of our cost-method investments at September 30, 2015 and June 30, 2015, was $30.2 million and $25.6 million, respectively, and is included in the non-current balance of other assets on the condensed consolidated balance sheets.

We periodically evaluate the carrying value of our cost-method investments, when events and circumstances indicate that the carrying amount of an asset may not be recovered. We estimate the fair value of our cost-method investments to assess whether impairment losses shall be recorded using Level 3 inputs. These investments include our holdings in privately held service and research companies that are not exchange traded and therefore not supported with observable market prices. However, these investments are valued by reference to their net asset values that can be market supported and unobservable inputs including future cash flows. During the three months ended September 30, 2015 and 2014, we did not recognize any impairment losses related to our cost-method investments. We have determined that the fair value of our investments exceed their carrying values.

The following table shows a reconciliation of the changes in our cost-method investments during the three months ended September 30, 2015 and 2014 (in thousands):


	Three Months Ended September 30,
	2015		2014
Balance at the beginning of the period	$	25,600	$	14,850
Investments		4,582		500
Balance at the end of the period	$	30,182	$	15,350

(6)	Goodwill and Other Intangible Assets, net

Goodwill

Changes in the carrying amount of goodwill for the three months ended September 30, 2015, and 2014 were as follows (in thousands):


	Three Months Ended September 30,
	2015			2014
Balance at the beginning of the period	$	264,261		$	289,312
Business acquisition		-			6,454
Foreign currency translation adjustments		(1,443	)		(18,502	)
Balance at the end of the period	$	262,818		$	277,264

Other Intangible Assets

Other intangible assets were comprised of the following as of September 30, 2015, and June 30, 2015 (in thousands):


	September 30, 2015			June 30, 2015
Developed/core product technology	$	66,104		$	67,548
Accumulated amortization		(51,144	)		(50,373	)
Developed/core product technology, net		14,960			17,175
Trade names		2,478			2,500
Accumulated amortization		(2,214	)		(2,206	)
Trade names, net		264			294
Non-compete agreements		1,590			1,747
Accumulated amortization		(1,590	)		(1,704	)
Non compete agreements, net		-			43
Customer relationships		29,102			30,538
Accumulated amortization		(19,532	)		(19,308	)
Customer relationships, net		9,570			11,230
Patents		63,533			66,585
Accumulated amortization		(45,727	)		(48,185	)
Patents, net		17,806			18,400
Total other intangibles, net	$	42,600		$	47,142


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Intangible assets consist of patents, customer relationships, trade names, non-compete agreements and developed/core product technology. We amortize intangible assets over the estimated useful life of the assets, generally between two and nine years. There are no expected residual values related to these intangible assets.

(7)	Long-Term Debt

Long-term debt at September 30, 2015 and June 30, 2015 consisted of the following (in thousands):


	September 30, 2015		June 30, 2015
Current long-term debt	$	-	$	-
Non-current long-term debt		500,587		300,594
Total long-term debt	$	500,587	$	300,594

Credit Facility

On October 31, 2013, we entered into a credit agreement, as borrower, with lenders, including Union Bank, N.A., as administrative agent, joint lead arranger, swing line lender and letters of credit issuer, and HSBC Bank USA, National Association, as syndication agent and joint lead arranger. Our obligations under the credit agreement are guaranteed by ResMed Corp. and ResMed Motor Technologies Inc., two of our U.S. subsidiaries.

The credit agreement provides a $700 million senior unsecured five-year revolving credit facility, with an uncommitted option to increase the credit facility by an additional $300 million. The credit facility also includes a $25 million sublimit for letters of credit. The credit facility terminates on October 31, 2018, when all unpaid principal and interest under the loans must be repaid. The outstanding principal amount due under the credit facility will bear interest at a rate equal to LIBOR plus 1.0% to 2.0% (depending on the then-applicable leverage ratio). At September 30, 2015, the interest rate that was being charged on the outstanding principal amount was 1.2%. An applicable commitment fee of 0.15% to 0.25% (depending on the then-applicable leverage ratio) applies on the unused portion of the credit facility.

When we entered into the credit agreement, we used a portion of the proceeds from the initial funding of the credit facility to repay the outstanding balance under our previous revolving credit facility with Union Bank, N.A and other lenders. On that repayment, the previous credit agreement, dated as of February 10, 2011, between us and lenders (including Union Bank, N.A., as administrative agent, swing line lender and letter of credit issuer, HSBC Bank USA, National Association, as syndication agent and Union Bank, N.A., HSBC Bank USA, National Association, Commonwealth Bank of Australia and Wells Fargo Bank), was terminated and the commitments under the previous credit agreement were also terminated.

Our obligations under the current credit agreement are unsecured but are guaranteed by two of our U.S. subsidiaries. The credit agreement contains customary covenants, including certain financial covenants and an obligation that we maintain certain financial ratios, including a maximum leverage ratio of funded debt to EBITDA (as defined in the credit agreement) and an interest coverage ratio. The entire principal amount of the credit facility and any accrued but unpaid interest may be declared immediately due and payable if an event of default occurs, as defined in the credit agreement. Events of default under the credit agreement include failure to make payments when due, the occurrence of a default in the performance of any covenants in the credit agreement or related documents, or certain changes of control of ResMed Inc., ResMed Corp., ResMed Motor Technologies Inc., ResMed Limited, ResMed Holdings Ltd/LLC or ResMed EAP Holdings LLC.

At September 30, 2015, there was $500.0 million outstanding under the credit agreement.

(8)	Product Warranties

Changes in the liability for warranty costs, which is included in accrued expenses in our condensed consolidated balance sheets, for the three months ended September 30, 2015 and 2014 are as follows (in thousands):


	Three Months Ended September 30,
	2015			2014
Balance at the beginning of the period	$	9,823		$	11,798
Warranty accruals for the period		1,790			3,376
Warranty costs incurred for the period		(2,039	)		(1,567	)
Foreign currency translation adjustments		(691	)		(714	)
Balance at the end of the period	$	8,883		$	12,893


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(9)	Stock-Based Employee Compensation

We measure the compensation expense of all stock-based awards at fair value on the grant date. We estimate the fair value of stock options and purchase rights granted under the employee stock purchase plan (the “ESPP”) using the Black-Scholes valuation model. The fair value of restricted stock units is equal to the market value of the underlying shares as determined at the grant date less the fair value of dividends that holders are not entitled to, during the vesting period. The fair value of performance restricted stock units which contain a market condition, are estimated using a Monte-Carlo simulation model. We recognize the fair value as compensation expense using the straight-line method over the service period for awards expected to vest.

We estimate the fair value of purchase rights granted under the ESPP using the following assumptions:


	Three Months Ended September 30,
	2015			2014
Stock options:
Weighted average grant date fair value	$	-		$	-
Weighted average risk-free interest rate		-			-
Expected option life in years		-			-
Dividend yield		-			-
Expected volatility		-			-
ESPP purchase rights:
Weighted average risk-free interest rate		0.1	%		0.1	%
Expected option life in years		6 months			6 months
Dividend yield		1.73	%		2.00	%
Expected volatility		26	%		24	%

(10)	Stockholders’ Equity

Common Stock. During the three months ended September 30, 2015 and 2014 we repurchased 1.2 million and 0.8 million shares at a cost of $62.0 million and $42.9 million, respectively. Since the inception of our share repurchase programs and through September 30, 2015, we have repurchased a total of 40.4 million shares at a cost of $1.5 billion. Shares that are repurchased are classified as treasury stock pending future use and reduce the number of shares outstanding used in calculating earnings per share. At September 30, 2015, 14.3 million additional shares can be repurchased under the approved share repurchase program.

Preferred Stock. In April 1997, the board of directors designated 2,000,000 shares of our $0.01 par value preferred stock as Series A Junior Participating Preferred Stock. No shares were issued or outstanding at September 30, 2015 and June 30, 2015.

Stock Options and Restricted Stock Units. We have granted stock options and restricted stock units to personnel, including officers and directors, in accordance with the ResMed Inc. 2009 Incentive Award Plan (the “2009 Plan”). These options and restricted stock units have expiration dates of seven years from the date of grant and vest over one to four years. We have granted the options with an exercise price equal to the market value as determined at the date of grant.

The maximum number of shares of our common stock authorized for issuance under the 2009 Plan is 43.7 million shares. The number of securities remaining available for future issuance under the 2009 Plan at September 30, 2015 is 13.8 million. The number of shares of our common stock available for issuance under the 2009 Plan will be reduced by (i) 2.8 shares for each one share of common stock delivered in settlement of any “full-value award,” which is any award other than a stock option, stock appreciation right or other award for which the holder pays the intrinsic value and (ii) one share for each share of common stock delivered in settlement of all other awards. The maximum number of shares, that may be subject to awards granted under the 2009 Plan to any individual during any calendar year, may not exceed 3 million shares of our common stock (except in a participant’s initial year of hiring, when up to 4.5 million shares of our common stock may be granted).

At September 30, 2015, there were $57.1 million in unrecognized compensation costs related to unvested stock-based compensation arrangements. This is expected to be recognized over a weighted average period of 2.0 years. The aggregate intrinsic value of the stock-based compensation arrangements outstanding and exercisable at September 30, 2015 was $168.5 million and $46.3 million, respectively. The aggregate intrinsic value of the options exercised during the three months ended September 30, 2015 and 2014, was $8.9 million and $9.7 million, respectively.


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

The following table summarizes option activity during the three months ended September 30, 2015:


			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period		2,809,238	$	29.63		2.5
Granted		-		-
Exercised		(250,688)		18.34
Forfeited		(12,546)		44.32
Outstanding at end of period		2,546,004	$	30.65		2.5
Exercise price of granted options	$	-
Options exercisable at end of period		1,987,218	$	27.67

The following table summarizes the activity of restricted stock units during the three months ended September 30, 2015:


		Weighted Average Grant- Date Fair Value		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period	2,312,529	$	43.65		1.2
Granted	7,477		51.49
Vested	(25,245)		31.30
Forfeited	(5,839)		44.90
Outstanding at end of period	2,288,922	$	43.81		0.9

Employee Stock Purchase Plan (the “ESPP”). Under the ESPP, we offer participants the right to purchase shares of our common stock at a discount during successive offering periods. Each offering period under the ESPP will be for a period of time determined by the board of directors’ compensation committee of no less than 3 months and no more than 27 months. The purchase price for our common stock under the ESPP will be the lower of 85% of the fair market value of our common stock on the date of grant or 85% of the fair market value of our common stock on the date of purchase. An individual participant cannot subscribe for more than $25,000 in common stock during any calendar year. At September 30, 2015, the number of shares remaining available for future issuance under the ESPP is 1.5 million shares.


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(11)	Fair Value Measurements

In determining the fair value measurements of our financial assets and liabilities, we consider the principal and most advantageous market in which we transact and consider assumptions that market participants would use when pricing the financial asset or liability. We maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The hierarchies of inputs are as follows:


•	Level 1:	Input prices quoted in an active market for identical financial assets or liabilities;

•	Level 2:	Inputs other than prices quoted in Level 1, such as prices quoted for similar financial assets and liabilities in active markets, prices for identical assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data; and

•	Level 3:	Input prices quoted that are significant to the fair value of the financial assets or liabilities which are not observable nor supported by an active market.

The following table summarizes our financial assets and liabilities, as at September 30, 2015 and June 30, 2015, using the valuation input hierarchy (in thousands):


	Level 1		Level 2		Level 3			Total
Balances at September 30, 2015
Foreign currency hedging instruments, net	$	-	$	1,664	$	-		$	1,664
Business acquisition contingent consideration	$	-	$	-	$	(1,514	)	$	(1,514	)
Balances at June 30, 2015
Foreign currency hedging instruments, net	$	-	$	1,038	$	-		$	1,038
Business acquisition contingent consideration	$	-	$	-	$	(1,584	)	$	(1,584	)

We determine the fair value of our financial assets and liabilities as follows:


•		Foreign currency hedging instruments – These financial instruments are valued using third-party valuation models based on market observable inputs, including interest rate curves, on-market spot currency prices, volatilities and credit risk.

•		Contingent consideration – These liabilities include the fair value estimates of additional future payments that may be required for some of our previous business acquisitions based on the achievement of certain performance milestones. Each potential future payment is valued using the estimated probability of achieving each milestone, which is then discounted to present value.

The following is a reconciliation of changes in the fair value of contingent consideration for the three months ended September 30, 2015 and 2014 (in thousands):


	Three Months Ended September 30,
	2015			2014
Balance at the beginning of the period	$	(1,584	)	$	(480	)
Acquisition date fair value of contingent consideration		-			(905	)
Changes in fair value included in operating income		-			132
Payments		-			458
Foreign currency translation adjustments		70			(80	)
Balance at the end of the period	$	(1,514	)	$	(875	)

We did not have any significant non-financial assets or liabilities measured at fair value on September 30, 2015 or June 30, 2015.


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(12)	Legal Actions and Contingencies

Litigation

In the normal course of business, we are subject to routine litigation incidental to our business. While the results of this litigation cannot be predicted with certainty, we believe that their final outcome will not, individually or in aggregate, have a material adverse effect on our consolidated financial statements taken as a whole.

Obligations Under Recourse Provisions

We use independent leasing companies to provide financing to certain customers for the purchase of our products. In some cases, we are liable in the event of a customer default, to the leasing companies, within certain limits, for unpaid installment receivables transferred to the leasing companies. The gross amount of receivables sold with recourse during the three months ended September 30, 2015 and 2014, amounted to $16.1 million and $2.0 million, respectively. The maximum potential amount of contingent liability under these arrangements at September 30, 2015 and June 30, 2015 were $9.1 million, and $7.2 million, respectively. The recourse liability recognized by us at September 30, 2015 and June 30, 2015, in relation to these arrangements was $0.5 million and $0.5 million, respectively.

(13) Derivative Instruments and Hedging Activities

We transact business in various foreign currencies, including a number of major European currencies as well as the Australian and Singapore dollars. We have significant foreign currency exposure through both our Australian and Singaporean manufacturing activities, and international sales operations. We have established a foreign currency hedging program using purchased currency options and forward contracts to hedge foreign-currency-denominated financial assets, liabilities and manufacturing cash flows. The terms of such foreign currency hedging contracts generally do not exceed three years. The goal of this hedging program is to economically manage the financial impact of foreign currency exposures denominated mainly in Euros, and Australian and Singapore dollars. Under this program, increases or decreases in our foreign currency denominated financial assets, liabilities, and firm commitments are partially offset by gains and losses on the hedging instruments.

We do not designate these foreign currency contracts as hedges. We have determined our hedge program to be a non-effective hedge as defined under the FASB issued authoritative guidance. All movements in the fair value of the foreign currency instruments are recorded within other income, net in our condensed consolidated statements of income. We do not enter into financial instruments for trading or speculative purposes.

We held foreign currency instruments with notional amounts totaling $620.2 million and $576.5 million at September 30, 2015 and June 30, 2015, respectively, to hedge foreign currency fluctuations. These contracts mature at various dates prior to September 30, 2018.

The following table summarizes the amount and location of our derivative financial instruments as of September 30, 2015 and June 30, 2015 (in thousands):


	September 30, 2015			June 30, 2015			Balance Sheet Caption
Foreign currency hedging instruments	$	3,684		$	1,644		Other assets - current
Foreign currency hedging instruments		1,574			1,348		Other assets - non current
Foreign currency hedging instruments		(790	)		(1,954	)	Accrued expenses
Foreign currency hedging instruments		(2,804	)		-		Other long-term liabilities
	$	1,664		$	1,038

The following table summarizes the amount and location of gains (losses) associated with our derivative financial instruments for the three months ended September 30, 2015 and September 30, 2014, respectively (in thousands):


	Gain /(Loss) Recognized						Income Statement Caption
	Three Months Ended September 30,
	2015			2014
Foreign currency hedging instruments	$	(39,353	)	$	(11,054	)	Other, net
Other foreign-currency-denominated transactions		37,081			12,148		Other, net
	$	(2,272	)	$	1,094

We are exposed to credit-related losses in the event of non-performance by counter parties to financial instruments. We minimize counterparty credit risk by entering into derivative transactions with major financial institutions and we do not expect material losses as a result of default by our counterparties.


PART I – FINANCIAL INFORMATION		Item 1

RESMED INC. AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

(14)	Subsequent Events

On October 2, 2015 we completed the acquisition of 100% of the shares in Curative Medical Technology Inc., a leading provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories in China. This acquisition will be accounted for as a business combination using purchase accounting and will be included in our condensed consolidated financial statements from the acquisition date. The acquisition is not considered a material business combination and was funded through cash on-hand. We have not incurred any material acquisition-related costs. The preliminary purchase price allocation will be completed during the quarter ending December 31, 2015.


PART I – FINANCIAL INFORMATION		Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

This report contains or may contain certain forward-looking statements and information that are based on the beliefs of our management as well as estimates and assumptions made by, and information currently available to, our management. All statements other than statements regarding historical facts are forward-looking statements. The words “believe,” “expect,” “anticipate,” “will continue,” “will,” “estimate,” “plan,” “future” and other similar expressions, and negative statements of such expressions, generally identify forward-looking statements, including, in particular, statements regarding the development and approval of new products and product applications, market expansion, pending litigation and the development of new markets for our products, such as cardiovascular and stroke markets. These forward-looking statements are made in accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements reflect the views of our management at the time the statements are made and are subject to a number of risks, uncertainties, estimates and assumptions, including, without limitation, and in addition to those identified in the text surrounding such statements, those identified in our annual report on Form 10-K for the fiscal year ended June 30, 2015 and elsewhere in this report.

In addition, important factors to consider in evaluating such forward-looking statements include changes or developments in healthcare reform, social, economic, market, legal or regulatory circumstances, changes in our business or growth strategy or an inability to execute our strategy due to changes in our industry or the economy generally, the emergence of new or growing competitors, the actions or omissions of third parties, including suppliers, customers, competitors and governmental authorities and various other factors. If any one or more of these risks or uncertainties materialize, or underlying estimates or assumptions prove incorrect, actual results may vary significantly from those expressed in our forward-looking statements, and there can be no assurance that the forward-looking statements contained in this report will in fact occur.

Before deciding to purchase, hold or sell our common stock, you should carefully consider the risks described in our annual report on Form 10-K, in addition to the other cautionary statements and risks described elsewhere in this report and in our other filings with the Securities and Exchange Commission (the SEC), including our subsequent reports on Forms 10-Q and 8-K. These risks and uncertainties are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business. If any of these known or unknown risks or uncertainties actually occurs with material adverse effects on us, our business, financial condition and results of operations could be seriously harmed. In that event, the market price for our common stock will likely decline and you may lose all or part of your investment.


PART I – FINANCIAL INFORMATION		Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

The following is an overview of our results of operations for the three months ended September 30, 2015. Management’s discussion and analysis of financial condition and results of operations is intended to help the reader understand the results of operations and financial condition of ResMed Inc. Management’s discussion and analysis is provided as a supplement to, and should be read in conjunction with, the selected financial data and condensed consolidated financial statements and notes, included in this report.

We are a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing (“SDB”) and other respiratory disorders. During the three months ended September 30, 2015, we continued our efforts to build awareness of the consequences of untreated SDB, and to grow our business in this market. In our efforts, we have endeavored to raise awareness through market and clinical initiatives highlighting the relationship between SDB/obstructive sleep apnea and co-morbidities, such as cardiac disease, diabetes, hypertension and obesity, as well as the dangers of sleep apnea in regard to occupational health and safety, especially in the transport industry.

We are committed to ongoing investment in research and development and product enhancements. During the three months ended September 30, 2015, we invested $27.2 million on research and development activities. Since the development of continuous positive airway pressure (“CPAP”) therapy, we have developed a number of innovative products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. Our new product release schedule remains active across both our mask and flow generator categories.

Net revenue in North and Latin America for the three months ended September 30, 2015 increased by 23%, including a 39% increase for flow generators and a 9% increase for masks and accessories, compared to the three months ended September 30, 2014. Since the launch of our Air Solutions Platform and connected medical devices, in August 2014, we have over one million cloud-connected devices on bedside tables, providing actionable data every day for patients, customers, providers and payors. Our informatics capabilities enable our global team to enhance and deliver innovative products and solutions that improve patient outcomes, create efficiencies for our customers, help providers better manage chronic disease and lower healthcare costs.

In October 2015, we completed the acquisition of Curative Medical Technology Inc., a leading provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories in China. ResMed and Curative are now the combined market leader in sleep-disordered breathing and respiratory care in China.

During the three months ended September 30, 2015, our net revenue increased by 8% when compared to the three months ended September 30, 2014. Gross margin was 58.0% for the three months ended September 30, 2015 compared to 62.4% for the three months ended September 30, 2014. Diluted earnings per share for the three months ended September 30, 2015 was $0.57 per share, compared to $0.58 per share for the three months ended September 30, 2014.

At September 30, 2015, our cash and cash equivalents totaled $822.1 million, our total assets were $2.3 billion and our stockholders’ equity was $1.5 billion.

In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, we provide certain financial information on a “constant currency basis”, which is in addition to the actual financial information presented. In order to calculate our constant currency information, we translate the current period financial information using the foreign currency exchange rates that were in effect during the previous comparable period. However, constant currency measures should not be considered in isolation or as an alternative to U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.


PART I – FINANCIAL INFORMATION		Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Net Revenue

Net revenue increased for the three months ended September 30, 2015 to $411.6 million compared to $380.4 million for the three months ended September 30, 2014, an increase of $31.2 million or 8% (a 15% increase on a constant currency basis). The increase in net revenue is primarily attributable to an increase in unit sales of our flow generators, masks and accessories, partially offset by a decline in average selling prices. Movements in international currencies against the U.S. dollar unfavorably impacted revenues by approximately $26.8 million for the three months ended September 30, 2015.

Net revenue in North and Latin America for the three months ended September 30, 2015 was $254.1 million, compared to $207.2 million for the three months ended September 30, 2014, an increase of $46.9 million, or 23%. The increase in net revenue is primarily attributable to an increase in unit sales of our flow generators, masks and accessories, partially offset by a decline in average selling prices. Net revenue in markets outside North and Latin America, for the three months ended September 30, 2015, decreased to $157.5 million compared to $173.2 million for the three months ended September 30, 2014, a decrease of 9% (a 5% increase in constant currency terms).

Net revenue from the sales of flow generators, including humidifiers, for the three months ended September 30, 2015 totaled $239.6 million, an increase of 12% compared to the three months ended September 30, 2014 of $214.3 million, including an increase of 39% in North and Latin America and a decrease of 10% elsewhere (a 5% increase in constant currency terms). Net revenue from the sales of masks and other accessories for the three months ended September 30, 2015 totaled $172.0 million, an increase of 4% compared to the three months ended September 30, 2014 of $166.1 million, reflecting an increase of 9% in North and Latin America and a decrease of 8% elsewhere (a 7% increase in constant currency terms).

The following table summarizes the percentage movements in our net revenue for the three months ended September 30, 2015 compared to the three months ended September 30, 2014:


	North and Latin America			International			Total			International (Constant Currency)*			Total (Constant Currency)*
Flow generators		39	%		-10	%		12	%		5	%	20%
Masks and other accessories		9	%		-8	%		4	%		7	%	9%
Total		23	%		-9	%		8	%		5	%	15%

*	Constant currency numbers exclude the impact of movements in international currencies.

Gross Profit

Gross profit increased for the three months ended September 30, 2015 to $238.6 million from $237.3 million for the three months ended September 30, 2014, an increase of $1.3 million or 1%. Gross profit as a percentage of net revenue for the three months ended September 30, 2015 decreased to 58.0% from 62.4% for the three months ended September 30, 2014.

The decline in gross margins was primarily due to an unfavorable product mix as sales of our lower margin products represented a higher proportion of our sales, declines in our average selling prices and an unfavorable geographic mix with sales in our lower margin geographic areas representing a higher proportion of our overall sales.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased for the three months ended September 30, 2015 to $111.1 million from $110.5 million for the three months ended September 30, 2014, an increase of $0.6 million or 1%. Selling, general and administrative expenses were favorably impacted by the movement of international currencies against the U.S. dollar, which decreased our expenses by approximately $12.1 million, as reported in U.S. dollars. Excluding the impact of foreign currency movements, selling, general and administrative expenses for the three months ended September 30, 2015 increased by 11% compared to the three months ended September 30, 2014. The increase in selling, general and administrative expenses was primarily due to additional personnel to support our commercial activities, increased legal expenses and the impact of recent acquisitions. Selling, general and administrative expenses, as a percentage of net revenue, were 27.0% for the three months ended September 30, 2015, compared to 29.1% for the three months ended September 30, 2014.


PART I – FINANCIAL INFORMATION		Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Research and Development Expenses

Research and development expenses decreased for the three months ended September 30, 2015 to $27.2 million from $30.0 million for the three months ended September 30, 2014, a decrease of $2.8 million, or 9%. Research and development expenses were favorably impacted by the movement of international currencies against the U.S. dollar, which decreased our expenses by approximately $6.6 million for the three months ended September 30, 2015, as reported in U.S. dollars. Excluding the impact of foreign currency movements, research and development expenses increased by 12% compared to the three months ended September 30, 2014. The increase in research and development expenses in constant currency terms was primarily due to an increase in the number of research and development personnel and an increase in materials and tooling costs incurred to facilitate development of new products. Research and development expenses, as a percentage of net revenue, were 6.6% for the three months ended September 30, 2015, compared to 7.9% for the three months ended September 30, 2014.

Amortization of Acquired Intangible Assets

Amortization of acquired intangible assets for the three months ended September 30, 2015 totaled $2.3 million compared to $2.1 million for the three months ended September 30, 2014.

Total Other Income, Net

Total other income, net for the three months ended September 30, 2015 was $1.4 million, compared to $7.3 million, for the three months ended September 30, 2014. The decrease in total other income, net, was due primarily to losses on foreign currency hedging instruments, lower interest income resulting from lower interest rates on cash balances held and the depreciation of the Australian dollar against the U.S. dollar.

Income Taxes

Our effective income tax rate for the three months ended September 30, 2015 was 19.1% compared to 18.3% for the three months ended September 30, 2014. Our effective income tax rate is affected by the geographic mix of our taxable income, including the lower taxes associated with our Singapore and Malaysia manufacturing operations. Our Singapore and Malaysia operations operate under certain tax holidays and tax incentive programs that will expire in whole or in part at various dates through June 30, 2020. As of September 30, 2015, we have not provided for U.S. income taxes for the undistributed earnings of our foreign subsidiaries. We intend these earnings to be permanently reinvested outside the United States.

Net Income and Earnings per Share

As a result of the factors above, our net income for the three months ended September 30, 2015 was $80.4 million compared to net income of $83.3 million for the three months ended September 30, 2014, a decrease of 3% over the three months ended September 30, 2014.

As a result of the decrease in our net income partially offset by the lower share count due to our stock repurchases, our diluted earnings per share for the three months ended September 30, 2015 were $0.57, compared to $0.58 for the three months ended September 30, 2014, a decrease of 2%.


PART I – FINANCIAL INFORMATION		Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Liquidity and Capital Resources

As of September 30, 2015 and June 30, 2015, we had cash and cash equivalents of $822.1 million and $717.2 million, respectively. Working capital was $1.3 billion and $1.2 billion, at September 30, 2015 and June 30, 2015, respectively.

As of September 30, 2015 and June 30, 2015, our cash and cash equivalent balances held within the United States amounted to $32.1 million and $32.0 million, respectively. Our remaining cash and cash equivalent balances at September 30, 2015 and June 30, 2015, of $790.0 million and $685.2 million, respectively, were held by our non-U.S. subsidiaries and would be subject to tax if repatriated. If these funds were needed for our operations in the United States, we would be required to accrue and pay United States taxes to repatriate these funds. However, we intend to permanently reinvest these funds outside of the United States and our current plans do not demonstrate a need to repatriate them to fund our United States operations. Our cash and cash equivalent balances are held at highly rated financial institutions.

Inventories at September 30, 2015 were $258.6 million, an increase of $61.4 million or 31% from the September 30, 2014 balance of $197.2 million. The increase in inventories was mainly associated with our new product introductions and to support the increase in unit sales.

Accounts receivable at September 30, 2015 were $327.2 million, a decrease of $1.4 million or 0.4% over the September 30, 2014 accounts receivable balance of $328.6 million. Accounts receivable days outstanding of 75 days at September 30, 2015 was lower than the 78 days at September 30, 2014. Our allowance for doubtful accounts as a percentage of total accounts receivable at September 30, 2015 was 3.9%, compared to 3.3% at June 30, 2015.

During the three months ended September 30, 2015, we generated cash of $122.1 million from operations compared to $86.5 million for the three months ended September 30, 2014. Movements in foreign currency exchange rates during the three months ended September 30, 2015 had the effect of decreasing our cash and cash equivalents by $61.5 million, as reported in U.S. dollars. During the three months ended September 30, 2015 and 2014, we repurchased 1.2 million and 0.8 million shares at a cost of $62.0 million and $42.9 million, respectively. During the three months ended September 30, 2015 and 2014, we also paid dividends totaling $42.1 million and $39.2 million, respectively.

Capital expenditures for the three months ended September 30, 2015 and 2014 amounted to $16.4 million and $20.7 million, respectively. The capital expenditures for the three months ended September 30, 2015 primarily reflected investment in production tooling, equipment and machinery, computer hardware and software, and rental and loan equipment. At September 30, 2015, our balance sheet reflects net property, plant and equipment of $369.0 million compared to $387.8 million at June 30, 2015. At September 30, 2015, no capital lease obligations exist. Details of contractual obligations at September 30, 2015 are as follows:


			Payments Due by September 30,
In $000’s	Total		2016		2017		2018		2019		2020		Thereafter
Long Term Debt	$	500,587	$	-	$	-	$	-	$	500,000	$	-	$	587
Interest on Long Term Debt		19,493		6,300		6,300		6,300		551		28		14
Operating Leases		56,062		16,551		11,984		8,280		4,431		3,375		11,441
Purchase Obligations		114,694		113,956		738		-		-		-		-
Total	$	690,836	$	136,807	$	19,022	$	14,580	$	504,982	$	3,403	$	12,042

Details of other commercial commitments as at September 30, 2015 are as follows:
			Amount of Commitment Expiration Per Period
In $000’s	Total		2016		2017		2018		2019		2020		Thereafter
Standby Letter of Credit	$	8,506	$	-	$	1,486	$	6,318	$	-	$	-	$	702
Guarantees*		9,088		172		115		-		2		66		8,733
Total	$	17,594	$	172	$	1,601	$	6,318	$	2	$	66	$	9,435

*	The above guarantees mainly relate to requirements under contractual obligations with insurance companies transacting with our German subsidiaries and guarantees provided under our facility leasing obligations.


PART I – FINANCIAL INFORMATION		Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Credit Facility

When we entered into the credit agreement, we used a portion of the proceeds from the initial funding of the credit facility to repay the outstanding balance under our previous revolving credit facility with Union Bank, N.A and other lenders. On that repayment, the previous credit agreement, dated as of February 10, 2011, between us and lenders (including Union Bank, N.A., as administrative agent, swing line lender and L/C Issuer, HSBC Bank USA, National Association, as syndication agent and Union Bank, N.A., HSBC Bank USA, National Association, Commonwealth Bank of Australia and Wells Fargo Bank), was terminated and the commitments under that previous credit agreement were also terminated.

At September 30, 2015, we were in compliance with our debt covenants and there was $500.0 million outstanding under the credit agreement.

We expect to satisfy all of our liquidity requirements through a combination of cash on hand, cash generated from operations and debt facilities.


PART I – FINANCIAL INFORMATION		Item 2

RESMED INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Common Stock

During the three months ended September 30, 2015, we repurchased 1.2 million shares at a cost of $62.0 million. At September 30, 2015, we have repurchased a total of 40.4 million shares at a cost of $1.5 billion. Shares that are repurchased are classified as treasury stock pending future use and reduce the number of shares outstanding used in calculating earnings per share. At September 30, 2015, 14.3 million additional shares can be repurchased under the current share repurchase program.

Critical Accounting Principles and Estimates

The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis we evaluate our estimates, including those related to allowance for doubtful accounts, inventory reserves, warranty obligations, goodwill, potentially impaired assets, intangible assets, income taxes and contingencies.

We state these accounting policies in the notes to the financial statements and at relevant sections in this discussion and analysis. The estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could vary from those estimates under different assumptions or conditions.

For a full discussion of our critical accounting policies, see our Annual Report on Form 10-K for the year ended June 30, 2015.

Recently Issued Accounting Pronouncements

See note 1 to the condensed consolidated financial statements for a description of recently issued accounting pronouncements, including the expected dates of adoption and estimated effects on our results of operations, financial positions and cash flows.

Off-Balance Sheet Arrangements

As of September 30, 2015, we are not involved in any significant off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K promulgated by the SEC.


PART I – FINANCIAL INFORMATION		Item 3

RESMED INC. AND SUBSIDIARIES

Quantitative and Qualitative Disclosures About Market Risk

Foreign Currency Market Risk

Our reporting currency is the U.S. dollar, although the financial statements of our non-U.S. subsidiaries are maintained in their respective local currencies. We transact business in various foreign currencies, including a number of major European currencies as well as the Australian and Singapore dollar. We have significant foreign currency exposure through our Australian and Singapore manufacturing activities and our international sales operations. We have established a foreign currency hedging program using purchased currency options and forward contracts to hedge foreign-currency-denominated financial assets, liabilities and manufacturing cash flows. The goal of this hedging program is to economically manage the financial impact of foreign currency exposures predominantly denominated in euros, Australian dollars and Singapore dollars. Under this program, increases or decreases in our foreign-currency-denominated financial assets, liabilities, and firm commitments are partially offset by gains and losses on the hedging instruments. We do not enter into financial instruments for trading or speculative purposes. The foreign currency derivatives portfolio is recorded in the condensed consolidated balance sheets at fair value and included in other assets or other liabilities. All movements in the fair value of the foreign currency derivatives are recorded within other income, net, on our condensed consolidated statements of income.

The table below provides information (in U.S. dollars) on our significant foreign-currency-denominated balances by legal entity functional currency as of September 30, 2015 (in thousands):


	Australian Dollar (AUD)			U.S. Dollar (USD)			Euro (EUR)			Singapore Dollar (SGD)			Canadian Dollar (CAD)			Great Britain Pound (GBP)			Chinese Yuan (CNY)
AUD Functional:
Assets		-			395,890			172,757			1,955			3			-			6,700
Liabilities		-			(160,781	)		(56,285	)		(38	)		(270	)		(11,946	)		(1,253	)
Forward Contracts		-			(240,000	)		(117,321	)		-			-			12,102			(3,146	)
Net Total		-			(4,891	)		(849	)		1,917			(267	)		156			2,301
USD Functional:
Assets		-			-			-			-			13,408			-			-
Liability		-			-			(53	)		-			(1,303	)		-			-
Forward Contracts		-			-			-			-			(8,992	)		-			-
Net Total		-			-			(53	)		-			3,113			-			-
EURO Functional:
Assets		7			1,020			-			-			-			4,437			-
Liability		(1	)		(1,618	)		-			-			-			(9	)		-
Forward Contracts		-			-			-			-			-			(4,538	)		-
Net Total		6			(598	)		-			-			-			(110	)		-
GBP Functional:
Assets		-			376			40,122			-			-			-			-
Liability		-			(286	)		(38,304	)		-			-			-			-
Forward Contracts		-			-			-			-			-			-			-
Net Total		-			90			1,818			-			-			-			-
SGD Functional :
Assets		172			221,348			54,473			-			-			-			324
Liability		(685	)		(117,715	)		(40,647	)		-			-			-			(682	)
Forward Contracts		-			(100,000	)		(11,173	)		-			-			-			-
Net Total		(513	)		3,633			2,653			-			-			-			(358	)


PART I – FINANCIAL INFORMATION		Item 3

RESMED INC. AND SUBSIDIARIES

Quantitative and Qualitative Disclosures About Market Risk

The table below provides information about our foreign currency derivative financial instruments and presents the information in U.S. dollar equivalents. The table summarizes information on instruments and transactions that are sensitive to foreign currency exchange rates, including foreign currency call options, collars and forward contracts held at September 30, 2015. The table presents the notional amounts and weighted average exchange rates by contractual maturity dates for our foreign currency derivative financial instruments, including the forward contracts used to hedge our foreign currency denominated assets and liabilities. These notional amounts generally are used to calculate payments to be exchanged under the contracts (in thousands, except exchange rates).


					Fair Value Assets / (Liabilities)
Foreign Exchange Contracts	Year 1	Year 2	Year 3	Total	September 30, 2015	June 30, 2015
Receive AUD/Pay USD
Contract amount	240,000	-	-	240,000	789	(649)
Ave. contractual exchange rate	AUD 1 = USD 0.6980			AUD 1 = USD 0.6980
Receive AUD/Pay Euro
Contract amount	162,000	45,000	33,000	240,000	(6)	2,094
Ave. contractual exchange rate	AUD 1 = Euro 0.6453	AUD 1 = Euro 0.7175	AUD 1 = Euro 0.6744	AUD 1 = Euro 0. 6617
Receive SGD/Pay Euro
Contract amount	11,000	-	-	11,000	146	52
Ave. contractual exchange rate	SGD 1 = Euro 0.6201			SGD 1 = Euro 0.6201
Receive SGD/Pay USD
Contract amount	100,000	-	-	100,000	535	(276)
Ave. contractual exchange rate	SGD 1 = USD 0.6988			SGD 1 = USD 0.6988
Receive GBP/Pay AUD
Contract amount	12,000	-	-	12,000	(128)	(96)
Ave. contractual exchange rate	AUD 1 = GBP 0.4584			AUD 1 = GBP 0.4584
Receive EUR/Pay GBP
Contract amount	5,000	-	-	5,000	(24)	(26)
Ave. contractual exchange rate	EUR 1 = GBP 0.7426			EUR 1 = GBP 0.7426
Receive AUD/Pay CNY
Contract amount	3,000	-	-	3,000	(269)	(66)
Ave. contractual exchange rate	AUD 1 = CNY 4.8800			AUD 1 = CNY 4.8800
Receive USD/Pay CAD
Contract amount	9,000	-	-	9,000	621	5
Ave. contractual exchange rate	USD 1 = CAD 1.2482			USD 1 = CAD 1.2482

Interest Rate Risk

We are exposed to risk associated with changes in interest rates affecting the return on our cash and cash equivalents and debt. At September 30, 2015, we held cash and cash equivalents of $822.1 million, principally comprised of bank term deposits and at-call accounts, and they are invested at short-term fixed and variable interest rates. At September 30, 2015, we had total long-term debt, including the current portion of those obligations of $500.6 million, of which $500.0 million is subject to variable interest rates. A hypothetical 10% change in interest rates during the three months ended September 30, 2015, would not have had a material impact on pretax income. We have no interest rate hedging agreements.


PART I – FINANCIAL INFORMATION		Item 4

RESMED INC. AND SUBSIDIARIES

Controls and Procedures

We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports made pursuant to the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and in reaching a reasonable level of assurance management necessarily was required to apply its judgment in evaluating the cost benefit relationship of possible controls and procedures.

As required by Rule 13a-15(b) of the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of September 30, 2015.

There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


PART II – OTHER INFORMATION		Item 1-6

RESMED INC. AND SUBSIDIARIES

Item 1

Legal Proceedings

We are involved in various legal proceedings and claims. Litigation is inherently uncertain. Accordingly, we cannot predict the outcome of these matters. But we do not expect the outcome of these matters to have a material adverse effect on our consolidated financial statements when taken as a whole.

In 2013, we filed actions in the U.S. and Germany against Chinese manufacturer BMC Medical Co., Ltd and its U.S. distributor, 3B Medical, Inc. to stop the infringement of several ResMed patents. The U.S. International Trade Commission initiated an investigation, and in December 2014, ruled that certain of BMC’s masks infringed ResMed’s patents and should be excluded from importation or sale in the US. BMC subsequently notified the Commission that it discontinued US sales of the mask products affected by the Commission’s order. The International Trade Commission also ruled that the claims of the patent against BMC’s humidifier patent were anticipated by prior art, invalidated those claims, and declined to exclude BMC’s humidifier products from importation or sale. Each party has appealed the International Trade Commission’s ruling. A companion case in the United States District Court for the Southern District of California remains stayed pending those appeals. In 2013, we obtained preliminary injunctions prohibiting BMC from marketing and selling certain flow generators and mask assemblies accused of patent infringement in Germany. The preliminary injunction against BMC’s mask assemblies remains in effect, but in November 2014 the court dissolved the preliminary injunction against the sale of BMC’s flow generators, and the court’s action dissolving that preliminary injunction was affirmed on appeal. ResMed continues to pursue the underlying German patent infringement action against BMCs flow generators and mask assemblies.

In 2015, BMC’s U.S. distributor, 3B Medical, Inc., filed suit in the United States District Court for the Middle District of Florida against ResMed Inc. and ResMed Corp. for alleged federal and state antitrust violations. Specifically, 3B Medical alleges that in addition to enforcing its patents, ResMed has entered into exclusive dealing arrangements with customers, tied sales of masks to sales of flow generators, and spread false information that 3B would go out of business due to ResMed’s patent infringement action. 3B Medical seeks damages and an injunction. ResMed Inc. has been dismissed from the case, and ResMed Corp. has denied the allegations.

Item 1A

Risk Factors

The discussion of our business and operations should be read together with the risk factors contained in our annual report on Form 10-K for the fiscal year ended June 30, 2015, which was filed with the SEC and describes the various risks and uncertainties to which we are or may become subject. As of September 30, 2015, there have been no material changes to the risk factors set forth in our Annual Report on Form 10-K for the year ended June 30, 2015 with the exception of the following:

Laws regulating consumer contacts could adversely affect our business operations or create liabilities. Our business activities include contacts with consumers in different parts of the world. Certain laws, such as the US Telephone Consumer Protection Act, regulate telemarketing practices and certain automated outbound contacts with consumers, such as phone calls, texts or emails. Our use of outbound contacts may be restricted by existing laws, or by laws, regulations, or regulatory decisions that may be adopted in the future. If we are found to have violated these laws or regulations, we may be subjected to substantial fines, penalties, or liabilities to consumers.

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

Purchases of equity securities. The following table summarizes purchases by us of our common stock during the three months ended September 30, 2015:


Period	Total Number of Shares Purchased		Average Price Paid per Share (USD)		Total Number of Shares Purchased as Part of Publicly Announced Programs⁽¹⁾		Maximum Number of Shares that May Yet Be Purchased Under the Program⁽¹⁾
July 1 - 31, 2015		0		-		39,186,234		15,529,779
August 1 - 31, 2015		445,000		52.92		39,631,234		15,084,779
September 1 - 30, 2015		755,000		50.91		40,386,234		14,329,779
Total		1,200,000	$	51.66		40,386,234		14,329,779

(1)

On February 21, 2014, our board of directors approved our current share repurchase program, authorizing us to acquire up to an aggregate of 20.0 million shares of our common stock. The program allows us to repurchase shares of our common stock from time to time for cash in the open market, or in negotiated or block transactions, as market and business conditions warrant and subject to applicable legal requirements. There is no expiration date for this program, and the program may be accelerated, suspended, delayed or discontinued at any time at the discretion of our board of directors. All share repurchases after February 21, 2014 have been executed under this program. Since the inception of the share buyback programs, we have repurchased 40.4 million shares at a total cost of $1.5 billion.


PART II – OTHER INFORMATION		Item 1-6

RESMED INC. AND SUBSIDIARIES

Item 3

Defaults Upon Senior Securities

None

Item 4

Mine Safety Disclosures

None

Item 5

Other Information

None


PART II – OTHER INFORMATION		Item 1-6

RESMED INC. AND SUBSIDIARIES

Item 6

Exhibits

Exhibits (numbered in accordance with Item 601 of Regulation S-K)



3.1		First Restated Certificate of Incorporation of ResMed Inc., as amended. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Report on Form 10-Q for the quarter ended September 30, 2013)

3.2		Fifth Amended and Restated Bylaws of ResMed Inc. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K/A filed on September 17, 2012)

31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32		Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		The following financial statements from ResMed Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, filed on October 27, 2015, formatted in XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Cash Flows, (v) the Notes to the Condensed Consolidated Financial Statements.


PART II – OTHER INFORMATION		Signatures

Signatures

We have authorized the persons whose signatures appear below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

October 27, 2015

ResMed Inc.

/s/ MICHAEL J. FARRELL

Michael J. Farrell

Chief executive officer

(Principal Executive Officer)

/s/ BRETT A. SANDERCOCK

Brett A. Sandercock

Chief financial officer

(Principal Financial Officer)

EX-31.1 2 d87082dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

RESMED INC. AND SUBSIDIARIES

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Michael J. Farrell, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of ResMed Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

October 27, 2015

/s/ MICHAEL J. FARRELL

Michael J. Farrell

Chief executive officer

(Principal Executive Officer)

EX-31.2 3 d87082dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

RESMED INC. AND SUBSIDIARIES

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Brett A. Sandercock, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of ResMed Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

October 27, 2015

/s/ BRETT A. SANDERCOCK

Brett A. Sandercock

Chief financial officer

(Principal Financial Officer)

EX-32 4 d87082dex32.htm EX-32 EX-32

Exhibit 32

RESMED INC. AND SUBSIDIARIES

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of ResMed Inc., a Delaware corporation (the “Company”), hereby certifies, to his knowledge, that:

(i)	the accompanying Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2015 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

October 27, 2015

/s/ MICHAEL J. FARRELL

Michael J. Farrell

Chief executive officer

(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to ResMed Inc. and will be retained by ResMed Inc. and furnished to the Securities and Exchange Commission or its staff upon request. These certifications will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor will these certifications be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates them by reference.

RESMED INC. AND SUBSIDIARIES

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(i)	the accompanying Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2015 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

October 27, 2015

/s/ BRETT A. SANDERCOCK

Brett A. Sandercock

Chief financial officer

(Principal Financial Officer)

EX-101.INS 5 rmd-20150930.xml XBRL INSTANCE DOCUMENT 0000943819 2014-07-01 2015-06-30 0000943819 rmd:EmployeeStockPurchasePlanMember 2015-09-30 0000943819 us-gaap:EmployeeStockOptionMember 2015-07-01 2015-09-30 0000943819 rmd:EmployeeStockPurchasePlanPurchaseRightsMember 2015-07-01 2015-09-30 0000943819 us-gaap:EmployeeStockOptionMember 2014-07-01 2014-09-30 0000943819 rmd:EmployeeStockPurchasePlanPurchaseRightsMember 2014-07-01 2014-09-30 0000943819 us-gaap:RestrictedStockUnitsRSUMember 2014-07-01 2015-06-30 0000943819 us-gaap:RestrictedStockUnitsRSUMember 2015-09-30 0000943819 us-gaap:RestrictedStockUnitsRSUMember 2015-06-30 0000943819 us-gaap:RestrictedStockUnitsRSUMember 2015-07-01 2015-09-30 0000943819 us-gaap:VehiclesMember 2015-09-30 0000943819 us-gaap:MachineryAndEquipmentMember 2015-09-30 0000943819 us-gaap:LeaseholdImprovementsMember 2015-09-30 0000943819 us-gaap:LandMember 2015-09-30 0000943819 us-gaap:FurnitureAndFixturesMember 2015-09-30 0000943819 us-gaap:ComputerEquipmentMember 2015-09-30 0000943819 us-gaap:BuildingMember 2015-09-30 0000943819 rmd:ClinicalDemonstrationAndRentalEquipmentMember 2015-09-30 0000943819 us-gaap:VehiclesMember 2015-06-30 0000943819 us-gaap:MachineryAndEquipmentMember 2015-06-30 0000943819 us-gaap:LeaseholdImprovementsMember 2015-06-30 0000943819 us-gaap:LandMember 2015-06-30 0000943819 us-gaap:FurnitureAndFixturesMember 2015-06-30 0000943819 us-gaap:ComputerEquipmentMember 2015-06-30 0000943819 us-gaap:BuildingMember 2015-06-30 0000943819 rmd:ClinicalDemonstrationAndRentalEquipmentMember 2015-06-30 0000943819 1997-04-30 0000943819 us-gaap:GuaranteeOfIndebtednessOfOthersMember 2015-09-30 0000943819 us-gaap:GuaranteeOfIndebtednessOfOthersMember 2015-06-30 0000943819 us-gaap:LetterOfCreditMember rmd:UnionBankNAndHsbcBankUsaMember 2013-10-31 0000943819 rmd:UnionBankNAndHsbcBankUsaMember 2015-07-01 2015-09-30 0000943819 rmd:UnionBankNAndHsbcBankUsaMember us-gaap:MinimumMember 2015-07-01 2015-09-30 0000943819 rmd:UnionBankNAndHsbcBankUsaMember us-gaap:MaximumMember 2015-07-01 2015-09-30 0000943819 us-gaap:NondesignatedMember 2015-07-01 2015-09-30 0000943819 us-gaap:NondesignatedMember 2014-07-01 2014-09-30 0000943819 us-gaap:MinimumMember 2015-07-01 2015-09-30 0000943819 us-gaap:MaximumMember 2015-07-01 2015-09-30 0000943819 us-gaap:TradeNamesMember 2015-09-30 0000943819 us-gaap:PatentsMember 2015-09-30 0000943819 us-gaap:CustomerRelationshipsMember 2015-09-30 0000943819 rmd:IntangiblesAndNonCompeteAgreementsMember 2015-09-30 0000943819 rmd:DevelopedOrCoreProductTechnologyMember 2015-09-30 0000943819 us-gaap:TradeNamesMember 2015-06-30 0000943819 us-gaap:PatentsMember 2015-06-30 0000943819 us-gaap:CustomerRelationshipsMember 2015-06-30 0000943819 rmd:IntangiblesAndNonCompeteAgreementsMember 2015-06-30 0000943819 rmd:DevelopedOrCoreProductTechnologyMember 2015-06-30 0000943819 us-gaap:ForeignExchangeContractMember 2015-07-01 2015-09-30 0000943819 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember rmd:OtherIncomeExpenseNetMember 2015-07-01 2015-09-30 0000943819 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember rmd:OtherIncomeExpenseNetMember 2014-07-01 2014-09-30 0000943819 us-gaap:ForeignExchangeContractMember 2015-09-30 0000943819 us-gaap:ForeignExchangeContractMember 2015-06-30 0000943819 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2015-09-30 0000943819 rmd:AccruedExpensesMember us-gaap:ForeignExchangeContractMember 2015-09-30 0000943819 rmd:AccruedExpensesMember us-gaap:ForeignExchangeContractMember 2015-06-30 0000943819 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember 2015-09-30 0000943819 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2015-09-30 0000943819 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember 2015-06-30 0000943819 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2015-06-30 0000943819 rmd:UnionBankNAndHsbcBankUsaMember 2015-09-30 0000943819 rmd:UnionBankNAndHsbcBankUsaMember us-gaap:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-07-01 2015-09-30 0000943819 rmd:UnionBankNAndHsbcBankUsaMember us-gaap:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-07-01 2015-09-30 0000943819 rmd:EmployeeStockPurchasePlanMember us-gaap:MaximumMember 2015-09-30 0000943819 2014-09-30 0000943819 2014-06-30 0000943819 us-gaap:FairValueInputsLevel3Member 2015-09-30 0000943819 us-gaap:FairValueInputsLevel2Member 2015-09-30 0000943819 us-gaap:FairValueInputsLevel1Member 2015-09-30 0000943819 us-gaap:FairValueInputsLevel3Member 2015-06-30 0000943819 us-gaap:FairValueInputsLevel2Member 2015-06-30 0000943819 us-gaap:FairValueInputsLevel1Member 2015-06-30 0000943819 rmd:CurativeMedicalTechnologyIncMember us-gaap:SubsequentEventMember 2015-10-02 0000943819 2015-06-30 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:UnionBankNAndHsbcBankUsaMember 2013-10-31 2013-10-31 0000943819 us-gaap:GuaranteeOfIndebtednessOfOthersMember 2015-07-01 2015-09-30 0000943819 us-gaap:GuaranteeOfIndebtednessOfOthersMember 2014-07-01 2014-09-30 0000943819 rmd:EmployeeStockPurchasePlanMember 2015-07-01 2015-09-30 0000943819 us-gaap:RevolvingCreditFacilityMember rmd:UnionBankNAndHsbcBankUsaMember 2013-10-31 0000943819 2015-09-30 0000943819 rmd:OtherForeignCurrencyDenominatedTransactionsMember us-gaap:NondesignatedMember rmd:OtherIncomeExpenseNetMember 2015-07-01 2015-09-30 0000943819 rmd:OtherForeignCurrencyDenominatedTransactionsMember us-gaap:NondesignatedMember rmd:OtherIncomeExpenseNetMember 2014-07-01 2014-09-30 0000943819 rmd:EmployeeStockPurchasePlanMember us-gaap:MinimumMember 2015-07-01 2015-09-30 0000943819 rmd:EmployeeStockPurchasePlanMember us-gaap:MaximumMember 2015-07-01 2015-09-30 0000943819 2014-07-01 2014-09-30 0000943819 2015-10-20 0000943819 2015-07-01 2015-09-30 iso4217:USD xbrli:shares xbrli:pure rmd:entity iso4217:USD xbrli:shares false --06-30 Q1 2016 2015-09-30 10-Q 0000943819 139649869 Large Accelerated Filer RESMED INC rmd 2094000 2307000 905000 7318000 905000 80000 -70000 458000 P27M P3M 12148000 37081000 3000000 2405000 4500000 2 <div> <div style="margin-left:0pt;margin-right:0pt;"> Organization and Basis of Presentation <p style="margin:0pt 0pt 0pt 26.95pt;line-height:50%;text-indent:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">   <p style="margin:0pt 0pt 0pt 26.95pt;text-indent:0.05pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> ResMed Inc. (referred to herein as “we”, “us”, “our” or the “Company”) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group.  Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea.  Our manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States.  Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden. <p style="margin:0pt 0pt 0pt 26.95pt;line-height:50%;text-indent:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">   <p style="margin:0pt 0pt 0pt 26.95pt;text-indent:0.05pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods.  The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the year ending June 30, 2016. <p style="margin:0pt 0pt 0pt 26.95pt;text-indent:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">   The condensed consolidated financial statements for the three months ended September 30, 2015 and 2014 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Form 10-K for the year ended June 30, 2015. </div> </div> 0.85 0.85 2000000 16100000 2.8 300000000

81112000

77482000

362568000

327168000

16278000

26550000

1754000

132976000

117651000

382488000

376496000

-173516000

-295624000

1228795000

1248077000

12276000

13394000

154551

98697

2184260000

2254679000

1444182000

1532800000

740078000

721879000

1.00

1584000

1514000

905730000

881694000

717249000

822053000

-24036000

104804000

0.28

0.30

0.004

350000000

179660939

179925750

140474705

139539516

25000

562000

558000

-41848000

-41705000

14850000

15350000

25600000

30182000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (5)      Cost-Method Investments   The aggregate carrying amount of our cost-method investments at September 30, 2015 and June 30, 2015, was $30.2 million and $25.6 million, respectively, and is included in the non-current balance of other assets on the condensed consolidated balance sheets.    We periodically evaluate the carrying value of our cost-method investments, when events and circumstances indicate that the carrying amount of an asset may not be recovered.  We estimate the fair value of our cost-method investments to assess whether impairment losses shall be recorded using Level 3 inputs. These investments include our holdings in privately held service and research companies that are not exchange traded and therefore not supported with observable market prices. However, these investments are valued by reference to their net asset values that can be market supported and unobservable inputs including future cash flows.  During the three months ended September 30, 2015 and 2014, we did not recognize any impairment losses related to our cost-method investments.  We have determined that the fair value of our investments exceed their carrying values.   The following table shows a reconciliation of the changes in our cost-method investments during the three months ended September 30, 2015 and 2014 (in thousands):   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:52.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:52.76%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="4" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:52.76%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2014 </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.76%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balance at the beginning of the period </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>25,600  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,850  </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.76%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Investments </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,582  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>500  </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.76%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balance at the end of the period </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.52%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,182  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,350  </td> </tr> </table></div>   </div> </div>

143086000

173028000

0.020

0.010

0.012

P5Y

36097000

34848000

19284000

23446000

36338000

41494000

12528000

11990000

796000

776000

8062000

7968000

18582000

18403000

576500000

620200000

1644000

1348000

3684000

1574000

1954000

790000

2804000

1038000

1664000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (13)    Derivative Instruments and Hedging Activities   We transact business in various foreign currencies, including a number of major European currencies as well as the Australian and Singapore dollars. We have significant foreign currency exposure through both our Australian and Singaporean manufacturing activities, and international sales operations.  We have established a foreign currency hedging program using purchased currency options and forward contracts to hedge foreign-currency-denominated financial assets, liabilities and manufacturing cash flows.  The terms of such foreign currency hedging contracts generally do not exceed three years.  The goal of this hedging program is to economically manage the financial impact of foreign currency exposures denominated mainly in Euros, and Australian and Singapore dollars.  Under this program, increases or decreases in our foreign currency denominated financial assets, liabilities, and firm commitments are partially offset by gains and losses on the hedging instruments.   We do not designate these foreign currency contracts as hedges.  We have determined our hedge program to be a non-effective hedge as defined under the FASB issued authoritative guidance. All movements in the fair value of the foreign currency instruments are recorded within other income, net in our condensed consolidated statements of income.  We do not enter into financial instruments for trading or speculative purposes.   We held foreign currency instruments with notional amounts totaling $620.2 million and $576.5 million at September 30, 2015 and June 30, 2015, respectively, to hedge foreign currency fluctuations.  These contracts mature at various dates prior to September 30, 2018.    The following table summarizes the amount and location of our derivative financial instruments as of September 30, 2015 and June 30, 2015 (in thousands):   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> September 30, 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> June 30, 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balance Sheet Caption </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency hedging instruments </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,684  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,644  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Other assets - current </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency hedging instruments </td> <td valign="top" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,574  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,348  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Other assets - non current </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency hedging instruments </td> <td valign="top" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(790) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,954) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accrued expenses </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency hedging instruments </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,804) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Other long-term liabilities </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,664  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,038  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> </table></div>   The following table summarizes the amount and location of gains (losses) associated with our derivative financial instruments for the three months ended September 30, 2015 and September 30, 2014, respectively (in thousands):   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="4" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Gain /(Loss) Recognized </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Income Statement Caption </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="4" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Three Months Ended September 30, </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2014 </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency hedging instruments </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(39,353) </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(11,054) </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Other, net </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Other foreign-currency-denominated transactions </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>37,081  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,148  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Other, net </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,272) </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,094  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> </table></div>   We are exposed to credit-related losses in the event of non-performance by counter parties to financial instruments.  We minimize counterparty credit risk by entering into derivative transactions with major financial institutions and we do not expect material losses as a result of default by our counterparties. </div> </div>

-11054000

-39353000

P3Y

<div> <div style="margin-left:0pt;margin-right:0pt;"> (9)      Stock-Based Employee Compensation   We measure the compensation expense of all stock-based awards at fair value on the grant date.  We estimate the fair value of stock options and purchase rights granted under the employee stock purchase plan (the “ESPP”) using the Black-Scholes valuation model. The fair value of restricted stock units is equal to the market value of the underlying shares as determined at the grant date less the fair value of dividends that holders are not entitled to, during the vesting period.  The fair value of performance restricted stock units which contain a market condition, are estimated using a Monte-Carlo simulation model. We recognize the fair value as compensation expense using the straight-line method over the service period for awards expected to vest. We estimate the fair value of purchase rights granted under the ESPP using the following assumptions:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="4" valign="middle" style="width:35.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="middle" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:17.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2015 </td> <td colspan="2" valign="middle" style="width:17.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2014 </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Stock options: </td> <td valign="middle" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:15.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:15.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Weighted average grant date fair value </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Weighted average risk-free interest rate </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Expected option life in years </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Dividend yield </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Expected volatility </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:59.82%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> ESPP purchase rights: </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Weighted average risk-free interest rate </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 0.1% </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 0.1% </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Expected option life in years </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 6 months </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 6 months </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Dividend yield </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 1.73% </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2.00% </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Expected volatility </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 26% </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 24% </td> </tr> </table></div>   </div> </div>

0.59

0.57

0.58

0.57

<div> <div style="margin-left:0pt;margin-right:0pt;"> (2)      Earnings Per Share <p style="margin:0pt 0pt 0pt 27pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:-27pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">   Basic earnings per share is computed by dividing the net income available to common stockholders by the weighted average number of shares of common stock outstanding. For purposes of calculating diluted earnings per share, the denominator includes both the weighted average number of shares of common stock outstanding and the number of dilutive common stock equivalents such as stock options and restricted stock units. <p style="margin:0pt 0pt 0pt 27pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:-27pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">   Stock options and restricted stock units of 98,697 and 154,551, for the three months ended September 30, 2015 and 2014, respectively, were not included in the computation of diluted earnings per share as the effect would have been anti-dilutive. <p style="margin:0pt 0pt 0pt 27pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-indent:-27pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">   Basic and diluted earnings per share for the three months ended September 30, 2015 and 2014 are calculated as follows (in thousands except per share data):   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="4" valign="middle" style="width:28.28%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:14.14%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2015 </td> <td colspan="2" valign="middle" style="width:14.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2014 </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Numerator: </td> <td valign="middle" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Net Income </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>80,403  </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>83,260  </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Denominator: </td> <td valign="middle" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Basic weighted-average common shares outstanding </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,309  </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,127  </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Effect of dilutive securities: </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Stock options and restricted stock units </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,637  </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,556  </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Diluted weighted average shares </td> <td valign="middle" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>141,946  </td> <td valign="middle" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:12.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>142,683  </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Basic earnings per share </td> <td valign="middle" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:12.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.57  </td> <td valign="middle" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:12.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.59  </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:66.60%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Diluted earnings per share </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.57  </td> <td valign="middle" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:12.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>0.58  </td> </tr> </table></div>   </div> </div>

-65004000

-61463000

57100000

P2Y

2575000

2536000

2575000

2536000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (11)     Fair Value Measurements   In determining the fair value measurements of our financial assets and liabilities, we consider the principal and most advantageous market in which we transact and consider assumptions that market participants would use when pricing the financial asset or liability. We maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.   The hierarchies of inputs are as follows:   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:27pt;"></td><td valign="top" align="left" style="width: 20.00pt; display: inline;"> · </td><td style="width:52pt;"></td><td align="left" valign="top"> Level 1:Input prices quoted in an active market for identical financial assets or liabilities;</td></tr></table></div>   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:27pt;"></td><td valign="top" align="left" style="width: 20.00pt; display: inline;"> · </td><td style="width:52pt;"></td><td align="left" valign="top"> Level 2:Inputs other than prices quoted in Level 1, such as prices quoted for similar financial assets and liabilities in active markets, prices for identical assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data; and</td></tr></table></div>   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:27pt;"></td><td valign="top" align="left" style="width: 20.00pt; display: inline;"> · </td><td style="width:52pt;"></td><td align="left" valign="top"> Level 3:Input prices quoted that are significant to the fair value of the financial assets or liabilities which are not observable nor supported by an active market. </td></tr></table></div>   The following table summarizes our financial assets and liabilities, as at September 30, 2015 and June 30, 2015, using the valuation input hierarchy (in thousands):   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:52.80%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Level 1 </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Level 2 </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Level 3 </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Total </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balances at September 30, 2015 </td> <td valign="top" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency hedging instruments, net </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,664  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,664  </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Business acquisition contingent consideration </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,514) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,514) </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balances at June 30, 2015 </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency hedging instruments, net </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,038  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,038  </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Business acquisition contingent consideration </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,584) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,584) </td> </tr> </table></div>     We determine the fair value of our financial assets and liabilities as follows:   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:27pt;"></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> · </td><td style="width:0pt;"></td><td align="left" valign="top"> Foreign currency hedging instruments – These financial instruments are valued using third-party valuation models based on market observable inputs, including interest rate curves, on-market spot currency prices, volatilities and credit risk.</td></tr></table></div>   <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:27pt;"></td><td valign="top" align="left" style="width: 18.00pt; display: inline;"> · </td><td style="width:0pt;"></td><td align="left" valign="top"> Contingent consideration – These liabilities include the fair value estimates of additional future payments that may be required for some of our previous business acquisitions based on the achievement of certain performance milestones.  Each potential future payment is valued using the estimated probability of achieving each milestone, which is then discounted to present value.</td></tr></table></div>   The following is a reconciliation of changes in the fair value of contingent consideration for the three months ended September 30, 2015 and 2014 (in thousands):   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:65.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:65.04%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="4" valign="middle" style="width:29.86%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:65.04%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2015 </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2014 </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:65.04%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balance at the beginning of the period </td> <td valign="middle" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:13.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,584) </td> <td valign="middle" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:13.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(480) </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:65.04%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Acquisition date fair value of contingent consideration </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(905) </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:65.04%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Changes in fair value included in operating income </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>132  </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:65.04%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Payments </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>458  </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:65.04%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency translation adjustments </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>70  </td> <td valign="middle" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(80) </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:65.04%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balance at the end of the period </td> <td valign="middle" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:13.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,514) </td> <td valign="middle" style="width:01.86%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:13.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(875) </td> </tr> </table></div>   We did not have any significant non-financial assets or liabilities measured at fair value on September 30, 2015 or June 30, 2015. </div> </div>

132000

480000

875000

1584000

1514000

50373000

1704000

19308000

48185000

2206000

51144000

1590000

19532000

45727000

2214000

67548000

1747000

30538000

66585000

2500000

66104000

1590000

29102000

63533000

2478000

47142000

17175000

43000

11230000

18400000

294000

42600000

14960000

9570000

17806000

264000

P9Y

P2Y

1038000

1664000

1094000

-2272000

709000

289312000

277264000

264261000

262818000

6454000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (6)     Goodwill and Other Intangible Assets, net <p style="margin:0pt -0.3pt 0pt 28.35pt;text-indent:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 6pt">   <p style="margin:0pt -0.3pt 0pt 28.35pt;text-indent:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> Goodwill <p style="margin:6pt -0.3pt 0pt 28.35pt;text-indent:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> Changes in the carrying amount of goodwill for the three months ended September 30, 2015, and 2014 were as follows (in thousands):   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="4" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2014 </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balance at the beginning of the period </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>264,261  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>289,312  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Business acquisition </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,454  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency translation adjustments </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,443) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(18,502) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balance at the end of the period </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>262,818  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>277,264  </td> </tr> </table></div>   Other Intangible Assets Other intangible assets were comprised of the following as of September 30, 2015, and June 30, 2015 (in thousands):   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> September 30, 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> June 30, 2015 </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Developed/core product technology </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>66,104  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>67,548  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(51,144) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(50,373) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Developed/core product technology, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,960  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17,175  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Trade names </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,478  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,500  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,214) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,206) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Trade names, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>264  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>294  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Non-compete agreements </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,590  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,747  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,590) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,704) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Non compete agreements, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>43  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Customer relationships </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,102  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,538  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(19,532) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(19,308) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Customer relationships, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,570  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,230  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Patents </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>63,533  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>66,585  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(45,727) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(48,185) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Patents, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17,806  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,400  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Total other intangibles, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>42,600  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>47,142  </td> </tr> </table></div>   Intangible assets consist of patents, customer relationships, trade names, non-compete agreements and developed/core product technology.  We amortize intangible assets over the estimated useful life of the assets, generally between two and nine years. There are no expected residual values related to these intangible assets. </div> </div>

-18502000

-1443000

237313000

238619000

101930000

99444000

14373000

18118000

18670000

19041000

8872000

3641000

-20804000

-30498000

37897000

17194000

15168000

3526000

311403000

305418000

1233000

1247000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (3)      Inventories   Inventories were comprised of the following at September 30, 2015 and June 30, 2015 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:52.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.16%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> September 30, 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> June 30, 2015 </td> </tr> <tr> <td valign="middle" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.16%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Raw materials </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>75,490  </td> <td valign="middle" style="width:01.64%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>74,416  </td> </tr> <tr> <td valign="middle" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.16%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Work in progress </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,215  </td> <td valign="middle" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,550  </td> </tr> <tr> <td valign="middle" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.16%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Finished goods </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>180,904  </td> <td valign="middle" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>169,893  </td> </tr> <tr> <td valign="middle" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.16%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Total inventories </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>258,609  </td> <td valign="middle" style="width:01.64%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.80%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>246,859  </td> </tr> </table></div>   </div> </div>

169893000

180904000

246859000

258609000

74416000

75490000

2550000

2215000

5584000

3422000

596953000

793866000

2184260000

2254679000

267259000

257307000

329694000

536559000

500000000

0.0025

0.0015

2018-10-31

25000000

700000000

300594000

500587000

300594000

500587000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (7)      Long-Term Debt Long-term debt at September 30, 2015 and June 30, 2015 consisted of the following (in thousands):   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> September 30, 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> June 30, 2015 </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Current long-term debt </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Non-current long-term debt </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>500,587  </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>300,594  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Total long-term debt </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>500,587  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>300,594  </td> </tr> </table></div>   Credit Facility   On October 31, 2013, we entered into a credit agreement, as borrower, with lenders, including Union Bank, N.A., as administrative agent, joint lead arranger, swing line lender and letters of credit issuer, and HSBC Bank USA, National Association, as syndication agent and joint lead arranger. Our obligations under the credit agreement are guaranteed by ResMed Corp. and ResMed Motor Technologies Inc., two of our U.S. subsidiaries.   The credit agreement provides a $700 million senior unsecured five-year revolving credit facility, with an uncommitted option to increase the credit facility by an additional $300 million. The credit facility also includes a $25 million sublimit for letters of credit. The credit facility terminates on October 31, 2018, when all unpaid principal and interest under the loans must be repaid. The outstanding principal amount due under the credit facility will bear interest at a rate equal to LIBOR plus 1.0% to 2.0% (depending on the then-applicable leverage ratio). At September 30, 2015, the interest rate that was being charged on the outstanding principal amount was 1.2%.  An applicable commitment fee of 0.15% to 0.25% (depending on the then-applicable leverage ratio) applies on the unused portion of the credit facility.   When we entered into the credit agreement, we used a portion of the proceeds from the initial funding of the credit facility to repay the outstanding balance under our previous revolving credit facility with Union Bank, N.A and other lenders. On that repayment, the previous credit agreement, dated as of February 10, 2011, between us and lenders (including Union Bank, N.A., as administrative agent, swing line lender and letter of credit issuer, HSBC Bank USA, National Association, as syndication agent and Union Bank, N.A., HSBC Bank USA, National Association, Commonwealth Bank of Australia and Wells Fargo Bank), was terminated and the commitments under the previous credit agreement were also terminated.   Our obligations under the current credit agreement are unsecured but are guaranteed by two of our U.S. subsidiaries. The credit agreement contains customary covenants, including certain financial covenants and an obligation that we maintain certain financial ratios, including a maximum leverage ratio of funded debt to EBITDA (as defined in the credit agreement) and an interest coverage ratio. The entire principal amount of the credit facility and any accrued but unpaid interest may be declared immediately due and payable if an event of default occurs, as defined in the credit agreement. Events of default under the credit agreement include failure to make payments when due, the occurrence of a default in the performance of any covenants in the credit agreement or related documents, or certain changes of control of ResMed Inc., ResMed Corp., ResMed Motor Technologies Inc., ResMed Limited, ResMed Holdings Ltd/LLC or ResMed EAP Holdings LLC.   At September 30, 2015, there was $500.0 million outstanding under the credit agreement.   </div> </div>

500000

7200000

9100000

-3965000

106944000

-41603000

-62749000

86536000

122072000

83260000

80403000

<div> <div style="margin-left:0pt;margin-right:0pt;"> New Accounting Pronouncements <p style="margin:0pt 0pt 0pt 26.95pt;line-height:50%;text-indent:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">   <p style="margin:0pt 0pt 0pt 26.95pt;text-indent:0.05pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> In May, 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers”, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company beginning in the first quarter of fiscal year 2019. Early application is not permitted. We are currently assessing the impact of the adoption of ASU 2014-09 on our financial condition, results of operations and cash flows. <p style="margin:0pt 0pt 0pt 26.95pt;text-indent:0.05pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">   <p style="margin:0pt 0pt 0pt 26.95pt;text-indent:0.05pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"> In April, 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs". ASU 2015-03 will more closely align the presentation of debt issuance costs under U.S. GAAP with the presentation under comparable International Financial Reporting Standards (IFRS) by requiring that debt issuance costs be presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. The new standard is effective for us beginning in the first quarter of fiscal 2017. We do not expect this updated standard to have a material impact on our consolidated financial statements and related disclosures.         <p style="margin:0pt 0pt 0pt 26.95pt;text-indent:0.05pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">   In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory” which requires an entity to measure inventory within the scope of this ASU at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The amendments in this guidance more closely align the measurement of inventory in GAAP with the measurement of inventory in IFRS.  The new standard is effective for us beginning in the first quarter of fiscal 2018.  We do not expect this updated standard to have a material impact on our consolidated financial statements and related disclosures. </div> </div>

7342000

3168000

7255000

1419000

142638000

140594000

94675000

98025000

28389000

35487000

-125108000

-122108000

2804000

1671000

-2003000

11206000

39341000

46803000

57857000

39199000

42079000

458000

7318000

2366000

2423000

500000

4582000

20681000

16403000

0.01

2000000

81168000

83476000

468000

4930000

4352000

75000000

200000000

11798000

12893000

9823000

8883000

-714000

-691000

1567000

2039000

3376000

1790000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (4)      Property, Plant and Equipment   Property, plant and equipment were comprised of the following as of September 30, 2015 and June 30, 2015 (in thousands):    <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> September 30, 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> June 30, 2015 </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Machinery and equipment </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>188,059  </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>198,047  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Computer equipment </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>126,928  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>125,423  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Furniture and fixtures </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>37,396  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>38,511  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Vehicles </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,680  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,371  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Clinical, demonstration and rental equipment </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>81,174  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>80,911  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Leasehold improvements </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,915  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,553  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Land </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>51,905  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>54,915  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Buildings </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>223,423  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>235,515  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>745,480  </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>770,246  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated depreciation and amortization </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(376,496) </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(382,488) </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Property, plant and equipment, net </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>368,984  </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>387,758  </td> </tr> </table></div>   </div> </div>

770246000

80911000

235515000

125423000

38511000

54915000

31553000

198047000

5371000

745480000

81174000

223423000

126928000

37396000

51905000

30915000

188059000

5680000

387758000

368984000

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> September 30, 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> June 30, 2015 </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Machinery and equipment </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>188,059  </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>198,047  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Computer equipment </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>126,928  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>125,423  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Furniture and fixtures </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>37,396  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>38,511  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Vehicles </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,680  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,371  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Clinical, demonstration and rental equipment </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>81,174  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>80,911  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Leasehold improvements </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,915  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,553  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Land </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>51,905  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>54,915  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Buildings </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>223,423  </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>235,515  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>745,480  </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>770,246  </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated depreciation and amortization </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(376,496) </td> <td valign="middle" style="width:01.56%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(382,488) </td> </tr> <tr> <td valign="middle" style="width:05.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:53.44%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Property, plant and equipment, net </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>368,984  </td> <td valign="middle" style="width:01.56%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>387,758  </td> </tr> </table></div>   </div> </div>

10000

8000

30024000

27192000

1976020000

2014344000

380399000

411647000

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:52.80%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Level 1 </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Level 2 </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Level 3 </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Total </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balances at September 30, 2015 </td> <td valign="top" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency hedging instruments, net </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,664  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,664  </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Business acquisition contingent consideration </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,514) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,514) </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Balances at June 30, 2015 </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.98%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Foreign currency hedging instruments, net </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,038  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,038  </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.80%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Business acquisition contingent consideration </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,584) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:08.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,584) </td> </tr> </table></div>   </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> September 30, 2015 </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> June 30, 2015 </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Developed/core product technology </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>66,104  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>67,548  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(51,144) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(50,373) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Developed/core product technology, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,960  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17,175  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Trade names </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,478  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,500  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,214) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(2,206) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Trade names, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>264  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>294  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Non-compete agreements </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,590  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,747  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,590) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,704) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Non compete agreements, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>43  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Customer relationships </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29,102  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30,538  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(19,532) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(19,308) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Customer relationships, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,570  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,230  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Patents </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>63,533  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>66,585  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Accumulated amortization </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(45,727) </td> <td valign="middle" style="width:01.52%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(48,185) </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Patents, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>17,806  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,400  </td> </tr> <tr> <td valign="bottom" style="width:05.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:52.24%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Total other intangibles, net </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>42,600  </td> <td valign="middle" style="width:01.52%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.82%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>47,142  </td> </tr> </table></div>   </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="4" valign="middle" style="width:35.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Three Months Ended September 30, </td> </tr> <tr> <td valign="middle" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:17.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2015 </td> <td colspan="2" valign="middle" style="width:17.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2014 </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Stock options: </td> <td valign="middle" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:15.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:15.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Weighted average grant date fair value </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Weighted average risk-free interest rate </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Expected option life in years </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Dividend yield </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Expected volatility </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:59.82%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> ESPP purchase rights: </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Weighted average risk-free interest rate </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 0.1% </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 0.1% </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Expected option life in years </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 6 months </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 6 months </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Dividend yield </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 1.73% </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2.00% </td> </tr> <tr> <td valign="bottom" style="width:05.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:59.82%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Expected volatility </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 26% </td> <td valign="middle" style="width:02.08%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:15.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 24% </td> </tr> </table></div>   </div> </div>

110520000

111095000

11367000

12383000

P4Y

P1Y

5839

44.90

7477

51.49

2312529

2288922

43.65

43.81

P1Y2M12D

P10M24D

25245

31.30

P7Y

0.0200

0.0173

P6M

P0M

P6M

P0M

0.24

0.26

0.001

43700000

13800000

1500000

46300000

27.67

9700000

8900000

12546

168500000

2809238

2546004

29.63

30.65

P2Y6M

18.34

44.32

1987218

1587307000

1460813000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (10)    Stockholders’ Equity   Common Stock.    During the three months ended September 30, 2015 and 2014 we repurchased 1.2 million and 0.8 million shares at a cost of $62.0 million and $42.9 million, respectively. Since the inception of our share repurchase programs and through September 30, 2015, we have repurchased a total of 40.4 million shares at a cost of $1.5 billion.  Shares that are repurchased are classified as treasury stock pending future use and reduce the number of shares outstanding used in calculating earnings per share.  At September 30, 2015, 14.3 million additional shares can be repurchased under the approved share repurchase program.   Preferred Stock.    In April 1997, the board of directors designated 2,000,000 shares of our $0.01 par value preferred stock as Series A Junior Participating Preferred Stock. No shares were issued or outstanding at September 30, 2015 and June 30, 2015.   Stock Options and Restricted Stock Units.    We have granted stock options and restricted stock units to personnel, including officers and directors, in accordance with the ResMed Inc. 2009 Incentive Award Plan (the “2009 Plan”).  These options and restricted stock units have expiration dates of seven years from the date of grant and vest over one to four years. We have granted the options with an exercise price equal to the market value as determined at the date of grant.   The maximum number of shares of our common stock authorized for issuance under the 2009 Plan is 43.7 million shares. The number of securities remaining available for future issuance under the 2009 Plan at September 30, 2015 is 13.8 million.  The number of shares of our common stock available for issuance under the 2009 Plan will be reduced by (i) 2.8 shares for each one share of common stock delivered in settlement of any “full-value award,” which is any award other than a stock option, stock appreciation right or other award for which the holder pays the intrinsic value and (ii) one share for each share of common stock delivered in settlement of all other awards.  The maximum number of shares, that may be subject to awards granted under the 2009 Plan to any individual during any calendar year, may not exceed 3 million shares of our common stock (except in a participant’s initial year of hiring, when up to 4.5 million shares of our common stock may be granted).   At September 30, 2015, there were $57.1 million in unrecognized compensation costs related to unvested stock-based compensation arrangements. This is expected to be recognized over a weighted average period of 2.0 years.  The aggregate intrinsic value of the stock-based compensation arrangements outstanding and exercisable at September 30, 2015 was $168.5 million and $46.3 million, respectively.  The aggregate intrinsic value of the options exercised during the three months ended September 30, 2015 and 2014, was $8.9 million and $9.7 million, respectively.  The following table summarizes option activity during the three months ended September 30, 2015:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="middle" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;"> Weighted Average Exercise Price </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;"> Weighted Average Remaining Contractual Term in Years </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Outstanding at beginning of period </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,809,238  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>29.63  </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2.5 </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Granted </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Exercised </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(250,688) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18.34  </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Forfeited </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(12,546) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44.32  </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Outstanding at end of period </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,546,004  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>30.65  </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 2.5 </td> </tr> <tr> <td valign="top" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Exercise price of granted options </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">  - </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="top" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Options exercisable at end of period </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,987,218  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>27.67  </td> <td valign="top" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> </table></div>   The following table summarizes the activity of restricted stock units during the three months ended September 30, 2015:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;">   </td> <td valign="top" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;">   </td> <td colspan="2" valign="middle" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;"> Weighted Average Grant-Date Fair Value </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:22.50pt;padding:0pt;"> Weighted Average Remaining Contractual Term in Years </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Outstanding at beginning of period </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,312,529  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>43.65  </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 1.2 </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Granted </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,477  </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>51.49  </td> <td valign="top" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Vested </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(25,245) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31.30  </td> <td valign="top" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Forfeited </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(5,839) </td> <td valign="middle" style="width:01.54%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44.90  </td> <td valign="top" style="width:19.94%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:05.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:31.96%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> Outstanding at end of period </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;">   </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,288,922  </td> <td valign="middle" style="width:01.54%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:11.25pt;padding:0pt;"> $ </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;font-family:Times New Roman;font-size:8pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>43.81  </td> <td valign="middle" style="width:19.94%;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;background-color: #auto;height:11.25pt;padding:0pt;"> 0.9 </td> </tr> </table></div>   Employee Stock Purchase Plan (the “ESPP”).  Under the ESPP, we offer participants the right to purchase shares of our common stock at a discount during successive offering periods. Each offering period under the ESPP will be for a period of time determined by the board of directors’ compensation committee of no less than 3 months and no more than 27 months. The purchase price for our common stock under the ESPP will be the lower of 85% of the fair market value of our common stock on the date of grant or 85% of the fair market value of our common stock on the date of purchase. An individual participant cannot subscribe for more than $25,000 in common stock during any calendar year.  At September 30, 2015, the number of shares remaining available for future issuance under the ESPP is 1.5 million shares.   </div> </div>

250688

14300000

<div> <div style="margin-left:0pt;margin-right:0pt;"> (14)    Subsequent Events   On October 2, 2015 we completed the acquisition of 100% of the shares in Curative Medical Technology Inc., a leading provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories in China. This acquisition will be accounted for as a business combination using purchase accounting and will be included in our condensed consolidated financial statements from the acquisition date.  The acquisition is not considered a material business combination and was funded through cash on-hand. We have not incurred any material acquisition-related costs.  The preliminary purchase price allocation will be completed during the quarter ending December 31, 2015.  </div> </div>

39186234

40386234

800000

1200000

1444554000

1506542000

42900000

62000000

2556000

1637000

142683000

141946000

140127000

140309000

EX-101.SCH 6 rmd-20150930.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statements Of Income link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statements Of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Inventories (Schedule Of Inventories) (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Property, Plant And Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - Goodwill And Other Intangible Assets, Net (Schedule Of Other Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Long-Term Debt (Schedule Of Long-Term Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 41303 - Disclosure - Derivative Instruments And Hedging Activities (Summary Of Gains (Losses) Associated With Derivative Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Summary Of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Property, Plant And Equipment link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Cost-Method Investments link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Goodwill And Other Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Product Warranties link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Stock-Based Employee Compensation link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Legal Actions And Contingencies link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Derivative Instruments And Hedging Activities link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - Summary Of Significant Accounting Policies (Policy) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Property, Plant And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Cost-Method Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Goodwill And Other Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Product Warranties (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Stock-Based Employee Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 31303 - Disclosure - Derivative Instruments And Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Earnings Per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Cost-Method Investments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Cost-Method Investments (Schedule Of Reconciliation Of Changes In Cost-Method Investments) (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Goodwill And Other Intangible Assets, Net (Schedule Of Changes In Carrying Amount Of Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Long-Term Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Product Warranties (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Stock-Based Employee Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Stock-Based Employee Compensation (Schedule Of Assumptions For Fair Value Of Stock Option Plans And Purchase Rights Granted) (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Stockholders' Equity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Stockholders' Equity (Schedule Of Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41003 - Disclosure - Stockholders' Equity (Schedule Of Activity Of Restricted Stock Units) (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Fair Value Measurements (Summary Of Financial Assets And Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Legal Actions And Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Derivative Instruments And Hedging Activities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41302 - Disclosure - Derivative Instruments And Hedging Activities (Summary Of Amount And Location Of Derivative Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 rmd-20150930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 rmd-20150930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 rmd-20150930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information [Abstract] Document And Entity Information [Abstract] Statement [Table] Statement [Line Items] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Trading Symbol Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Consolidated Balance Sheets [Abstract] Assets [Abstract] Assets Current assets: Cash and cash Equivalents Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Accounts receivable, net of allowance for doubtful accounts of $12,276 and $10,971 at June 30, 2015 and June 30, 2014, respectively Accounts receivable, net of allowance for doubtful accounts of $13,394 and $12,276 at September 30, 2015 and June 30, 2015, respectively Inventories, net (note 5) Total inventories Inventories (note 3) Current deferred tax asset Deferred income taxes Other current assets Prepaid expenses and other current assets Assets, Current Total current assets Non-current assets: Property, plant and equipment, net (note 6) Property, plant and equipment, net Property, plant and equipment, net (note 4) Goodwill And Other intangible Assets Goodwill and other intangible assets, net (note 6) Deferred income taxes Deferred income taxes Other assets Other assets Assets, Noncurrent Total non-current assets Assets, Total Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Current liabilities: Accounts payable Accrued Liabilities Current Accrued expenses Deferred revenue, current Deferred revenue Accrued Income Taxes, Current Income taxes payable Current deferred tax liability Deferred income taxes Liabilities, Current Total current liabilities Non-current liabilities: Non-current deferred tax liability Deferred income taxes Deferred revenue, noncurrent Deferred revenue Long-term Debt, Excluding Current Maturities Long-term debt (note 7) Non-current long-term debt Other Liabilities, Noncurrent Other long-term liabilities Income taxes payable, noncurrent Income taxes payable Liabilities, Noncurrent Total non-current liabilities Liabilities, Total Total liabilities Commitments and Contingencies Commitments and contingencies (note 12) Stockholders' equity Abstract Stockholders' equity: (note 10) Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued Common stock, $0.004 par value, 350,000,000 shares authorized; 179,660,939 issued and 140,474,705 outstanding at June 30, 2015 and 176,747,039 issued and 140,304,544 outstanding at June 30, 2014 Common stock, $0.004 par value, 350,000,000 shares authorized; 179,925,750 issued and 139,539,516 outstanding at September 30, 2015 and 179,660,939 issued and 140,474,705 outstanding at June 30, 2015 Additional Paid In Capital Common Stock Additional paid-in capital Retained earnings Treasury stock, at cost, 39,186,234 shares at June 30, 2015, and 36,442,495 shares at June 30, 2014 Treasury stock, at cost, 40,386,234 shares at September 30, 2015, and 39,186,234 shares at June 30, 2015 Cost of shares repurchased pursuant to the repurchase program Accumulated other comprehensive income Accumulated other comprehensive (loss) income Stockholders' Equity Total stockholders' equity Liabilities and Stockholders' Equity Total liabilities and stockholders' equity Accounts receivable, allowance for doubtful accounts Preferred stock, par value Preferred stock at par value Preferred stock, shares authorized Preferred stock, shares issued Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Treasury stock, shares held Number of shares repurchased pursuant to the repurchase program Consolidated Statements Of Income [Abstract] Sales Revenue Net Net revenue Cost of sales Cost of sales (excluding amortization of acquired intangible assets) Gross Profit Gross profit Operating expenses: Selling, general and administrative Research and development The aggregate expense charged against earnings to allocate the cost of acquired intangible assets. Amortization of acquired intangible assets 1 Amortization of acquired intangible assets Operating Expenses Total operating expenses Operating Income (Loss) Income from operations Other income, net: Interest income Interest income, net Other Nonoperating Income (Expense) Other, net Nonoperating Income (Expense) Total other income, net Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Cumulative Effects of Changes in Accounting Principles, Noncontrolling Interest Income before income taxes Income Tax Expense Benefit Income taxes Net income Net income Net income Basic earnings per share Basic earnings per share Diluted earnings per share (note 2-k) Diluted earnings per share Diluted earnings per share (note 2) Common Stock, Dividends, Per Share, Declared Dividend declared per share Weighted average shares used to calculate basic earnings per share Basic shares outstanding (000's) Basic weighted-average common shares outstanding Diluted shares outstanding (000's) Diluted shares outstanding (000's) Diluted weighted average shares Consolidated Statements Of Comprehensive Income [Abstract] Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive income: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation (loss) gain adjustments Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive (loss) income Consolidated Statements Of Cash Flows [Abstract] Cash flows from operating activities: Adjustment to reconcile net income to net cash provided by operating activities: Depreciation and amortization Gain (Loss) on Disposition of Business Gain on divestment of business Stock-based compensation costs Tax benefit from stock option exercises Excess tax benefit from stock-based compensation arrangements Changes in operating assets and liabilities, net of effect of acquisitions: Increase (Decrease) in Accounts Receivables Accounts receivable, net Inventories, net Inventories, net Prepaid expenses, net deferred income taxes and other current assets Prepaid expenses, net deferred income taxes and other current assets Accounts payable, accrued expenses and other liabilities Net cash provided by operating activities Net cash provided by operating activities Cash flows from investing activities: Purchases of property plant and equipment Purchases of property, plant and equipment Patent registration costs Patent registration costs Business acquisitions, net of cash acquired Business acquisitions, net of cash acquired Purchase of cost-method investments Investments in cost-method investments Investments Proceeds from Divestiture of Businesses Proceeds from divestiture of business Proceeds from exercise of foreign currency options Payments on maturity of foreign currency contracts Net cash used in investing activities Net cash provided by (used in) investing activities Cash flows from financing activities: Proceeds from issuance of common stock, net ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess tax benefit from stock-based compensation arrangements Purchases of treasury stock Purchases of treasury stock Payment of business combination earn-out Payment of business combination contingent consideration Proceeds from Issuance of Long-term Debt Proceeds from borrowings, net of borrowing costs Repayment of borrowings Repayment of borrowings Payments of Dividends Dividends paid Net cash -used in/provided by financing activities Net cash provided by (used in) financing activities Effect of exchange rate changes on cash Net increase in cash and cash equivalents Net (decrease) increase in cash and cash equivalents Supplemental disclosure of cash flow information: Income Taxes Paid, Net Income taxes paid, net of refunds Interest paid Interest paid Noncash or Part Noncash Acquisition, Value of Assets Acquired Fair value of assets acquired, excluding cash Business Acquisition, Purchase Price Allocation, Liabilities Assumed Liabilities assumed Goodwill on acquisition Business acquisition Noncash or Part Noncash Acquisition, Deferred Payments Noncash or Part Noncash Acquisition, Deferred Payments Deferred payments Business Acquisition, Contingent Consideration, Recognized Liability Business Acquisition, Contingent Consideration, Recognized Liability Fair value of contingent consideration Business Acquisition, Cost Of Acquired Entity, Purchase Price Excluding Cash Business Acquisition, Cost Of Acquired Entity, Purchase Price Excluding Cash Total purchase price, excluding contingent consideration Summary Of Significant Accounting Policies [Abstract] Business Description and Accounting Policies [Text Block] Summary Of Significant Accounting Policies Earnings Per Share [Abstract] Earnings Per Share [Text Block] Earnings Per Share Inventories [Abstract] Inventories [Text Block] Inventories Property, Plant And Equipment, Net [Abstract] Property, Plant and Equipment Disclosure [Text Block] Property, Plant And Equipment Cost-Method Investments [Abstract] Cost-method Investments, Description [Text Block] Cost-Method Investments Goodwill And Other Intangible Assets, Net [Abstract] Goodwill [Text Block] Goodwill And Other Intangible Assets, Net Long-Term Debt [Abstract] Long-Term Debt [Text block] Long-Term Debt Product Warranties [Abstract] Product Warranty Disclosure [Text Block] Product Warranties Stock-Based Employee Compensation [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Employee Compensation Stockholders' Equity [Abstract] Stockholders Equity Note Disclosure Text Block Stockholders' Equity Fair Value Measurements [Abstract] Fair Value Measurements [Text Block] Fair Value Measurements Legal Actions And Contingencies [Abstract] Legal Actions and Contingencies [Text block] Legal Actions And Contingencies Derivative Instruments And Hedging Activities [Abstract] Derivative Instruments and Hedging Activities [Text Block] Derivative Instruments And Hedging Activities Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Organization And Basis Of Presentation [Policy Text Bock] Organization And Basis Of Presentation [Policy Text Bock] Organization And Basis Of Presentation New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Pronouncements Schedule of Calculation of Numerator and Denominator in Earnings Per Share [Table Text Block] Schedule Of Basic And Diluted Earnings Per Share Schedule of Inventory, Current [Table Text Block] Schedule Of Inventories Property, Plant and Equipment [text bock] Components Of Property, Plant And Equipment Schedule of Cost Method Investments [Table Text Block] Schedule Of Reconciliation Of Changes In Cost-Method Investments Schedule of Goodwill [Table Text Block] Schedule Of Changes In Carrying Amount Of Goodwill Other Intangible Assets [Text Block] Schedule Of Other Intangible Assets Schedule of Long-term Debt Instruments [Table Text Block] Schedule Of Long-Term Debt Schedule of Product Warranty Liability [Table Text Block] Schedule Of Changes In Liability For Warranty Costs Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule Of Assumptions For Fair Value Of Stock Option Plans And Purchase Rights Granted Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule Of Option Activity Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Schedule Of Activity Of Restricted Stock Units Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary Of Financial Assets And Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Summary Of Amount And Location Of Derivative Financial Instruments Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block] Summary Of Gains (Losses) Associated With Derivative Financial Instruments Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Stock options not included in the computation of diluted earnings per share Weighted Average Number Diluted Shares Outstanding Adjustment Stock options and restricted stock units Inventory, Raw Materials, Net of Reserves Raw materials Inventory, Work in Process, Net of Reserves Work in progress Inventory, Finished Goods, Net of Reserves Finished goods Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment by Type [Axis] Property Plant And Equipment Type [Domain] Property, Plant and Equipment, Type [Domain] Machinery And Equipment [Member] Machinery And Equipment [Member] Computer Equipment [Member] Computer Equipment [Member] Furniture And Fixtures [Member] Furniture And Fixtures [Member] Vehicles [Member] Vehicles [Member] Clinical, Demonstration and Rental Equipment [Member] Clinical Demonstration And Rental Equipment [Member] Clinical, Demonstration And Rental Equipment [Member] Leasehold Improvements [Member] Leasehold Improvements [Member] Land [Member] Land [Member] EX-101.PRE 10 rmd-20150930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R39.htm IDEA: XBRL DOCUMENT

Goodwill And Other Intangible Assets, Net (Schedule Of Changes In Carrying Amount Of Goodwill) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Goodwill And Other Intangible Assets, Net [Abstract]
Balance at the beginning of the period	$ 264,261	$ 289,312
Business acquisition		6,454
Foreign currency translation adjustments	(1,443)	(18,502)
Balance at the end of the period	$ 262,818	$ 277,264

XML 12 R54.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details)	Oct. 02, 2015
Subsequent Event [Member] \| Curative Medical Technology Inc [Member]
Subsequent Event [Line Items]
Percentage of outstanding shares acquired	100.00%

XML 13 R48.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Summary Of Financial Assets And Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency hedging instruments, net	$ 1,664	$ 1,038
Business acquisition contingent consideration	$ (1,514)	$ (1,584)
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency hedging instruments, net
Business acquisition contingent consideration
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency hedging instruments, net	$ 1,664	$ 1,038
Business acquisition contingent consideration
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency hedging instruments, net
Business acquisition contingent consideration	$ (1,514)	$ (1,584)

EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`%N*6T=XY$XD]0$``#\A```3````6T-O;G1E;G1?5'EP97-= M+GAM;,W:S4[C,!`'\%>IG[_Y"G.=G88X[+J4_+?&(MM3U;'VGD:SRWV@Y%Y6VOO!M#H9-[+M MV!UDG;O5RK34N?;!YBUURJ7I4XY7LSL=THVV.07;#6P*[#]Y7>+L8PI&'TAW ML2=*=JAC>AHH'JN_C[Q4OJ*5?AC2NPH_W[LZT#"MB;WQSZ6N=SE+S+\MJQR- M;ZIPN/%OG1E;AN;']6\[ROD_7LO!3=S:X2KH1W-08'NR,95C;;49CXWJT87- M#^5):%^A-!8Z??_3T*=@9-/AA$B\JP\!TH<$Z4.!]-&`]'$&TL=G MD#Z^@/3Q%:0/OD!I!$54CD(J1S&5HZ#*453E**QR%%QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M M*;V"^GH`A3&^.R6:E((C-Z."N[_8_`)02P,$%`````@`6XI;1ZKL&"/T`0`` M_R```!H```!X;"]??3,L1DS;''6!=#9!(=+G=Y-'EN&A MR_7J1SHVY=!WN3T,>?'G=.SR:OI^7;6E#*L0\J9-IR;?]$/JIJ>[?CPU9;H= M]V%H-J_-/@6MZV48+^=4CP\?9R^>M^MJ?-Y*M?C9C/M4UM7O?GS-;4HEA_.' MW$P+3(_?AO2=Y?O=[K!)3_WFUREUY8N*\&^!*LP'Z7R04H)L/L@H03X?Y)2@ M.!\4*4'+^:`E)>AV/NB6$G0W'W1'";J?#[JG!$D-9*PY20AKCM8"N!:.UP+` M%H[8`L@6CMD"T!:.V@+8%H[;`N`6CMP"Z!:.W0+P%H[>"O16CMX*]%;27AMM MMCEZ*]!;.7HKT%LY>BO06SEZ*]!;.7HKT%LY>BO06SEZ*]!;.7H;T-LX>AO0 MVSAZ&]#;2&CO0VSEZ.]#;.7H[ MT-LY>D>@=^3H'8'>D:-W!'I'CMX1Z!TY>D>@=R3]5GFA=VZ;,6U?RGCH]OG: M-?\-AT47>.?R=DS73SE/A0T76I=II13.UZN_6^>I?T/"I_\Z/+X#4$L#!!0` M```(`%N*6TFV2G2@P=IGXUR(5<=.;8>5_?I=)R4+-`FD#^,% MY_JMT-KXTO,,"R&BYA0A$G<72D?4 MXJ->>FJQX`R&BB412.MU.YT+#UXMR`""=IP[;?D#=\IU'`O.J.5*^@^<:674 MPI*[5P9BX.T"4@9ZG@)+-+=KOY-ABJ84,V54P"V>Y2^H,)"A_AE3S*V*8BK7 M7O8TXO+9_(IG:D@M%%G;&YGWD&H(\-`M[[DQQ7Q?8Y["<6]#*I<0%+'O-S>U M>`1M7*9GW=,.?O(2;.R9;Z`!E\L)Y=KX@Y6]7`&S2K^U:64_VJ5`,==T\SC# M^$R+S*D!M[QJK:CF5-H6,?P//G9;V;&9-5V+V%CM/RG];$(`:P9>;DR716QQ MS7M^OYR;>7M+#-N!9CQ8D*U_4^E2'/:%*+?:Q6RW[@@US(@ M=]*B',F]S(["YA5+DJ]NE31*\`#%%9`;*JAD0*;O2G@(GAQ-Z'[.U.*7B]*0 M\0+#8ZHIQPU.8PXU82EGFD01U6N'F?*EY-@*ZBK(F$JP@J6<.ZHEZL"0"6B2 MSETI[%ZN\'BE\;(IW7^[X-8G9"+HIFLO"8]=U!4)&MM^`!NJ@#COQJ8)EF*_ M*17\YD*D;LJC*96;=VS`]5&CF84FVB.]\FN'EBK/W+41(&;@YHKL7MQ@!+WYK$C MR7I\K3:[7P[69OTI%2*MK52M\,Z[!\OCAZN$(C8]#K-1B#/*4&G#REYIS>YV8#EUVZS3@_@2G)FK]1^N4BJ!WL?OF] M7\\IOPSJ.>>'O;G*=?/NU_#.;U]O^S^;_Q=02P,$%`````@`6XI;1[@LVA0_ M`0``:0,``!$```!D;V-0N-6U_\^_XZ00E@GCX,D9"PX5 M^*M#76G/A%TD6T3+"/%B"S7WDU"A0W)M7,TQA&Y#+!<[O@&29]DUJ0&YY,C) M$9C:GIB4A11,..!H7(>7HL?;O:LB3`H"%=2@T1,ZH20I7_1.FT879-"717!< M<8]+(]5:@;QMA[+?J=`9P=7^)`?9MX]___00,R3I*@]>]55-TTR:::P+`U/R MMGQ\CF>3*NV1:P%!Y17#UL(B.7=^G=[=KQZ2,L_H+*59FL]7=,[H#9OE[\?) M+OP-ANMNB'_K^&PP;A<55C!RMU$CXW+C9P1)\,(IB\KH4;B(^2:.,+__^`2! MXT&=,%ZV';2-<=*7\7X-T?'EA)5MC&M/J1_1Q:LJOP!02P,$%`````@`6XI; M1YE&UL[5I;<]HX%'[O MK]!X9_9M"\8V@;:T$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J; M/`0LZ?O.14?GZ#AY\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL M:$#05%%:;U\@M.4?,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP M&U@@?\YOI^1.6HCA5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C. M=GSVQ.V?C,K:=#1M&N#C\7@XMLO2BW`A(5M>5`TR``6'!VULS2`Y9>*?IUE!K9';O=05SP6.XY MB1'^QL4$UFG2&98T1G*=D`4.`#?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB! M]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95 MO-RCEU@5`9<8WS2J-2S%UGB5P/&MG#P=$Q+-E`L&08:7)"82J3E^34@3_BNE MVOZKR2.FJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PU MDSY@R.S-D77.UI$.$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;] MN'Z&U3-L+([W1]072N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E M>G@*-Y;&O%"N@GL!_]':-\*K^(+`.7\N?<^E[[GT/:'2MSAD6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^ M+,_Y/%_GM,T+,T.WF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1 M^^?!4;"C[SR6'<>(\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L M%.!D8"V@!X.O40+R4E5@,5O&`RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9 M;2)2.<)IF!-GJ\K>9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F M2J+S&5.^YRM)Q%4XOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M M#`DL6XA9$N)-7>W5YYNTB42%(JP#`4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG! M/3-R0]A4)?.NVB8+A=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH`1JV*^NJ]/^26<.[1[ M\8$@F_S6VZ3VW>`,?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY M@%CS#*%F.-^'19H:,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\ MW/[O#;#"Q([A[8N_`5!+`P04````"`!;BEM']*EWJF@"``!"#```#0```'AL M+W-T>6QE(7=N(2`L?Q(XM@,)M"[^VD M8W\_KYX;4,\.I'Z1>TA^O8>\\==4;>@@\.MAJE[0-""^,<1>G]P$ M.B`.JV>P0E3[!\8]%51(H'1I:`46X8AAYW&'*$DD,6".&*$;!T\,8*NI\6.$ M"VESNPS#/&._SR2+)()^\WM[NJ1GMX-9'J%T=WD:B,,2*84EG^L'T-B+3:D7 MQP7'3J3U>\6[D&@33*9;`7;0>1,A,RR[S`%LH3BD.%W=_Y#OHT^V$,?AZAE!4LAR;/V-X60 M:@!+"%98*I)N(W\E*A=XK9H*]M;Y/H7'+OD]-9U^UWHUN@0_>GN.3FZA^YHE M6,[M9_%P25?7KQ^9?3OA0.;'5LT1$DZP.:;5GJVTV?E*>Y^:.D6UWYRK,G/) M.5MI_[MK7M-.MWKV3L?N4)#4A"K"6PW(W+'NC6ZZTTS[;JTYLW7?J.VL0HF^ MT.]DT609SE%-U0-9"64G(]C;/XW\8-9Y+3J*"/;V+YR1FKE+8_^O(?X'4$L# M!!0````(`%N*6T="._4AHP0``*81```/````>&PO=V]R:V)O;VLN>&ULE9A; M;]LX$$;_"J&738%F;=V2)J@+-)>V!I(FJ(/TF99HFP@ENB25-/WU2TIQ^\D> M:YLG77E$#L^,*+VWIT_:/,RU?F`_*U7;4S.)5LZM3TV_>BUJ?VVA M3<6=/S3+D5XL9"$N=-%4HG:C9#P^&AFAN).ZMBNYMM$+S?X-S:Z-X*5=">$J MU<$J+NOHPWM[NI!*W`MC/9CQ]?HKK\0D^JDBIKAUEZ5THIQ$F3_43Z)WPC3K MLT:J<)"/\V@48)NAWAI6Z%)TL+N5M-]?+D2L%`O>*'?G.[MY[B2*DRQ)CCI& MN.U>BB>+P'""\<+)1W''YY-H'#'>./U)*B?,!7?BL]'-6M9+SXK80AKK9F&X M[9V5K&4E?X5^^R.[TD]?M)&_=.VXFA5&*]6V"A?:1OX)]O<9WT0X-9W)92Y^H/,Q?4>C&SQ^`C@%TO`NZY*;VQEIV*XP/,C<"VKZ# MMN]VVT[K1]][;['`V3V!1B>[C6Z-KPW&/;]EMXIOE/O1R'6(!)HV1M7&5"RM M.[P6;J5+%GIB71M+1/1L)73]K'7Y))5J.W'C5CX$4Y^/]3*D#_N(*'0V)J2] MTO7R\$Z8BEV(>6\<*&E,6.H#4C:%8]^Y,3X@_6#&:&9,J#ESNG@X/./6"W59 MK95^%J*54M26]T2(TC:-\P[:SXC''>3U$76X%!-V-"S@MAY",/M=K/J76F MZ3(M,+^(MNKK(# M_YI0PKY!3*^\$JI"VI+M4=B$%G9_!K,#1*&]"5E8R1S>=`M1:&]"V#N8R_ZU M#B@4.2%$[N M-"?F+$6A4T+HP1Q-$T2AU"DA-94;7T/P`_T-0U1OU4#X3:%F?EU;-OZE<+-` M%/J=$G[W4@T8K+N`*/0[)?P>S+JWO0&BWRGA]]ZLZP*&*/0\)3S?B^H&BRAT M/25<'TS@%%U/T?64<'T0E8UQX8>V9X3MV[4`G#JX$!BK#&W/"-NW4>C#56^5 MG:'M&6$[55Y\;[A4O5S.4/6,4'VPOF09HGI+Y'T+D9WZ\CM0B5'2,*5<\(U??6O>X-CRA4/2-4WXOZ)@I=%XA"U3-"]<$54XZJ MYZAZ3J@^6(US7*GDJ'K^VL*>8V'/4?6<4'T8E2(*;<\IV[?7<632Y&AZGKU\ M1?_Y<"[%0M:B#+\5;/L(_UU>A'\-?M-]*F1Y6%*&XVM=^N>&GP016S1*G?MS M-_65YNVG=$?>_%WX\!]02P,$%`````@`6XI;1\/B":52`@``]`<``!@```!X M;"]W;W)K^/_S'>]91^@G*S#FSE==-6SG%IRW M6\]CYP+7B+V0%C?BSY70&G'1I#>/M12CBS+5E0=]/_9J5#9NGJF^=YIGY,ZK MLL'OU&'WND;TWP%7I-NYP!TZ/LI;P66'EV?>Z+N4-6Y821J'XNO.W8/M$812 MHA2_2]PQH^[(Y$^$?,K&S\O.]64.N,)G+D,@43SP$5>5C"3(?_N@3Z8TFO4A M^JL:KDC_A!@^DNI/>>&%R-9WG0N^HGO%/TCWAOLQ1#+@F51,?9WSG7%2#Q;7 MJ=&7+LM&E9W^$P:];=X`>P,<#3#\UA#TAF`TZ*GS=&9J7#\01WE&2>>P%LG5 M!ELAIS*(B.PP%8WJZ1(C8Z+WD?N9]Y!A>@54BH.I`*/"$[%G`="=VJ%AAW.` MHZD(E@'!`-#-?6#8PV5[.-A#;0\->S3-3RL.IB)>!D06(#+LFUF`J4B6`;$% MB`U[.@LP%^/,50M3B52@ZIVMI#E5RWITYQO^_[TL%ATS]OZ4'6?FU-]#/^\-.VA MZL-C^[KH3FU=;2Y!A_T"E;*+0[4[SE?+R[NO[6K9O/7[W;'^VLZZM\.A:O]9 MU_OF_#B'^>W%M]WKMA]>+%;+Q4?<9G>HC]VN.<[:^N5Q_@4>2JT&R47QYZX^ M=^SW;##_U#3?AX??-X]S-7BH]_5S/Q11A:_WNJSW^Z&D4//?8Z$_ZQP"^>]; MZ;]>FAOL/U5=73;[OW:;?AOTQ5:UH6W[RO4R\7[4,XHP8MD'4DD11DI MS(=D$>H73>#-Q/7Q"_)X>S^>;O'Z&D\\WL46W;415\GQ(O&(RI`D*[G,@4-= MW'>C$S>:N_%Q->;J1K-J"!U8459&,HN&R2;=F,2-X6X*T8UAU:#Q5HFR,I)I MZTU&;FSBQC(WI$0WEE6C01=:-&.CU!!E9,8E7ASW`J(7QT<-:6=%+Y$*(*>7 M?.+%O&L%C"$7HGY*R.=UAH\WO=3)#.RX'[H?CRHI$$#07^6(/;A>M3< M.M$77N[K6.>=,QD9!D@=<4J1D1T!KTF9D#S94:0#T"HG1Y@ZPONS8=2,W0E% M(7=Z+$.#.1E*,0J,4ZK93+R5`*4^`T)9GM$'$2C;93EB(A>(U697BRR52%B*DY>4Y!")R$>F(< MR"%(7`::IG,$&$.G#6BKHQUA(7+V%]`D3KB/-0RGT?- M.#.TUQ/HB&1AK77W_6!*5^1TU23Z04Y-M,;(Y(AD8#%G7F#*5H3[)$.(1I"\ ME,:B(J.O,*4J>5!CDLTCI2,L5AG'>;L>9"2&8J708%L!S#M)]U4(B>@7-$:^8;1*&4F M%JY(1T%7Y#A*B8H14>65"SDJPVXNIYZ4E.@S.!`1T!EYCS6MFG:34A(C2LJK M(W+\&0I8DA?'2!>P;7/Z@5).4L3)I*;;R5!%\X:\M9*NC'0F&#(9>SY*24F< ME"F2]>@HTH"D*:B'#I22D?B=#3R.8,B[*'VRLDX2H08MK<9ZP>EA"1.2",3 MDCCY4($F>?$L(R&$#97"C'TKI8PDSD@C,Y(X(S^!4=;(ZTV9*,.YU^0PC%*B M$B=J.DANKC@K/V$1QLE$IB(A.#*0<[N5KHGS$K15'L3EH(R%81GD M>Y_I.ZZ4K)J3U2IQQNEH!RJ=A,99%PO%D]""76N>JM?ZCZI]W1V[V5/3]\WA MY5X?^N9TNYK^N!]?_0M02P,$ M%`````@`6XI;1[!&DD5C`@``,0@``!@```!X;"]W;W)K4"J25"^MJ M(N2PNWJ\[2@Y#Z:Z\GP`8J\F9>-FZ3#WUF4INXFJ;.A;Y_!;79/NSX%6K-^[ MT)TFWLMK(=2$EZ7>[#N7-6UXR1JGHY>]^PIW.1PD@^)G27MN]!T%?V3L0PV^ MG_A0A#9W&E.JTI%DIE_CT'_Y51&LS]%_SJ4*_&/A-.<5;_*LR@D M+7"=,[V06R7>6?^-CC5$*N")57SX=4XW+E@]65RG)I^Z+9NA[?65&(\VN\$? M#?YL@.%#0S`:@I7!TV1#75^((%G:L=[A+5%/&^ZDO%-!9&2'#]$Z?;MD95S. MWK,8IMY=Q1DE_B`YF!+?IL@7BFB6>#*_%<*?(/3PU3>(53VSRQ%:>V"S:2F)7;#*@%0,R&=`R`]8, M:'GC06A3Y=NJ399DQ9*8+(GU?B1&EB`"#Y[08^4F$UXQ89,)6YFPN480QGZ$ M(CO32AG'``?X.1,$*RBU&\]4R)KK,&JF!8XC^876ERQ?2D,0HA"!_]BU(%QS MF?L>@G8N:"0+09#$?A#:L4QE@.%2J:D\8W-OR97^(-VU;+AS9$*>$\.F?F%, M4!D/O,BXA3R_YT%%+T)UD4JH3S0]$*R=#NCY7T+V%U!+`P04````"`!;BEM' M_K\1(I`#``#8#@``&````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`8X%04BNC@/5R(Q6AU`CIPG]&S7M)0_3WD_HWVZUV?\225)S^ M;D^JT69A`$[DC*]4O?/A.QE;2(U@S:FTOZ"^2L791`D`PY]N;3N[#NY+'H^T M=0(:"6@FS'76"?%(B.^$Q';JG-F^OF*%RT+P`<@>FS\[VFJX,"):&4BK)MQQ MZZQ MWT/^G)],_,3Q$Y\/'RWFK@D'Z2QD`Q,8KZ&J!U2,,OC<2[KH)?6];)[SLT4O MF<]_?729NEXRS^67"*$(;M9PU0*7^KC_^LD7?G+_\L#UP\W]0DF4PW3U=!>P M3;*T$WI7GQ%QL2-!@II?.^7NY9R=I\X>F:>SR!_T-'+#XRY3%CV^D)]87-I. M@B-7^F':5W3F7!'M#[[HZ_KLOUO7>V;T^,OC_`D> M"IL,DE'QSZXZ=<'WV6#^N6F^#Q=_;1[G9O!0[:N7?NBB]!\_JZ+:[X>>?.0? MYTX_8@X-P^^7WO\8T_7VG\NN*IK]O[M-O_5NS7RVJ5[+]WW_K3G]69US&!V^ M-/MN_#M[>>_ZIKXTF<_J\M?TN3N,GZ?I%V?.S?0&>&Z`UP;7.'H#.C>@CP9V MS'1R-N;U>]F7JV7;G&;=L1QF&QZ\O!TZ\3W/NK&W=AHNGUGG[_Y<@8'EXN?0 MT5F#HV;--%?%PO>NAL`Y;XY!<]0"%*$BH_L1Z!)ANGPBE@3>[\!>.K!3!S;H M(#?<8S9E,4D.H\09:TA3%4Q%F)K[7A*13,*2B1B-5"23L@XL]YE,V:2!3W"? MLIE4!5J[8"KGL@@.0"+M,*Z!NOK69]%ED:+)5-L% MT[DT7#^W':5R93!00LR#*.D&#&^@XFT-C&^0WJ(MUZ%)7<1F"Q*%P%@(.@O! ML5`6;SCB,DICAEGB$!@/0>5A`0QU&4'$$X]&1$*&.E`!M#Z+SI%LN*F%AK@L M,1$;.4IN(N,FJ-PL,`2BC5GI*'&(#(>HXQ`YYG*ZL=:YSG/#1$PZ2APBPR'J M.$3&N10S>V.(F,Y"&E,5H17+'1D/,8)A*!F&C&'ZHEECR";K(:_GQ%0YQ3Q? MLM!#7NGIE0:&1=S-2D.H8BH-E#!$!D/4"T]DD$LRE^A`X#J_+J+F7,(0&0Q1 M+S_1"2)$!)*00P8Y?5]?8P@Y_SIMC+I4"Z;+$A,#'Y(P)`9#U!\.8I33*S:N M@1@O$H3$0(@ZF`G8-/B]7Z<0+`TEF$F>F7M-2R$+_7I%;O80DP=8T M8OF01"8Q9)).<>+(!)OJ.[?0^6@$+#.5[;)C8EC.@=I M'C-Q5Q1?#D08BBFF"XE.8N@DO;0E]KKL;M1R(3LSLC%'4Q*>EL&3]!&V'(I1;XQ6,M$R)I*^ M9FS(NM0F$<^6E:BS#'56WP4M"5Y$0-5^.MAC!+M1\EI&ICPJD.2295RRJ#V= MA65<^OR2LPC.;NNJ?1O/M+O92_-^Z*=SU>O=Z[GY$PYGO^+^&AZ*Z?3[HYO5 M\EB^57^7[=ONT,V>F[YOZO$8^+5I^LK;,U^\O6U5;JX7^^JU'[YFPT!-9^#3 M1=\<+T?ZU_\KK/X'4$L#!!0````(`%N*6T&PO M=V]R:W-H965T&ULA5/+;MLP$/P5@A\0RK+<%H8L($Y0-(<` M00[MF996$A&2JY*4E?Y]^9`4.PB2B[B[FIF=Y:.N6'/ MF*U[4-S>X`#:_VG1*.Y\:CIF!P.\B20E69YEWYCB0M.JC+4G4Y4X.BDT/!EB M1Z6X^7<$B=.!;NA2>!9=[T*!525;>8U0H*U`30RT!WJ[V1^+@(B`WP(F>Q&3 MX/V$^!*2A^9`LV`!)-0N*'"_G.$.I`Q"OO'?6?.M92!>QHOZSSBM=W_B%NY0 M_A&-Z[W9C)(&6CY*]XS3+YA'V`7!&J6-7U*/UJ%:*)0H_II6H>,ZI3^[8J9] M3,AG0KX2?F31>&H4;=YSQZO2X$3LP,/9;?8>;H*(5R8VJIDTO3=J??5<;8IM MR^6P^%J@6`2*)%!\-F+" M'*\QNW=-V,6>*C!=O#J6U#AJE[9TK:ZW\S:/9_(&K\J!=_#(32>T)2=T_F3C M,;2(#KR)[&9'2>_?SYI(:%T(O_O8I"N5$H?#\D#65UK]!U!+`P04````"`!; MBEM'>-S,=:$!``"Q`P``&````'AL+W=OI#^^S``%9M#VN;T/W[]05HLJJV+WAF M..?,&5_*"+.IZ9C=C#`FTA2 MDN59=L,4%YI69:P]FZK$T4FAX=D0.RK%S9\#2)SV=$.7PHOH>A<*K"K9RFN$ M`FT%:F*@W=/[S>Y0!$0$O`J8[%E,@OK4.U4"A1_".M0L=U2G^VV4S[FI#/A'PEW$4"2XVBS1_<\:HT.!$[\'!V MFYV'FR#BE8F-:B9-[XU:7SU5F^*F9*<@-&,2Y7"!61',JW_9(J>7]/R,GG]/ MWR[T;7*XO7!X^[U`L0@42:#XWX@)<[C$W/W3A)WMJ0+3Q:MC28VC=FE+U^IZ M.^_S>":?\*H<>`>_N.F$MN2(SI]L/(86T8$WD5U=4]+[][,F$EH7PEL?FW2E M4N)P6![(^DJKOU!+`P04````"`!;BEM'SLP6.*,!``"Q`P``&````'AL+W=O M MVF5%2VQ/MG1N.C-FZ M!\7M'0Z@_9\6C>+.IZ9C=C#`FTA2DN59]H$I+C2MREA[-%6)HY-"PZ,A=E2* MFS]GD#B=Z(XNA2?1]2X46%6RE=<(!=H*U,1`>Z+WN^.Y"(@(^"E@LIN8!.\7 MQ.>0?&].-`L60$+M@@+WRQ4>0,H@Y!O_GC5?6P;B-E[4O\9IO?L+M_"`\I=H M7._-9I0TT/)1NB>T"AW7*?W)]S/M;4(^ M$_*5\"F+QE.C:/,+=[PJ#4[$#CR[HX2:(>&5BHYI)TWNCUE>OU:[X7+)K M$)HQB7*^P:P(YM7?;)'36WJ^H>?OT_<+?9\<[K?=#]G[`L4B4"2!XG\C)LSY M!G/X=TBVV5,%IHM7QY(:1^W2EJ[5]7;>Y_%,7N%5.?`.?G#3"6W)!9T_V7@, M+:(#;R*[.U#2^_>S)A):%\*//C;I2J7$X;`\D/655G\!4$L#!!0````(`%N* M6T<";A"QH@$``+$#```9````>&PO=V]R:W-H965T6CG-"\VA[`D3U#9;=,<:%I5<;:LZE*')T4&IX-L:-2W/P]@L3I0#=T*;R(KG>AP*J2K;Q& M*-!6H"8&V@.]W^R/14!$P"\!D[V(2?!^0GP-R8_F0+-@`234+BAPOYSA`:0, M0K[QGUGSHV4@7L:+^F.;$9)`RT?I7O!Z0GF$79!L$9I MXY?4HW6H%@HEBK^E5>BX3NE/<3O3/B?D,R%?"7=9-)X:19O?N>-5:7`B=N#A M[#9[#S=!Q"L3&]5,FMX;M;YZKC:[O&3G(#1C$N5XA5D1S*M_VB*GU_3\@IY_ M3=\N]&URN+URN/U:H%@$BB10_&_$A#E>8XI_FK"+/55@NGAU+*EQU"YMZ5I= M;^=]'L_D`UZ5`^_@)S>=T):&ULA5/+;MLP$/P5@A\0RK*=%(8L('81M(<` M00[MF996$F&2JY"4E?Q]^;`4.S":B[B[FIF=Y:,8T1QM!^#(NY+:;FGG7+]A MS%8=*&[OL`?M_S1H%'<^-2VSO0%>1Y*2+,^R>Z:XT+0L8NW%E`4.3@H-+X;8 M02EN/G8@<=S2!9T*KZ+M7"BPLF`SKQ8*M!6HB8%F2Q\7F]TJ("+@CX#17L0D M>#\@'D/RN][2+%@`"94+"MPO)]B#E$'(-WX[:WZV#,3+>%)_BM-Z]P=N88_R MKZA=Y\UFE-30\$&Z5QQ_P7F$=1"L4-KX)=5@':J)0HGB[VD5.JYC^K.<:+<) M^9F0SX0?632>&D6;/[GC96%P)+;GX>P6&P\W0<0K$QO53)K>&[6^>BH7ZW7! M3D'HC$F4W15F1C"O?K-%3J_I^04]_YZ^G.C+Y'!YY?#^>X'5)+!*`JO_C9@P MNVO,PYFI//O9TXD-"Z$#SXVZ4JEQ&$_/9#YE9;_`%!+`P04````"`!; MBEM'FQ^IKZ,!``"Q`P``&0```'AL+W=OT*+2_Q MS.2<,V=\*48TK[8#<.1=26WWM'.NWS%FJPX4MU?8@_9_&C2*.Y^:EMG>`*\C M24F69]DU4UQH6A:Q]F3*`@[PR8@(N!%P&C/8A*\'Q%?0_*KWM,L6``)E0L*W"\GN`,I M@Y!O_#9I?K8,Q/-X5G^(TWKW1V[A#N4?4;O.F\THJ:'A@W3/.#["-,(V"%8H M;?R2:K`.U4RA1/'WM`H=US']V:XGVM>$?"+D"^$FB\93HVCSGCM>%@9'8GL> MSFZU\W`31+PRL5'-I.F]4>NKIW*UO2G8*0A-F$0Y7&`6!//J7[;(Z24]/Z/G MW]/7,WV='*XO'/[\7F`S"VR2P.9_(R;,X0)SG?W3A)WMJ0+3QJMC286#=FE+ ME^IR.V_S>":?\++H>0N_N6F%MN2(SI]L/(8&T8$WD5UM*>G\^UD2"8T+X0\? MFW2E4N*PGQ_(\DK+#U!+`P04````"`!;BEM'*8KN'*(!``"Q`P``&0```'AL M+W=OQ-W5S.PL'^6$YLWV`(Z\*ZGM@?;. M#7O&;-V#XO8&!]#^3XM&<>=3TS$[&.!-)"G)BBS;,<6%IE49:R^F*G%T4FAX M,<2.2G'SZP@2IP/-Z5)X%5WO0H%5)5MYC5"@K4!-#+0'>I?OC]N`B(#O`B9[ M$9/@_83X%I*GYD"S8`$DU"XH<+^D1YA%N@V"-TL8OJ4?K4"T42A1_3ZO0<9W2GV(W MTSXG%#.A6`E?LV@\-8HVOW''J]+@1.S`P]GE>P\W0<0K$QO53)K>&[6^>J[R M75ZR&PO=V]R:W-H965T6CG-"\V![`D3U#97NFN-"T*F/MR50ECDX*#4^&V%$I;OZ<0.)TI!NZ%)Y%U[M08%7) M5EXC%&@K4!,#[9'>;PZG(B`BX)>`R5[%)'@_([Z$Y$=SI%FP`!)J%Q2X7R[P M`%(&(=_X==9\;QF(U_&B_BU.Z]V?N84'E+]%XWIO-J.D@9:/TCWC]!WF$79! ML$9IXY?4HW6H%@HEBK^E5>BX3NG/-IMI'Q/RF9"OA*^1P%*C:/.1.UZ5!B=B M!Q[.;G/P1':WHZ3W[V=-)+0NA%]\ M;-*52HG#87D@ZRNM_@)02P,$%`````@`6XI;1_*$R1>A`0``L0,``!D```!X M;"]W;W)K&ULA5/;3N,P$/T5RQ^`TS1E=1V2WOG MA@UCMNY!<7N!`VC_IT6CN/.IZ9@=#/`FDI1D>99=,<6%IE49:\^F*G%T4FAX M-L2.2G'S;P<2IRU=T;GP(KK>A0*K2K;P&J%`6X&:&&BW]':UV14!$0%_!$SV M)";!^Q[Q-21/S99FP0)(J%U0X'XYP!U(&81\X[>CYD?+0#R-9_6'.*UWO^<6 M[E#^%8WKO=F,D@9:/DKW@M,C'$>X#((U2AN_I!ZM0S53*%'\/:U"QW5*?XJ9 M]C4A/Q+RA7"31>.I4;1YSQVO2H,3L0,/9[?:>+@)(EZ9V*AFTO3>J/750[6Z MNB[9(0@=,8FR.\,L".;5OVR1TW-Z?D+/?Z:O9_HZ.5R?.;SY6:"8!8HD4'PW M8L+LSC&_/C5A)WNJP'3QZEA2XZA=VM*ENMS.VSR>R0>\*@?>P6]N.J$MV:/S M)QN/H45TX$UD%Y>4]/[]+(F$UH7PVL&PO=V]R:W-H965T<.>-+,:)YM1V`(^]*:KNCG7/]EC%;=:"XO<(>M/_3H%'<^=2TS/8& M>!U)2K(\RWXPQ86F91%KCZ8L<'!2:'@TQ`Y*="@94% M6WBU4*"M0$T,-#MZN]KN-P$1`<\"1GL2D^#]@/@:DC_UCF;!`DBH7%#@?CG" M'4@9A'SCMTGSLV4@GL:S^J\XK7=_X!;N4+Z(VG7>;$9)#0T?I'O"\3=,(UP' MP0JEC5]2#=:AFBF4*/Z>5J'C.J8_ZWRB72;D$R%?"#^S:#PUBC;ON>-E87`D MMN?A[%9;#S=!Q"L3&]5,FMX;M;YZ+%_V"*GY_3\ MA)[_F[Z>Z>OD<'WF\#_Z;V:!31+8?#=BPNS/,5]=LI,]56#:>'4LJ7#0+FWI M4EUNYVT\1/8)+XN>M_#`32NT)0=T_F3C,32(#KR)[.J:DLZ_GR61T+@0WOC8 MI"N5$H?]_$"65UK^!5!+`P04````"`!;BEM'<4;S6J$!``"Q`P``&0```'AL M+W=O8;090W-[@"-K_Z=`H[GQJ>F9'`[R-)"59GF6W3'&A:5W%VK.I*YR<%!J> M#;&34MS\/8#$>4\W="F\B'YPH<#JBJV\5BC05J`F!KH]?=CL#F5`1,`O`;.] MB$GP?D1\#.I4;3YC3M>5P9G8D<>SFZS\W`31+PRL5'-I.F]4>NKIWIS M5U3L%(3.F$0Y7&%6!//JG[;(Z34]OZ#G7].+A5XDA\65P_)K@7(1*)-`^;\1 M$^9PC=G^TX1=[*D"T\>K8TF#DW9I2]?J>CL?\G@F'_"Z&GD//[GIA;;DB,Z? M;#R&#M&!-Y'=;"D9_/M9$PF="^&=CTVZ4BEQ."X/9'VE]3M02P,$%`````@` M6XI;1WN"=)BB`0``L0,``!D```!X;"]W;W)K&UL MA5/+;MLP$/P5@A\0RK(2!X8L($Y0M(<"00[MF996$A&2JY"4E?Y]^9`4NPB: MB[B[FIF=Y:.N6'/F*U[4-S>X`#:_VG1*.Y\:CIF!P.\ MB20E69YE=TQQH6E5QMJSJ4H\'I.\PCW`;! M&J6-7U*/UJ%:*)0H_IY6H>,ZI3_%=J9]3LAG0KX2[K-H/#6*-I^XXU5I<")V MX.'L-GL/-T'$*Q,;U4R:WANUOGJN-KN[DIV#T(Q)E.,59D4PK_YIBYQ>T_,+ M>OXU?;O0M\GA]LKA[FN!8A$HDD#QOQ$3YGB-N?^G";O84P6FBU?'DAI'[=*6 MKM7U=C[D\4P^X%4Y\`Y^`PMH@-O(KNYI:3W[V=-)+0NA#L? MFW2E4N)P6![(^DJKOU!+`P04````"`!;BEM'J3O^5*@5MR[5-3.=!EX&DI(L39(?3''1TCP+M4>=9]A;*5IX MU,3T2G']=@*)PY&NZ%1X$G5C?8'E&9MYI5#0&H$MT5`=Z>WJ<-IX1`#\%3"8 M14R\]S/BLT_^E$>:>`L@H;!>@;OE`G<@I1=RC5]&S?>6GKB,)_5?85KG_LP- MW*'\)TK;.+,))254O)?V"8??,(ZP]8(%2A.^I.B-1351*%'\-:ZB#>L0_VQW M(^US0CH2TIFP3X+QV"C8O.>6YYG&@9B.^[-;'1Q<>Q&G3$Q0TW%Z9]2XZB5? M[7YF[.*%1DRDG*XP,X(Y]4];I/2:GB[HZ??T]41?1X?K9?=]\KW`9A+81('- M5R-&S.D*L_\X)%OLJ0)=AZMC2(%]:^.6SM7Y=MZFX4S>X7G6\1H>N*Y%:\@9 MK3O9<`P5H@5G(KG94M*X]S,G$BKKPYV+=;Q2,;'830]D?J7Y?U!+`P04```` M"`!;BEM'FD\F\:(!``"Q`P``&0```'AL+W=O_1->[4&!5 MR59>(Q1H*U`3`^V>WFUVAR(@(N!9P&3/8A*\'Q%?0O*KV=,L6``)M0L*W"\G MN`Y1_1.-Z;S:CI(&6C](]X?0`\PC7 M0;!&:>.7U*-UJ!8*)8J_IE7HN$[I3_Y]IGU.R&="OA)NLV@\-8HV?W#'J]+@ M1.S`P]EM=AYN@HA7)C:JF32]-VI]]51M;O.2G8+0C$F4PP5F13"O_FF+G%[2 M\S-Z_C5]N]"WR>'VPN'V:X%B$2B20/&_$1/F<(DI/C1A9WNJP'3QZEA2XZA= MVM*UNM[.NSR>R3N\*@?>P6]N.J$M.:+S)QN/H45TX$UD5]>4]/[]K(F$UH7P MFX]-NE(I<3@L#V1]I=4;4$L#!!0````(`%N*6T?@H?P]L`$``!8$```9```` M>&PO=V]R:W-H965T9K[VJ/).]X:R% M5X5T+P15_X_`Y7#`&SP5WEC=&%<@>49F7LD$M)K)%BFH#OA^LS^F#N$![PP& MO=@CE_TDY8<[O)0''+D(P*$P3H':Y0P/P+D3LL:?H^:/I2,N]Y/ZD^_6IC]1 M#0^2_V.E:6S8"*,2*MIS\R:'9QA;\`D+R;7_146OC103!2-!O\+*6K\.X4N: MC+3+A'@DQ#-A%_G@PY)<%T@F@20()*L6 M;]=;1&OY25;-6HY,T]OKX65=2&K`AHAN;HK&/=#YPJ(S;WMF]"OW.BG;7#D3%3=:"X MN<$!>O>G0:VX=:ENF1DT\#J0E&19DGQABHN>ED6H/>FRP-%*T<.3)F94BNM_ M9Y`XG6A*E\*S:#OK"ZPLV,JKA8+>".R)AN9$']+C.?>(`/@M8#*;F'CO%\07 MG_RL3S3Q%D!"9;T"=\L5'D%*+^0:_YTUWUIZXC9>U+^':9W["S?PB/*/J&WG MS":4U-#P4=IGG'[`/,*M%ZQ0FO`EU6@LJH5"B>*O<15]6*?X)[^?:1\3LIF0 MK82O23`>&P6;W[CE9:%Q(F;@_NS2HX-K+^*4B0EJ.D[OC!I7O9;I?5*PJQ>: M,9%RWF%6!'/J'[;(Z)Z>;>C9Y_3#0C]$AX=M]_SN:]2[;94P6Z#5?'D`K'WL8M7:OK[7S(PIF\P3FEI+.O9\UD=!8']ZY6,D`0``L0,``!D```!X;"]W;W)K&ULA5/+ M;J0P$/P5RQ\0,PRSCQ&#E,EJE1Q6BG+8/7N@`2LVS=IF2/X^?@"!*%(NN+NI MJJ[V(Q]1/YL6P)(7)3MSHJVU_9$Q4[:@N+G!'CKWIT:MN'6I;ICI-?`JD)1D M:9)\8XJ+CA9YJ#WJ(L?!2M'!HR9F4(KKUS-('$]T1^?"DVA:ZPNLR-G"JX2" MS@CLB(;Z1&]WQW/F$0'P5\!H5C'QWB^(SSYYJ$XT\19`0FF]`G?+%>Y`2B_D M&O^?--];>N(ZGM5_AVF=^PLW<(?RGZALZ\PFE%10\T':)QSO81KAX`5+E"9\ M23D8BVJF4*+X2UQ%%]8Q_DFSB?8Y(9T(Z4+XD03CL5&P^8M;7N0:1V)Z[L]N M=W1P[46<,C%!3Q,N/UI@$``+$#```9````>&PO M=V]R:W-H965T5.R,V?:6MN? M&#-E"XJ;.^RA0.)XICLZ%UY$TUI?8$7.%EXE%'1&8$U.#JZ]B%,F)JCI.+TS:ESU5NR^ M''-V\T(3)E(N&\R"8$[]PQ8IW=+3%3W]G+Z?Z?OH<+_N?MA_+I#-`ED4R#8C MWF]'C)C+%O/P7Q.VVE,%N@E7QY`2A\[&+5VJR^U\3,.9O,.+O.<-_.2Z$9TA M5[3N9,,QU(@6G(GD[D!)Z][/DDBHK0_O7:SCE8J)Q7Y^(,LK+?X!4$L#!!0` M```(`%N*6T<39%"UI0$``+$#```9````>&PO=V]R:W-H965T?-9I34T/!!NF<]P&82V"2!S;)_EEV/F##':\SG(=EB3Q68-EX= M2RH1':SI:3S[V=. M)#0NA#]\;-*52HG#?GH@\RLMWP%02P,$%`````@`6XI;1XM.U;BP`0``%@0` M`!D```!X;"]W;W)K&ULA51;;YLP%/XKEG]`32!T M6T20FE;5]C"IZL/V[,`!K/I";1.Z?S]?@$(5*2^Q??AN1\=.,2K]9CH`BSX$ ME^:(.VO[`R&FZD!0",HD+HM0>]%E MH0;+F807C,0[/!=>6=M97R!E019>S01(PY1$&IHC?M@=3KE' M!,`?!J-9[9'/?E;JS1]^U4><^`C`H;)>@;KE`H_`N1=RQN^3YJ>E)Z[WL_IS MZ-:E/U,#CXK_9;7M7-@$HQH:.G#[JL:?,+40$E:*F_"+JL%8)68*1H)^Q)7) ML([Q2YY-M.N$="*D"^%[$H)'HQ#SB5I:%EJ-R/34SVYW<'#M19PR,D%-Q^Y= M4..JES)-TH)KBUNT[.9GL6$V=H]_W%;8#\+ M[*/`?M-BMFTQ8DY;S/ZV2?[%)-\(Y%=-MIC[+R9D-3@!N@WWTZ!*#=+&N2W5 MY0D\I&'PG_"RZ&D+OZENF33HK*R[/F'6C5(67(CDSJ7HW"-=#AP:Z[??W%[' M>QL/5O7S*US^"LK_4$L#!!0````(`%N*6T?(&)MII@$``+$#```9````>&PO M=V]R:W-H965T&+"!.$;2' M`D$.[9F65A(1DJN0E)7^??F0%+D(T%[$W=7,["P?Q8CFU78`CKPKJ>V1=L[U M!\9LU8'B]@9[T/Y/@T9QYU/3,ML;X'4D* M4?X2M>N\V8R2&AH^2/>"XS>81K@-@A5*&[^D&JQ#-5,H4?P]K4+'=4Q_\OU$ M^YR03X1\(=QGT7AJ%&U^Y8Z7A<&1V)Z'L]L'\]8L*R0>\+'K>P@]N6J$M M.:/S)QN/H4%TX$UD-[>4=/[]+(F$QH5P[V.3KE1*'/;S`UE>:?D'4$L#!!0` M```(`%N*6T>?K<2II`$``+$#```9````>&PO=V]R:W-H965T%AB=#[*@4-__.('$ZT9PNA6?1]2X4 M6%6RE=<(!=H*U,1`>Z(/^?&\#X@(^"U@LIN8!.\7Q)>0_&Q.-`L60$+M@@+W MRQ4>0T"AW7*?TY%#/M8T(Q$XJ5\#6+QE.C:/,;=[PJ M#4[$#CR<77[T!_V("7.^Q;QWR39[JL!T\>I8 M4N.H7=K2M;K>SH=XB.P-7I4#[^`7-YW0EES0^9.-Q]`B.O`FLKL#);U_/VLB MH74A_.)CDZY42AP.RP-97VGU'U!+`P04````"`!;BEM'K&VC2J,!``"Q`P`` M&0```'AL+W=OR>/="`%9MF;3-D_W[]`,)$D7+!W4U5=;4?Q83ZS70`EKPK MV9LC[:P=#HR9J@/%S0T.T+L_#6K%K4MUR\R@@=>!I"3+DN26*2YZ6A:A]J++ M`D4?4=O.F4THJ:'AH[2O.#W!/,+>"U8H3?B2:C06U4*A1/'WN(H^ MK%/\&36N M>BFS=%>PBQ>:,9%RVF+2%<&<^I?2^0+P)Y M%,BO1LRO1XR8TS5F_ZD)V^RI`MV&JV-(A6-OXY:NU?5VWF?A3#[@93'P%GYQ MW8K>D#-:=[+A&!I$"\Y$2#K*RW_`U!+ M`P04````"`!;BEM'NR;_CK(!```6!```&0```'AL+W=OC\ M??T`"E6DSB:V+^=U=>WD@])OI@6PZ%UP:8ZXM;8[$&+*%@0U-ZH#Z;[42@MJ MW5$WQ'0::!5(@I,L26Z)H$SB(@^U)UWDJK><27C2R/1"4/WO!%P-1YSBJ?#, MFM;Z`BER,O,J)D`:IB324!_Q0WHX[3PB`%X8#&:Q1S[[6:DW?_A='7'B(P"' MTGH%ZI8+/`+G7L@9_QTU/RT]<;F?U'^&;EWZ,S7PJ/@KJVSKPB8855#3GMMG M-?R"L860L%3Q"DC$]1T[-X%-:YZ*;+T-B<7+S1B(N6TQ*0S@CCU MJQ897M.SI<7W],U$W\2$FZ7[_C_\MY/`-@IL5RWNURU&S&F-N?O>9/?%9+<2 MN+]JLL)DR1<3LAB<`-V$^VE0J7IIX]SFZOP$'K(P^$]XD7>T@3]4-TP:=%;6 M79\PZUHI"RY$&_CP:IN>H7S7T'Q`5!+`P04```` M"`!;BEM'A%,VXJT!```6!```&0```'AL+W=OWV&)NR!4'-@^I`NB^UTH):=]0--IT& M6@62X)BDZ0\L*)-)D8?:FRYRU5O.)+QI9'HAJ/Y_!*Z&0[))IL([:UKK"[C( M\@;KE M#"_`N1=RQI^CYL72$Y?[2?UGZ-:E/U$#+XK_8Y5M7=@T0174M.?V70V_8&PA M)"P5-^$7E;VQ2DR4!`GZ%5PV>P?77L0I(Q/4=.S>!36N>BX(V>3X[(5&3*0)%WM($_5#=,&G12UEV?,.M:*0LN1/K@ M4K3NDWU_'>QH-5W?0*Y[^"XAM02P,$%`````@`6XI;1Y",8$FQ M`0``%@0``!D```!X;"]W;W)K&ULA53-;J,P$'X5 MBP>H"4G:;$20FE;5[F&EJH?=LP,#6+4]U#:A^_;KGT"ABI1+;`_?WVCLY`/J M=],"6/(IA3*'I+6VVU-JRA8D,W?8@7)?:M2267?4#36=!E8%DA0T2]-[*AE7 M29&'VJLN-3&]E$S_.X+`X9"LDK'PQIO6^@(M-J?]QZ1`#\X3"8V9[X["?$=W_X51V2U$<``:7U"LPM9W@"(;R0,_ZX:'Y9 M>N)\/ZJ_A&Y=^A,S\(3B+Z]LZ\*F":F@9KVP;SC\A$L+(6&)PH1?4O;&HAPI M"9'L,ZY,S"X+_@1=ZQ!GXSW7!ER`FMNSYAUC6B!1,*!V*!LM!`*DLB5$<^OX!,]+U7I[9W*O( M,SXJVO7P*I`<&2/BWP4HGTY>X"V)MZYIE4G@/,,KK^H8]++C/1)0G[QS<"QB M@["`WQU,$,R%<"6N=?4(T$Z([P8X..V>VKQ>B2)X)/B$Y$'/8P5'# MA1'1RDA:->'&I3N3.GO+PRC(\,T(S9C08BY;S!V!M?INB=#[3`^W)?8*%%M$ M&GU=(5HJN/`<;0W&Z=<"\2(0.X'XTQ0>3":N#8?I+>;YV^$YW4,56U20Q$GR M.#"\.1\&HK'W5J*2C[URLUNSZ],XA^9\'_(7_63<#;_+Y-E`&OA%1-/U$EVY MTK?''G7-N0+MSW_2/EO]J->`0JW,-C4-N'ON`L6'Y=6N?QWY?U!+`P04```` M"`!;BEM'LTKDO3\"```"!P``&0```'AL+W=OJ3D?=J[+JAIWB+V1`??BRH70#G&QI%>7 M#12CLRKJ6A=Z7NQVJ.F=(E=[[[3(R8VW38_?*6"WKD/TWQ&W9-P[OC-O?#37 MFLL-M\C=I>[<=+AG#>D!Q9>]<_!W92852O"[P2,SSH%D/Q'R*1<_SWO'DPBX MQ167#D@<[KC$;2N-1/#?R?,1*0O-\]G]N^I6T)\0PR5I_S1G7@M8SP%G?$&W MEG^0\0>>6HBD845:IGY!=6.<='.)`SKTI8]-KXZCOI)Z4YF]`$X%<"E8T2G3&Q>R]@$.3N M71I-&J@T1U/C+PI7N%LCH+,NAV:$+:`T%4GP/"&8$_3R$)B`8?+<()P-0FT0 M&@:9MV9,=!=:TBM)ZH5>8%.5*U4`8^\Y2[1AB59/)%S'1!HF,F)\P>)E-EFY MD?GPA5L3;W#B%4YDQ8G-G#A(K#"F"$91_!PEV:`D*Y38BI*L6O:ST"HKUS(8 MIR^\=>D&)S5?&G\=DVJ:U(CQWJ+$)BHWHNPY2;8AR58WQIIRS%Y!V8C2#8IK MS)8.TZN:N0Q4Y-9S_;]?=I>Q?H!R-FWVCV+O"].OF!1B"4 M7*1.P*JYDY)0JH/4PK^GS']+:N.Z/Z=_-=4J^C,6I&3T5UO)1L$&OE>1&M^H M?&/C-S*5@'3@A5%AOM[E)B3K9HOO=?C#MFUOVM'^.<23;=\0389H,83P4T,\ M&>*-`5@R4]<7+'&1&PO=V]R:W-H965T.#UL?[)%&;@ZAR=2>/ MHC9/=K*I5''JT4[]]2L%O)-ET4MGII(O555 MWOQ]%*4\+6,8#Q//Q?Z@[42R6B3GN&U1B5H5LHX:L5O&#_!^C3(+:1&_"G%2 MH_O(BG^1\M4.?FR7,;`:1"DVVE+DYO(NUJ(L+9-9^4]/^G]-&SB^']B_M>D: M^2^Y$FM9_BZV^F#4@CC:BEW^5NIG>?HN^ARH)=S(4K6_T>9-:5D-(7%4Y1_= MM:C;ZZE[PD`?-AV`^@!T#H#D:@#N`[`7D'3*VKR^YCI?+1IYBM0QM_\VO#?P MQI(8YDBU;$UGE\E,F=GW%2)XD;Q;HAZ#6LRC@YE"K!T$/4,2(V!2!1I4=,,' MY*@@MPGP0$`Z`NP04%07]7(;?9_1GY#1I=[="#+>/>BTV^D["U"X,T*">_II%3TS0D)^K;0F?;XC=" ME(;8DHZ+`V;@@BT.C(S=NRS(KVGDU#0-H>"^+7RV+7X[1-DU6_KS7`_J\D4( MCSO,^$#GXC"EGXQ)1F?F8[X7/_-F7]0J>I':'+_;L_).2BT,&[@S;A_,9]%Y M4(J=MK?,_@W=AT(WT/(X?/>&ULC93-;J,P%(5?Q>(! M:L!0HH@@39-4,XN1JB[:M1,N`=7&U'9"Y^WK'Z`P8D;=Q#]\YW#/-7'>"_FF M:@"-/CAKU2ZHM>ZV&*MS#9RJ.]%!:YY40G*JS5)>L.HDT-*).,-Q&-YC3ILV M*'*W]R2+7%PU:UIXDDA=.:?RSP,PT>^"*!@WGIM+K>T&+G(\Z&F@5[,YLK6?A'BSBU_E+@AM"<#@K*T#-<,-]L"8-3(O?A\\ MOUYIA?/YZ/[HTIKJ3U3!7K#7IM2U*38,4`D5O3+]+/J?,$1(K>%9,.5^T?FJ MM."C)$"F230PV.5;#Q&,8XL/$,X-H%N:?!F0T2+P!652P65:9 M^6YXIG4,":--O$;MYY3I:QBN48&>"U^;:F!8,*FVGF>V(_R?YA1;=>"],EU/Q"5!+`P04 M````"`!;BEM'=*PO!?\!``!:,"Q?>$=:_>7*!<-* M'T45RDX0?+$D1L,8PBQDN&F#(K>Q5U'DO%>T:':%=F!F$!OQHR2&\/C/<3Y^_F\..R#Z"Q M0"@Y*Z.`]7(C):'4".G$?T;->TI#]/>3^C=;K79_PI*4G/YN+JK69F$`+N2* M>ZK>^/"=C"4@(WCF5-I?<.ZEXFRB!(#A#[`#D!TV?W:TTW!A1+0RD%9-N';IRJ2.WHH8?S*"%F6B9!CDSR$N3HFV\!BI] M$(+_X21[<)(MG,2K;M3- M!TJNRFPWII7N];N#XMTTR^:!6OP#4$L#!!0````(`%N*6T?K;DH=$`(``,H% M```9````>&PO=V]R:W-H965TZ@TFD-[=I*7@,;&U';"]-_7"Q`<(:67>.';GAV_LN?B0]8`"GTR MVLI-4"O5K<-0'FM@1+[P#EK]Y M1%7RJZ)-"V\"R2MC1/S=`>7])HB#<>.]N=3*;(15&4Z\4\.@E0UOD8#S)MC& MZWUA$!;PJX%>SN;(9#]P_F$6/TZ;(#(1@,)1&06BAQOL@5(CI(W_#)IW2T.< MST?U;[9:G?Y`).PY_=V<5*W#1@$ZP9EG*I-Z]53A/RO!FA`8,MIC='!-/B%"K+UK@P*?CN<62 MP7Z.*)+G#LGHX);;9!XP>WTND(X"J1-(O5.(_)"%*\-AV@&3XCQ>@NT]V.HU MB?'S.-E#G,R+D_H^F?/)9CYYFJ7/7?('E]QSR99<=OG,Y4N%>!5O%J\`@]6%/,3=''"V1MA("ZV=TATY-=6N?_OM#NU MIRTV;^QA?Z?;ENLR=YFJ[,@%?A)Q:5J)#ESI%VR?VYES!3I?]**/K=:-=5I0 M."LS+MMT.QKE:V'H+((D+$H M*+.\\I>+X=ISO5SH0UODE7JNO>90EEG][TD5^OC@@W^Z\"O?[MK^0K!X M=5ZJJLEUY=5J\^`_PGW*PUXR*'[GZMC,SKW>_(O6KWWCQ_K!9[T'5:A5VZ?( MNL.;2E51])FZGO].23_Z[`/GYZ?LWX9R._LO6:-27?S)U^VN<\M\;ZTVV:%H M?^GC=S75,#A0KQO3)['X]Y-1R/XS\QF\+L`3@%X#G@W(\] M@$\!_"-`#)6.SH:ZOF9MMES4^N@U^ZR_VW#?R>L^29?9:X9L]3A<765-=_5M MB5&T"-[Z1),&!\W37`-G1=!EMW:!OAF.\RYL':2&(KS>`S_U,#8?N5&$O)Y` MG!*(,8$P$L2F23F6,6JJ02,P8LRF2@V5!('7S83$3&B82:XGB,AP1+<.AR0. MY#R!)(6&XW#(6:%1!$S85*FADJ&(KYN)B9G8,`-6,_&LFR\A@+"[,66,2W[= M3D+L))]-E#6Z0)(7:## MA)E$8[THI'7H4E,5SE;993NQ3ALI8Y&"(X@4^Y(<+B32/F!)C\0GC(N7U8S%>:,':IB8($74""!B%$*%': M'9FZ&)PL493@IRB9WF[1?!N)6623I:8L%B[/9TZAPTWH.#Q1.84.OQDZG$*' MF]`A=V`4/1&1P\+EE"7<9(G#^SP7M%IQ<[5TN?+0I5I#%--[&\RVEJ6JM\.6 MN_%6^E"UX\[R?/6\K7_$86OZ(5\N]ME6_6/X'4$L#!!0````(`%N*6T=3 M-)O$I0(``+@+```9````>&PO=V]R:W-H965T[AI*H/=\]NXB2H@'/8:7K__FQ,TNP*-28/`/U+$3 M?-L7-74$<9Q%#:_:<#GOKSUWR[D\Z;IJQ7,7J%/3\.[?2M3RO`A9>+GP4NT/ MVEZ(EO/H6K>M&M&J2K9!)W:+\(D]KJ&PD![QNQ)G=7,>6/&O4K[9P<_M(HRM M!E&+C;84W!S>Q5K4M64RG?\.I)\];>'M^87]>V_7R'_E2JQE_:?:ZH-1&X?! M5NSXJ=8O\OQ##!Y22[B1M>K_@\U):=E<2L*@X1_N6+7]\>SN%/%0-EX`0P%< M"R#_LB`9"I+/`N?4*>M]?>.:+^>=/`?JR.W39H\&WED2PQRHGJUSTV6<*7/U M?0D%FT?OEFC`0(]980R,8=88DUPQD=$P*@0N0MSP"1#![#Y!Y4.DS;8])X^-UO-2.M9JA5=I\@)6;3J68SHB!#!#DVZS!KC"GN-\E)DQP1 ME*--$*;TF,N"-"D0`;M/4)*Y+*?.)8N)!)OV&PTPMG16`\BMG=Q_[3!&NZ&H ME,G8M*X(R,<5T#XH4>5H(%8#R+E*)KBBZ6,H?F6&NZ5#M]O\@4<7&CR&DE?F M'A0T>FQR]A@-'\M\UDMVZS7UGE@:0H83YA%C5E#+Q63+)56!4E:.OPL0*/%Q M"S2*$",*C]AFCW7D>_&+=_NJ5<&K MU&:[UN^M=E)J8:CB!S-Q![.-O@YJL=/V-+Q=`,MCY=]\G6SOOP/4$L# M!!0````(`%N*6T?K&PO=V]R:W-H965TVBTF@6[=H)EV"-C:GMA.G; MUS]`(6(FW6!?<\[Q=X/CO!?R334`&KUSUJI]T&C=[3!6IP8X40^B@]:\J87D M1)M2GK'J))#*F3C#<1@^8DYH&Q2Y6WN112XNFM$67B12%\Z)_',`)OI]$`7C MPBL]-]HNX"+'DZ^B'%I%18LDU/O@.=J5F54XP4\*O9K-D64_"O%FB^_5/@@M M`C`X:9M`S'"%$ABS06;CWT/FORVM<3X?T[^Z;@W]D2@H!?M%*]T8V#!`%=3D MPO2KZ+_!T((C/`FFW!.=+DH+/EH"Q,F['VGKQMZ_V6P'V[HA'@SQ9(C23PW) M8$AN#-B3N;Z^$$V*7(H>J8[8CQWMC%S:$).,E$N3_NBV2\"G'5QLT M:&*G.^:/'^'Y`,@:D/B!9M+%=0GK-8:[) MHC5)^8'D0XST!B.=8T3A#9N>O(&7X0>::M0D>AS1%VYZT60H,)"Q],6F-NEJE@4&L[W9BY M]'\V7VC1C5?'='\5?P%02P,$%`````@`6XI;1]%I%KXL`@``&ULA57)CILP&'X5Q+T#F(`A(D@)HU%[ MJ#2:0WMV$B>@P9C:3IB^?;T`,\91F=-(FT`PC`-"&HZORSTW#LK"WH3;=/A M=^;Q&R&(_3W@E@X[/_*GB8_F6@LU$91%,//.#<$=;VCG,7S9^?MH6V4*H0&_ M&CQPJ^^I[$=*/]7@QWGGARH";O%)*`4DFSNN<-LJ(6G\9]1\6"JBW9_4W_1J M9?HCXKBB[>_F+&H9-O2],[Z@6RL^Z/`=CTM(E.")MEP_O=.-"THFBN\1]&7: MIM/M8-XDFY'F)H"1`&;"[.,FQ",A?A"T0V"2Z76](H'*@M'!XSU2AQUM)9PI M$:GL<:W&S';)E7$Y>R_C"!3!70F-&*`Q!QL3S8A`JCLM@+^D`XON-*AL!(R? M.\23@QGN8SM@FCP7V$P"&R.PL2.FX3(D-,LPF$YC\@S$+E!E@Z((YMGS+,DJ M2[(XD95-8K(DM@W,0Q>HLD%Q#-/G4=)5E'019>.,DEHNWT`8Y\XL"U24I/!Y M&+@*`Q=GE#C#0-LFS2-GE@4(6LOZ;Y1L%25;1`'.ZY)9+EF6N:^+#8I`EJ_O M?F!]S`2SJRYRW#O16R?,AS;/SG5T#U0Q6,T?9'TUY?`A4Q8]NN*?B%V;CGM' M*F2IT77A0JG`,E[X(G>LEG^`>=#BBU!=J+;2%$4S$+2?2OS\GRG_`5!+`P04 M````"`!;BEM'F/G)C60"``!9"0``&0```'AL+W=O;OS/'8N<(W8"VEQ(YY<":T1 M%UUZ\UA+,;JHH+KRH._'7HW*QLU2-?9*LY3<>54V^)4Z[%[7B/X[XHIT>Q>X MSX&W\E9P.>!EJ3?&7\>P"X'D90HQ>\2=VS2=B3\B9!WV?EY MV;N^9,`5/G-I@<3M@7-<5=))S/QW,/V<4P9.VT_W[RI=@7]"#.>D^E->>"%H M?=>YX"NZ5_R-=#_PD(,B/).*J:MSOC-.ZF>(Z]3HH[^7C;IW_9.-/X29`^`0 M`,>`<1YS0#`$!)\!H@]I-&B@TARG&C`J/.%NG`*Z\W`X"8>F"?*I(@F69PB>,X1]$L$L MB7C9('P:]-U#.#-(E@TBC2":&6SF6?::XU03`9,DMTBL&+&&$<\PMD:,>!G# M(K%B)!I&,L6`OA%CKC%SV#16D(T&LID90"/(9OE]6"16C*V&L9UA!$:,[3*& M16+%`+[&(;>U"4BXP@)H?PH`7_U5`-0IX(I5.A?!R/A"K"([C+YU@&#%6M5$ ML1G&)K+#A#I,N&*]:J+$##,3^6L^D[ZE@6C%JM5$QHTOUT1;#<:;5*P:TYNJ MY,PYDWO#^VHRCHZGA0.4%4\;/\I3A*J$GS99VJ(;_H7HK6R83]GF0&4]3V7]02P,$%`````@`6XI; M1ZUIZ;48!```1Q0``!D```!X;"]W;W)K&ULE5C= MLY+V6-;\;.I?S4'K-OA3%E7S-#NT[?$Q#)O-09=9\V".NNI^V9FZS-KN MLMZ'S;'6V78(*HL0HDB%9997L\5\N/>M7LS-J2WR2G^K@^94EEG]_U(7YOPT M8[/+C>_Y_M#V-\+%/+S&;?-25TUNJJ#6NZ?9)_;X+`;(@/B1ZW-C?0]Z\2_& M_.HO_ML^S:)>@R[TINU39-W'JU[IHN@S=0F9!F?T9/_-J M^#R/OR31%.8.@"D`K@$\?C>`3P'\&@#O!X@I0/@RR"E`O@4,-81C[L^29?1/'SM$TT8&#!+&\.N MB+#+[J2`&0X'1,%<%"N,`1=FC3'@3W9(H)4XR8$B=3;(]QQ!,%UKJQ@&L;R%.&@3[ MJ9M%1'C_,'@;4$&HDLG!(HLK>HB8"[7V0CW?1MT6S:AHVU*5NR,GS,3C'.D; MD-LZ@.I`?BF86PA\+,0-N2V$4R'(=P5Y`(A)"`9Q#Q[JS@S9LW`V^I(AV^6Q M[]*DOLN0\0IW5S'DO-S74QDU589<59`UQ=C$9OLJ/"0>1-13&3)5X;9OALS2 MN[FI63+DEL)MX,SV0"%]N:@#LA1QN9V9V:8E8^9)!M2U`+F6C)SK'8$@]I@L MH$8#:'\GF;,HL&V$J<1W"(':"2`[D>"<+K"]0BC?1SM0RP#D!I*[2^/V?B5U M/(RFG18"IKXM#]1?`/F+]-@?P-4UIATH(-?PV8("]0)0'L8#:(OE/>?4#@#9 M@93NE8Q!RH.'6@$@*Y"QFR>YFX?:`*2HZ3Q2$C,((_NG4%.^Y;CODV"X#_\\9T]RL3IUW#4=86@93'7H?3CN&H&93/RW!*JTWOK5;0)YV(/.:6@*0'#^T8@9J![JDO M+][VDP[DOXX76JO9V"?H3U_(_25[7(TG7&]I M%O-CMM=?LWJ?5TWP8MK6E,-!S,Z85G?ZHH>NN(/.MM>+0N_:_FO<5SV>CNVN9X>+OU!+`P04````"`!;BEM'MQ0%=[0"``#S"0``&0```'AL+W=O M)E5] MV)[=Q$E0`6?8:;IO/QL3:EN.2O<28_._^]V=P]G5A8TO_$BI"-[Z;N";\"C$ MZ2Z.^?9(>\(C=J*#?+-G8T^$G(Z'F)]&2G:34=_%,$GRN"?M$-;5M/8XUA4[ MBZX=Z.,8\'/?D_'O`^W891."\+KPU!Z.0BW$=14O=KNVIP-OV1",=+$[\%= M`["23(I?+;UPXSE0P3\S]J(F/W:;,%$QT(YNA7)!Y/!*&]IURI,D_YF=OC.5 MH?E\]?YM2E>&_TPX;5CWN]V)HXPV"8,=W9-S)Y[8Y3N=<\B4PRWK^/0;;,]< ML/YJ$@8]>=-C.TSC1;_!Z6SF-X"S`5P,="5N&J#9`#D&L8YLRNLK$:2N1G8) M^(FHW09W4CXJ)])SP"=OHRZ7S(S+U=<:Y;B*7Y6C60,GS8.I`3Y%8WLI%DTL M(_"&`4,;`0T'T(NP%-G'!'0EZ.D],I/`X&,'Z=5!JAVD5HZE'62FT]":00=9 M)"5$*VJ1.:#,!.'$!FG-@ZG)5B23.XS<8@!O,KF1S!>8)7FQ(AGL@+`%@EX0 M-D$`9FG^,:=P.(7%05Y.8>Z.I"1)ZM,UQ?_L8ND$5%H!I=Y=+#^YBR!Q(*I/ M&93,F_8LTOF`LL`0K,@'`)=E?>0XMUG%S`)F[PVPFDT!_?\;6X1\HN:F M2`<3&V=L3\?#=/?@P9:=!Z&/V&5UN=_QTO6(M][SZ'U!+`P04```` M"`!;BEM'>)S958<"``"X"```&0```'AL+W=OVTW3_?OX@U+9H M@W838O.>\[S'EGVHKI2]\!,A(GCKNX%OPI,0YW44\=V)])BOZ)D,\LV!LAX+ M.63'B)\9P7L=U'<1C.,\ZG$[A'6EYYY87=&+Z-J!/+&`7_H>L[^/I*/730C" MV\1S>SP)-1'5533%[=N>#+RE0\#(81,^@'4#4B71BE\MN7+K?Z#,;RE]48,? M^TT8*P^D(SNA4F#Y>"4-Z3J529+_C$G?F2K0_G_+_DV7*^UO,2<-[7ZW>W&2 M;N,PV),#OG3BF5Z_D[&&3"7;:#?E[-&Q2/8?,! M<`R`4P!`GP8D8T`R!4"]=)%QINOZB@6N*T:O`3]CM=M@+>5,)9&9`ZZS,;-< MLC(N9U_K!*55]*H2C1JH-8^V!LPI&B=+CB9-)!W,VH"ABX!6`CB+>*;U[)AT-N:)\3M1X(O^.B*Q&T1-VU`V4!SMZ&83I M$]/LU*0?H&XT[_*Z.N,C^8G9L1UXL*5"MBO=6PZ4"B)=Q"MYJ$[R,V(:=.0@ MU-]"G3;36,U`T//M.V'Z6*G_`5!+`P04````"`!;BEM'O\GQ&TP"```/"0`` M&0```'AL+W=O'CSA0-(0^L%RA+CU M6>**;>V<\WKC..R0HQ*R)U*C2GPY$5I"+KKT[+":(GAL@TKL>*X;.24L*CM- MVK$WFB;DPG%1H3=JL4M90OIWAS!IMC:P^X'WXIQS.>"DB7.+.Q8EJEA!*HNB MT]9^!IL,1%+2*GX5J&&#MB7A]X1\R,Z/X]9V)0/"Z,"E!12O*\H0QM))S/RG M,_V:4P8.V[W[:[M<@;^'#&4$_RZ./!>TKFT=T0E>,'\GS7?4K2&4A@>"6?NT M#A?&2=F'V%8)/]6[J-IWH[[$;A M)(X`&*7P>@K5??8TBO6\@=\;!,K`'Q@$KJM#KM0RE*9J-2"*@C%1IHE8/(R$ST:&96!L'J7F:49C?4 MA&!,DDU()C%B`R.^EY4.(Y['F)!,8JP-C+6&X<\;`-=(B"Q-CV4$``,"@`6[ MI1/-;!==M6B_`,_$\1;D1A--)&=*,XUBEA&@UY$%&PX$9GZ"A_-C;EH0+M@S MFFCJATQHIE$B$R5:4,TZT5PY,V7_U3-G<'35\(Q^0GHN*F;M"1>G8'MDG0CA M2)BY3V)IN;B=W#H8G;ALKD2;JO-:=3BI^^O'[0Z4_@-02P,$%`````@`6XI; M1PU"\$LH`@``B`8``!D```!X;"]W;W)K&ULC57) MCILP&'X5B_L,^Y*(("6IJO90:32']NP0)Z"Q,;6=,'W[>@%BD*OT@A>^S0L_ MY4#9!V\0$N"3X([OO$:(?NO[O&X0@?R5]JB3;RZ4$2CDD%U]WC,$SYI$L!\% M0>83V'9>5>JY-U:5]"9PVZ$W!OB-$,C^'!"FP\X+O6GBO;TV0DWX5>G/O'-+ M4,=;V@&&+CMO'VZ/&X70@)\M&KC5!RK[B=(/-?A^WGF!BH`PJH52@+*YHR/" M6`E)X]^CYL-2$>W^I/Y5KU:F/T&.CA3_:L^BD6$##YS1!=ZP>*?#-S0N(56" M-<5(!`C]-VW:Z')$LJ5+:EQ2VV5C'=L_7;*52[9PR9TNF>42 MQM%SDWQEDB],"J=);IDD:?'H=!]AQ:H(E^?KF]]X02QJZY\'-3TU@GS]7M$/R*YMQ\&)"EE_=+&X4"J03!>\R@UKY&]A'F!T$:J;JYTTE=(, M!.VGNC__?*J_4$L#!!0````(`%N*6T=OLZK:!@(``*L%```9````>&PO=V]R M:W-H965T7*.$52'?D-BI9C5!H2)3#T_1125#=>GIG8*\\SUDE2-_B5`]%1 MBOB_(R:LWWN!-P;>ZELE=0#F&9QX94UQ(VK6`(ZO>^\0[,ZI1AC`[QKWPMD# M[?W"V+L^_"SWGJ\M8((+J1606N[XA`G10BKQWT'SD5(3W?VH_MU4J]Q?D,`G M1O[4I:R46=\#);ZBCL@WUO_`0PF)%BP8$>87%)V0C(X4#U#T8=>Z,6MOOWSS M!]HZ(1P(X428\JP3HH$0/0CQEX1X(,0+`K2EF$:Y\%"/Y`$``!8%```9````>&PO=V]R:W-H965T,4 M2Q7RVA4]!UP:$B5NX'FQ2W';.5EJ%0@WR"BSROLYPHV/.TW37Q!()P%0BL0 M;@3BK4E_ZL.".@.*`V\7/(3E:UB4Q+LOV(GN[$0;.\GG`O'=AL3_NR')G8-D M(_"T[=1BSEO,M[LB[NH<4N"UN9\"%6SHI#V&2W9Y`DZ!.<);VN(9?F-=M M)]"%274;S-&M&).@3'@[M5>->J26@$`E]311;@DPU`@``T@<``!D```!X;"]W;W)K&ULE55+CYLP&/PKB'L7#.:1B"#M4E7MH=)J#^W929R`UF!J.V'[[^L' MI-A"&W+!#^8;9@8_BH&R=UYC++R/EG1\Y]="]-L@X(<:MX@_T1YW\LV)LA8) M.63G@/<,HZ,N:DD0A6$:M*CI_++0RUA M%!;!51&-F$AC7N:8:`E168CD!@FD@$45T:3"#)\C2P6X3Q!/!-`0Q!:!(S(S M-@RFTQB0IG`)5%F@,,[O2X&.%&A)B>\3)$X8R:-AI(Z"U")P?"8FC'3F,T[S M15"56HE!>%]*YDC)+"DK5D;NA)$_&L;&4;!9$<9F[C/)EL.P0#%VK.3.`&MC5G;6;;_OOX``@@INY?8'MY[ M\V8,DZP5\E65E&KPP5FM=D&I=;,-0W4J*2?J232T-D\N0G*BS5%>0]5(2LZ. MQ%F((5R%G%1UD&R"/=H6"%J(0_RI:*M&>V#-'X5XM8=?YUT`K0?*Z$E;"6*6 M=UI0QJR2R?S6B=YS6N)XWZO_<.4:^T>B:"'8W^JL2^,6!N!,+^3&](MH?]*N MAL0*G@13[A><;DH+WE,"P,F'7ZO:K:U_LH8=;9F`.P(>"$.>94+4$:([(7:5 M>F>NKN]$DSR3H@6J(?:VT=;`I14QRD`Y->G;92I3)OJ>QWB3A>]6J,-@ASF, M,6A`A$9],04.IG0\HN.E!,48D4:/,T1]!G_<1^,B(OA8(.X%8B\03P30U&3J MR_"8VF&^89SB)50Q1B&XB1][269>DHD7_%A@->O&ZJO=2&<.THE`-*TS\=U( MQ]V(-E&R""LF,(1@\HF&K&=VUA,[GQ#8S!JR^6I#$)Q9L/-@))$LOB`=R!<; MI7"]^!X5$QC"*%[/#(6C+YA3>76338&3N-7:?UU#=)B>>VPGP"Q^L%/538:[ M3)XUY$I_$WFM:@6.0IOYXH;!10A-C3_X9*ZN-'-_.#!ZT7:;VCOUD]`?M&CZ MP3[\N^3_`5!+`P04````"`!;BEM'@B3IPXX!``!Z`P``&0```'AL+W=OMVZE1*VZ=J_?,=!IX%41*LBQ)EDQQT=*R"+$7719XL%*T\**).2C%]?<& M)/9KFM(Q\"KVC?4!5A9LTE5"06L$MD1#O::WZ6J3^XR0\":@-R);``D[ZPG<+4>X`RD]R!7^')B_);WPU![I#V%:U_V6&[A#^2XJV[AF M$THJJ/E!VE?L'V$8X=(#=RA-^)+=P5A4HX02Q;_B*MJP]G%G>3/(_A9D@R"; M!&DX"18+A3;ON>5EH;$GIN/^[M*52]<>XLC$!)J.T[M&C8L>RWRQ+-C1@X:< M*-G,&UL[7U;<^/&E?!S^"NZ7..*5$5R2-WF$L=5&HW&F40S MTDHSF=U*?0\@T11A@P"-BS1R^2'_89^V:O=W[/O^E/R2/9?N1@.-!D%I[&3S MJ5*.9:(OIT^?/GWN_4V>%^+S*D[RWW^U+(KURZ=/\_E2KH)\G*YE`E\6:;8* M"OC/[/IIOLYD$.9+*8M5_'1O,CEZN@JBY"M1)M&/I3Q)RZ3X_5<'!WM???M- M'GW[3?'MZW1>KF12B.,D%*=)$15WXFW"8T9I(D8B7P:9S+]Y6GS[S5/LP_WV MQ;LT*98Y]`EEV/QZ)==CL3\9BKW)]+#Y\7Q>C.%#^\=-\/SE>)8763`O_I^W MYX>[M6Q^G$Y&_]+\[1A:A]3C31Q<-[\N@CAWAC%S7,@L2A'`4+P."J>=7O_@ M-[_I7.2;*)\'L?@W&63B#?SHH+G94LW;VO9?ILU?/F1!&"77XNIN-4OCYM=L MY>R;0OBEO(X0RS#O^V#EK.[R].K=Z6OQ]OV)I_\)0)P!M&^!-CZ+/\F[9KN3 M,LN:Z_?A>LR"[EN)X/I?0"MJ$W-X'=KI: M`8E=%>G\AZ&X(KH7YV61%T&">'16D29Y&D"*B1'Q8IF4.HSB;]L&<.G6M+W%6T-ZN_9NFPC@*9E$<%;!; M#@(,A:V#.R2OEN]9*:L-\NYR)H$D2J?_6VOS?7/4]]*"MFM#NQ9UEB;7HT)F M*Q'*F<;_,P_^8].X8V9W.S8V[FB`_"HJD,28X.=P(P.;DLF\.E#3O2:\*$V\ MS-?!7/[^*Q`7_H'!3-ORAK000,;4:=R]A#D( M)V5,UY]BMND*2&H)1QSXO=B)TSS?58R[G;KS%BK;>`X(W#X]NR[HG8L`#^!2 M%A&((+N]+^RN,?W":>L-O.'JW7C$S"'8V-(Y%WU[]#F27C#JS3;"T-J\#P"J M:>J7U)HG1/58RKAE:&M_KPKX%S/8\X50EU!%*1I&BUR&&\C'UHP.MI_;3V'O M04+P7)XGP`Q0CLM!.@3"EY_G<N5JO9!Q#@Z&`VTJBJH!'.@A744**!XJ++AO,@0'. M6>(-8:5Q2N*5J];U750[HTD=Z#W"R")+5[HU;%R[6,#,CP0X!PEO$Y`7).R- MU:AUE-8O"MKF+!Y@9Q)XC.P4HM]V?$/J:N?CKX(\FINK20`Z^%@X$EX4EX5U MB54ME5#A""K0Y28*)>WV/`YP"[VC,Q0N(Q`[(!;\UB5?#4W_'AUG\Z1VZSE< M8HO[I,>X?@YPWG(%\YXYE/<&:"&Z3I2P/+\3J.SG,9\9=6U?@]`!1_+[,F<1 MLX4'][WKN]:(JNL;N`?[J\S494%=[".(_`SU3(^"8A8BBA1OX12D9.`$B2%L M_!W_BY1I8&Q(>Z&8W?4;_[4$9,PCQB`Q,XL-.(KAS"<2V#-C*?>-$F2P]]>R?8^7 M^(EN.`L+Q#QID9909@P*AM M%6AJLT.4R6KZJS54EZ+9EYPVD7B4(*%L(,&+$F['`($#W*^[+!).3SB1"8H/ MU^KV]1'7*T6BM:TU.T]+U==MVSXJ3H+DA,./5A)DP5"MKI4`+[)T+F6HT,#G M)2I*N#0Z#LQ%<,?SP#)6`;1&XQZT7S2Y'BK,R$K[;=Q.F1-![;9NQZ8M7$0) MB/J;MK"V7)1]23U`W-8DWK9S8.]^49-W/?BQ48CCSP!"M?7*CH!Z)+#W4(DX MW=#.TBQ+;_%J-P1A?FJGIDLXN14DIKM/#,A)4=YRJ]K0[K!,P[%`-":.)]!8 M+.:*^R%*8(:VF7=`-$%<2[KZZ"^B[KZ66:\)%Y7O&9S'!(4E.M!D^=^J/XI. MWIY7Y7H=$]<'*3*,\CEJV9Y*+0;#OHDF7+O6W$W;9M M?!-$2HNDFT-=,8J7#$6EL[3MQ)EM&X!#LW+9CS&SXHU7,2^O'5)1IK.(.IQ] M3PK+ZFMU1(%4H[FL+:KG.%?E:A7`L0;!Z0HX6;2(YLCP<8!WH:BQUC MAP!I#&Y7B3)H+O[VU_^\E7_[ZW\-\:\RUW^E909_BC03I%P`$O%,X=H!:3_`\3!W ML!D;.E\G*2(&FR'G-A)A'DNY'L'A3#.@"&1M^'5)W,S('^A@B6!E*6R*;@J@ M`#M2Q)7B=I;D@N$11;!.9#`6YP!_!28U-=JL0*3%Z9Q$=L#4<8DT`;+.$+8] MN0X`F4#!;S*\GX;B.PE<(@%AXUT0!W=Y%/!:8'4?D\@(_?D8OG^/IBX4,Z)9 M:0B#+1-P)*4SL3.(-9N>WFKS)P`N3%<`Y6U4_"0S$'Z`?5C0_S&`G1V*]VEV M&]S1Y%>W$JZ7\>`#C(*V-]IZQ$:9!(#!@@3F)$2YC_ZJ5!EUN9`=TR@UR^`& MU6V9P#&'"XZ%4!HX"^DV!\"6XN/X:JR-'_$=?D:S;*B-?S@]<`D8?$TV&Z!M MZO'=\?$%43=23X0,-5I98%C\FI9&4R%VHD31`&XM'"U0`%<"G>+4[!@TE7F, M=GVDNDMY72I5\&KTKR1.('YQ^BLY1VE*VV!/]75)GH@\)^T10+TZ/4$@Q\05 M,B3"^(YV"2@4E*RT4-0IT02J)VC"ODC3`@T#J"$H"P[<[`8+A`'8"/O!+V7,[E=&#F\U MW^4Y\J!:&^O@:K[2Z*(G01J#$X:;H!W>1^^MC]"<'(;+A"!\/ MWLO;VBV9I0G\/>>Y!F_Q,KICLS`SM#<&)*O7%5JI@@RV\U4*_Q([;XZO7NUJ M?U1KPX]K7*+8.;[ZN`ML;TQ3C"8OZ`:]9(LQ2_`G6AUB))W`>0`)+^/KEH^$ M.HJ(&U@E14THMG?:J47 MO1;Y5V,--8[!&[Q"0S:J*Q+7'J-&CZ.M&Z.1S]ZHT*2``J,`X:\T,:IVY M%?'M#,T_@C075HX!4]7!!`46C7RUX[;S]LWEU2Y>57Q6>+%!T0K/3%IL.>5U MS)1/D:+X6"P-XB8=[-7EN;4!JJ[/@12#U@H@Z!D@#H@0KO^"9F'*9),3"E?$$@#=ZQ2D]*%2 M4H!)(^G3D6"R"G0TI8(`P#3\U7-B5W6D5SB$`>K'LZLEGK=?@+*?_R-0MF.I MTLZS"P#WJLT1YK;HTN?W=H7;8>!SZ2%.D2C($U;ADL5KH%]LD^("$(5>;R/S!Y!*0;9(4&O60AV`E2IR>Q!@1O6M.A$T2(>U/K:U+B_1 ML9WKT=;5E8L6,SC8A0[-P%!NT&T&5SU;XOPOG@^/7CSC<*7#@^'AX50,[REO MUP,ZT>*AE(FFXL.$4MW&?O=OH!@:6V%O27BO%*H`>.U((W"L:)-"`/PC/D"5 MT$2$FX\Z24P6_!U:E/)'HMT.1K'F@Y,=[+X$C0>GL^/BZ],-<#K\OX/!^W(E MR6;SQ/-0/O' MG9/`%U7)@]R+R))I0EX77K=34>DG31@=6#7=$<(+`'&'0&/6_&/'&F7P;Y[X(YR&`R MNZO#1-MPPA=89OW\I@0Z-8;:1?09_\X'?Y9+M(KE@Q,0KS!($,0@">?.N$CY M_)`#I1KL#'U`>-&A$)"E-TJ_/X/&@U=E1/;E?&"'3H9=H0/=6":72QN=H/(T M>L?NU;=^]ZJG61=9'.X*3R\VH%X#<5^3]\Q535@8:G7\]D\HN`7*>;(_&>^) M%6B#&F=/Q-[A^$C_U+REL$64.W>4'8BMU2X$TPJHUUJ9QY)54];@5@:1D>UM M2"\@[$J4V1$;-67-^(\Z$#)D0P2:+71X=Y0!T2"K9S&?#':2E4N/+A@DO`RR MW^$M/6,+R`UZ$TC`U6H$G\Z:(,8_?$/HP'!Y&M-[FLC:ZMPPB!RN362RG"I;9W&LPMD'2I#(5GU*"P.6^3E&E4:J:SFZ0R')RE6N6Y8OQJ+ M/X#V=H-!>84#.,Y&^`O9`+"0&&A`P>L(1VF`0P;?5H&Q MQRK?Z+T;8-*[H__V:$\]V3G:%;4L*._@>-GIE@,K-LW#_:[UH%OI`\-J1TF& M\:D!O]@.MP59#4:#SIA-RWO5BRH&'AP/=-1R(U3ZWN+<\$O(GU'2[)EJIH(M;$[4Q9FR\)5$*QD[A_+:L2]*)D,XRD+ M%'Z`'G@3O`.\IP"K9GL>:S30/A?FKZBE+:-UQVCM[7DTCNKKZ*P:J-77PLGU M]N=&PAR\=6A"^4?)5:.'FGL`*FIX:\69'=COWROV?_`R9`NAHFS3,)"6N<2\ MFCA:&.>FSJNL//`S6=RBO:&X3=DB"V>0/#,LH612B1*5#Q086!26@#1UE5M7 MHI8,&L"-G2P[2C'\@%F#Z/SH_MHEE3_;%?7&@T;R8E]%U_)Y-X_XUL?6)([6 M0`%2&M$_M33,>A.5\M7L!]H;&JH+\2:8DT=C<)Z(\WF1$A!3FG:?Q!A)L6:4 M\P';*>;G8.F95&@%11MB`P7.2HR9I5_N'IU0E.*CU?' M,*WV.@%_3I622&#D=\ICC]R?(L>P=PL8'.>3SN+H6GGRV+]%EV8#+T3CUV6` MJ?^2A5@5^G229NLQ3:%^>)>B[?2#/I,;"M;BX1:*)M1V!NC'FU.& M+%$S>T'9A\]QFA8"=%]<,.I,56XF:)H&'O8R-+L$<9Y6-F18P=YAM8`2T+Z* M.-C+V??V\5A.QD@GU#T;U/U<*+T05:LRHDDJ@B'659[7*<@J`@5L"9 M61O#7CRW;;:VAF$)*BRE2RH&3!*L9K@39D94MSAR5OZ(?!&0??;VU?FE6,=E M+J;CR=?XTQ[^>R>4:Q4VHA1L^"<9*<2RP"8=RKG4O&7M/QWM<"IDN$!'M)Z)N.]PWLL MB$>7QL!0)A2S3`YE2VFI8WT\^(2;WV1P;4>9V"`-&30'7=?BMAF!0.^`!HS; MM812AS13HIX[!Y':#,+D@D1/,HYSN%>SZY1:[+*AS3`C8S&QCH)]DWAW M0RE1R"2KP<:#CCM)B02M=U-U%Z)/V2 MA#DXAZ>OWGYX?2QV8(]"N2"[BE:$&PO;G!$#R?@ M(>],7A3NAKJ.S#0J9M`D;T:K%0S"]CN\6W`,E6`E(K)5DK&38W<601G#GZ"Z MH$BV>95C<8*48U*HHQ:2?<)Y!EL83 M<27#V=>$?T.<2(<+I?A](C&V+6O';=&E(#TG;U:C0].&9"*E2%Z[Y79W'!&C M(R`;;@0G,="8%WOX"^[KA!?!W\,N]4GC@]8,'-U`KQI]JB$,T512*D>CV14VTV)*E-3APWH,1D(67HVL]Y++22F,,I]3*XV#E$R?B,=H%RD M0]LWH!-`F1+;%F=?"IZ%FC0#XO>!7J@5BHM@V(8LEA+P9,O129#%J0+ M[2#,S62(%&8!9MN:\W+%%+T5KZM%O[P$^!JQ+1:Q5+`:!48T/9'O!U=R6QT]9*36UM.A,1 M)XKSJCY_^^M_J%X#NXKC`[RA*+R#QJFP'J)9H!9P,!D_K\P\IEY6P"&]6#3Q M:,^2@BA$X6!O_*(]0F&,275SJ71QC"Y3ZCJE&%*,604+1Q`%*Y4PJ)(1VZ2R M6^5\M=<1P`$E2_]"',`B#KH7,1T?BIFV?JF*F,:O7AN6(GSA9$:+B'7O>@ZZ MT-81Y;$N<^VW!YE,-N(E6ZJRJ(3N6I"G&U_FM1)-#\;[U694YCTUDW+`VPNJ M^%"PICB>T+L1XT%5/DN1G4Z.P-S29ZQ#S"AAAVX\-YF\P+_P>@>0CO$.HR`W(]]0"_R%,QDY2*4'L+1$N`PC%206 MLB47B!JU6V:UE>&-+AMT56V*/9A738!#R`!D0=QS9C/-"',0[:(;9?(%G!1%;-(AT-X`%+LHXWBD MMA;I>5@EKU!R^1W_K,RKP,51Y+0/X5`O;6T%))*X0>R!H^)H"%*/:61<*=_! M:#O)M3D>+ET,$%;0`%GO1+#B:G5FP=LO-HYM4!2Y^&AT*.STU;R"EO:;MVH;!>VH.'(2_=>: M:2<%R#*YLXF$P[^WQ-Q^&P\-8-' MZ$HS*D5;$2K;]UU2@)+FBILJ3N'V1:SR60K$S%)AE/81N+'H2@F!1:.H5?GJ MK2#4)BDJ[;$7:$Y2A^*L=.C;V0D;P*9'SZVMX>C4@Z-*`&G*?KU`UFQ>L_?P M_I%J*H96/*_$407EBXH;-X!L#[BC6B"P1[G6*%21G;NM@;/TF6.UO:?Z(KO` MB\S]?FEN`YVXC&>4(B"`8O^-=)KSNDS34E$'=+N]\>'@.SX>2@]3*$93U4*B ML;0Y4*VTCAKBM'[QZDO4J%LYJ9'G]7W4Q-0<<`.Z22[5N/9;4K[`+A!B1EB8 M7U#MFS^34OS+;0;H668S_DR,I/\N3,8O!L8&Q[*G+HM5%^ZT\6H,LJEM;B"5 M"<1*NLT,0V9T\T6(LJ@>LDLZ*"AM-Y\K3SIM0U[.L>`"UUB`.2K[48Z9WWC] MUW]N&D.T($%F%XO]%=&J%F&K\NMZ8^,>>J5S4BV!QT>-;!P0DJ%_;YH?C:!!TAI37-?LZHRAA:EZ%A^@>/ MI)=$40#6_6_1!*J,'#4^R^=9I#:E0A+F(Y`Z%R4-T<8C0W0&.#@2Z?:2,"$> MQ=VQ:(H-CO.E.NAV8G1[+2RWV=;QO]/IKO",A:G=FK"-(;"R(Z[L:=7&5@Y6 M7Z'*6VFJ;"G?M1U`0W4C@O`&-AD8&[JT%?G`3K+,>ZO*5&"*;\!U]WDPRS"I MY4[.'+!Y"2@_EJDJ MXQ0HV<#HH*0UA:A_8\*ULVEIK;#F[ZHI]M04N:W'.-,I<(8FL;;>`B?/`3]Q ML)E>V)Q@@0X4I$:KK\'?7?43M8P4-:;1K!1N31MKK]`IS!:J.<8LSE)^RP:+ MB3I9*IB+^CL$HD+9?ONNF)ERJXZ;,A34;?4MM-G<(74T].(LN!+$M4EI40%V M-CXWRY:]3G6P10Y9Y56HO%2$?T/P=XY359&4)D.-6XY5U;Y*#PRNSW,IPVLN M1("%N:P8<'8W\/^W90)X:P4:1P7E$%C@U(-R?VU(/EF220MI]=G;)J_ILP20 M\OY=&>WL\FC5=RM52U-#E(4C9-5W3=]E+EA53/51=IFN;9>LAR,"E#=(GVDR MT@E>:S@A!G@^E,/*D:*KJZD8"73KC''9)QYT6TNM\QT.<6G@7+ODB)];EG`E M.9@`&-MN8@JP$=_$$@]JYTS4UZRM,'"%-597X&S=&#N.CG*QW:3`D`&\-)%: M'@9$(7=UP$-!IK%YMI]T#3Q21W+@*FEF]AC`H&86*Z2CH'`?):^S#4(79;-N MPXI'1>UY9O-Z/,FB5['0^P:!_#I1'\?6@6^X1KL6A;DL%3*L/K42:J84-E<. M@4ZZ=O,73WCZ5.4V\ININ M?%@PK%:0A?1-&&EK*'!9TS$BVTY:WH5/&![0`B4O7 M)>W[EO,I@A]DPJ6[;C$89CPXMT)=V>1P*15>+S#Y(2?[T"<6U0%("B:7G,I! M#,Y*:TYUOH15W!H+[>BP05T7KXJ[TAJZX=H4",<%,HF=SX-<5KN*)$\7&Q\G M'9095,E=*OYQJ,5%!\JAKH.EH:(T"!7P9@)%`65Q3/R\>@0@-R4`,Y-+Y8[/ MIH=K>H3&KC=8C9)C"08BEDQC^@$&4YZ#`7HR/;*,XV0XM5S];<9=[9VHKK,* M9HN!5N&'1FU'+[EMDN[KEV4S_HL*3DXN>O*LBF)H`]2@J@+%LL.#[%YN(63# MKNLDP"HGKK8:,D-/FK9RZX<&C&ZU;BH(P*^C5*(=LL8_*)'PV%OU?:O.V]LT M]G>%9X:@=08\_,:J8,0IP.$-:$$H8C5>+Z!#9H>.5S:B%159/BVQXW,G7$:E>!SBYMOEE77[-=M`$/'RI)'"F`-@OO6BJP MJN154Z9.E4Q`YF;YPZ[3(#;W:Q,G$:T/15E8"52T13[*-8A#D[-'$IE^U+2;,1_%`_SLD>#")TMHK9U`] M%")$O7GL*PU(>JW*'7(;*VFB,@/;A3%5K$;!+$I7:QR+8RJRJBH7M>LR')#9 M6$93O39U7Y0LX+Q5MB%8WI*HR/:(_6I5&9%)<`98YQL-<:3&L^3"AV!N-%_< MQK"Z[SPVEU^PYE?M*4YQ$A!#[V4JLNIA*+5OI)/0^O5O]$W29+O^S<>1^_4: M#3H>'J8UW7\WF='M,)?;Q:51,J%6OWIM]O96#>?G1K5)ARCH';6G.V?T]-RE M$50'ZFD:\]*<(8*1OF=U528*BO?'VY15#38!CG1T MC;IUFHH9,G_;C#:CHK_$'.D68Z6Q=9?8JZ1]1:H7VT`M\R..2,Q663=3>_?M M%3%YL/Q9GR\JRDK"NFT6UC4:MUIAP.:UG'(`JX0^='C0=6'`)%70?>MFELL? M2\0.)P5N;+"]>'^`+^$T1K&K4>P912J;+X[EB-JAO^Z<1U)K+SZA)LTO/IW77WSJ=<0>'X]Z?#SJ\?$H^?AX MU./C48^/1_W__GB4H'I^C>GR.ZO$YJL?GJ!#$ MQ^>H-E&V(X:TO#:U\X'B+QS3P-5\"?P"-O1\(?CU&+0/Z*=B-C]L]?BXS@,? MU^FU,QV/\?Q#/GGC711*/6E"U$S6IRV>S7E\7N:^S\OT(K'+>M0L_*(#1>'> M[/ENS?_QIQ5ZX[['(WNJOE_A[KT/6I3;GGDSTP`)CYS:2HKDA;ZZYSY?XYRC[WP?FSE;2*Z MK614=(99%8Y(?N`@49-9?LD%[%32^@,VY[$^W3],?;I>9*-(0L7P.C7M'@M: M6`-V'C]=R(*DP[;B81M1^W^L2D7?3'HO%5:N>LLNSP%HR)O.JD@P-XOH,8UU M>TB:6&PH,8U+H[:''\D4;D=4?+3S\#F9_=>YTO])ELG1XTPI-8M.D@ZV M.5_8^1S5J;-FW%H0?8Q9;<:L=FS*=QR3>J9B4H^KF-1/:)?==G/^N6)'^QAF MWZ.\C@C:%3NO91%$,:Q\I(R.K4*1,68^Z('W/K!M:QVN+^'CU6NQ\V17/!%/ MK2!*DAR&U@\?=.CP$%K:_]V$<%O+<#?R_)9@AY%U&X9]S3>CO&8&]MA[?2CM M0E3-Y.L(:0WKKR/TU(S!S@W8M`W?XW7S[1?4^>*Y^,L99CB_Q;`=)\=Z@R&5 M4E6;?7J;:;><+'%?;ZULUG7[^5_>$0-SEF/LV)N;5O9M'/J-LF][FVN[MW]J M8P]_7;.''U-M8;*';P:JLI._M>SD_N:(0=]'8U?OP);''N[AN?V($82%L4F% M<&BGZZ%US^/&O<%^J+W^/JOM)\>V<3;/ZC:)D@\PWV]OI[\71EJT%>?P]12L MO]!B/2WOLSID_X4W#Q+J;-%O_W:/'WSHE&_1-EU#^N7L;U\AUMM;^TK?;>YLI.[_W^#A.!RI7W MN_,$\+#]E=UFOSVVX+EWTN?.Z5ZT=VLZ#-IXK+.7\V)L7HA5],EA,RU*FV&Z MAZJE`P&2)O"2QFNTG32K6(+['%;C:;5FO^:3?^XCL7[J\+PLJM5_'Y(&O_D- M1IRT[+Y5UJKQM%?SX;AFY^EX;^)87K=8F_@9:%R_).G@W4?/BL#XI5_.N5]# M)Q?+;:@:MI/?8?O/'[L?F]VPR^]-\8:/5_I)0WPAXF?13J7;8>Y,O3Q[;DBV M+P>`S@\AP-JKJ:2?X(L+ZNE!HB'WV=,-F*)W5[\LV(BA-`FA.9'X#+^?8R5> M`.R2@I7I&=O=W@>M7@#.O,!`Z4GTB"#]CJ_BNL=DXAZ3)I]\V*;0>[5?=HH' M(W"O;=E-/N_W`-]'_&AW`K?";_++>]IUNVGLX5G\I M#VI]-RN;3KN51;N??*1%YB)5ZK\&_W%5B0C#H^UVRG"MGH7INM7[^6@W]O*X M1AW+69=_U#GGRDOJ6HULIZEWBLIO.N0$\7+EM$6_;W,3_6QGZA[Q(P^,Y,EU MF,11&Y?8.VC[M=VGVT=2;)/_*AKT4*+5YT#U:6]IJ_1]1S]>9]P'WY+:U/A$ MO=Q5MU7:#UO]+%K"^3R-'5"Y_JY@V$U.@ZWM"1WO3IE/3C5SL^?M3.)DQYO-W7LS]9/,[E^ M5)U#HKP*;6\O]7AWR2?/.,-YGP#RK[(VO1I&!T*@>;LJ[OY;W[L]KOC^"SVG MTT:OAJ5W/*#SB[WOXS=;?K&G>5J6_(5FL4-:[C.+^V9/V_9T/5CBM>14FE2Z M:):(:-(LY_=0H7Q3R:OY),;&AS6:$#P_;+MW?U6X]/#W=;\U'O%UA!`ZQ#U4 MS7OMX*GOD65U\32>@FEVW_=(3@?]3&WWA=J\_=)YD52\EM]&::7[=A&M([ZN MKUXPW:MYZ1TK%]/%4&P.]/)V]<1ZFN\FX,[;PD2+]06O%D6V<6)OR)ZG9V?T MGE=]:0]LO`]F-P[IP?C&?MZ=V-C3NT/;+O^!N/P2&U3%/9+-!&YQ#%HT,8\U MD#W&>^'3U3:?X\WQG?6CW=Y&[%Q>?U ME_9ZKFL[ZF@-GOTBI]@SCLN^O?N?ZWYXN>])]$8@=Y[&J3;KB+T# M$(3NW-M/U6_0S>`V;&OFC3C>(K3X7EY?"Y''U6LOUJ@:'JI`<&F*Y6"K]VE2 M5<_A>F!=QKG>,<+-CEN%"3MF:PZP[HA,H<#K#=_W_>$VOIW[TC')]]G>>T88 M.]+DUN'&CB*B8H]=['8_HF$OV7IPI]?[#?;55$/7.RX!W.+)!AIK/.+10<^7 MS><-BK3E?0BVO%&I#:S-EO+IZ5#)+[N*_OL4B>HI@[8'#!R;\W81VGVBIGPX MM:;JPN7[>BWGUK+F;L7U98O%7'.9$]VMJEOD.\(?=*7WS5,.]>,1K@+8JNAM MB>F'![W7MZ@',GKSDFIFE(@J3M:YK;+E?8(6MN^H013KHWV".@3)QX%[W2M! M:XHR3P07V;S?7#K._E3%V3\0J-B?&,2058Y5^TKV37I_:GM@-'^=ZBQ*`=06 M\-^JX#[(7;F!Q(;P`<1HCS.D=0B51=!%F-PNIG:6J35*//=7GX/TLU!)`$CU M?>EBU/LTJ)XC#<+HM96+\,&N^KP=1%MF.CCZIE.\N3OJ:Z)*,6\:QU[%AOK+ M?F>S,V97Q'C-5FI;M)7]C*3/S+V#IY-)W?;Z-,^+;_\74$L!`A0#%`````@` M6XI;1WCD3B3U`0``/R$``!,``````````````(`!`````%M#;VYT96YT7U1Y M<&5S72YX;6Q02P$"%`,4````"`!;BEM'2'4%[L4````K`@``"P`````````` M````@`$F`@``7W)E;',O+G)E;'-02P$"%`,4````"`!;BEM'JNP8(_0!``#_ M(```&@``````````````@`$4`P``>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E M;'-02P$"%`,4````"`!;BEM'#\]^1TD#``#$#0``$```````````````@`%` M!0``9&]C4')O<',O87!P+GAM;%!+`0(4`Q0````(`%N*6T>X+-H4/P$``&D# M```1``````````````"``;<(``!D;V-097)PC$`8``)PG```3``````````````"``24*``!X;"]T:&5M M92]T:&5M93$N>&UL4$L!`A0#%`````@`6XI;1_2I=ZIH`@``0@P```T````` M`````````(`!9A```'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! M`A0#%`````@`6XI;1\/B":52`@``]`<``!@``````````````(`!R1<``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`6XI;1_Z_ M$2*0`P``V`X``!@``````````````(`!WR$``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`A0#%`````@`6XI;1R,T)\ZB`0``L0,``!@````` M`````````(`!#"T``'AL+W=O0N``!X;"]W;W)K M&PO=V]R:W-H965T&UL4$L! M`A0#%`````@`6XI;1P)N$+&B`0``L0,``!D``````````````(`!E#(``'AL M+W=O&PO=V]R:W-H965T;'ZFOHP$``+$#```9``````````````"` M`48V``!X;"]W;W)K&UL4$L!`A0#%`````@`6XI; M1RF*[ARB`0``L0,``!D``````````````(`!(#@``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`6XI;1PQ)E-NA`0``L0,` M`!D``````````````(`!JCT``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`6XI;1ZDW#V&C`0``L0,``!D````````````` M`(`!,T,``'AL+W=O&PO=V]R:W-H965T M9&``!X;"]W;W)K&UL4$L!`A0# M%`````@`6XI;1XLMQ_:D`0``L0,``!D``````````````(`!S4@``'AL+W=O M&PO=V]R:W-H965TQ,N/UI@$``+$#```9``````````````"``8-, M``!X;"]W;W)K&UL4$L!`A0#%`````@`6XI;1Q-D M4+6E`0``L0,``!D``````````````(`!8$X``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`6XI;1Y^MQ*FD`0``L0,``!D` M`````````````(`!`%0``'AL+W=O&PO M=V]R:W-H965T[)O^.L@$` M`!8$```9``````````````"``;57``!X;"]W;W)K&UL4$L!`A0#%`````@`6XI;1X13-N*M`0``%@0``!D``````````````(`! MGED``'AL+W=O&PO=V]R:W-H965T\]_;&UL4$L!`A0#%``` M``@`6XI;1[-*Y+T_`@```@<``!D``````````````(`!:U\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`6XI;1^BV00K) M`0``J`0``!D``````````````(`!1F<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`6XI;1\A8V5V%`P``ZA```!D````` M`````````(`!PVT``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`A0#%`````@`6XI;1]%I%KXL`@`````>&PO=V]R:W-H965TM:>FU&`0``$<4```9```````````` M``"``5E[``!X;"]W;W)K&UL4$L!`A0#%`````@` M6XI;1[<4!7>T`@``\PD``!D``````````````(`!J'\``'AL+W=O)S958<"``"X"```&0`` M````````````@`&3@@``>&PO=V]R:W-H965T_R?$;3`(```\)```9``````````````"``5&%``!X;"]W M;W)K&UL4$L!`A0#%`````@`6XI;1PU"\$LH`@`` MB`8``!D``````````````(`!U(<``'AL+W=O&PO=V]R:W-H965TY M\%"/Y`$``!8%```9``````````````"``7",``!X;"]W;W)K&UL4$L!`A0#%`````@`6XI;1_>;@DPU`@``T@<``!D````````` M`````(`!BXX``'AL+W=O&PO=V]R:W-H M965T").G#C@$``'H#```9 M``````````````"``563``!X;"]W;W)K&UL4$L! M`A0#%`````@`6XI;1P!CA"7&+0``*MX``!0``````````````(`!&I4``'AL H+W-H87)E9%-T&UL4$L%!@`````_`#\`*Q$``!+#```````` ` end XML 15 R46.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Schedule Of Option Activity) (Details) - $ / shares	3 Months Ended	12 Months Ended
	Sep. 30, 2015	Jun. 30, 2015
Stockholders' Equity [Abstract]
Options, Outstanding at beginning of period	2,809,238
Options, Granted
Options, Exercised	(250,688)
Options, Forfeited	(12,546)
Options, Outstanding at end of period	2,546,004	2,809,238
Options, Exercise price of granted options
Options exercisable at end of period	1,987,218
Weighted Average Exercise Price, Outstanding at beginning of period	$ 29.63
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised	$ 18.34
Weighted Average Exercise Price, Forfeited	44.32
Weighted Average Exercise Price, Outstanding at end of period	30.65	$ 29.63
Weighted Average Exercise Price, Options exercisable at end of period	$ 27.67
Weighted Average Remaining Term to Vest in Years, Outstanding	2 years 6 months	2 years 6 months

XML 16 R33.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Narrative) (Details) - shares	3 Months Ended
Earnings Per Share (Narrative) (Details) - shares	Sep. 30, 2015	Sep. 30, 2014
Earnings Per Share [Abstract]
Stock options not included in the computation of diluted earnings per share	98,697	154,551

XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 18 R25.htm IDEA: XBRL DOCUMENT

Cost-Method Investments (Tables)

3 Months Ended

Sep. 30, 2015

Cost-Method Investments [Abstract]

Schedule Of Reconciliation Of Changes In Cost-Method Investments


	Three Months Ended September 30,
	2015		2014
Balance at the beginning of the period	$	25,600	$	14,850
Investments		4,582		500
Balance at the end of the period	$	30,182	$	15,350

XML 19 R50.htm IDEA: XBRL DOCUMENT

Legal Actions And Contingencies (Details) - Contingent Obligations Under Recourse Provisions [Member] - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2015
Loss Contingencies [Line Items]
Receivables sold to leasing companies under debt factoring arrangements	$ 16.1	$ 2.0
Recourse liability recognized	0.5		$ 0.5
Maximum potential contingent liability	$ 9.1		$ 7.2

XML 20 R42.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Schedule Of Long-Term Debt) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
Long-Term Debt [Abstract]
Current long-term debt
Non-current long-term debt	$ 500,587	$ 300,594
Total long-term debt	$ 500,587	$ 300,594

XML 21 R37.htm IDEA: XBRL DOCUMENT

Cost-Method Investments (Narrative) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015	Sep. 30, 2014	Jun. 30, 2014
Cost-Method Investments [Abstract]
Aggregate carrying amount of cost-method investments	$ 30,182	$ 25,600	$ 15,350	$ 14,850

XML 22 R52.htm IDEA: XBRL DOCUMENT

Derivative Instruments And Hedging Activities (Summary Of Amount And Location Of Derivative Financial Instruments) (Details) - Foreign Currency Contracts [Member] - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
Derivatives, Fair Value [Line Items]
Net foreign currency hedging instruments	$ 1,664	$ 1,038
Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Foreign currency hedging instruments, assets	3,684	1,644
Other Noncurrent Assets [Member]
Derivatives, Fair Value [Line Items]
Foreign currency hedging instruments, assets	1,574	1,348
Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Foreign currency hedging instruments, liabilities	(790)	$ (1,954)
Other Long-Term Liabilities [Member]
Derivatives, Fair Value [Line Items]
Foreign currency hedging instruments, liabilities	$ (2,804)

XML 23 R47.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Schedule Of Activity Of Restricted Stock Units) (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	3 Months Ended	12 Months Ended
	Sep. 30, 2015	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units, Outstanding at beginning of period	2,312,529
Restricted Stock Units, Granted	7,477
Restricted Stock Units, Vested	(25,245)
Restricted Stock Units, Forfeited	(5,839)
Restricted Stock Units, Outstanding at end of period	2,288,922	2,312,529
Weighted Average Grant-Date Fair Value, Outstanding at beginning of period	$ 43.65
Weighted Average Grant-Date Fair Value, Granted	51.49
Weighted Average Grant-Date Fair Value, Vested	31.30
Weighted Average Grant-Date Fair Value, Forfeited	44.90
Weighted Average Grant-Date Fair Value, Outstanding at end of period	$ 43.81	$ 43.65
Weighted Average Remaining Contractual Term in Years, Outstanding	10 months 24 days	1 year 2 months 12 days

XML 24 R9.htm IDEA: XBRL DOCUMENT

Inventories

3 Months Ended

Sep. 30, 2015

Inventories [Abstract]

Inventories

(3) Inventories

Inventories were comprised of the following at September 30, 2015 and June 30, 2015 (in thousands):


	September 30, 2015		June 30, 2015
Raw materials	$	75,490	$	74,416
Work in progress		2,215		2,550
Finished goods		180,904		169,893
Total inventories	$	258,609	$	246,859

XML 25 R43.htm IDEA: XBRL DOCUMENT

Product Warranties (Details) - USD ($) $ in Thousands	3 Months Ended
Product Warranties (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Sep. 30, 2014
Product Warranties [Abstract]
Balance at the beginning of the period	$ 9,823	$ 11,798
Warranty accruals for the period	1,790	3,376
Warranty costs incurred for the period	(2,039)	(1,567)
Foreign currency translation adjustments	(691)	(714)
Balance at the end of the period	$ 8,883	$ 12,893

XML 26 R29.htm IDEA: XBRL DOCUMENT

Stock-Based Employee Compensation (Tables)

3 Months Ended

Sep. 30, 2015

Stock-Based Employee Compensation [Abstract]

Schedule Of Assumptions For Fair Value Of Stock Option Plans And Purchase Rights Granted


	Three Months Ended September 30,
	2015		2014
Stock options:
Weighted average grant date fair value	$	-	$	-
Weighted average risk-free interest rate		-		-
Expected option life in years		-		-
Dividend yield		-		-
Expected volatility		-		-

ESPP purchase rights:
Weighted average risk-free interest rate		0.1%		0.1%
Expected option life in years		6 months		6 months
Dividend yield		1.73%		2.00%
Expected volatility		26%		24%

XML 27 R28.htm IDEA: XBRL DOCUMENT

Product Warranties (Tables)

3 Months Ended

Sep. 30, 2015

Product Warranties [Abstract]

Schedule Of Changes In Liability For Warranty Costs


	Three Months Ended September 30,
	2015		2014
Balance at the beginning of the period	$	9,823	$	11,798
Warranty accruals for the period		1,790		3,376
Warranty costs incurred for the period		(2,039)		(1,567)
Foreign currency translation adjustments		(691)		(714)
Balance at the end of the period	$	8,883	$	12,893

XML 28 R44.htm IDEA: XBRL DOCUMENT

Stock-Based Employee Compensation (Schedule Of Assumptions For Fair Value Of Stock Option Plans And Purchase Rights Granted) (Details) - $ / shares	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value
Weighted average risk-free interest rate
Expected option life in years	0 months	0 months
Dividend yield
Expected volatility, minimum
ESPP Purchase Rights [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average risk-free interest rate	0.10%	0.10%
Expected option life in years	6 months	6 months
Dividend yield	1.73%	2.00%
Expected volatility, minimum	26.00%	24.00%

XML 29 R30.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

3 Months Ended

Sep. 30, 2015

Stockholders' Equity [Abstract]

Schedule Of Option Activity


			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period		2,809,238	$	29.63	2.5
Granted		-		-
Exercised		(250,688)		18.34
Forfeited		(12,546)		44.32
Outstanding at end of period		2,546,004	$	30.65	2.5
Exercise price of granted options	$	-
Options exercisable at end of period		1,987,218	$	27.67

Schedule Of Activity Of Restricted Stock Units


		Weighted Average Grant-Date Fair Value		Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period	2,312,529	$	43.65	1.2
Granted	7,477		51.49
Vested	(25,245)		31.30
Forfeited	(5,839)		44.90
Outstanding at end of period	2,288,922	$	43.81	0.9

XML 30 R31.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Sep. 30, 2015

Fair Value Measurements [Abstract]

Summary Of Financial Assets And Liabilities


		Level 1		Level 2		Level 3		Total
Balances at September 30, 2015
Foreign currency hedging instruments, net	$	-	$	1,664	$	-	$	1,664
Business acquisition contingent consideration	$	-	$	-	$	(1,514)	$	(1,514)
Balances at June 30, 2015
Foreign currency hedging instruments, net	$	-	$	1,038	$	-	$	1,038
Business acquisition contingent consideration	$	-	$	-	$	(1,584)	$	(1,584)

Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs


	Three Months Ended September 30,
		2015		2014
Balance at the beginning of the period	$	(1,584)	$	(480)
Acquisition date fair value of contingent consideration		-		(905)
Changes in fair value included in operating income		-		132
Payments		-		458
Foreign currency translation adjustments		70		(80)
Balance at the end of the period	$	(1,514)	$	(875)

XML 31 R8.htm IDEA: XBRL DOCUMENT

Earnings Per Share

3 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Earnings Per Share

(2) Earnings Per Share

Basic and diluted earnings per share for the three months ended September 30, 2015 and 2014 are calculated as follows (in thousands except per share data):


	Three Months Ended September 30,
	2015		2014
Numerator:
Net Income	$	80,403	$	83,260
Denominator:
Basic weighted-average common shares outstanding		140,309		140,127
Effect of dilutive securities:
Stock options and restricted stock units		1,637		2,556
Diluted weighted average shares		141,946		142,683
Basic earnings per share	$	0.57	$	0.59
Diluted earnings per share	$	0.57	$	0.58

XML 32 R32.htm IDEA: XBRL DOCUMENT

Derivative Instruments And Hedging Activities (Tables)

3 Months Ended

Sep. 30, 2015

Derivative Instruments And Hedging Activities [Abstract]

Summary Of Amount And Location Of Derivative Financial Instruments


	September 30, 2015		June 30, 2015		Balance Sheet Caption
Foreign currency hedging instruments	$	3,684	$	1,644		Other assets - current
Foreign currency hedging instruments		1,574		1,348		Other assets - non current
Foreign currency hedging instruments		(790)		(1,954)		Accrued expenses
Foreign currency hedging instruments		(2,804)		-		Other long-term liabilities
	$	1,664	$	1,038

Summary Of Gains (Losses) Associated With Derivative Financial Instruments


	Gain /(Loss) Recognized				Income Statement Caption
	Three Months Ended September 30,
	2015		2014
Foreign currency hedging instruments	$	(39,353)	$	(11,054)		Other, net
Other foreign-currency-denominated transactions		37,081		12,148		Other, net
	$	(2,272)	$	1,094

XML 33 R40.htm IDEA: XBRL DOCUMENT

Goodwill And Other Intangible Assets, Net (Schedule Of Other Intangible Assets) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Jun. 30, 2015
Finite-Lived Intangible Assets [Line Items]
Total other intangibles, net	$ 42,600	$ 47,142
Developed/Core Product Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	66,104	67,548
Accumulated amortization	(51,144)	(50,373)
Total other intangibles, net	14,960	17,175
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	2,478	2,500
Accumulated amortization	(2,214)	(2,206)
Total other intangibles, net	264	294
Non Compete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	1,590	1,747
Accumulated amortization	(1,590)	(1,704)
Total other intangibles, net		43
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	29,102	30,538
Accumulated amortization	(19,532)	(19,308)
Total other intangibles, net	9,570	11,230
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Other intangibles, gross	63,533	66,585
Accumulated amortization	(45,727)	(48,185)
Total other intangibles, net	$ 17,806	$ 18,400
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, estimated useful life	2 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, estimated useful life	9 years

XML 34 R53.htm IDEA: XBRL DOCUMENT

Derivative Instruments And Hedging Activities (Summary Of Gains (Losses) Associated With Derivative Financial Instruments) (Details) - Derivatives Not Designated As Hedging Instruments [Member] - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	$ (2,272)	$ 1,094
Foreign Currency Contracts [Member] \| Other, Net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency-hedging instruments	(39,353)	(11,054)
Other Foreign-Currency-Denominated Transactions [Member] \| Other, Net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other foreign-currency-denominated transactions	$ 37,081	$ 12,148

XML 35 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
Current assets:
Cash and cash equivalents	$ 822,053	$ 717,249
Accounts receivable, net of allowance for doubtful accounts of $13,394 and $12,276 at September 30, 2015 and June 30, 2015, respectively	327,168	362,568
Inventories (note 3)	258,609	246,859
Deferred income taxes	41,494	36,338
Prepaid expenses and other current assets	83,476	81,168
Total current assets	1,532,800	1,444,182
Non-current assets:
Property, plant and equipment, net (note 4)	368,984	387,758
Goodwill and other intangible assets, net (note 6)	305,418	311,403
Deferred income taxes	11,990	12,528
Other assets	35,487	28,389
Total non-current assets	721,879	740,078
Total assets	2,254,679	2,184,260
Current liabilities:
Accounts payable	77,482	81,112
Accrued expenses	117,651	132,976
Deferred revenue	34,848	36,097
Income taxes payable	26,550	16,278
Deferred income taxes	776	796
Total current liabilities	257,307	267,259
Non-current liabilities:
Deferred income taxes	7,968	8,062
Deferred revenue	23,446	19,284
Long-term debt (note 7)	500,587	300,594
Other long-term liabilities	2,804
Income taxes payable	1,754	1,754
Total non-current liabilities	536,559	329,694
Total liabilities	$ 793,866	$ 596,953
Commitments and contingencies (note 12)
Stockholders' equity: (note 10)
Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued
Common stock, $0.004 par value, 350,000,000 shares authorized; 179,925,750 issued and 139,539,516 outstanding at September 30, 2015 and 179,660,939 issued and 140,474,705 outstanding at June 30, 2015	$ 558	$ 562
Additional paid-in capital	1,248,077	1,228,795
Retained earnings	2,014,344	1,976,020
Treasury stock, at cost, 40,386,234 shares at September 30, 2015, and 39,186,234 shares at June 30, 2015	(1,506,542)	(1,444,554)
Accumulated other comprehensive (loss) income	(295,624)	(173,516)
Total stockholders' equity	1,460,813	1,587,307
Total liabilities and stockholders' equity	$ 2,254,679	$ 2,184,260

XML 36 R45.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Narrative) (Details)	3 Months Ended
Stockholders' Equity (Narrative) (Details)	Sep. 30, 2015 USD ($) $ / shares shares	Sep. 30, 2014 USD ($) shares	Jun. 30, 2015 USD ($) $ / shares shares	Apr. 30, 1997 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost of common shares repurchased \| $	$ 62,000,000	$ 42,900,000
Common shares repurchased	1,200,000	800,000
Additional shares that can be repurchased under the approved share repurchase program	14,300,000
Number of shares repurchased pursuant to the repurchase program	40,386,234		39,186,234
Cost of shares repurchased pursuant to the repurchase program \| $	$ 1,506,542,000		$ 1,444,554,000
Preferred stock, shares authorized	2,000,000		2,000,000	2,000,000
Preferred stock at par value \| $ / shares	$ 0.01		$ 0.01	$ 0.01
Preferred stock, shares issued	0		0
Preferred stock, shares outstanding	0		0
Stock option and restricted stock units expiration period	7 years
Common stock authorized for issuance	43,700,000
Number of securities remaining available for future issuance	13,800,000
Reduction in the number of shares of common stock available for issuance	2.8
Maximum number of shares subject to awards granted	3,000,000
Number of common stock shares granted in participant's initial year of hiring	4,500,000
Unrecognized compensation costs related to unvested stock-based compensation arrangements \| $	$ 57,100,000
Expected weighted average period of unrecognized compensation costs related to unvested stock-based compensation arrangements	2 years
Aggregate intrinsic value of the stock-based compensation arrangements outstanding \| $	$ 168,500,000
Aggregate intrinsic value of the stock-based compensation arrangements exercisable \| $	46,300,000
Aggregate intrinsic value of the options exercised \| $	$ 8,900,000	$ 9,700,000
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities remaining available for future issuance	1,500,000
Percentage of purchase price of common stock lower than the fair market value of common stock on the date of grant	85.00%
Percentage of purchase price of common stock lower than the fair market value of common stock on the date of purchase	85.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options and restricted stock units vesting period	1 year
Minimum [Member] \| Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee stock purchase program offering period	3 months
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options and restricted stock units vesting period	4 years
Maximum [Member] \| Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee stock purchase program offering period	27 months
Common stock shares subscribed \| $	$ 25,000

XML 37 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 80,403	$ 83,260
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	18,403	18,582
Gain on divestment of business		(709)
Stock-based compensation costs	12,383	11,367
Excess tax benefit from stock-based compensation arrangements	(2,536)	(2,575)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	30,498	20,804
Inventories, net	(17,194)	(37,897)
Prepaid expenses, net deferred income taxes and other current assets	(3,526)	(15,168)
Accounts payable, accrued expenses and other liabilities	3,641	8,872
Net cash provided by operating activities	122,072	86,536
Cash flows from investing activities:
Purchases of property, plant and equipment	(16,403)	(20,681)
Patent registration costs	(2,423)	(2,366)
Business acquisitions, net of cash acquired		(7,318)
Investments in cost-method investments	(4,582)	(500)
Proceeds from divestiture of business		468
Payments on maturity of foreign currency contracts	(39,341)	(11,206)
Net cash provided by (used in) investing activities	(62,749)	(41,603)
Cash flows from financing activities:
Proceeds from issuance of common stock, net	4,352	4,930
Excess tax benefit from stock-based compensation arrangements	2,536	2,575
Purchases of treasury stock	(57,857)	(46,803)
Payment of business combination contingent consideration		(458)
Proceeds from borrowings, net of borrowing costs	200,000	75,000
Repayment of borrowings	(8)	(10)
Dividends paid	(42,079)	(39,199)
Net cash provided by (used in) financing activities	106,944	(3,965)
Effect of exchange rate changes on cash	(61,463)	(65,004)
Net (decrease) increase in cash and cash equivalents	104,804	(24,036)
Cash and cash equivalents at beginning of period	717,249	905,730
Cash and cash equivalents at end of period	822,053	881,694
Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds	18,118	14,373
Interest paid	$ 1,247	1,233
Fair value of assets acquired, excluding cash		7,342
Liabilities assumed		(3,168)
Goodwill on acquisition		6,454
Deferred payments		(2,405)
Fair value of contingent consideration		(905)
Total purchase price, excluding contingent consideration		$ 7,318

XML 38 R35.htm IDEA: XBRL DOCUMENT

Inventories (Schedule Of Inventories) (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
Inventories [Abstract]
Raw materials	$ 75,490	$ 74,416
Work in progress	2,215	2,550
Finished goods	180,904	169,893
Total inventories	$ 258,609	$ 246,859

XML 39 R22.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Tables)

3 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Schedule Of Basic And Diluted Earnings Per Share


	Three Months Ended September 30,
	2015		2014
Numerator:
Net Income	$	80,403	$	83,260
Denominator:
Basic weighted-average common shares outstanding		140,309		140,127
Effect of dilutive securities:
Stock options and restricted stock units		1,637		2,556
Diluted weighted average shares		141,946		142,683
Basic earnings per share	$	0.57	$	0.59
Diluted earnings per share	$	0.57	$	0.58

XML 40 R36.htm IDEA: XBRL DOCUMENT

Property, Plant And Equipment, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 745,480	$ 770,246
Accumulated depreciation and amortization	(376,496)	(382,488)
Property, plant and equipment, net	368,984	387,758
Machinery And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	188,059	198,047
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	126,928	125,423
Furniture And Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	37,396	38,511
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	5,680	5,371
Clinical, Demonstration And Rental Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	81,174	80,911
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	30,915	31,553
Land [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	51,905	54,915
Buildings [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 223,423	$ 235,515

XML 41 R24.htm IDEA: XBRL DOCUMENT

Property, Plant And Equipment (Tables)

3 Months Ended

Sep. 30, 2015

Property, Plant And Equipment, Net [Abstract]

Components Of Property, Plant And Equipment


	September 30, 2015		June 30, 2015
Machinery and equipment	$	188,059	$	198,047
Computer equipment		126,928		125,423
Furniture and fixtures		37,396		38,511
Vehicles		5,680		5,371
Clinical, demonstration and rental equipment		81,174		80,911
Leasehold improvements		30,915		31,553
Land		51,905		54,915
Buildings		223,423		235,515
		745,480		770,246
Accumulated depreciation and amortization		(376,496)		(382,488)
Property, plant and equipment, net	$	368,984	$	387,758

XML 42 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 43 R7.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies	3 Months Ended
Summary Of Significant Accounting Policies	Sep. 30, 2015
Summary Of Significant Accounting Policies [Abstract]
Summary Of Significant Accounting Policies	(1) Summary of Significant Accounting Policies Organization and Basis of Presentation ResMed Inc. (referred to herein as “we”, “us”, “our” or the “Company”) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group. Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. Our manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States. Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods. The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the year ending June 30, 2016. The condensed consolidated financial statements for the three months ended September 30, 2015 and 2014 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Form 10-K for the year ended June 30, 2015. New Accounting Pronouncements In May, 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers”, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company beginning in the first quarter of fiscal year 2019. Early application is not permitted. We are currently assessing the impact of the adoption of ASU 2014-09 on our financial condition, results of operations and cash flows. In April, 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs". ASU 2015-03 will more closely align the presentation of debt issuance costs under U.S. GAAP with the presentation under comparable International Financial Reporting Standards (IFRS) by requiring that debt issuance costs be presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. The new standard is effective for us beginning in the first quarter of fiscal 2017. We do not expect this updated standard to have a material impact on our consolidated financial statements and related disclosures. In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory” which requires an entity to measure inventory within the scope of this ASU at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The amendments in this guidance more closely align the measurement of inventory in GAAP with the measurement of inventory in IFRS. The new standard is effective for us beginning in the first quarter of fiscal 2018. We do not expect this updated standard to have a material impact on our consolidated financial statements and related disclosures.

XML 44 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 13,394	$ 12,276
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$ 0.004	$ 0.004
Common stock, shares authorized	350,000,000	350,000,000
Common stock, shares issued	179,925,750	179,660,939
Common stock, shares outstanding	139,539,516	140,474,705
Treasury stock, shares held	40,386,234	39,186,234

XML 45 R17.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Sep. 30, 2015

Fair Value Measurements [Abstract]

Fair Value Measurements

(11) Fair Value Measurements

The hierarchies of inputs are as follows:

Level 1:Input prices quoted in an active market for identical financial assets or liabilities;

Level 2:Inputs other than prices quoted in Level 1, such as prices quoted for similar financial assets and liabilities in active markets, prices for identical assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data; and

Level 3:Input prices quoted that are significant to the fair value of the financial assets or liabilities which are not observable nor supported by an active market.

The following table summarizes our financial assets and liabilities, as at September 30, 2015 and June 30, 2015, using the valuation input hierarchy (in thousands):


		Level 1		Level 2		Level 3		Total
Balances at September 30, 2015
Foreign currency hedging instruments, net	$	-	$	1,664	$	-	$	1,664
Business acquisition contingent consideration	$	-	$	-	$	(1,514)	$	(1,514)
Balances at June 30, 2015
Foreign currency hedging instruments, net	$	-	$	1,038	$	-	$	1,038
Business acquisition contingent consideration	$	-	$	-	$	(1,584)	$	(1,584)

We determine the fair value of our financial assets and liabilities as follows:

Foreign currency hedging instruments – These financial instruments are valued using third-party valuation models based on market observable inputs, including interest rate curves, on-market spot currency prices, volatilities and credit risk.

Contingent consideration – These liabilities include the fair value estimates of additional future payments that may be required for some of our previous business acquisitions based on the achievement of certain performance milestones. Each potential future payment is valued using the estimated probability of achieving each milestone, which is then discounted to present value.

The following is a reconciliation of changes in the fair value of contingent consideration for the three months ended September 30, 2015 and 2014 (in thousands):


	Three Months Ended September 30,
		2015		2014
Balance at the beginning of the period	$	(1,584)	$	(480)
Acquisition date fair value of contingent consideration		-		(905)
Changes in fair value included in operating income		-		132
Payments		-		458
Foreign currency translation adjustments		70		(80)
Balance at the end of the period	$	(1,514)	$	(875)

We did not have any significant non-financial assets or liabilities measured at fair value on September 30, 2015 or June 30, 2015.

XML 46 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Sep. 30, 2015	Oct. 20, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Trading Symbol	rmd
Entity Registrant Name	RESMED INC
Entity Central Index Key	0000943819
Current Fiscal Year End Date	--06-30
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		139,649,869

ZIP 47 0001193125-15-354886-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-15-354886-xbrl.zip M4$L#!!0````(`$6*6T>V=JGPDZ```*`1#@`0`!P`HO5A'J+U9U>`L``00E#@``!#D!``#L/6ESXS:RGW>K]C]@O?52 M294EBSHLR^.9+?F:./'87LO.V_?)!9&0A(0B&8"TK?SZUPV0(JG+HG58TC!; MR?SGE$L[1'FF*[%G>[GO4`6J#0YW_OWEW_\ M_>2?A<)_3^^OB>6:09\Y/C$%HSZSR`OW>^2,"1\?7CEFD=RY+TQ`2WM`SH0K M98<+1FI%HU*LU8HE4BB$XYU2";U1J/1.%"MPZXPD,6'?9/C'A[HQJBKQ4;Z M2686N^[S`30@K=5"R2A4C.3(/`.-HF\->W/GF4G?%47!9)]91=/M*VZ6&I52 MU)]+MUHVZK,@Z![1"Z`;74J]X0L=*MNJ<]B@((S0(/DD-L+HQL%_OUVWS![K MT\*0$I`O(2?(WF.IFNY9ARAV'_L#CWW>D[SOV4BQ>M83K/-Y#^@N1+057Z6U M1P[T.*A3KN.S5Y^TF.F#NBL-@A8S?,R!8^>!H-CV5'\RGE`*3P_NT^%3I81_ MU#1*\`HH.O<'X5_P-[?P28*X0!GA'\.AO%%:T@=&'QR$#\==F2.%74#(1P6*B46I$+'@*Q?MT9U/GAO99\Y7+)^#ZTP4(PQTPUO)=\X^[ M0)@]L"'L]8WUVTRLG'?('M9%QS1\`(^TT1VS5\_F)OXR0] M>U^`H.,W"#HYF#AVC,U!&IVW9*OUW@]%UE`BBYYE$]FH$M=0B<.I]"Q;?BG;K,UMFXT%;/-=@IYIJ]'O>][M M^7(K!3_3="?1MX.*4$TJ0C6W^#4(>L[9N/H!@LXM?IT6_X&*<#CG''\/Z8#@ M)N17BEV/#O?E?>MQ*X4?/9Y)TR8(?$5Q>"[A#8_&M>!RT_P0P1U^5!J5RW'[ MHNBII0[AP@#^`,,)O^E8%W\&W$-23@=C#,IU!YVX+^)I!3M!S;>NJ[PGWF6&W733:&73NN("I8^VB M/(=D[;;X+@,!X44@&/2[Y*_X:Q?-,[?O!3X3NSRW3J%QMP5[&G`; M-P_LH#S3I.VF&+%4?&9SAYO4/F=]%Q#023#TOX>NU-Y%B\4"PZ[2.UI&6+,<]@=%W">P^ZZ@/,<=IO%E^>P.RW>/(?=4<'F.>Q6BS'/ M83<@AUU<^%44OM%HU#]\UWU$!2)3*%574)JY=J7$TPE@F.Q=H^LQPFY6WGUN\QL25QQOQTQRYL+L*WKT"3J\!6 MJ<#B_LTH/574OJ)*'%$*9G'_DIKJB28D;N<.BIM3;.!4^ M.L#O4^K\<0,SP<^R;>+O1TFW0SW&B4K6!<9Y\I;4,ZGF%+;JR78V7U>H?96" M42I4C!5O:]MAG=HDN6[`89'E*T"\"Y*"^TX7I2%"[0?]7%&RX#%D8Z+HG>1C MKI0+*B5]S95R&4J9Y./WHY0_,ZL+<>HYD[SKZ)P[J5TW+L2HNHEM23E_,D6Q MH">0M(/BGG*X+A?WAIRH6O(1NBG6O>4Q3!X[[,B\_QW,M]/*HY>@L#Z[YL_, MNG(@Y>WRMLV:4C)?G@Z^T=]=<693*5.R?1#48GBAQY;4P3+0&"O`*)&;7O9< MCFCOJ+\].UW>)=<4A=^'4,\"Z;M])NZ9K9RY['%OET4\@][=%CAFZG$G"6DJ MA)>XSX#YK-D5;)NVL662/*;G\Q*^^RIPSIZ9[7K,NA5GKF!WPK4"TW]@9L]Q M;;<[V%$%F(_L31?_^/)E'J)M1(BVBCTW>8CVP2':I@@U#]'6%*)]M,#S$.W# M0[1-4($\1/NP$&T-]Q:=PV#/T/&97>%>476E]SV7?Z2/,``#>->Y>#5[6'[$ M'5F"FENR;W86A8GC"[-(W(&BZMK488$%LF';E6/"C-ORH0D1N';-^'UT26J# MG^YT\>J!P-D-R[7Q/>BL8,TO"_@9@M9>>(:D=]`HIRPUYT:9&V5NE.O:$#"M MM)E'2A\0*:V^9)F+]T>HREIZJH@W)BX$G-0`CT9)/WY62KG4:3RGI6:ZA;VOH!";EZKFJ M23WWH;D/_9B)_KU*FOO0W(=^2!R:WXBP[ILNUO,=W#5<=!!?K4P%IVV;W5-_ MY*I/U[%GM?:Y&6?!8],QC%EBC$DU<3S./2'=P M+?OCKF[(S>S#S2S+B=3DXG=5M,R6'K7*GO6E.>T/%G#OM31.S`4(>69H*),"MF1_!D#-Q3/\9^S+(R/MVZ$84W@3?I+B3>8L,RV?PM]8 M*2*7J:)0*I?*2O,XFI;3+.J2:N`;_PW;M9^YTTWU&C&Z'U^UF MW8X_DSF[>DU^JBX[O"A_=EUVV&VURQ_Y]STV^_L>&[!R-N44:*XZVZ0Z&W5Y M<=;%H4U7B:4O^FR!EWC/YX+RR"B/C%;U`:&1^O6&)25KV#`VC MWHEI#LZ9X_:Y.KC_`#.4I*:Z4FS$(O-;&K)O-QU>3)"%X_FM#;LR/2[C*I7< M:'.CS8UV^].77?EHR\;M;?L^OQB3;ZW<$/5;Y=;*#5"_=,CRX0G5AUV]A>NN MFYA40KI<7E%2^>&$KDG]_UDH/#K<)RVF`KI"03\.\!ER"1L3W+#X,U`2`\=^ M-Q!"`BO=E%OI,RH#P;YPZ5;+1OWXL75^Q1 MP>2TD<>'.#E(4*`[32(XMO4T.`]^IH%-'Z,R-@8Z;"WT><GKWDTJ3V_S$J+K2:9P)3B-;'9XT8PSQW394AZ2YWRHXNX9G,!/0_ MAH8W=;1I`!&G[.#@OX>3``Y'&P>G<7D/0Y-^9^J(XP!Q#T@F..#L_Y.&@$/$ M`U\HRSIC>)C9QC6FUU_9(!.$I+^>.N(80+??=QT5?[641=T&/DY'%B2Q*>AC M4RE!6U--VDR)Q4S>!ROXO'=U!&4;OD-A-GP/VN*[)Q MXIJ*+B--TV0VNF9F$356$I'4X*.0[UF72Q\7_#!*<7-V<):&E M!XS!X5=<@/+6H-]V[4QPP!EK`*DA],CJSJB^*WS^EQKCMJ/V4(GQF^J-F3!' MXL<1@9>3$B]4T)(:55#!DX,,\)>+\`B3WD2X4JJ_'^$)^].&R\<^_)(P3VOT M[IGI=AW^%[.B>PYGJW-&OC=*M2$5"R'U!FW2C_FBU7J8L0ENLHM7TPY0%<^H M["V3OGK%.)I-8!;,8B*G,&:XP;3I)X"L2F"9D'@;]W354Y4Z]4=FFM;O@?1Q MVID]%VO?-)USHK]U]*;KRW>5]Y([25OU*LA7RAW<$S5TD[B&P;(H MY`ZOAKUE:D;9J,;&EIG)JY+/=[/%X"WY5.JE(V,9\@D=STV`8&\[.GMI!>W? MF>D_N,T7*BSY5>T1M";D35,GGA2^AX!OJ11//!E@QHCB+7(0Y]R*.RK\\(]$ M#''.P#]`G+2*>:=<340V&?%($!"2F\@5%V5L#>?$!&.G@QA'XU&&FS]=(2=G MQ!NU@6Z$#96QO+R<9D&2O)CX6]&E3I@-`9A3*KF\[=R!^H&L=`#AVAPL")AQ M"MS+E+O^8/N?+/[\0]?_1,+?1/H#FWW>ZT/FSIV"S3K^<CLN`XC_SIOX/^(?H7:X"B.,8[CG8%^%/YQS/%2F`*$4FY74*_WJ0.T%SJT MS^W!\0/O@VN^82_DWNU31[=)2+..B0%H#=%7^&-C1(+%I6?3P3'AC@WBUR^^ M,$4X9/968B1CR(BDF`AU+*($1=P.28H*01W@ZTG>'7A9.8EH%7H:HUKI?]*< MC=GJN]X$GFX%SU7/'VC?^^2TI?=I27R;KH%;S*I)VGB/=Y-;!&;J(OE1A/Z= M^"Z!Z9MQ4%!)%'/_]0I^X.S3"XO_.O^TGVH+Y/0V-Q#)1N(*`@%"J@M^6Y,Z M@V2WGP@8!B7GS*8P;V)13WBN]E.DXXH^8`HH?L-CI\1H-*J(+24]L#Q="54# M8D\%+"3UJW`#KYC0F.&OAQXT=7L$D"4R:$/BQ:G@3.Z3%T9T)+1/0`)!!^*/ M`/!!ZP4E^H/YA,$DZ:D5B@@V%6"?@!*38&<)J?S0#+GC:G^Z0%/2FPG.V32X&7C>Z3KTS`0(-]8#OHEN14 MDP<$X]P%(ZB84$[$0GUB$XGQ!6\'0P3'WM[F_78>_?0!EI6;H MFM`.`X>".8>!LH6)DOHE(52SE!5T((US3$YM`!-F6Y+T*!A]FS&'>()Y5&AK MP8&%A59!0/][Y+'8*I(N<\#2;7N`S*(T(Y"@U'=?UH2L`%TS7JTE[0(8,4CQ!@=K, M9Q.E-=$77FGGYGH<NE^7_8(ST8<2>1(W$``>=L]H*&6IE3;D?K.(H&XAG"A4T]=S`ME#+ M(794)@W`?P\G: M?6'B`28=7./[IB)^M=*7ZG3KX+:3VXZJ2JUC"6*T;E1-UHW*>U]*Q:.:YL^J MJ%PI'Z-A=IZ5T3`Q-^]AJN//>,FQ;$$V^^!>,U!IIZMS9(B#'L'VQ#EK8ZD1 M,D1H:@J!,9%*,=^Q"K2RBP5FUI_57JY$C7!C$AYQ\:G/?6#K MK8=C/;A7C@F3I63I*OUD<6_V942SM$*M&(1K4I%>S,V,<#=O>-JBJ1-%>4<' MR.=P[^H$$1_.O4GCR#",LL)K-I!W(C+_;I%ZO7KT?D1B0[MA_C+X4CDLUPZ/ M)N(S"=9"6,W/I$JY;BR"%7X#4Z\"/]!7)I?!*..P7!_#:#*<]Z.384/B8:U6 M6@XZ\;?$%F-0O59]`Z$8TD(XS<^EQ7%*?&YZ*5I4*3?JAY-0&@?T?GPR,,BH M']:,=^(3]+%RQJQSY@D8E>JU>BQ(Z7PHN4_V3F#QQ1]@[.M#V\5PX6(A[W54 MKAZ-6>52\%H;M1F\8OVPVAA3GM52J[_E!F&<8#T\)XG;@=!V,/`$!WS;`2-: M2(0%HUZI&5.IF@?^LI'/L/6SW*@=EL=,M&[XYAU*=P^FD#@A^1=TRHY`K\4Y"I>/#V<:):M58S$K0M`\%UTSQ[$_H8S7AZJKY:DM6IEH6L MI6P<5EAOS`EJ*:Z@6JT:HZE=K]Z!P.(4 MO$I^['#[\YX/&=+>+()6\76&<1X=;"M)Y562M"8:*O,>^]@(U5UL@C$V@((W M-76EW[/Z&.-;Z9?8UF1\*_UHX,>I[CF3IN!>5&09;FU3*_X0:ZLU?WLSSSO4 MYSW9$&Z5*:@W-G8SS(_&3Y,V?\W[JQ7T^[C=S>V0%A#'.Q"C`0)CNT(H<2A> M@G1S^W#1>K@]N[TYO[AI79S#C];M]=5Y\^'B_/+JIGES=M6\;CTT]X;;26AZ M[\G\E,5J-8Y.UK$BQ?ET*LFM+.%MS+C!6/DU(7_(S]>-ENG M6,^0`3C-B1T?/?32Y,=FZ_$GR%"+"D2AU$A74N[9,W,""#2%VR>X3",@I9?: MX9\!<]P^$R.%&!TQAL$K.GQPW7C+*X9W(KK'5D>$>@\6A%0B!`-=].O<#\,I M%15B<(5CV(G@"B]HEAV8ON!U#[#C."-V70SFH(=DXIF;3+UM1G@6"0Y,47$D_M+#*-<'['!'*#+'^$.Q97]*C(U3/-X?1SJV^R)7$NONBLGGWG%1 M[]CT($/3X6#H'\'S#1T?Z''HVFJ%4F6?[+5`Z6W`.;*!Y"((JC$>D"3#$XUX M6;7<*T;V@&-HU]%WT:YL5S*T*N2,<&0W/=BI)8N?4 MR[J72I@%;OLE:C>87BT'&XPG@7OFX>&"E&O_\>KROO43E@VT%];$0J(Z"9\V M2R2_KJ:C36W50_88\W69VP)G;N((X?E,/2.HF)\*H?@9NW.=(:L-^!JF':WD MS^,:`SF_1P2IU)6C"PLL>M*`5V#4P--YR!`2KC-@>8)"QH[I/]:20A^HG=Q\ MZ<-GW(Q4!`;^/WM/_]PFDNSOK^K]#Y3OMBJIDK6`0!_) M)56.D]SF*HE3B?=MW4\N#".;6P1:/NSX_OK7/0,(2<@"@21`_>KVQ9)@IJ>_ MIZ>G>_U;U")@\_H$<:3\P"MP7N51'[`P;B-$XMZD@/_'T<. M0-O>`BKG>%7:#/DL0FURX&;Q':\>ZH*Y%QA@B<3Q&_BFJ)>YOA8ZSTCZ#,40 M`)BI6[G!G,R6L;_`(0RP;#N>>Q*-P<8H::V:>)P[30.4\]X41"-T0"WJ<#?0 M:BSTLQ-@N9#MHC./4+YHYW3&Y6Q(;),"S^,_>)<4="#*PD5X&;ME/&_SF8SL M0AU01H/ERRV%)JT'SA+M3<;*<.5.W0'A+'%C1QFIVN38^"Q0L$-597VP'SA% MPXND$LE[)OZML[S]N:K)@V$!Z/-!V=,B2C:V461M+!=AZ4*+X(5@N*G$`;Q, MS:(2EU"V)ZU7FN!)YU*B21Y7W`K&VU<-KV9W;'0\Z+$-\2 MPJNZ6./^9,MQ""!'/-0AGRN[OCV3/GO<97J.Y[_ZFR@3EUW;ZQNE`<1)/W@[X49P=!*)_#3^[\2*0=]B\US2,`0_@ M)BT9(+,3E/ZXMQVVGLH#F\#,4*;AXA911"-QK\WBQ"Z3P38:T/;$8;IECLT> MF`AGPI"V.)EP8/(03V%$>!9&ZO&DG0?;BG@R&D\DDXR[.Q_T6,AZ:WM-PWI@ MB`2Q`2Z^YPR-/YDK0J2/]Y[#^I4C=[NP45:\!%$;+#''4GNYUR-NG9@#`XE7 M2)2PU287AV^^]V!CME]5XS;0^]HNP8)6$;6!:C"/WG\P*0HP'&FQ.>,<*#FB M4&:L#@P-[5$3.I MD5:]FH@UZJO[(M;FO.98BA842K-J>*IX5)@RZ".)@#FRKY#Z52(_&D$->)+[ M>M/DK$Z05DE''N`!XN;EPC_KH:.X;MU[W"2`Y4DK;[UGIF.LUAPJ%XS4UXJ# MR7UUO`SZMNEK!OCYP&,>P`.Y)H"_&?Z5S^_363P^G+Q8)LJ8!Z`L:[D0;IJO M#@!+8;`V`$4)](LHO/=\KN9+8&Z]0+B>%@@O,%45F(K7SJL5ID\BT:$*CI31 M9#B4)X/),_"(:7:%I3AN`):)JH_TYW!3"):K*.2G[<*GKX`<3=9&VDC6GP$H M,U;)96LG'5 MHD?);@RR=FJE#]5-,*W.4P6@XL=HNC[>&:#5RL&Y58NKGE5JREA;`W'3S/6` M6/(D$D`5+6.KG$@GCB)8X,4=,\ON.RX1K]TM67I6/LFEAP:XY+%[X>N)N*#_$B^]#VKX9S7"3(:X@ M\'HBBS2&/.$V7,&QO+Q(G!N!D?X'K.&U*=,^N?4@4O4-VR\$+\;^Q=U0!)P+ M"^;>VSX_)G0\_`DD`LO$Q$#X*'01/Q[DU6"E`8R'M6'Y(5/`ED9/JMX@!'&Y M-'X)8N[;#P`KH/J>.59R9S=.XP\8+[26.95%7"7565A2E"?T#2NN4<$+2DR] M^(D@FN,-C"2-Q+O%X?D1:UQ#35P'Z4N_>8^P`K\7GWXLZ5`_OE1BB2B-5W7HFLS];#C#>=D+@W!/3"\9'#&=+$I97J/EFM( M+N]!4B5FDR;;.;=`>L%]""\*X)O@Y:LJN4T'.;<;[I>],EOF1]L*[X%X\B_I M#C"^"L<<9VY8J+HP%LD_!W/#3#['[\?[#Q/H;;VZ M-5]>7NBG'\5G"_4"(!HGP,WBV3*\LMY7M%\*77?E,Y:_#!O_+D('.3\;YI]W M/IASZUQD9$I_,Z+0>QU3&UN"P")C_*TL>+=-_O+(Z"F@$7EU;UO@7F9X9W6N M2NRSS#HQ*X761F+-`!J'K1!+5_NC(1&K&+&6Z5`5];+2UTE.CH)Z9=+754(] MR9>YRW<>E+1GD*H6PAU%$58#,WC91+Q25^?`42/OC%_-\!4N<9&F&:?`JGIO*,L+74=R<1IRL1YD);G(RH6B]<;Z5KD@ M;^UTO;6*6]K&DZA>-;8I;?UH!W8=-#S[C0`U[;2Z;19%Z^EC=8^.%K%[IX^I MV\;N^O9=!7E/I^L]5=T6-B.T?+1@%\/F[&T,Z?7R]77W/K_JD9=$ZX,7EU`Q&BR*M]:BVW6.@6JD9U1PB4!3XX(>DX]HWYJ,Y M-NZ>K3M8!X*+K%C=M.(ML#^W[&OFS_)Y29%O!IR;!LA-F4_):G/6F7()>_"< M!W"`EI]9X9$JZ'K[3?_W)G3@FE;7+,IHQZVS+^-R%%4*/`V&\F2TI$+S)]D1 MD!(EGK35.F4[`/+5<\T:D*),U+'V'"R+>78'ISAJU(&F#:N`X M5+C-@CHX:S3)9_3%U MNO+^O"9?QN!W\NC?+1 M\YE]YWZ(:QIA*7O?,,,"]7\YAPVU59NZ??E'1=A"GQP-9X,U-_9`.%O?R+6" MR0;#-5^[X0AK`)/IHSWC['/:`J:2<.(6^,(T_8A9'W[.L2CB,;`UT4MA*UU[ M;1@KP6F-P-AH;7/07(1M$,V,DWEX_*FKK97W@L"O!4WG(41,7@L(;`.]AJ6N M<\E!G*)A*=H^L]0%C-AGZ#=FW=GN'39"?N!\2ZVFB[6:'A2NCKU`O93!/2_4 M%V-?6J"_R+$?U81/@OYA4=0%K]@$7AJAX M_0,&,N98/M;"^H1^T)>2.J8!S&Q/;=.`-:T`\B2QGW,N_EAOTHON[J5;#^O- M1O[&">`SX"^:PEI%M4HC9>>XLC52P37$#E<*#.RC":L1BN3YDJLLP`-[.[C' M>K/KP-['`C3WD<"SN(1OTK[46CSHS1>=WF&41\,7I\*H@WF]8!R))1.<)^^= M@W;Q9K:[TC!9E-[NI3T+.35@Y&4T;"E[BS5#L9XL[Q\=1.;]YN4M(+UC+N`- MRSE;7E(Y&"O,KAWXEV587EVT\BC2$T-.V]A8U4GHC[P92EFXS`R!^0NE#*8IYFIWI/[R9;F3RV/!VC$VL%BZ&.CPNG!VR=#1<: MQ1"2N*$=5FUE8&+]]GV#6[K MX4_L!!$Y`@%@NT"'477P+@DE;P?P+*/RFOYN?`80-TU`L1;P@ MWWH8W!(5ZE5?2Q.`KG;RII8`IU1Y^-AW"@=*?T(M`:@X^FFA7IGT-4(]2"W>E+B>2QL3VIC0QH0V M)F2ZR%,[H*?V8C217Y)_1DS>:297>A-=(S9O.YO3-J1FKR@N\(A%6F^><$9]WDL];E%(G M+8AT3L:!MC3ME)HC':TXGGMWCO4)L_4S:7M#VQNZ9WMLM7<:?<C!5#ZXW7M'>M/#_7$ M]<3UIX=ZJAY,U8/;>F;6S-T!'6Q64U=IU5*-JI8>);OCGX;M2K^^^.P%P4OI M.S.].Q=^SVEV2S5H6T#-3[QUIO0CZ:=)96@;JRJ[:<^Z1:.VF;-&8/^8^N^: M'\Q\$0N)"CEI[G8!F.FJ="!,8)4#,W+YV/,N]!PO#B&6YASI,MS#G0WIO9+K^_%OJ&&Q@FYGE0T;N6A7&. MEJS>M>OQ@U%/'BO-;9%"'$\<7W-!"+6G-+DI4",XOL'\36T)?D@>3A2`7I)E2HL9V6F'%1/NX/)AD^P_9,7H"1/X* M"'88B2>P%-TCDRP/5A+R[E1F"&_@X/!HO&@#_H?%Z2*'K]EB4P/_!#"P.%X& M3%ANOPBE$VX75(*UOCE3.!F>N5V_KT=F+"VR&?7(!CO',_\\^W__H\D_6-]I*\LQ-=A1#:=BN)\ M+@L"O!V-5Z-A]2X*UWS>1F((L/\>`W>6!^ M![I>_+2#]*$X-^W#3_/><._8)4SC`UF_\!MKZ5/QRMZS`)[E"/\<5$?G[_LRZX3$3\=`'T;0,4"'&.),BUQ9+_AW^4-0SX`G3 MGAE.\.;L?'#V]EQ19%T#99Y'FRT8W0,ZKA23CS\(=6O(MMCH`:5%/&]C+#5^=-[M&ZXO)RSR; M5_2O'R%0X9P31_HPFSO>$V-2EI"[.1DI.G6MN>BLQ9U:\QRSBY7[\BZUC`_I MHDJR8Z)X;CP*C(*+><48Q'P[?`?PFEJ6'[N/F)X#GAQ<$* M``8+A'^3+\9@T>@-\<>S`TS%))(W7_A1\\@'705@<%$.Q/```FQDF"@/S!*N M%2^G+\#B7>D%/L%G_]M/4"*7KS_\^/9M\?G]ZY=2%/#BQO#<.P<_S'O/ M`90C4`(3,\]B3E^Z7@,7W+?0MTV$1TR.E@/\V4!B?T7@ZH$7B>,"L_S)PL5K M^!V'WWG"J0-4C]PAM!CV_`%B68C;96Q*`%.0@S)0@L`XKH6_P4L`.PP<<,>; M>Y\N^*4.][Y[DA7YR5H?D`KP-_C9MF?EDFI]O5FG?,/:'^]M\YYK=2QU8R1K MAR_`TP9D]L26(&8!*\:^P:L(L/-+PW<\<%YGD;.$^C]POKA:SBH.C""?;Q=T M!4`-Y)YSE`-@^/#>LR3=13=8@S\CS=NE%>Q'66]]4E_3$4OCU/J5>W+8T+]GE$/>%T-[^M] MC2K9$\MW%O7$\HTL;9PO$8=WEEJ6==5,#ZGS508:4@IRH.=9C$Y@OS.E($D/ MGJX>[/R%Q8:4Q5-&7;V$TNVR>+O0K8NI9+73K5Q9O)(FJBEQS9:IOV::J$XX MB_N4K4##.`IDCGKT-Z9S%@[S-AIRQ')!.:SKMDW5`^S7!/)VV MA#04W\3QY)`US]J30]9X$M$5T88;''+)FJW_CGE$(_>57TB4R'L2#/#SR\,C#HVNCY-*1S3J" MS5+ZHP%%Z\B?(]E8EPW@89G"=NP]&7+?LC^FK-@*?E/'2>KMUU@IO"5=*[L MH,QQ;>QJ>NG-YLP-##SE^\[`=V#6I1>$P8][PV?OC(!9 MWXRG&2`WN`8,\EE(8P)/S/)>#!L!UT-*?3P MA9GGPO2@7.X]!S`2X+OXRN-J?K,;S6YA,F\JY@OPK^S[DA>%06BX.&E?^NCY M>#MM[@7QDX9C1K@G!XBL6,FN+Z+'IP8*>C/;-4(8`Z!V(@O&`$K=5P=,@G\$ M1M*7.#3V`UM^A_T5V>!(H\67@LB\EXP@&4UT[>8C89:W;_.(@_@1;4'0ETCJ M2>IKE?H?!5D/&7K-*2X[V63<&TY&E8?A8%8>1=&UGJXKE MTA!9%1(#SK&D'VP>,JX0!G)/0O^)`X].9P\QC5%%4!'.4P_4#^A:UPL3S61A M/B`.*Y0O=\E2M9*KY%"5X`ML.H5AJV/HT8L<2[H'=2C=,N8"Y*%]GFBU/JDB M4D5[<$!0/)YA\=UD3<)7$T\!+7P``SF.]QA(+[B4>5$`S\)(/TT8)3.?983& MRU=[Y_6#\?)XOZRVK&J&>N/ZD4$]HWEGB8/%NJ,Y(+D@N0"Y&+04X?R-KD@AXP<,G+( M=@ICO5]<7Z)`UFZV2"@ZVOR?WM./+WHO+W2T)B#7,\+2ZTMOAL\W;MMU7-+DWD"?-C8,U01R(O=O, MWHHZHG!6$[B?G*[V.UT?1%6*;&&<@)F1;XVDIK^:X6CXQ/$MN1H-<*L=-K+JIC0TC4[I&A*;Z)M MM42G+A+$XFUF<;4W'&^])4+.%CE;Y&P5S]E:KPC>%B>K"2S M0]@EK,%^%DD%2<5QI&)KXB*Y9N2:[2E.?WP:[2<0=CSOK`L'*R=AA^A`YH#> M&4D%244[I6);\N=LPA%&P[J M6L1L[GA/C/U@_H-MLD77^&Q?^:^>^\`"<,`N'@W?"JZ]T'"ROV/#^:]>^&\& M8)O>G0OLM-R(_"*XN9H67:)^]E8?*5R79%:X+S@/A`X0"-NS/GI^_!4^IY3J MBOY-_?Q?8A)3?PZA3 MFE5]I"\S217(#K7(DM*NZH/A\1=Y-@_+A=3SC"'YWO=L`]`8Z,Y_<><2E'_C$L?E< MJEZGIV[%: M'8Z'A/JCM#H<]&5"/7']::&>N)X:?#;HA*RIIY@E_*1.M)@\7A)L\0:?DSRC MT0GL-[G!9RDQ(CUXNGJP\]DY":W[FI-CN":3C%`*[YETRP`$3-G!NHGXQ9PG M`!S*5M'UCN8E$.::-+K>D4UX>Z'T]+'VDL2!Q('$`<1!&\L;A($\L]/US.C^ M>1G==6'^%=D!3[B4+"-DTM2P?41[Q-`WPV0L`!PT*OX9V!83"5G-B"ITT#)U M+*K0"&DJU36L7O&2%C0Z)YDAF3E%-VTBZ^2FD9M&;EH%.W+)+U@%\$360;-= MTXDP@0"^]I)D??S6F^WGBCI9&[(VY*&1S)#,=,E#4P8J50TB3XT\M3KLR3?C M:887WLF6D"UIC08C_XMDYM1EYGC^EU:Z+A#Y7^1_=2?/OUZ#\M'S`517PN(3 MS#6?I-`WW,#AQY:286'CC38Y:)09?6QKT[4Z=".YKMJ,Q.W$[4WG]A>4)$8^ MU<$;*1V?2'O-WV>NU<[,_1;:E]/,5>Z<&5)ZNM+`W'T2"!*((_EEHX)I8>+C M`8M@J^VL@KV/:IP;ZGW&PV(0\:P/]%7Y$2' MK6;94B+ MOK47^=)4E%(V',D(`@;?&^!W.POI[DF/++V7(;QQD'#3GN,;\.C,"T+)L!X, M-S3NF!<%$N#M3Q9BON#CO6W>X_L\/&J8(7\C'0PFC&9S%-D`!@:W/WYS;OBA MC3,@F(]>Y%A2%#`8C;DXN9FN;!ETR?-3P)_ZTA^P7N.G/0,$\:=Q"%QSJI,` M0E0K8A6`K]4G(W?]60Z#0"-"L+4C%LZ5OK9`QAJ]&T*_(K6JUWY_?;:M?G4Z@)_^ M9:T4A!LEA%A"8.;'G$#0`OZ,F[?B18.+?";%?W-G<7EH295%*4DI%WDIFE.( M]LC`KS,N9F;KL4KE#4&:'T^S6\_93<`6LI!-G/C;SW>C=:;)X9IES"_A5U>? MH2O_,?-G21(O435+[X90KJ0:$GNI>)PIJ;DW$60,UO"@JO,-NO"\55>K=8S?Y5V&J2J2!30:;BM$R%2J8B,16@ MZF%3AUM7PUTW&[%E[4E!!%M5<.^7GT`C$L#.T#&V[Y2Y%M4ZD#A4;$&$\D=IK#M1A) M%<%2'K`7!C2:P:K@K:#@X0-X9,#G2\T+)#S.XT_^*W)9^DU/BH+D9`!Y7R1C M@^22_`RPKOO2B`]X.7NP9Q.QJU[T2'0FIZU[P.A=P37?%_^F/J);GO M;F'K>)>5ODX2>/^9$RH/U)O0N)ZXOI30SUQ/7']Z:&>N)ZXODNHST3/ MVK0Q/O[UM*;>(2RZ&^[^!<+#W&LNN@ONQ#VGXZ.[A&EHY'VEEMPLVYPF6$DY ME?"I.B$OK2G$0!)T,`E228)(@DB"*DC0@"2()(@D:"<)NO9"PRDE/Q0AZ%B$ M(%?X]A,D:#R-]BEJ<PM.S:MVWX&O=5*X9]:=Z#`:A'[$2Y7U))>% MAPHH=ZMOSP$[+>40=P]U3X^08M9`&[9/HNV]618)'0E=Y_IK*;WA4*NKYPE) M"$D(F24R2UVBWRD+7P M)0$`SV#ZCIWL-2$=5*U,N7K\XF_AT_S2\?X93F=VP*$,L3 MRQ/+$\L3RQ/+$\L3R[>`Y6DK?;I;:;J_0/<7FF1_*.;;0AW9&**U\!22A(Z$ M[NB)HO)@3/<72$(:+B&M)1J9I7;3[Y2%KN%FB6(7%+O84X[3\6E$]Q.$@D*:>XWB/P2NI*NJ& M_8G>'2[)Z!.A7A59_B75)UPMK/\.ZLEDCA-;I3=GLO@0N*RFY"__7PW6F>:'*Y9QORR>7Z&K/C;XJ^2 M]%TB:9;8#2%;=4U7)*LK(90J*X/7TO4]"UA&_64?-'PFM*0E8<#U#G2G[5OG M<\,/G_@//+XJS3R+.8%T:P3P('XV_#]9*'FW`?,?N/C;[CS"=#+;-9W($O`` M[E@02KX1,@3W@<'OGGL>OQS,O7"QBKEOF_C[@^?`E(E&!@UM^LRR81`[^+._ MP4]<88-?%_JDM,N2:O"!3AJ<-#AI<-+@M6OPRPVG6'E:.^N?"M6ZYMZ"BK5G MH&(#='115'$L4//3*(Q`N\^-)Z'JPWLC!,7])-TRR6=_138H5G!X?=BWSE(G M>>ZS!]N+0-7GG+]E#`#"8)CW-GM@.#J^;C(_-&Q7FC,?1IWA)5X)T`S@P;XZ MZ&?45?K7!QA"`C,`(]AK$$MVL&J:%HNU`%+O5N#FB2^<`X./,1PTG;@G/=[; M$6-"&`N:@,3]N0X0NCA<@.5"R\*'JC-I9'GD-,VG65D^N<0:ZGWYP'E8 M[256[2VZQD-"_3%0KPSZ,J&>N/ZT4$]/V=2[M/K MIY!CUC@;=$#'+%?T3G2[ND])BVMX8PEO//*\90"0BR>JWI1_,6>^[5F'LF-= MJ'O9'"VZA\L:^<:OB=4S&WI9@X2#A..DA4,;RWONPT(^7/M\."H>N[LFN\B4 M7;$P@;]8FELS8A,=M%H=BTTT0K8:\CVM$;SD?=&$D02U`SO31FHAZJ$ M3%X<>7%-(]$^KKK2P'L$)!XD'DT0C_&H8!J: M^+AS_==N%>+L2OU7;","_.IZH71O/(#3X3Y)`0!M3VW3<+DXG*_U$?'\I3+- M,V8$$=96!H\EFS3OYM5YA7?_%8&()5_TBR`[83BQ5EC/FS,E/NW8J#6R#"IE M/_SCUR@XOS.,^:N/`.S_(:Q?Q`HPFX^%WUT"T=XYG_OGV?_]' MDO[QW*M_V.'][^ZB18`8ZOM2.5WX%/D^J.AW1F`'GV,L/OW3L-W/7A!\BG/5 M/KD?#!\OD`;\X@'`$U-WYR]C\2E@YO1C7*#M[MOKKV;RB99S+1!:H(W9^>#L[?*0`7"/[_^O2RB'MP%&^;E8RWAZ2*XN9K>#`LC M1AO+M2#F60B/@X3BW`&&H*M(2#A!WRXB^ECK*A8F);"@'!X+-H#"/ML/J#A" MP[VS87YH_]=(NV-O(/1-/.S-,\.^>_IB_,?S+QTP M:Q<_[>#&GUDW[]D#<[PYLZ[\2\]GWWS/BLSPFIGW+EC/NZ>^G-YBQD%W<^XVP1%,20,I*UKB$H>><2G#QOQOSO M3)R,!??VO#!>)@-YW%7$?#/"$BRBC96QWE547/N&Q;X:X.D7Q(:JRL/F(6/2 M&(VK*%H#%4IU_-2GW,ML MTC++ZS-=+NP`U+/0QGB'PZ%2?+O9E+4?Q?-KPN+KT%[J1)$+>W5-6G1)[370 M!X4#34U:9GGMI8WV9(V^LK!2T%@;*5IA5H/)Z@+LV$I5&2FK9P;-7G=M"E4K M+'+'7G8M&V1%'12V'TU9<#DUJO!CGY8ML;P*G13V@:JOL?AQDZ8.#XG\QCBE MBC89MF;==2B2B3YJW7I+ZA'P40I'Z9NRQ/)Z9+@//?)[P*:1\]F>+A]>KR:] MZ-FDE\7"OV/MIZ5E?3%^VK-H%J_I[;?)OXM`O(#B:'##3%FXU6IPBQM[E_&% MO4N`T#?,D+^3'NLO\IVJ94_(JP&C?-6>A'[*R8U4V&>?>4 M_OF;S7S#-^^?/J.67Z),^HS(=>`/*!MEYM>]$:).^-6BFNT$:3LX'&U+).<, M5[5OHPB18Y):)61[@;^PD)T@;7<5LFN\>0[+`1.;9)Z^8U-XYMKX62)K-H7M M-V;=V>[=>X;YS_R%)="_>JX5_\2LPCIS=<-5?`G[6?L&)V0/:S]7U9%:S^*3 MGZ_<'X;#KJ;OHL!V65!K;O1(GBP!NVG.%<@\SWJT':=2]K$ZG@R4950EXQ:> MK?A"U=%HU7TO/5MQCQ"F4H=*/6LK,ILZ5L8E9N-%_WUF`?,`^W_C]ROKY*JA MIN>C.F_B#2"Z:WNJG-L))83^[&U\.RB]&9&Y*22NLXCK4'AE)/XL[C_:&I,3S\-:V68FH'OGT4-^=N M/2$)W=`Y/"D$+F"MTR=<;R6;QJ^_X0UQ8V9%\%(WE2Z2Z0=_!G^3,C[ MI\\\WC^=K?=/YW?A>EPYH&&1'AGXXT8`[SN.]QA(+_A<7A3`$\'+5_MA_37= MG$^W=JJ"C)&+KP?+\B_I=5A^KU4RF>/$5ZC?G,EG_',P-\SD<_Q^C!T3:&/, M`_8J^>.U&!@X3.[#X*]7C>GR\G:HAG+HRG_E[J##FFLNL[$\RQ*JW;I.L]'654'\,U"N3_IA03UQ_6J@GKM\'ZFLJ(->.8LFG4$`N MET+Y?E+G>]'OMZPEK`)V+8!R[6R+T8!]RKKFZ@3VCU39BK]ZS3?[7\1F_\/Z M9K^4&)$>/%T]V/E2Y0?2@^I.>O#TJBW7JP8QI+F3I.R5;L`$L\YX:$]$Z_S%FX?16MS@TD5B]9VK,&3 M.M1ZZE"IJ]$&"08)1D<$8SSI#91#=:8E?ZV%_AIUIBWEKB69Q@;F:P8V9E4> MRCFCKIJ=/L+K*FL]6.I$\3+O9 M/1RYM-#&G.:92]=,D3I4>V-EW.#32!(-$HWCB,9HU%.'92-@XF/91K,*+"!I MP;H[LQVC;^S66]E*7UM>4\/K"FPH;[$#>H;S3%O=87^B[X"';6YX%D\7/K:Y M_=VU3<]BTI",#T9G/?#ECJFHFR`+SF0(#?;:HE ML-1JMZ8B`C71(W]'59085"R@<;O7]MY);.9&EHA%UZ:[C'JZ-DU`/Z*=H?_.OR'8#_<<,3:[OW'>2&Z+CD>F(D9:%^.U$2S)B'3-B M=(UV7]*6-N#ZU?1\)LU%`RXI3#MPM>74NGT9YZ=Y,M>UQ/1A3Y&WGLN17)!< MG)AU+5O6$QR#9BC M+6Y2$TXW3LF&=.R40NUIHR;?-R7V)O:NQ-ZZO'4+0`[2Z3I(=`9'9W!D3NBL MHN!9A=I3%3J"([;N'EO+0SJ!(^^(3N#JBA_165NG#0B=1*RV46IP$(G8F]B[ M&GM/J/1^(WB_FVY2XVE4KY?TU7//L0P9"YEDW/F,';30/IU(M,N6=.Q$0NGI MDR8G)1%[$WM78N^1-B)?J0G,WTQ?B0[$IWAT1D>V1,Z["AZV#$!@Z+2(1[Q=>?X>B"/Z12/_",ZQ=M# M.(E.\3IM3.A\8LF:@(\T:G)>.#$X,7BUS'"EIPZH%E,CV+^;;E/C:52OU_3- M".G>'-F/$SF5&`YZ^F!K#@?Q-_%W2_E[V-/'5,N[$=S?3/>(3MWHU(WL"9U. M%#R=T/3>2!W1J1OQ=MQ3QCJ=NI%_1*=N=<2/Z)BMT]:#3B%66V:-Y6&# MPTC$X<3AU3A\W-.HYTDSV)\:#B2%]XS'YX*#??.OG6HPG>E.^\F MN)[,/R`1_UX_I<@<%;EWK?:&V\T1209)QLE)QJBG:%OOD:XX:N*C`?9G=;CD MUQSVDA2`7Y+%?T4Y2Y&SK%7%E4GAGF^#,_E/'?<'^C+*_Q,%H3U]$E_%'U[9 M*"KGML6\.\#__7Z6MGA12<7Y4^H&2$80L#"03,\-[""4O*DT3P(KYH:\YG"I M34AN-6S)<"W)8@_,\>;,^M7T?";-?<^*S%`*F7GO`DO?/?4S&$__^H,EYUTL MXZXD<*+_*H$K(S%`X8R?CD4!FT:.Y-A3AN#CC^+AGG3'7.8;CO,DW;+PD3%7 M6E,695$7/GJ5Q^#8J3R*"S]4!^6)&7[0EZ[!.P2\P7^N)[&?]6@[SH5K+1C\@H/UW@Y,QPLBGUV#`+YS////M__[/Y+TC]5WKWW# M#02W7U@HIX*=03Q0S>1F(/,/9U+DVN+! MW^$/13T#.3"!59W@S=GYX.SMN3+6915T_#K@^9/7!JB>!50O`*BF#7:'T_>" MX)OO3>VP3NRI@]%`68%J,=-N()3$BSH8#Y5),1`^N:`;V6?X]:/OS2X!"-N- MP+.ZFC,!0_".34$YBN>NC9\L^/`3]"LX![9K^$^?0C8+OGHN@N][#HCQW2VFL@4CD+R\Y7 M"9Z2B%;&BC+>#9X/8+?<@+T#JU^SVE'&PU&>?*Q-6AVRLNB:R)JR$V0^,P+V MGHE_/[D7I@F[C1!0_(3^.1A1^,:/F/79-FYMQPYM5JL='(]'ZBK<.X"T]V65 MI,=@N$Z./2[K.S.9_8##U.JCJ/)87M-V6T&H&>BR_LI`UB9KFJ,RT)_39GO,RM64"``5QB= MODBWHK6I;5T9;N.((C#M?5UEE8RN#O>PK.4]$]A9&-:),!*8>/Y+B[@(;JZF M-\/B4"N*)J^Z&MOGK`7*$KB5=6W-`=D!2N[(H;]2*T.K@S4$IA/M"$)9E:!J MJWIK,PA",SSE;+_+@/0VCDJF>_],A%*$WT08%J,:\6<15UV*7U<\B:L>=7LQ M>)D7\"KZ5T;/5HQ/ZEH2G+1="\9\=:Z.FA*NK"\2.\1([+`_T5<6*S=EJ?F1 MV84=?\20',96?3M@5A+;G,)6T7L$S2,9H?2#S6$7>]*(`?@I>OBJ`THQ\Q2@(0"L^-.4Y\3O3F3#[CGX.Y82:? MX_?C:D@>61TSR/=J1Y*`=.Q&DOL>I-2=OEC@2AOK9#9IE0?R2N'Y:]H$BH)ZYO M+.I+IL,VQ64Z?J9EV])A<_RD[J?#[C=E'U8!VQ;`N7JV14!@HW+X_+V#MW,Z M>`+?^AYV)]$A.AZ9CDM!AU(D)/-%YFM7N6L\C>H5LN_&HX1IC[YM.%0[K26: M<4\IZNO[**I)ED];5+;W8V6-\J&BO^F?A8MM1;\I\V M2182W]J3SA=?E;BXA[QT'F/2]?R9X12^R[?G6XL)5L2PM17!>N[.[8;;N4GD M!:\RX]WFJ^EW%C#_8:640-GKWN#6CR>KMY6W3ED'C&6*S<(Z("S!<*JB5X=0%)T3M8[V41)- MU\?K>B%OTAI`*UO]0U-7*R<5`6U3P:.R'*9/AA-]6:]O+%ST_)PEY&XR&`^' MI>>\<*T?(1B^>\\!%RSX\%=DAT_5Q$L9:[SV2CXDN1-6!J^,;.G:<#2I![S+ MR/>!IZKA:SA2]8WPQ#/L`$$9^S8:R*-=(<#Z?#6@8:""T&B;@%A,LALEUF%Z._R\[_6+LS;-^-$R$\>G2F\ULKND^,O:- M^;@'->[*E!&[B8>_R1O^XJ<=W/@SZP;`]]QWAOOG5Q"9WX);$__^/3"^\(M* MZ1C?#?>.\9>2;[X8/^U9-!//K>)#R^)#.WN+E2]4/1\76U;X`N?VA<7<^,[S?5XRYM+``BVY M-D:1;P9\@8-T33FK29?+0G`QDNE62%T%%\]ID$]?/Z(Z?TZ#;%OX$5'VG3UX MS@..N#S?`7$W>E[]ED2>Y]Y=,W_VGMU6M(VRK*_:QLS8I68M80EAUO%HAUD3 MG^1G8+]R;>?-6>A'[*PD!GZM8?SGUOK,^'5Y-,]3;:,K4122VBA9!)(&5J5K M;(6R%Z.7:P'*LF-4*8-7>7(D_#E27D+2%PG5KI!GF(E3+Q68VY%<%Q@SDH"Y M3<]BTIFUE0E64!$B*BS4IT4+RL7-0O)JTJW4FI-V0&]CN+]\4+]-=?.: MTA.QO>5Y&I`JD],>D8A%=?.ZC/K\YFR$>N+Z+J.>N+X!=?.:XC(=/UNUJ2G% M@'[J(4U%\[I?;(V*YG6#CAA868C?(:KGD1%KNA$KL=FGZGFEI"TY6W&6XIYM MN1O3O@H6KR.$:NT2P.'H)"WTX#G)%LD6R58#9(N\Q-/U$JD232D9 M^^JYY^91/44JT='RT'K7KH#JLMS3QZ.Z;D<3RQ/+-YWE!\CRDZV%F,BO.EV_ MJAOA[T-7I6EG\*V%!N8T(P1=LT/[=[U(-$@T6BD:N[EHXF/)PC2'+#RSYR3U MY\KNJ.,=EKJ_JR>/`G^WGF/EWE^(KR0G%])> MN=*5&7H\QT7A>1&#GO3()*[=F06OAIYD2*;@`>/.9PSO_O8D(Y!N^=U%YL,+ M=G@O.@<]>,=T(K0K$K]+*>$%RI[TM7_1YZ\9U@R+_H1X[^N!P9A\O/]X M-D8"F6%)AN_C/688-^#771#X>'1^3\;A]V(#O!<3PV4'083/XZ^__7AWR:>4 M?O]Q`=/RVV7@$5\$@6?:_!,'(WAR+=ODGP4,_.T<,/K25>1+WBU0CS\=2!$' M!>_DK.(%7F+2763`FR$#]-T^2=]9\`7^NO3\>9]/$7_QQ0L]7[IFYKT+>O\. MBW=\"Z#:P+=O`&I?]'6\;K8E$5J!U M^9=FB,B)2?]U'@O/?>\!8`%!K!$0X**8!`WWB@_@%S(Q0.U4> M>@H:J/(@YT_,\"4_N7J>8'0:&\Q8/1HN`&[RZ@G\4M^<:Q[0KJ`N?68$+*M0 MDG=1@<"+Z*;':JPZ208UDJ0O7><`;3B!%UN!FMA(7<_6VYV+(E#E,X07>&G- MEN2O"",IMFN$L!P8H3(L*R9W7'E`X+%[!GSB.,!D_$ML7@O"H,0WD)>S@PS@TU**%D16[=_*9X>`<

BH#HJE;[\2W7>`*`J#Z+6`LD+ MB\V9P#VJAWNN%MQS8SYWP%O!NZT.>V`^%IGA%^=?]J6+O!O%/?YN2@5.@/`> MB/&(GAOC>NH>3!:J(C'/LV3'MVJ@E5H=0_V\^^H7P/L+#)EIC1IIRAC*=N59 MY;ZB-X3/Y+Y:!RBE&4U@6&A`?#QRHP"X9^[YW)+%M]17-$*?MHM=I)9@33UO5FLI<"[`5TSC6)^S&4E%!XT4T]KVNK6 M<`S73.P2;EOFX(W9'MB7C5Z9<,I6-JC<5GHPO)_L9F'SYPJ]R:<62Q.KB&=8 M7[EEH(-G<*?B([OU83OX!+CG>AD,_BT+'QF@$=X5NUD^$19UV&';_-P..6># M7&USO`Y7H?&P9)CG/C+#`8SSAP&PBPB7XM@&'_D/K,\@?02)\/@3+WOB(+E;9RQL9-@`@@DX@87Z6-'L@;DPZ%)-23-XA;^V_CJWT$M3&/`XKS"V8L9Q2:AG88V\'`THU0_O/EV_OY!> M@,!9#,;D>CU7J[],H$O]2H1[,;A`"SQH^VS=A]R@UL60\*]I^E%,C7@3DTXS M`ZT/NQ2+F8[!["8X!ZYFZ+/44(&98[QBEA24;DP)\F$#O@ MVFW+*OO2AP>N7S)O/Q/RBS>ZL"#;`79"C,Z,/YD4FXM`;,T`2F$X.!S`E29W M3(UTAAB8.?.GJ!J2W]T,"VT"6/(P_.!P/6EY9L2G[>&W":>`J^_>,;'-!1[U M/0?_C".1(NR8C5/VM@8IX]\_XT::6>GGWSP'N2^0/H?6KY\_7R(,\4\?+KYE M?OY\24JXQ6=&*QIX\PX4Y`$-^?KA;=DI=+P<6U\0*.L^;I;MZCS:+09=1GMM M[31RJP2N%A(,@DL8'N@%JO/I`FV%X5R$EX;O/\&7_V%*@,NJC+G%UU@275 M@X6<4KK=P0(O>GPU_0;?VF#_\=>XN&JS^6&D/H^*S>NJ#QT-8HR)4@\ZOC+@ MG>#^FSC%LMX]_1XPZY/[4?C*[MV%"?MG49:>#Q[!=U?@=<6;AQJ[6YP/)L/E M)AS58#O8.DNVRE#DX433#KU0T8_CL`3%QCF#(@LM"-S!%EJ2HN=#=:1-#KW0 M^/%#4G0\U`?#(NLL"-O!UEE61%55'JG[7*AHBH-:N5;Z#%;[P"Q-M2L4);$W MEK5UL=\,Q2,X,1CP`(0!=EWXT^2[B>";Y]CFD_C_S:N&G5]N.>X,")LO_&K; M%9CF[%"W937B/`LZ2@"G<]>1FHVKFN.?+SX\>ZE.-6Q\A_\?8[' M4-*+BQ^_OY2^>GT^Q;D\Z8GB!G_["9\O7W_',"EL&?E1'.IYWS`Q8HEG8Y<\ MA@T._.*%]SS1Q#;O)9_]%=D^9O>X/-Z;',^9WIT+2^1+681]_7@:>$2\;H<2 M^SEG.!=\=RMBQJ$#B\&D''X8#5N*8"H.L>8`G8UGB7?8)1)CBMBPSC89?]M, MX!319UBP2$/Q&:#?9-+,"W`VF[LI*2@QJ#S`?A?9%@^XVJX(]?_SXN*;"-O: MF!V#BCZ0V'3*T"8R,8\+'!'$Z`9*+'Y.EW#IS>88O[UEP.V#R#] M!=NF^)1N:@1).U;5CA=SWW:R&4VH^5+%!WP3X?&$$OC.>/;&D MVE]\^OC]QTL\HA1:6"S6"'/AN4UG7F1Z)?D2P3UC(<\MD"Q0YB:.8$4FAS!- MSC#C0-S**5YZWH1S.G%[NZP1G/;YG';Z9 M&`#`C=_D^BX6ZL`$KT'H"Q!7!,P(X]3CQS@["5TSE#F788(58/N_7!L^8-"_ M+WW-^1;U"8Z!4:>9D'_F.''.*GJ$\>1`6A!PGH`1^0$'XS8"WP@`RCF>^YEQZQBN-CEP@"PF/"&DBQ<8CKABQ'U3U,M<7PN=9P`2+:%$ M.`0`9NI6;C`GLV7L+W`(`RS;CN>>1&.0JY]JU\3CW&D:H)R/=W)9-MBS$BKR M7'2DK_QO@.WXPX4)5`M;8X+PF0B@#@!V!Z-WB^XVM9JHCV\DO`Y\]: M!W!E(\F:,MD%N#2N'/]::YA8T=3A8)G@:_-5`:%J"2*)F-9+0L1GB8+U5-3>TUU/!@O,W/N'+N!41P7`UU;::U9%`R, M,/GL'A@*3+K`VT?P-<#!$$6XP?*@JV+P+=V%:_%/#J?;A86.+%HJ\+*NIM?& MSV\B3?\B#'W[-N+.T+4'ZG)U>54/41555^3Q^GH/M9BFXK'L&:VBJDW#8VZ; M^TJRH>+9V]H2<^?)@><@YEH9CI1U$(N:Q=W!+,LOX.D-=H;S6YS,#)ST+;Z_ M\]'W9N_!DW_@%U(^N4'H\\SCG)2`6M&MJ/+RD7TUV`ZVSI+T&DP&FG*(=7YG M\\@W[XV`IWCA59T?X;9SZ9(TT\`;'VQ:RX;Y:X6W).[UT5@?U0+OU?2]C?D5 MKE6K$`PFRF22"V!FPFH0E409;"1'.T/TA?EW#!#+]_8\*I^3*58K0^KC#;`6 M`B5_'==>O"5^%P>:P#JA&;U,]IIXROW924# M::$9:X)R8\2@45!N)/S^H>0/!!=1>._Y]G]7K-@62J\!)ZX]R)O@6YVK(EP; M:7MDN#92<_]P?1(GA55PM04:,4,%2(ICIR9(KC+W`?>(F,PT56&J#44%81)W MRWX&]BO7=MZ1S/`.N6":M>UA`^'BNKITP% M9JP#Q!*9ZP-M-*P*8B;48/.P@K@.MMAK75WJZ_;O6WSUPIOV8VB+-<`,*;?_<$KSX;)7=AG M=%21:.EHLB90.9/L"$B)L*TZG@SV!TAQK3T9KV[H]X&0`JIY/*X+CJ5S'7&2 M\RDN*OJ>Q<5%ZSS!&RE:`<@+0'6(Q96^^CA1#K>X9$->ZP&)/AP56$$R=6U@ MEM:7@TG-8,8?[=R-1=6(^V#-D2H"0NU@EXT!\:!\O6"_3W/OFGR)<;R2\RN= MJZ,FU]!Y,7Y9N;Q-I>3TJI/'7"(M>*EBYK:NK9"P010\I>I.EW'QL#A#.+WL MP7.('V.E(/*FD^N!=I"41>-5UI+2;BQ)MK/3G%\+O["6LW^7[J?`F.F=P'N? M83:U&]X'$N,U[-;+3O$T853I_'*<$<#;#EY4PP*;,((7!?!`\/)5]3X&]2B8 MYI9[RNCEN%^2+/^2]@>*L^69X\1=I-Z7@M:/I9KPP5KKKF7X/+(:?O'UG9_)&(=H%/M+LV" M"?6UH'X?38()]<3US48]O!Y"E7NLMTR&NVN M!]6=]&`GL'],/8@!S)U$A0AW=,)I9*0:IP";::0ZX2X>3K;>Q<=!O2-^9LS\6]Z#I8#0D#ZH)FIX\J`YY4*(,M2V*VUDK?M0S18O) MUI`CU1'3\D+MR8/)2V)J^4[T:;3_BVS+Z>91M(U,S3NC<=-SJXBN2"Y.,I1N-H; M3[8*QHJG)CYB=9'5X9)?&UZ69<]UA!*LB&%K:V6YO&2\A<%L[MM8W2O>3(A*7+R7/.^PO*%XU[\BL)+I-RME MN\HS\J-@B%O/L7)7LF="+GW;"69N4UVP?"=;[ZLRE1]I25VP05^CNF!'JY!$ M]?..52%)H0I)Q/6GA7KB^@;4!6N*RW3\0Y9VG83E^DG=/PEK=$&<;J#_F(55 MUF,$.XD.T?'(=%P*ZI0BX?^S=ZV];1OI^OL"^Q\&QBF0`F.7]TO3%,BEV9,B M:8K$I_O18,BQQ5V*U))4MNFO/T-)5B19CD2)E[D\WTS+ILB9YYWW>>]07U!? MI\J=\'O4K9"]B^()_ZC\LNV.[2=]XZ&-I%@3D,'/R'["U'LL*G0!V8I2!P$U MW+"S_`T(!@1##<$(N6`X?L?5W2!H"A$T5'>W.<=>%M/9G!^=PU,SM6I>CU!` MXQ9N#.W%EDZS6!X-K8.=UP!X`%X5P+O4.=R!$U0*5`I4ZJAR[WF9I_6\&?&9 M)^0V_;/YN:?B;F@7:!>AM8OM4SL\V(4->`?>%<%[0%W3!)D"F0*9ZH),_<$F M:9R!/D&=:*E.7.H%W75L!MP!=\'A;OL@3R!/($_=!/7X!VD<990D;%KD55VN M>@[F"2GY61EE"/=!XPAPRHVG<0*3FKX#A@6\:X)W@X;P3X%B@6)U0['>LJAB MDR)+2#J=E7S[>^SD#.4"Y2*T*"3`'OFN#=I*Z+S"F0*9"I;LA4E/?4 MT!FJ!*I$:%7BFC0T0)V`=UWP[AQC*H`Z@3J=>&")T==D..[T8IYFS:/)XGL2 MK?&_?AI%M9;^EF4?4\@$R`/RRD#>=JD+&@4:I7&?JA&/*+34&7T+T"SGL);P M'931M"CK]*_%+^!_TD;GP!C?U#E/;-^C3NB=.]L>4`?4A8=Z8'&3(NAFP#UH ME4*T2HUY!,/QJF].JZ0D9]+T2)=0S72[E;+T@E9-&]E>0,.@SR(^B`9$0T[1 M"'SJNP>[V>X0MN5EVSGWE\:5/>MCWO"1,#6EG6Y_]+3Z(^?<_Z,LJFIKLOWS MZN;][8VW'F5/YGFZ_.3_^`^F=4$2%J?3**N>75S:%S_[OF$Y'L?X$<^Y^+:N MGNQF=8N;1V_QXLOUEQE[_F=:W933Y.:^Q\&KS0X'_.\_+/H;K/_KW6)2U\'W M#HS0-$5_[?N_O4_Y.O+=+-MU35>6E[MO2-]V!TW+=2Q;EK=<]XKE?_=ZU2GV MR!>U`U<>J#:5'4>^E^N$\J!T7?[[9J/Z]]@--%U7&J"NYW=M_MVQ(AD&AN/+ M\J;W'0>/A:OM#RB%X?$:W'&=P!CAR<;6X*;I.Z*_]JD:W+('U6WGO=SI&MP+ MK4"6MSQ'@_MV."#'/N\]VVAP,S0&U.!GOM=]53'LPK;"\+@2/5Z_%.M_1M;S_9JOJ0" M-_Z-N03#=;'QJ#^OO&!KU\J&1VSIE5JZ_1K7Y^IZZQTVE#9MBLT;+U\?22YI5@Z4'ZL5>>J"^ MCZ5'>AG2R]1-+^LW]96_!3=;^)IST^[;`L(-E=;I%9(L_YB9,!_9K%[X)8AM M4-)8LB>)#O9QY'W\=CLM6I:,:/G*FO7, M^E2L^-D,`FJXH<#YT!`,",88@A%RP7!\=`4`04/#[DX&S*U2?#!&#A71`IQE M(VH6RZ.A=;#.!H`'X%4!O'M,LU50*5`I4*ECJ-0ZCWCAZKI=91*#3D&[:*A= M;)_:X<'N?<`[\*X(W@/J8BHOR!3(5#=DZKX"!/0)ZD1#=>)2K]=VWX`[X"X4 MW&T?Y`GD">2IFZ#>JA\#)&")T==D..YT MWX!<%M^3A(.T%-,HJDW(LBS[F$(F0!Z05P;RMDM=T"C0*(W[5(UX1*&ESNA; M@&8YA[6$[[C4Z36-')`'Y,6"O&]0RSE8=PIBI"\Q@G^IE7_I>1S/I_,LJEE" M$C8K69Q^32:/ID59IW\M?@'_DS8Z!\;XILYY8OL>=4+O>T`=4%<=ZH'%38K@ M$:B#5NE+J]281S`G9*<2=,C74(UT^U6RM(+6C5M9'L! M#8,^B_@@&A`-.44C\*GO'NQFNT/8EI?-M-S=^]U_N@]?S=Y?KMX\+\IIE!T+ M,-/:1-@YQ&;]]+.MI[U_C>5M^7<^NS`7MR&/XW+SMW;(K^[9N7T%?M4?W-8LK,Y+-DY/."[0>;71WSL*SMXL)TISH<> M+#CIN2H6E?&$K^TK]IEEQ6)U?_ESQO**=;EJMF%8SLX#?N.KNWK*EDMH^69H MG?Z4=<3%)_DE*O,F3VS#H?>*W:9Q>MZ4"[>QN M<[M'_!AEK/K`ESJ?L]T1[.=B,##L,-QZNIUO._U16@+-,4W/\5L\2CQAR3QC M[V]?%E7]CM63(GF3?V95O1#QZT:58#3\MHK[AD-D24@>.D1,3!N7932\=>5C M4O-H0[(A)V,-R78Q)!NHUVOI&]0/'*G08.E;QI!$H4SCAR=$C2'MW:']/`DY MRV>=5NN)XLXH$\6%6/TQG=W7DY(Q\HY_,*G(+WG"$K(U*[Z5&.$#N'K8JP)[T94\H;3S+V<7R1$XWE_:1'%G\7,I5 M;QG4[)5_03+$E(S./5VJ28;I4KNUJVMYB;+&0V6-K:IY'BL$:HKYWC0CA^?+ M?T+US[DV@X&"$GFJ?RPDXX]6!X$2E+'J(`(L/5"OU](#]0)7_PQ-F<;WX(GJ M9N7+?Q1)4M_'*G3.NQK+/Z9':*O2AXR5`X]]/'@Y>0K8@6Y`M`60++%%?EJA\@7^W,O9;D5_&HS)%_7H"C)NQW+EK7;5$ M&-6(`?*`O."0MQO(AP?'/8!7ZLKHLZRB1UODFH8/3T M$*BFA_JG7A`-B(:4HG$:15M>(C__^/S\QY+L'T_*+]//49U^9AO_]8\HS=\6 M5?4F_UA'-6M^]_[V=9I'>9Q&V>^<##:KFL>8X($)'OKD\-OF58B""\PRT&OI M.;O9,],72P_4J[ST0#U0K]_2-ZA'Y8J@E2MH$"2A=:!^V$'IP35B+/^8_M+& M%41^>-)X@[XG'UA#;H]5JT)QP_`+#MVOK^Y7OC1! MZ#X,^B5==ZOZ,7M0VGUK-WNPMR"#BC(F'"W33UQ`U.0E`6(2-27L)*2G+6KG84QHN^QHOR7N8>)(S< M+DV8RWL3YI+O?3%-\ZAF":G+**^BN,GSD&5J+3QI8R>K*U=_ZE,C,,4=7`O$ M`_$=#T2SJ.D$0+PZUHB(^(8U`FM$86M$C91S04\Y/2;0PNFK!]]Z8E'+M\1S M^D(>(`^CV!_4.-SO27>Y$%0S]Q(-$8,+B>#CV+$HEI?H:XKV M2U3F'%,5_Y^/DZAD+Z(JC9_GR:LTF]>J!>Y"90`PN%9/YI,7F2\O48@C3-L((K*U!S M]45NFM&N%Q0.0GT/PC,S1M3:HOX:")A.^V0#.=SE:C<0.&7?5'2Z=[YO[1H( M0$-!0ZFJH@R,64CL&M8U07#^8".(` M>,L,;]/RXOJ9D8K%\S*M4U8-YL]20*>` M8FERZHU?NRJ%/`BZWL`W/%M2;0=(EOPDZV/=M/XI9HNN^B3*$U*RJB[3N.FX M7RT^G.=I3X/#U$]E`=]2.X7%I)Y]T.377!P`;VGA;5'7]>#1$@'\(%ORDZU5 MW\5U()'@H%!ZM$ M0+9`MD"VCL_98JL6V&3&RB7-DH5DB1`IT:(H2\3DX?'TD''E]NG0@E1`*N24 MBH.)BZ!FH&8]^>G'WZ-^'&'CL3,5`BM:Z"$$9`9D9Y`*2(6<4G%P0/@..UM> M8E;9\;/*6@T3>VPBV>LH+?^(LCE[7E6LKOB_OTVC3VFVR.E^QZ)J7K+D??ZA MR?,N^;J98%Q*.+-*>,[L;-3KG458&90WS.#'J[[_O&L6/_3VTNT"$*@^=-)(0$B++"`IU(:\W+8,00`@@!!`""`&$`$(` MHUMOHQO-1MK8W*^+DC]J3IJR%9;'7\B$)?PI[OB_5'4YG_(SM*(D9_50;N)^ MMV]H'73X`!2^CF^$!#`!]52WVT2^'HN7$"P9=DQGP1JO/M:DGN=T538.F8!, M0-E`V8B_8SH+EN#*!IX%>!9./-3$R)X9,)P_K_@G546B^#_SM$J;=A>+'AC\ M<1F_$_^Q2OD2+/I@2**81$M"@V:2(U$-G`^B!=%28I\@6M)MF=:B-9Y!]<2D MKNE\#VF`-$`:OBT-<"OHZU9`E<#)50*_SOFK=U(@L%^BE$V3&S\I;O^"(REN M[!T`Y`%Y0!Z0!^0!>4`>D)<`\C">]36>D>V/;'_DB8GMR15"R!`QA&!!L(2. MD)C4L`^.PX),0":@;*!LU-DQG05+<&4#SP(\"SUE&8V_1\CV1Z:8$II)#%$# MYX-H0;14VR>(EG1;IK5HC9O?'"#;'](`:3@D#3MNA>5E]"ECNW>Y_W0?IIH- MOUR];UZ4TR@[%E6FM0FK<\SO]=//MI[V_C66M^7?^>S"7&G31\&X^=ID\^*G M'^;5Y5T4S7[\&$]8,L_8^]O745K^$65S]KRJ6%T]SY.W:?0IS;C5R:IW+*KF M)4O>YQ]8$^CF@OHBJM+JNEGA:[[/+[(B_O?/?_\;(3]]X];_NPR-O_D:&?]8 M1S5;_,3_+,VC/$ZC['=6WC:KG\>,/\;77Q=+$_AM$2\LWNTO7QC&_.(#NWUV M\6J^-(IO_!OSIDEDO[DN;L(;VUA<7/R\`MUZ838`N(3#4LH:3*RNEV*S=3CM M_.-2D$W#^&Z-W`4`2.5AZH%ZO MI0?J@7K]EKY!O86E[WCI$7,_<6]$C;D_G+VVWS3H>T"H9#O4^JSB;\$M=;[@ MUL4!E<%M\X?GEAK+/^9PT(YF%F(?1]['\[M*8`M'WL)5DQ#R<<)835Y&L]99 M1Z`ABM&0%DY*=.3IO*IPJ-P)%6K8U8H6[_<-B5CZ/EZTV*9>T.><$T@%I$(^ MJ3"IYT`JNB39(\X[W>\L%1'P,MDY[^L)*TFTR((AERL&UJY[`PP=?0T==$\1 MRLYYZ"G7H=Y6?+TEQ=$V)D]S?4QI!-RU@;OMH$V).G`?.(5#.Z,D+W(8)C!, M8)C`,('J`E,;L@C/#PWA"E(!5W*?^O9=M=]+3MIJ>M@3:IDO2T=:TK"\WV1NMSB&9[8_4Y#+#T0+U> M2P_4"]S=T">]+`T8#])0M3AO+,*+05'#KVBNZ<:^]AT]_PJ?B?M M)9288DJLA;&/WI"MI.T5^\RR8L:2'^*B9&16%LD\KDG-XDG.7^CN2_?[MM]F MTJ_9EPRAQCT6EH@MP<:+-'H>-8WN0O"0"\B%&G+A4_=P%Q80-7V)&JJXVE9+ MSJ?S+*I90J)I4=;I7U'KIOF]^;3ER'@1-[^E)(%\F11DK-V'>Y&--NA5P:VOU53+*9#0\\0V#$% MA`/AYR'KG'0!`!!TI<@(0:'&!S4"6(51S=+M$R$X`!K]6!M>(C`@1TA M`M>5_PBQ-J45""(1VW9VATW8`&_`6S1XAP?A#9H$FG3J^23\'G7+DGXKG+CA!P:^U*(@]=28B]*:U+A`Q. M2#23I__)EI`22(E@E,NQX942`?IJ\B[A]ZA;#?)R7O$W9R4I6;9P1U63=(8( M'E2)#B$.*Z2F82&$!WRKB6_;H.[AV9%@2_JR)<3P$,.#/D&PX]A@1\@5BH4@ M'G"M'*YM(T`4#_P(4;P>W$F(XBFM3!"?V-(FG"/Y(N>%`^``^'F9X2:U;/1B M$@+^:M(FX?>H6];T>U2C;@[Z0Y.HA&=3USZ8PP%\`]^2XMNC;H!>WD*@7TQZ MA*@;HF[0)XA.'!F=<%SJ6SZB;L"U8K@.J!FXB+J!'R'JUH7_"&$VI;4'HA"[ M([,"PQ/8C02$`^'G(3R@#F:>B`%_$"45B-)U44<9*>H)*_E?U5%^EW[*T.'[ MK)KWF%-/5@ZXB?_3_4Y!'1U3=VU1[[`Z@F1`,K23#)^:SL$ZTAVBMKR,N/[9 MO=W]I_O@U6S]Y>K%\Z*<1MFQ^#*M38"=0VC63S_;>MK[UUC>EG_GLPMSU:7D M45ANOC;9O/CIAWEU>1=%LQ\_QA.6S#/V_O9UFJYM^9LF;M?)^7E6LKJZ; M=;SFV_HB*^)___SWOQ'RT\,;_*,HDO^F6;;^0Q+SA^(7']CMLXM7\W(15KKQ M;\P;RS#=F^OB)KRQC<7%Q<\K/*P?=0,;RPU:"D"S2ZOK):*W3HZ=?UP)F6%\ MMP;5`A(D9EFV.GJ>71@7B^MJ%L7WUZO_7XD.%XLLFE7LQ_L?GBYO3/B=K_C- MG^X^X#80)#`7VIW=_)T[YJ';=UZ;#M):#MBL`;PQ]/"P*N9AW;M#FE8R]!L$XF_!K1:^Y,[%`:7![93!,[D'[P\ZN$?H>E(R M1M[Q#R85^25/6$(^LEG-II]826R#MA(CG(/ZGH/*IRP/=`Y:)YV#*F1JCGD, M-@Z\DR2EUWV3KKWU&/OF0$4)=_R)Z=)4@BP.)ULOHBS*8T:BFM031CXQ_@@Y M?U12W"Y^,6-E6B2R9$6(4+.)T*]VM9Z6YU#+,P5.BH!@0##&$(P@I+;9-B<" M?$TCOG:F42O\%G5,U^85_Z2J2!3_9YY6J40%T/*I(.$J(Q0XS30;DP69@EBR/OY"ZC/)JV?.81,F_YE4]';*G MGWX1(L7TC6HU$4],ZC@VFM8`Z,H#/:"N\=A0%%`J?2D5JK//BDBR/)$S%BFA MCM$SYJ*:*K(\BP;FP8&/$`V(AG:BX?O4\MIZP):7J-$^OD;[08GU8[78;_+/ M7/:*\LO+A0>EWJ[@1F'V(4MA_Z'-+84`]5_2%&:;J*)'B:I>2]^P%0-+/Q+J M/72"`.J56?J6SE51*-/X?CO9G*M[>)+ZSE6A*Q+56/XQ/4%;==ADK`I%[..Y M^_CKG!_V)VTAU!?4UZER)_P>=2MD'Z+_DFG$!3N-,LQ)E>1D["G6\=".0NG5 MIEO>=ZD3=M:G>8_'`'(!N9!1+ASJF`<'QH"4Z4O*4)'8YAC[9U'^FW],9F5Q M5[)*EE1W^;3/R`G``_NM95,K%K7,@].^>XO/`.Z`^\!P=]VN9Y*!1(%$B>50 M'K"0,,W3:L(2H6]G"B%>% MAEC)TCE6L7J'D`;6P1P]2`6D0BNI,$WJAP<;C8.JZ4O54$O=JI9ZE<9"HC@N MY]'_LW>MOVWCRO[[`<[_0.3L`BG@:"W)SW8;(-O'HA=H$R1I+_93P$ATK+.R MY-4C:>Y??X>4_'9BRZ(D2AY@T_5#ELAY_C@J"D*-`*HY4JZWNKT^]EU%X-3$/?GRD!.V MLE=8P]3W*DT[]GG:&^K*02A)32K4 MF+HVQ')"E=7J0#VIJE;'$$F/4G]I1](WBO22PN%EH]5L*U[#T+JR>:-J M.!S(OQ<^52L67CF'RBZ)T0SRJ]2Q`QF2F2&2PC MC1CY3)V`_*!NS`H)N6X!!LA/Z?R\9A/JB`H+'^#J@%I13%URRX();Y3Z%Z-! MMBRJH\`>1[\57PS\4)Y'U;5. MYN7?YD;9(92NA]]50=@1NR)VK;,.E8==?[`0H6O=S!OZT8= MY1SE7&DY!T=I9BX'BI@5,:LR#$+,JKP.E8=9/_O!B#GU@:VJ'7T^/G_>M$/- MI]W6(']92A1T%'3%!;W3T;(7LB\)N:I1H4<%<4?HBM"UUDI467)M6N:J7FFU MZ.8K3QYLFI\W6L9@T!H:AL*)M344^^/,K&V:3OG+$`N080&R/&L*+$!V%,S"4DP-(3W6 M`T*I/S[2H]0CZ1M%^HS[%-OMD>K[%)67MU(3HJH5Y*B<25CR"FN0'1U#Y`;] M-FI6??K)`LL)&;D*'`N+C]67D5A\3)&]=\0=ZO.HT/P(+#Z&21)886F6(S%H M#UN&.5`X1Z)^0G^<*1)-4XVAUI/3_`Z+CQ6B%[`J0,2,B!D/PV'QL9KA`^5` M<0,,6(5M6,F"1V>H,Z@SJ#-5ZPQ6E<"C>0JB-`32RK-(KI6;[=XAE*Z7A6L6 M+*@NAG9J=-NMWF"@7%4)%'04=)F"K@\TLU-@L+@);E<%>4?HBM"USCI4'G3% M@F@U-7&5N?2F'9$_Y6W9.CWEL"M*.DJZ](IHIIPJ*5@4327XNEFT#K$K8E<5 M651HPB\61*NSS:LNH;%I;E[`V5:[+2=0A6)_U-F^35,.LZUVK^$Z@N!:Y?LB M6$:P7`\6%9.C0*;\A#$'R@])^B_QD\)T=4',]=O3/4[DH(1^-3;U$76KF8O1 M^FE-.1S8MS''$1ZWPQBT.I@-8;4:"]@2@]`)>B8LP=>B9G)5P6C<<:[<_>.. M\W*T36\-!_V6H1=9=^+XA+ZFZTE4C95=FK[6ZV-[.L4]P1H*3MYBMXV\W39V M-\38W6#CBCY/0"Q$DX[E^_V@;BP>3KU>NA9+!4?62U M5M'O[0BI$?M'U45,YYT%.CLZ"YC=;1ZC$=2O,IAW.PX8(U_ABW%(/GDVL\D- MFT9L#QVL%&1!`5L(.[.JSH?=S3*""'N*UG2R(NA6_5;''4 MC&^=(EV4*G'-FID_-5U4(\!BD;KUE`SMWG?M;;9X[-_(>`3L<*9+#L&SIJ0O9J]=0^,G6HGN#')-[J M&Q\$9<<+RO!07I;USKQ])$W;1XHS><2F$2,CZ@2<`W$![4`/V:^KA2MJ6B)E M^?M[S0\R%'$:#_4)]0GU"2-V"`X1'!8&#@,G_/MLQ#=XQ1J/A1$)`"FB.VO0 MVAG=6#WH%Z@7".X1W".\.UZM//Z?,6M3?(JXSXL"./#,:%%&,JZF^ M"#&=VD:O/K[KN/4(]0+U`C$=8CK$=(?KU4?G$8"&9Y-GA[E%E'UJJO-!$*>V ME:N/LSIN/4*]0+U`$(<@3JIA4^-<4@61N4??I9'C.M%S35R0:@?_$,NIJ$GU M<5I'KDFH&:@9".>.`\YMY="1'GS%4WH(R[(YGX8=[%.[\GUS=411@J/,XW'5 MNKOI1D;&E&=1WB7*CA(BGVZNKL@T#JPQ#?GY!+BVO$HB#=BN:30F:X#U4\$] M';>&*$IOE'@$9.IY>P1DRK,(CX@J[G`0DJEM_ZKJ!"`\1'B(\/#:*D`Y]5@4^ M2]?Z)D;K$,^A;FSJ!LAP&\-UZJE.(\&<&D=[\/AH30Z](:9[T=BIH4F5.JY> M72"=$KJ$NG%,NM')!>F2M_3>9?,?V\[C\K?;)LP'7H M9DP#]@<-F7U%GR?`[HLG&MBBK>9ETE7S!W5CRE]=A&$\23Z[Y22^!3GYPX4+ MS__]+T)^G]^;N3#;AS^9QP+J7GCVA3UQ/">,`KC+(^/(P@L9L6#H<(-K-GI_ M\C$.Q!/N^G?Z'>^?>W?KWPWOS+9X7!][=8^!Z>]C-/_`Y#S_X$_Z]&)-<"IN]_NHXMSXS M][BR$M`P!Z:D<5T$`?4>&->!/YZWJX7XYP<##.<]7+'`\6T]PVSNTN??7?/G M7/QTPODG7^E/9Q)/OK+)/0M.SJ\Z?^V:T6&C59X.(.K+=-#5IL.G?V)8&'WQ M0#MC_F%X&8U9<#NF7FH[/_O!B#FPCOKB)4\^A$SB4;?/TU527<.$`H>OT82Q MYOH17M]\3TFWICC+>O/EV^>3\^[`'$H@;78"E$SY.&#A+,'X(LDO_I.W)_Q( M(_:9.@%W;EE,NDRF=)>Y8IR<=SK:<*J:6P[C>&]7/J)*3-K`M@3/KKX3H90Y`DCW-*+6UCS+(<9KFKUT#1#&'S M%^0LF-AWGR93UW]F3$C855I,6R(- MRB;YS]!YZSGN^Q-0!G:2GP.S3U>XD.C5BQ3_324YV\N>%2%G>M]$.ZE125L>!8@%UV`:P`X24"V$,!5`#Q MR9K]M1/^_3E@[$M:*4W%%:PI5A9M&0'Z?4E0-L6;;N<)0*"&TNQTA@DH1K(L1QV`9(-A[4FV ME'=\P%[[;K]G=#LR5KW)^9?PE97OT\.&J3:^-/#85Z?6:4(=9H?[>VI@->:XKIS[0S"Q&7>H\)--P MRW*@)"IV.IJ9Y?"/Y)E(IN.K2'J5A-)61"^`X0V=7@_V?O=L%BQ!;1X^#%?& M*(ZP+X5LTDF^-BW]M7GM]GY[H?H#)S*+56Y.*%]`>CCH&_I.;"M]T&N4XG<: M^R[<-$RRK[/`L\W2$]U!WVRO%<78>,0!0\A0_0)`\T`WU"63Q^159I8KSL#KU3H[20TD7FPG?9\4-5HI2?1">1XR^S,&L^)$#DB& M%[TE9T9?3.M7;;S;*]&2]R5*]H-=?Y7W0LF2(V_[G M)S!W^(XD8K)/M:*]F)>!4SD*,V5BW@&%F61/M3BAW-[^>,%W,,$3WR."_5II MX@H6!7`OB<8,_GBOOZ0X/V&@VC:Y8=-(A+6(V6X1;F,(`&C^HD.>&`G8K%^S MO5D'*^N(=> MH;7EC5$*U7[I&-I0VIA:(&0ASRQS'IG[K)$;Q[.8$%?^(FEB!)3TXR"A\)), MDFG`E7H2BGF!=/OQPWB+2+>X*(_IXZH\4Q+Q?1@I;.I($,7.C"(R34/>6Q4C MU+K6S2\_]PFUM&U&+T&X(!)\X,$:W^&]Y=(P=$8.?PN7!8P")'N&QW,\!CB9 MAQ#(*.9+-Q*#H''Y"I@=IY+I)8%8H$5*'W\1>>#7V[SCED5=*^:IDO`9HP&/ M/H1P[U2,MP[[(MHJO?DM+RQL)9I>VW:X6H+NI-.WJ$?N5ZD<\S6%(!:=@IH^ MPD^J+T3$TQS$^S2P MNQ@]"6.2%0$0:R0`W1@M6A_POOV&;V93$Z>6WMORT8?Y136G`Z_3& M7&UG7$WL)5C0&Q8X,.0+\C^PDO8#(![;H7\I1$&BQ$F7_+X'N`\G^.OT/<\ MYK;X\L*-!6+S1R/'@B_$;^?N@5]!J&7Y@4WYDN3)B<;"D\#\O\*=OWB6!LK3 M'O)7S./K%R+B[X3'3\DIOW01WOGP3ES*OUI\^/'=FZT^\7;,`![M,2-!!S:O MXT!L<&:A%(P>LD>6?R62M)TEH\"?"-+Q\?'A"=:)B?$J3X17EY=@>3V6?\`@ M([EO,@*_+8ET&EF7=D[&F60(D0198VFL'EPSW\YA_\2`S6$F_%JP0'^S*'7= ME(,>L"P3>*K-OUZRWHUP996$I%,8=SB9,@( M@!#'5,+N+59RCS!\Y(%/P^)V.3^F9PZ;R0LHB00 M8S'S=*Y\-HQ:8\)[@B0Q")C^RM1MYH+W#I*X3/%1[+IG MJ3'ESKZU[,W)T]B!!SFA^)GXGOB\W!2/1($8K4"5UHSN4UA064[BP,5N'5^' M)#]+;L%GD-R9LR'9.8+UV'.8ADG3U,N9C0>O>NHX;Q:$6$Q\3HOL=`".+XTI M?%'67K(YK20:-Z'/7'+"^/Z_`+.XDTKN-_=OV^2-7P4$=6!5]>C8W+G9R:X& M_]2B+O-L6)URA]D2#_#\"'RBQ60L[$WI.P3;E.^4#Q=\"H>XQXU004K:_0=S1$-SQ0@R; MFPZ6A'M^R2U?W;Z6/Z(E,?`X$W?0WM@#8^X_>.D)VY5N+&'$88@K`HZ@JG%: MXC91B#.1)+7Z$[J4[<6A#3@6^(_-6@;"/803GC]/K*,H>4J3HL"EBZPHONKE M!U]DK`NE;$`C8`U^4K+LVF`!W#'O1:V5/AOM$MDA;>@'0/<'R M*+]PZKV!3!/*AYY_4)V>)L^1K6W9'LS'V3)VMGRU9VX]>[)"2Q+S!A)WMB6Q M;BAQF?0BY\AA/NDPMR*Q!=M!`]LZLH-<2':B]1:.?"7%3FVGSM5YY+NN_R34 M4]C0,)[`G."Z,%5D0KE<\5S+K&K\-CXM'V"VK+I,SF"F8!*T:/GW[>H2"\-4I#R;\4->!Y7"Q`AM2)(4M1F<%R M4"93J&LP&]KL0#E)3Y23V3EH(@Y"RS=LVT$!,E(Z(^BK/([FZ>+F\%1N1>P9#\)+,ZW1O6C[C MMH<8"F9LNGN-@V3*MX&*U!>]@RS,&"]BCTBD&)S3U\5(TR5(,79I2B%L5@;"6< M>)5Z86S)=[=LTY1`-QA5.]ZTC M"*Y5OB^"903+]6!1,3D*:?>&62<&7L\U*9!9%\1: MN1BMG]:4PX%-V(;'[3`&K1QF0UBMQ@*VQ"#T:GGY6>'_2H+1N.-?E M:)O>&@[Z+4,OLN[$\0E]3=>3J!HKNS1]K=?/JA;[HN!&^'`5/,$:"D[>Z$W,C8AP28DV(0$ MFY`TDEG8CJ$AI,>>`"CUQT=ZE'HD?:-(GW%/1A6T6K/^%B5"U,UX#G8@P887 M2O1)0(8HQA"Y4?^-QA6B&.C91]Y(^S-U`O*#]]!6)-4,^8F-2#`E!!N1U"4E M!!N1-&P;L&'YH%6>331YN0UCJ/#9Q/H)?4T30E`UEE6C8ZI],E$))UZE7L"0 M$3$C8L:SB=B(I&;X0#E0K*`!J\[Q]UN=?N9,4!1W%/=ZBGM7USJ9EW\E)3XK MX7=5$';$KHA=ZZQ#Y6'7'RQ$Z%HW\X:^7%KCCY;1Z2I7.QGE'.5<:M4X73/; MB%G5%G;$K(A9ZZQ#Y6%6;/I14Q-7F3]OVNG[TVYK8`Z5PZTHZ"CHTGM^#%5% MKEAF`J$K0M=&*%%ER;78]*/.=J^ZY,&F^7FC90P&K:$AI[\7BOU19]8V33DZ MIC;0%4ZM5<.'5ZD9;6V823?6`'/R-F-=-H5K8KU:`6Q-0RJNJO:4T._>=^VE M.RW*K'V:3%W_F3%R(ZJF7<6!-:8A(U+] MQW=OM`VQV$^R%@-8(OS\U7,/;)$GWA!C!!]-:1`YEC.E7I24@!-* M2"*?3&<##\@)SM\G]L_C- MO4\#\;WM!,R*_"!<$'3XC@]XRKR0\JK%8O1.%#'1#\3SB0L#A9L`9W*3W&U$?@H<[,_?+.(^,69;11Y>\(MM?FY\UE.&P/SK/Y494S5R MX<%3P)\X-C]"O60BB$4]SXA%3BICBX$=1/O99;4;@MFA5./M:X9K#AO;"[5>Y M!K][?Z(G;'D%71XRL*TC.PB=[$&T0V:UC(')\IO??XO#LP=*IV\%(!L#;F-! M^.F?V(F>O_D1^PCPQ?5#4-9;D+$_7+CF_-__(N3WE9]]`3UF]D=A1:X$(KD1 M\BZ^3%LBS#J.\6HO'A?8:S9Z?P*_$=CCKG^GWW%#H,+\*[R]%^4SKKGISK'5.LZ];FE'M,:_,$ M%\7^B6%=]^D1_@GGS,W"G/-TR3T7JJ7E]WI-W?1]LHA=68)*-02'Z-RIWGE# MMCFZQ:L%N4A"+W*@=:N5+5ZJ,JW4&G.-?Y<>N82%#0<>1@)&^`*.+VQ"9? M/$MKP8K/953L=DP#'R!H@K8\WSMSO$9;CP9YOR6V:[%O%9O:=+';=,$1ZC+NS,*%8)@<:`2W- MHG1FQ'$CX6W!+W?/@S0I=@$(=`8-'ZM@_-Z]\NDK@8.B,-](KDBY9_#LD^\* M"#7U(YZ?FV1Y)H7]!;,0(M])#TVMZ40XQ)U:@\<5?SE:^ M6])Y7>R@2NQ>1]U$G#X9D^#CU]T-Z2&C M!H0P'D>I:5(Y%A[B!@C2I6A#`#DVJ3$2PG&U7G`FO?E@EV.ZR6C6BQKVI8)) M$$R,^7*+M3!;HL=&83Y>T%?>SR=(_"J,"CP375KYSX:EQT@6FW)3;63"I)-I MU9*X$=+\>0TX`5C76^3QG_)ZW\K<3%@GG1K6@ES/2`YFODP&5H;J-NW1GKX MW:01/OP!4$L#!!0````(`$6*6T=1J;++?P\``-?7```4`!P`9I)D9J]:^[U6JUOC[\_#YSC%=$*/;]&R+PR\O"N"4>I6-,D'%^VNZ>GI^?MHQ&(Z1W8U(HY;D&)]PY;:]^N0UI M>^Z5T6XU.]UFI]4^-\ZO6NVK5M\8?5F5_`+,CG%Q40>[?[Y`>P8@=NG'DZGO MSZ^:S;>WM]/W%^*<>F0"%5O=9E3P9%GRZIWB5.FW;E2VW?S]R\.3-44SLX%= MZINN%==B9++JM2\O+YO\5RA*\17E]1\\R_2Y#@KY,H0EV%^-J%B#?6JT.XUN M^_2=VB<@`\/X0#P'/:*QP1FX\A=S]/&$XMG<88SS;U."QA]/R,QN,#&V+KLM M5OW?3S[H@ZG]UG.IYV";J>?&=!CFIRE"/CTQ&/'?'N]7&+#[BJCOD5."Z`S9 MIY8W8[II-X"Q;KO)BC=EZ#;WP?OJ(QV.P6B]&2H10!;QO:.X]69S@J;(I?@5 M[1529DO[QV?2Z9WCO95I:0+ZNV(98&HY'@T(^F02%YPI'2'R-#4)8N["#APT M'(/SP]:U:P^P$P`GZP4'R#>QLR76,MLO3Q;WP+D+G&-$8S82'TN"+-U,>)O@ M%P==4PI>&5J-A9M9HB3<)3)2GG0>/'?RC,AL@%X2K2>_EH1>H:'RT`T0P:\0 MCC#?3GW"HST*\O\%V1-P$=<6_(1]UKV"VHB"S#T+,]_Z M%>+"F-0==F%,QZ:3H%F2D+X]OZ&L+=.Q`H<';@\@V5"^C+O28Z"D.M$[A-HV MLE=?L<]:A("T!<&UL2('_T]2-$*21DB38P`4CF>ER#LL%O5(VEQ".#S@')OT MA4>=,$&8F.:EV^I>]B_YY*Y)W%;S>!H2`*'-9#LL`Y^<7[4Z[=];KM?J7_4[O(L%Y MPE:N21J$2:R(/OPW93Z;07Y8HDF9+3-J#0S:CNJ/B3>3DFC8OJ>"Q2,V(C!+ M/#$""BQZ<]:\Z9P8;PA/IC[_94XP#++^XN-)IQJUL2@.^C[[APV1KZ;#O8%_ M:Q*R`&_P7],)D$"=4G5U57.>YC:UO3U4-2MH5V,%4;BW@/!`H.QDD@?->2E&H7\65SD8?2N#U+53)\:4PKZ<6?9@5"J/KA:!=$92_-ZUG("MXT<) M=.$TN+CJP:A]:[!J879%8=8#-E^PPS/=X*6>?,_Z<^HYP#AE'LM?""R@J%HJ MW&FS:*>BC&R"T6(H:37V^IW^><4VNY6<-VVX"*-,J%&Q]O+G?)L%M=9E)G.Y M:LM#I:OVH@34R%RP[)-E8P6,:JGU:M6\W+$%LU=)-6^6/SPU2V*LQ6P@RD\\HE?D!@6^.KOP`2E8 M`6`MDNF)[).TO\ZM;>6Z,9!CX M[+`U6[05;>07US@@):NBK,?V;]O&2[Y&)H:YX:TYQ[[I)+"*YLV%%0](]5N" MK460_4R020.R*'3AFP4/2,.2X`HCZ88.*KVVK&#&1(^6^YHS+A!@IS%_1?YP M#+-&<69,A4I:7I<@KZHWAF_?W4M`KA:25V0HC^R$K1O?1I``/D!C;&'1_*NX MX@&9PY9@0POH*5K`A^;:.>?]'W[.NC\EJ1+A">A._@GHF*XQ'!LAY0K,?+GO M,.RU`HM.E0EG;S`U[P#&;KM3U:GHF*4[L&40KH_=`&QP.$>$VP*]06./H$12 M_].[3TRP/>R:9'$/\N>9!Z@)^@?^)O>NC\!`Q.SK]Q*QM\^.-ZYA$?_\V%,!Q? M6W\%F+!M4^FS;.TU52K4K+]"=P5;B\U'3X@'[I^1"\)A%R)>VS/L8NH3?F-= M?H^6JUQ_2R@!K\PJ217ZA_F;EQ[$\E4N+*^?EJN?WZH)2]?]#WQU0-5.\BOI M9RQJK&;$<^IX:Y'SNN?I=A;!+`$5)E:SBQ^>PI60UF)>MO*#H2!N8)@39[8$ MI354]-;I;SEP4G.T#.56O`26>=^^U'I85V4]+-5,A:MC&7`+=@;DUJAL',[@ MZ@YB&#QQER?2K,4S,5UJ6KR/N3;_*^QQ]O^"I<>*<(S8Y`9^\'V"7P*?'3M_ M]D9FT=[S;\6#?KY$PHHV@H)*I56+&&.;E>L$U':_<]&JEV$4H]DR8JAZ4(F? M.Y$:2LZ4AA(@;BRI[Y[_N@DH=A&E/*5#^;['Y1I)E./Y!--%?S$*B#4U*1H1 M;$&`&%[KQ#C)R(R50+.B%(`%C0\)^!$__",!8;D->+S,=$5(UA.#.]'2ISN7 M:AEKF8"2Y%(/CRX%-WF\A():=C6K#'K?34M1-MO.9K[QQHOH`9]0;H.`@(1& M"/@2+>KG53D"*U&&K[:M7]D.,@?E`E..S@"/S`4/"C*&8$4*!ZSXLJ2A>!B@ M'$/(E`3+WT_"X!/;80[_$5G>Q,5_QY=JK1^XW)G>@1M)^;(I/!6@Q1B2_5K- MTB/"Y(P=E4$#M/Q7E")2(E'1U)IQ-R+>*ZC1OEG\1MGR]6H!-'['+&M]3#P7 MWX&H/MUI%TM8F\V7+8]Z1/GUS]OL074[9'LDU=VMZIZ:.4'L64,>.LP=%"8L MDWMD!%8@4_5(C6-KT=1B39$]BLFL?NBR[:O#<11LB"9I@N)I`71``.UCL`TE M<11.V!HZ.!'^#O0-#*0V2YDCE^:YC>S"1VH,"L)0NPJI(DN`20F8\K/Y'BZN MLTU:V1@SY"@PF)UH'JE=E2^S>LS_UB/[>W?S043QWI?"JD=J35N+IO`@N:9& M$SV0*G9*N76^FXFD3$+[Z-?-/L)'&*-<:^9CC-*&(T/LNT7M*JS0U"[J9FIK M+XBP2>3&>Q/*(UH>L>^FMJNP0E.[U/J,D$"HRQW0)2>1)8GJ9WE[2B+O(H]: M9(BBQ<=G+US`$KZ,*3`D>0+Z&E+YI63L*2/%:`%W,:/V,IJSUK-=+RZ0+ M,NDNXXVVB9!D&@WD0J)[Q:TG8@4$]JZ&%-\,$S! MYZRJ?#<6.9'L>UM2N<9QYQ&0GX60S<\B#R`J?.5'QN]=ZI-@>8IP0YX%YK,= MT2,WL!*%IICFKNSV^@1:S)'Y`4DL)HKMK+CFL1K3EI)1NRRUNET]61*\PZ[I M6B7/]B6)ZF=F>YKM[R(/76\827:6>TH#`(CX\>."N_<+Z^EG%7O0:K[SD9=+ M+384RB]%9XATYRT!&32/U,3*EUFM4I$0(SZB>;B!7LI5%58\4D/:4C#UFOD/ MQU\0F2!`R&_+9Z`+S$14_ M4CM1$D<]]JEEQWL2IE%<\4B-9$O!U&+V'CO*`68B=.WB@6=5\ECM05(2]=B" M]FD\1I8_'$,0/S7="7J$@7+H9BD M&O9L&NG^=0[]ZZQB[U*&ZC9]SNY"J46"+Q.F2'3Q[7 M?!`C?Y*([P=B[V:0UYP=ZH4U]>O863I9OT1Z&U"U(H0DV'355 M"RO66--JF&JQ;K+"]M4C?[)S-QY;/E+2M+AFC56M"&K+&]>^U1@KW#4.R-3& MU[/-\34B_I/!R?,YX*J!GPQHHMK!-0^\./TJK!)&Z2!7],\G!\K$;&5[#DOKUPBR9)_N<+(A:9.^28-C5X=+JBPO76X,%.#3W ME5D'VR@$NK\@>Y+:-_/$Q$86PS&[;)*RVR;Y"Q$>FXTB^ROVIS&I<-N-Z21H M*KG<=G M9@OMIF\%W@7YG@>8S"<;B@&O7B'@>+)>[U"F<3!Z+P]]B>/2AR;C[\6D"/[X M/U!+`P04````"`!%BEM'"+5T^[T7``!0A`$`%``<`')M9"TR,#$U,#DS,%]D M968N>&UL550)``,1ZB]6$>HO5G5X"P`!!"4.```$.0$``.U=67/;.K)^OU7W M/_!Z'FY.U7B1%<3I%D9"$"44H`.E8\^L'`"F)E`!P M$4FU9+VD'`I+?_TUENX&P<]_?QU[U@NB#!/_RT'KZ.3`0KY#7.P/OQR$[-!F M#L8'?__;__[/Y_\[//SG9:]CN<0)Q\@/+(4,#;`%%EG1ZWVT=G9T8EU>!BW=VDS7HKXEFSX]*@U_^4J;IOX MGZS6R?%I^_CTI'5FG7TZ:7TZ.;<>[^'K=/#=NOHE;D'7%V6]9D2#_70P)*R?@JF$_3E@.'QQ!,8 MY;,118,O!W3L'@J-GWQLGXCJ?[G&S/$("REZI&3"[6+ZZ-E^<.&[-S]#/!&V M\X"":Q38V&,'ENCG6^]N#@?[+X@%A!Y1Q,;(/7+(6##:.N0RMEO'HOAQP2Z. M*T/TE1#W%_8\WE,W&"%ZYW/6A[COH0O&4,!XK\(@W-!#W8&R1$6X*Q2D.NUT MB#]\1G1\C?K!@TTIM],75!%@<]O587@*B/-#3DPWO!Z9(G1%QA/D,SGH%CKE M2@S'$_&,W1)Z:V/ZW?9"_H-LH"M_$4;).$./(75&O,D>'HX"]I5R4T5N17II M7MZ*=3TBGLL7(#%P@VG55I.GASKQ)/3O\$[YD^Z@Q^6GV.$JE>6_^;BR6:$" M`:K3QMS&[I$M_B]F9?84CLXBS$)Y2YEMH?K#A:-S,TQT5K3ZJI`TDWJ]ZO-M^$= M[G`@QLX?W#T!JN5UY:UPY0K[#/T,>>LW+Q6J1-ML++E-G;S":UR9 MF8'+N;J$I[M@15WE$0R;P7[P3$O>AR7.58V4*/`\UX. M73+F%E%,VM7:S8B*!G;H!:5EG56O4UBIC\,Q&O<1+2AHNFJ-0MJ>5TPT62$6 MB&L1\\T;5VB'=QT+($K5Z4PGH:/7`/DNA?4N[N2W*`3!$7K$277HB>6(4*6RIP&9/Y!1X>-**HQU_B1__N=@I:]7P;/<71'MV'WDR2%:P^O$&P&EE MNIP^\[XO7C'3X,I5,#*%E-?Q*E",S&3-FLA<7:C,3!8PV5PD)B'N.HE_?FB? M_=XZ;7UX_^%#Z_3TO-UJ-<'K;%'?%+%*V`"XOK>=$?81G2;%OH\W%TJ.C37J M(C*]Z2E)XJKY)DDTX@+`E(B=A@&B^5C2EFZ4H=-*&=)B`L#.;4BY,OEVDL.Y MQ:_B+V8DR%2A48[:E7)D@@6`IN]HA!TO@YKE0HW2\;Y2.I:AK$7!2I"&/_CS MBA?`CNU=HS$1<2`9DN,"]KALMF>>K$K4;Y2+LTJX*(%R0C&A.)C*-0[`L.D@ MFR&1O+D;3RAYB;(5QC%DK-$HB1\J'5!&7!"8LGW73$RB0*,\G%?+0P(&`+5? MAM@3)Y.,JE\NU*CZ?Z]4_[+`4-#\.$X]"SY>F="44BP(\+8DK])7Z'F.#+RTIR)"<@`9ABI31&;R95`DAB;L5L5A0,R&$II.)T M_NC#>;MU!B=MEE?M2A``F+CGRAN'8W/:*UT&0J)+84"IA%9:8@AZME^S]9PN M`\$CR])S6F(`>C8L/Y?3>_O?A%YY-F.&];50"QM8@35,K;<"%P(-F^:%M`_V MV'QFHW`K0-;Z$D:>DVPU[+=*..B=1[-&4/W^19E2O48OR.-NO=NE5T0>?75# M)WA&SL@G'AE.M;G4O!4A;%Y*VO(LH9H7*K30U3.U721@F=.GJ\4@;(36X$P/ MK/KQLY!-O./R0'SYVFF`+H84&5+7Q:I"B`NO.8;R@X4VBJY"%I`QHCWDR=@U M&^&)>4`9:T`(_U8PMHP8`;#V:`>9YT:6RD`X[E,!,TNH`'!A`+62;\B_?^Q` MR)@7@:;.F6<[C]N:-3<@,^7-LZL!WYX8B<]&!VW],TBAT\T.5M\U4%OFLJ2682(92# M#>:KGY(*UYY5.%]]'UFT>BB:M42[UKMYRQL^=B"(ZPZN*')Q<&L[XCZ:J>F4 M@:'\_E!!SD,%F3K?GR%XPV<(]IGKAO2\SUQO;(4QS-CZXG!RTH4F<#T@H.1T MQ*:&&O.-V=6`S/Q9QI=%5!K4[A*63H-^/&^W?H>3$:Z21"70ZO-5WWS>UJ7M M_W@05[*QOB/^_L9L;98JJP*$)3ZO[JB0-:??).6&L+VTP!Z52E/3?5K2$7..7HAW@OVAVFAS>ZZN0Z$9<=D MA"E'W@P%`$$=%`2(SN;FC,L65$4A.*!YZ5`C`,#"=YMBL1SV[,`4.EPMMH$E M7I-6*;3$KP(!1H)Q75$5!+*XZPQ)IWQ`"_L:Z@>]J)>C!.J"WB&^2_P[G\^C M?>XZ=0<#\:$C(7?G[K+;,R\@^>I"6.#UQIA:3_(!@D";RD_..(&546=S1Z]R M@\%^":0%^]4U`V.=50KP>(K3@CTC++[YZ M(#+U&B95!2&DHB`W:N%'AO'F=X.@^Q&N^/+<*3(DK-2&<>ZID)EQ!!HW(]'1P:3/, MGB;+!YE?MGQ`(A[`W?0HO/!*%'1!UQ:^E0 M=^JK8!L0+J%U"&O>"CV$`F)W M\(U]#6WQS4M"EWU#?;%&M?^Q@@V.&@;D,91CD#0=/3FI81C`.7?=_*=EDS1I MSW)_/#E=/LLM.XH_)SZ3U4H*F[YO+B&PQ26VA,B6E%G\*ANS(K'EMZJ8O,YN M)KD5B6[%LH.YI.YI9%,D59`$?D&I.)XH7S2^G"[*/-I3\>SBETW=?'?8K=W^ M1FY`E?U/C5^X6BH#YU1ZY=RF+BY-HP8PUY<'N<#")Q@^8#-O9ZFG*R!),*7- MI][!K07]WH+6[2J5]&J?GK=/`7VU:R-6I=0(`$.;[3$2&QQCZL]0'D*ZK\YQ MDS01@QJJ=^=2G_ZW8'T(":*Z>2RA%F@.9::*=!I:\=^*+@@Y M&MY<3KDZM:@O^UA[`[NMB>K2BHVFQ\A#9G?^(^(#R?T'$H,+N1I^(9P*V8*I4ZV\-V&GWXFX,%.DP@3H^/:))@U6(P"$PR];9+D: M+8+*68I/QR+*Q&>Z@FFY&Z-:)ZLW1B7;_G\K:AW.O5'[3*!1/5MY+U6M&<#] M/5;[>ZSV]UC5H>?]/5:-Z'F6J##,ZNDB<.ZKJG5B3X,&1)0QHP[T-(7*R%3* M!G0,HH2ZTXGV]^?MTS:?;I7?'D) MV2RD4SE`HA"*\S/$5"B"!? MEVOL;@;2"!L:JU+('IK,5CA*AM0>]Y#0(O:'LW=G8A@A-TV*_X/<9W*)%K5T M!E!5XSN<$ZQ(0]#,2C$&\D\2NYQC4\(%S9[IM)6JX.YFF51HH5'WR-M"E"\U MR=5G/F_H/.2,2A#>J:Z'TBSDL.E]M&F7/@7B&U/2'!\1E1!RT:RO#.']ZB;H MUFL`-NV1F=XQ%A8:T;,*$%[@;FXTSU!O`Z7=,&"![;M\YU>`UU0M$&^%-\=N M"CLTBDL?^%O[&Q)Q(NMX3*5X]J MMK_5[IHUP^9?;*A%:37?@]5#;NB(]N[\M"C=@;B:B_ARIYF42W@3MN\L>]CK M-M:L<302\%Q7)353'Y_Q2HOU%/;_C9S@F4A8LSN;%%P7JMTLN8U$1`OKH*$+ M[1)6I2?/5+A9KAH)=69!AK;BST_>(/J"':16Q@.1[TJ@:/?,GDE@>\G?12+] M@03_0D$/.63H&[:<-?;7K#4U&DFM46MOQB`C;X^O>O$C44[GAST:LT6AWC5H#:9!E(K3=V0N; MB#J8"1JT'6]735K(XV$K>M5V/89U:R9 M9NQJT5NSIM58T+M6G4';)B6$G0>`F4-QM)!J-CA9E9HUC$:/$&=!AWNY3.(C M&.)[1/Q)=]#C+7++#N(C6=^X!*SHW3/M?'?/I#YJ$0L@_EZ($'_-0@JQOZ`& M\@4U^T]5[#]54<;OW7^JHC!Z`!:D6B1Z3]_,%R"9ZT"X/J#.@9&Z6LFL"@`$ M5[=3VM\\L+]YH$9[B_:2B^]LLFXPBIRP./`W3_I%YR6J-LOB_>_N'0@-*A&: MSUP?]/2-^XV;[W+WNWO%0W,Z?#O&^UT.VHT9[W+W.WSG1&,Z?#O&>TOH`.%- MVJ]"@MV]1:-1-;X=*YYOG1K_^E*EHNWN#20P]/MV!L2&OTE6O7R[>Y,+("6_ MG?&1WO#!&Q^%Y=O=JV\`*?GMC(]X-QE2Q.`-CF+"[>ZM05`T_':&1>+=A"6] MS&^^O")^0&TG"&U/?.*N\A11/3+N\.U+P#0-Y:#4?/S>R[LAH\3;4S@>VW3: M'=QBW_8=;'L7C*&`7?ARG#.5E5N#EYNUWC^XI%/WW3$/-*'4`RACM_PO=# M$G#+>$;.6`/"";E2]JTD5H40*&>GA3D[W0AGFL,^M7!V"IRS=F'.VAOA3'/$ MI1;.VA`Y6V-;N.+;UN`H="`<.ZU%64IK67^3OJTG4&\)17CH7W%$R'>FL^B$ M5,A1E-(,E)!A!PUM[T+>BRE4,Q?<*1P3/%V-"Q+M;_9:%^'",H2XIA"=[K"FQC3*[)<3A]LD=<1KVO/'D\-L;@B#<") MQYGY2@[((O@`S-%I<6-1C8$68PT@P;/B5JJG<`GAKG&6#@.]/V^W`7T%NC8> ME:@!4/LUM.5MM!S@'5_H^@%RQ>K>'*R&WX(IF_Q%L5#4+P7O,Q7`5::%[ITMQSX3@TY%Y(<&53.N4/34?0 M8VZOX-;Z;/Q^?IOH0WH);BU,3."@!@6M$ M^503X!>4."7%7?<_D#L4\TITW1$'_L#M4I8K%B9HKX8)%EU:B3YEO"#NU5IT M:[V;=[SAXT(+L4V1@Y52FQBD*E)[F/TP!`G,5>"$!30L)$>A&0J`.70AX"S" M+&YD,;J3YBI`8@!YS$Y-E`K4[A$%VO&ODCRHOGZ#9\FQT`@BBXRA&*&PI>W>T5!R" MAUZ!S=_LB!"(S+8P M'2Y(=[!H9/[21:*UHB[;Z9HN6^(=D$C6Z,V/6%KQ.-'@XBV11--07@UA"T'9 MI>V)ST,^C1`*9E@NI^K%]W(:Z^4:,;[4RK*YWA6IH<.-'$11B&[P/O7%X7B> M]=M$ZI2)5B,`UA65<$:OR%0!B/.:9;%9Y`!R6RND)^W)G7%/[CT]DIB_ M.@2OHVI."[U,"(K7A[(C]*'Q\:EQ3JKF\B'?Z(2:?_S*- M7$[O?,XZ>@HX2%%=FF;&?OPN]=^+T+OX4NO#+^ M+T.N2_>B7".?C,75%\A]IK;/[.C&!VUNH$0;L+PR,S` MO0?"G=A(5N0:-R7*DA"V(ED&F*1'"0(`#9H)W+"0&6ML8#7+C"9N8C4S*@DN M[<8)-*,.D,4MAT'G(`K0,E:O&9>$_$ES M^DJ"A3;'9T.X1`->YME^-=*@6@@HE^_X4]AGZ&7*0-R_%D^3O M5V]76C1H12UN-G>]A,^49587W:KH$L)$!Z#Q@BVIBP$;S_3 M$`TD`0IC7\:?F+AP?H:8X8P0MK8TG&1LWO5'"P4H*>)/BLR378YZ0-:C#+/+ M(FH)U"Y3!GJ=JI+&ZM<99':?)OW[SY[O`;A),P74;)_;]]L\T/@CR, MHF_^X]__Y__XZ_\Z./C/X^MSM$S#[1HG!0HS'!1XB;Y&Q0,ZP5E!/SQ+PN_0 M5?H59^2;NV=TDJ5YOHHRC+[_[LV[[[[__KM#='!0TCL.<@*5)H@1?OO=F_J; MDY)VFOR$WAR^?OON]=O#-]^C[W\Z?//3X8_HZG,-^9DPNXK,H'&4_'Y'QD-$ MXB3_MV\>BF+ST^O77[]^_>[I+HN_2[-[@GCX[G4%^`V'_.DICUK07]]5L&]> M_^?G\YOP`:^#@RC)BR`)&RQ*1H;WYL.'#Z_9MP0TCW[*&?YY&@8%^PV,?"$E M!/W7005V0#\Z>//VX-V;[Y[RY3=$!PC]-4MC?(U7B#'P4_&\P?_V31ZM-S%E MG'WVD.&5G(LXRUY3_-<)OJ<_#AWA`QWAS0]TA'\I/SX/[G#\#:*07Z[/E`)] M:-$JD5Y/RF71Y[`8RETQ"V_Q$XN,2+RO^*2F-M[.16)1@1"G9-&P1C&G(2+.V M/K(U%??-]X9$%85&18@A?)1>I/<[? MX[NX*T]+F`SGZ38+\9"?L)HMV4@CE!G=--"KE5P&Y=1(]J]0EY!"S.(#,3'3#]XRB M!D*_,3`??GL2W?$9^3,W"28``MM`CV6I'=10<+;084%G#Q04,=B=C2+'X7?W MZ>/K)8ZH/;RG?U`S>"^8`?FHCFZWA&Q'DO[7;G]R%7OTA^Y^Y^SGE0^LCOP4 MQM5O>41&7-)1/\7!O83OSO?N?TTI@]7/V?K2Z>\I&;GW@]8PB`*Y]LYZ57%* M8H7&(CMP!3E(=!_%\XR#Z13[HS MM182S@X43'N%':640+%MHF)(S+K4(`!+2+ M'A=&RRC#A5/;N,T"NM5]\[R^2V4R=;YW;P-2!JO?O?6ET]]:,G+O]RUA$`=R M]8OR78-K?!_1G8*DN`C6L@1`#N;^]]6Q6_W,,ABGO[::@=Z/7F[:-+"(`KO] M\4](4,F"^"Q9XJ?_AY^5`O7@H'Y^!\W#P%1P^6VH,?U M-#]1ASLM$MA<82%*9^+08$#,(D9VE%,*PT0,=8$X,A*P/3@7N%Q]BI(@"2.R M`$KS2'/`.@P5^.S`0BSI:8(&#^Y\P".4\N_(*;9QE"FAE MHSU82%-5,-ZWV`X@D.%*N5`FY`'#^0G..$Z"_.$H6=+_?/QC&ST&,6$K/RI. M@BQ[)E/Z+T&\5=586.+"&,\@P41CLD)T;EP#N.H;&T%")$-#(?U#0)\E:&XZ M]80SBX,;=!04")//TQ7B3,PHGUAUZ%;".WP?)0G=UYU73N/D-XN$@--D&*9; MPL$U#C'AYB[&%[@HX[0JXFM1@"9-"S%:'BP\_OJ%.]G^W M"4;O#A>(W62@7XJ?O%^0T?(-#HOH$<>]K91)U/2(L[O4D'T":.O=XMV']Z6V M2LT5Z(;8)%[?X4RMLN_U*G/GYF?)(U%/FCT372GTV@:!<6,9FZ+;BM\[=]/^ MX#U#JT`BG',#>Y6D!4;??SO/7)460:QS%0N.;RD-%#5\0[GU,.V6BGW74ZP[ MESK%*TR"SO(V>.)K(./$J<6`<3@+(43_TX`[=TB,*GD M<`DJ#.*P8;K&5("^Q[IS@:L,;X)H^?%I@Y,"E*3(0Y:L[RL]1"-*!M2ILM-B^V)8W; MD;#;D-HMZ04JH6!R,AM&>5+FEXE>$!,9L)DN`X@JAFN6!(%109HVZ``B[Z]2D"0,V&D0D?_:>^J*8MI\:#"]VH+KLC-O" M@=M_FH9_=_X@[`48W4`!"V/]6L9%HY<".K=U#1>*S2/83:.I^(5;9ENN#'U9 M5MLLI\&7T8:-H080(@&<` M5<7=5?!,J^WL"DJ[P+"EI'+6946D;4BP\E$9&^I2R`V'!C61;(N7?4-7BZF" M!S,4O0`=6Y$#0YB+CA.9Q5!X),Y5LYZ@&Z^?C12@J@*!W[R]QH\XV1JBH@H8 M=K-6SKILD[8-";8Y*V-#O:F9<>@%FG4?P'9C=A3OX!']C&T,W])]8:N(+H,' MC>AJ`201O0\,%=%5G"@#(D=`#&/FJBC+F&XMPIEP^`"?R@@'*=;IC`$'_$C. M+JW1(D`>R%EG!]*B\&H1-<\EIR$'<]9R>'8N9^T'_AB_G<5[8.;6-B$``E>] M6K/<+GT5-C.\,&7K(E@##KB!VY7#:A$@S7Y48:P?.V/RV#ZDA$>!YE/&8%W& M(\7Q)&\PGL.*QN4P?;"H?A@ID&Y) M,F\AQ0`/&"L#8+J1)O>W.%N?XCMS9:<*&"C!T++>RBRDD.Y3"@T;_6R:`!^0 MM=L:4?`%^OA4EA=7J37Z'!3;3)JM.CJ-'B?.DH"7I2NM: M<@!7H@Y)Z70(@#6IUFF<&AJF.G5(IL-+/EOKX[F+_TS..U*&QOR]6"SW-W+- M%:U:%%].`@R5KAIX#\X#C+8DVT_W(8V;2!3/-H^&;'!XM5EDO4GDQ^:0S;8H M=,WW$,;[A=]>Q'Q!!+.0'MBSP8HA;=?&8@%KP\V<C:6WN M29H49*V&DU!MIEH,H(:^9B%:;7S5X.Z;]YIXD32\KS%8.70+!ZC=Z\Y"A"). MN3EDCV0 M%<170;0\2TZ"3436E<(OH=HOM$`$VE&V%JFUKVS$QO0EN5.\ MBL)(M=:S081Q('N11`H96(2)<8L+9UVV&@WR;/1L73C)`&/M1 MLRS:2Q_*N7VH6)"\=,\!JT2#S-]AFA/._?UB\??>^3B^*[KLD-!%X M]\/B_?NWB_#")_B>&KLN&.^N`YI4]G30SY-*11@5!K/58JV& M$R(S?:JFY#[#&\++0Y"38$'^RK>T7VB1HN(!"]^A39;>9\$:M%J@"GVLFH%, MMIL,/^`DCQXQ/\@]3W/:E^YR=1L\J0^)AU$!JRD8(VRGS&`("8C*@^'\R>XG M5E2J;OTBG;(Z&;`DP8&,KV)"XUN%J)!G!=:;POZ<#=B="7AP%F"U?R[O"N3F M_->:97X,G$LV_KTH4Y#V:C*?>2O0P`L:M.(,Z0[F75>P"?MF.:^0&")0KVR" MB>67_QQ5+R5^2K/3\IW$_F.,AI8/PV@`)6IC!&VE:4,(N$_2AG-G]Z*FX2E- M7\YYKX+L,KLI:.K%EE17.+NARR:K@STUL@^GP2;1U`?$*DS@,V,]6^:CU?K0 MQ8]CX=W$H9L22H&@O(GQGQ_5QU=6>N@C^>`]*E'47M/%`/86.3MF+^F=0?IE M7&?LZ'*`!BH$?XRJ+8+)H#BT%\8DLF)M2!Y5IPR<[*TPP:M5ADSS%FB0U2L# M9\1V984'DZ$@BN5,J,4`-RV;.5`##FE*EK-?VX0\FOIZHFCG/26T)R:DGO$4 MH/"FHYWKI&;CT43'11A4ARE!\<1X["LQ>_#P9C2T/K"T):$2SY.Z#BZ.S=%T M!>E!94>;:65I!P>#K>T0>3`6-I16\H#C>4K1#CO.HZI7SPN@<%=%8N9[9U4-X&<7]*+AN_?T1.H5`)ABYF>M?9?#7.BEGR M#7R;,5HQ=KFB3]_F-VFL7F5TH*`21"FS[9RP!0*0!DK&5]?I44.!N]`RF%7T M"M?=SH)UFA71/P-:\TX!@O"/;<2[1G8>30:\VOESEN;Y59:NE)7N+0@8LY8P M*9JT\+5S<^Z-W7\UFT(@#@)3:V'+XT;*H\/.R^*YR>DWY#M0J^?BH(L$_T#8YC^G0]3@A3\5&R/%JNHR2B`A31 M(RY%4N4AELA`6><@T5K)J!6F^QQU`%O]U)4C+]`]1V>57T&+`.0]LAR37_:! MR'1*,M8XW=`UE][X##A0M\KH[*-/"LS@+Y2\)O.B(-PG1K+".$HB8S`&T6PUFF MX9;^L&SP\=I6;40^D'3^_CYCE[:JF1&%#T%V3^^3WP=10A8*U95$NJU'ZP!# M"DSW]\)R&:%>)7PW2_8H\Z;=E7%DO?9!;]QN0;B4S:-4VC;U\R9UMDJ9X5-E M8XK\4?&:IINEGRV_O*X^[27V'EAP-+9?' M!Z\H\#P-\.T-VLAVR2S]@2K#3A-`@[Y(D[3-?.F3AET."SP88[<62#1](Y)S M1[#D2-%6GE\\7:`$%X";(&?)(\Y9+TTN`4EE,-&3^D16!0YU)*MGOWTF*X<% M.)35,2()1_SK.6]E&\_==N.963GPPR%*;U7-%P8DP`=$C*+T'A%18L`\)&)@ M1Q$Q1:PZHR@19THJK)X4&24-L$L,]0;O'&&0#_AC_D-M!<#F38GT4!'*%6(W MZ8$N0J,+@$_$I'C'\2T1YK+.]8_Q*LVP\";*QR>2T*79,DJ"[/FLP&OVE`3! M)"J+F1X,:=.,(T(6P\VJQ'Y!W2S#`17ES2B+:D7+E]]\8=L,BYIQT1T;N.SO M@#[CXB&E;22KW"]?5#&(<45?Z!/X0HPQ^@XVZ[M#F^Q\7*UP6.1TL_/D@7!$ M*_H35-YMIV-?920D1)NX>BBF$0E5,L%$.;`?J?P)_'@@MI:N#/''.,'J@A\E M-&2(4C+?#R\]4*#0H.!#93$$O-HL1B7"3%T%"[/'#.0=V+XO<&'<)>[``*6[ M,D9;*:X(X#ZM[8\N+Y:&BYY=L.^:0@&2J?#[05"V/`?O0D*;NDM/OK/R?-O)193OGOT]N!WH$W!J03QQ6UW_2$`+RD(5X=/H\=H MB9-E(Q8.8_(?B^O_&E3PZ]Q&L137NI5XD->[#4RIKGG?\`N\-?8"$7S$")!/ M2Q)PKQN.%*Z"1\L2SH=)\5<"NYZ!5C10P(E4E]&W]!9ZD:(PB$/6@!O=N4Q,C3XYA>P\7>TW MED"O#@\/_S)3C9/%W#V=;%]+2@?5KQN6/34\:J:AD+9,26P;M@RFXE5$,@EK M$9-4)'R)2GK^E!FI8^\<&W?V1#K3]MJTTGV5SRV@*XGN(Q35`Q2&,DPK3+!U MA*U0G66$"0UB%6''TY"N)RVB/O5`L7D7Y8I>-DF3HZ+(HKMM03N(WZ9706;N MNS,9=<`:N>F4TRNFVYTT3-7=5'PKRO.DSL)+#A:T80PM`B##D,4Y'PB)(]'U M`A]+XU^NDF@7V@HE#RX!UH&K1/Z49F0F3OA;!>'S;18D.1&-2IXLV;]B5@UQ MM/S'EM>(6"AHH-IGXL&OX#2KHFU"V"P,>!/H9I1N3#@LV4$5/TA@B-TF%UA" M#4]B'`4L>`;6;Z6\L%)>(2BK?-:-7II&03V8GPN'X:FLAPN%@0L$GQ8&ZE,% MNT1&GL#`++]W%=.;YQ#+]=?EZB3('S[%Z5=3,R<]"M03B68QVH\EJN$!GDTT M,3-H#4U(($;#BY4S<0K*T566TM.UY?'SEYPV<*AO!Q^12>N1ORYGN%T[@A!8 M[>!(D3L%A@.I0%0ACF*Q;\[49E?,9L5;X+0U8TT"<+'6)%'Y;7J-J0E$,6Y5 M#MZFTUCY/$,!O3HXH]I:CQ/.,([[-PQG$Z+?%J<>BB916346O2167X-(V;]" MZI>;PP7-NV/9, M]0^G!%3>1%#``>S$2]:ZU!\O$]H=^W)UO,VC!"OO,ZC!@7KT&MAO->Q5P+KO MWJMEI-\FEVY'E-?OB.V<1ODFS:.J#UB%/-.M'=I6;JE;.XX1AG"^C*I[@52( M.X40#M>.98TY7M*E+5G7ZN*M"AAHO:AEO;52E$*Z7R-JV.@W8*7ECP=W['62 M4`!GK0L!#>;C4T@,]C9X*J^JT9N>X?9!F] M$PZ\04\6-/3A)5J.S?XK+&%.@DU4!+'YF2)K`F`WH0>*V+D<;8D-<5]Z$&O] MG9ZF*X&PEN3]96F&'T?!710SJV==2VBF@UE3@[J!*\_C()>=?2V4'19RLG#' MT2,]G[!6H`S5%ZM5BZ6WUSZ>!Y:J8DIV59ZAH%<5\K="%PWZ*%-%`&PZV4&Z M6HRLAH3O#]01AG9`2&B*YW)AM*'GB9/9L]$RY1 MZR[@/&=:EI1:38U8>L6[PO%"GD+1^Q[.93U3A`\)Y57P3&=HNE\>AMF6:+1) MD`?G!GIBOOC_$-'MTE`=)0_\WYY-=3*WX;@+LD1BJ+4C"-8NK*WVH1Y$U@-N MYT($.5'?ZT1TJAA7,R*CZ'']B)I=:;,FJW-KL*Y8'LD,[O>\U^4$=6!:0E[Y MMX7(%CZMH>*+'QM9--:!114%/\I-R`1=%NB4+U$1B8F3%<]71(J"S-NTCRM[ MD4ZAJ"$$8&QVN(BBK=IC.[?1H:SU5QB$FX>`9E3IBL99AHPV%)OE6+C"AUI/ MS2/APD9$0!?LO@5GJYP^GB<.IQ)(ZV==)'CWDG/4MSEBU<2Z,GQ?O@VKJE(` M\Z*I!0'TE:K."/-;M72VK9Y4M-6&EH0G'F0AIM:9-/CP?F5DKM]>J,1HG9[6 MAZMLV5`]C.F-TSF5$G3VJEO]V\J):_F]'V2=4"U4I""$G6/M-YMT/ M#JV)^GZPL./!H25%CP\&K4OAOK:0']_Y/ M41(DX03'AUI"7GFYA<@6GJVAXHLW&UDT'A^N*@J>'!\*\_99GF\);R11%UXL ML,CQ%7CPRT.M0*K%H10)=&FHXKSSB[QT0D^N(. MB1PYD=!Z!AU,!=:?!@HK-H@_U4::N'5.0_X=(<#[#P19C3HDLFDGG5)6)Y MLNSJLV18=YT)ZRZ*?$!RP#6BZ/`G896@P%F81T>-$>6J^8!6OBTRL1V_3VBUY3WX1QE]U-4:Z*^GZ_L>(IJ2='C M#+`VFI=KCX^A:PIUS6)=I<) M*[5.EO0_]+[08Q!KBI.'D0#:]Q\A9FN;?P"^^UW]PZ4B6_`_<4`5Z#V@:"5\MA99S(X1UV/UYN]G$[`PKB*MG:\Z259JM M^<-CAD>$;+&!^D,/$Z[5,-H.U7T'Z2%\]5M*"]AH&>5AG.9EK7A85=T00ZW) MP7;G3-?XEK9ZNB)K+>)5"HW(`,&:("E8[C0XZD!!-"^2LB#KH4D;;C%(1$'9 M2VXP.[)#F>9=PC:,Z7+KE9CG5K+/X-*HB9@X+Z@`2C%%$"A#[K/9-N'F>P#C M[0XNL0`.(MVEF81!BRMPN_+I<#>)6`2)_I?959`5Y3^.FONWOP3Q%E^N^+WY MZO[N&]6"?!PMH+VC701O;1F-(>1^IV@\E_TLEZ.C-*/O=Q:H^K=`;X$811IX M.4UT-,L%==L)9$KQ/P51AAXK\:K.YR72@J[!X^V2G?&!+KKM1!8:%!+IM^M= MO5M*SVJ413:QW%I9D4+5<1FR2]E(>!E"6J> M4Z>3MQ9EHQ!E=`"IHI/`TTE=T7HB%K32]WGOD^B?38ON9XF\.])S'UPF44`5 M:G8B!A)X)N#8,O]MR*(6W05J*->9\+/3H/3G4()=P)I#%^WU_Y05\_8Q+2\N M5U76]I$P4#Q7"S*V'OM8[4'08R);M0RCZ4EL&Z,(;7P;0M"?&#><:VL7SPMT MN:JW[Q"GWML`J$=`)Y)=+_?Q[L^@$&5%PYQ:N:6#HNH2(-I0O-:FIWP1=&`L<;3`HH$. M)N+<;D=RJ)Y#!$*L"DQJT)0:8N1Z)NWFF&PJL>V]&+!X.L@2>B7I"F>L?81A M4E"#`Q5%&]AO%4`K8-T7.VL9Z1#]L1QNLE<#@ MUF.*0C+S`0^QNPL!6<+&G]M]OL"%(5S*0:%*VM1LMTO;^G``)6XJ)G2O'WL1 M%VO63^OJ8E-HU*,`FXM&#*G92.#AS$?)C-Z,P./C;@*`]BF1/]5E")06>&!= M2NP$ZC0IT2-!]"BQX4C6RZ-\/8UA(H**:EQ6"N]%S%6*9Q^#AY'PS!@M8_00 M?'],U#X$=JTU$*T5-73F#_`V#\1,+V_+.V$SH/(=FZ,X9F_>BQ^94V8;9+BL MR%ZT;GYDQ@3)E&S9ZO>IID\N?>9/+HFO,?DP)5#>.&L"9\*.GFD^&(`/=,]Z MJ("M2]:VR.YO6`_C3&Z3ZYY-+EI[SS[$_TD$[3N?!Y78R;+[UF@SI1FB_T`: MP+7:0P25%F_;$("KYK;G3EW>35,2-JN@AE9Y&XFRF$=/NC!TJV.ZHM5B=75$C'L1NJ"53LEU! MBHH:7"_":5NB`:>C-H@^6)SM2:D9"]C:!APZ=FSMV>DFNTT+^TG$`CU2;;AF M;\W4KR^)3U^PBACV0%-UZ=`0QWILN>]V+MA MZ.-Z$Z?/&".1NA?3A[7HQZ+HIKEE9ZJ>.X)>&:,\04[27U?0\2MI;R]VA&PY M04F877W*%[P(L7P4K^[E#S_ES:,68X@`;-]*67M(XR71##W[+IXOTL)TS&!" M`FK6:B5*JT>K%L-]:U8+=N2V52+]!7$T+V8*05Q;=/$>9@P/Z6,E=/!>1KM)<"ZD-EO1.E18/S)1@S1A73PSKW& MS(R\!03OR< MJ>)S$M)`Q703JJ558C%=Y,Q+6F56=%!`B'F("4IU-#R8@:SEMQ^/MN- M)-`YQ01J:!U2[$#/_0G%SLS:.D*@<`3P]8T[%2K/OX:'$> MKP:'>C=.SW[[H3@Y+,#+<#I&).V9*G#$X;V8.;I"&$\9U/!^F([^%$$%#&X\ MYN9>/>OQX*[`SE),UK#W,KL/DNB?0=D][3C(H_QR=47DQF575];\[)EQV#?O M<23_1HK;>N]K(`WWSWR- M8E#R8O775EO.%J$%*GVT[:N`RRH74@-FP.$#7FYC?+GJ=@FD`24DD>4TBK<% M7MX&=[&Y"F3?A6[GU.%+N,^]=^.QGM"4U5K\9Q.$VYA,2^><%27(R M:K5LP^04)^DZ2MB_HP1)VV32`6=W=YNT?AX5D:F9X;/9NJ0@480/H:!NB%?> M+1WH^R9T:&>W$T_NW7I<0'>V84SKOS6!!2I)>.F3N\EYV]L;;K2/>;P4[-O>R"YZY_=%ZDR9LXXVM,+WLA-?$"&FWIX&3F!4- MZ)EL@*#RZYF=W,Y>53RDOM+XE]&[R+U4<+%#' M58(L>V9'W&NZ:T._K2CZX"Z?HB0J\'GTB'N=J@9.=0,H0;O78*'E;F=-!M`= M!_+8/R&0]QWSH%!E.AE%SU7(ZX.KT@Y$0OV,O6>J$:$=T222W.]46(!NIF=) M._FQ%E-%W1]+K)#R<3H<*^EE*:D'S;0:83K=9NH'E`=.?;9DH-UMF+ARY[.C M`>B*0QC4.F:O45)-RDO'G$;N=O+:2/PIS1I%L)84/OAOKRW&T=<@6[*;TI>L M(W=.;]GQ*HD\WZ[Y9P.]>YI!H'U_2E7)(\,4(P#&C>G8UT8521,:Q$9:(#86 M*@=;H'HX)(SG9>AQH3KZOFU]']P\DI_J9 MAC"\]"MZB7UY1+659?%#\Y'QA/V)4N-48HI,PZAZ$8W&L&P=@43BO0!4C>!Y MS)E6070/@,>0"M_?4'&-R3HL"DDX8W)_2:(B9Z%WTK@Q>!0_@\A(90V)*`.' M\"Z\C.)_9*QIQBK##AN-IT+[&'DFUAU-=RHEL-,XF;9\B$QU/Q2^44I2KFK1 M&.&\[&ZRO"3JH8\*1,D]JS`?>K0PQ1C046E"12F.(W8?`/*@8BKNM?&H63(L MJI,,6E\C#%5UY%DBUD"T'*V\&.%C.)I1<=OU.LA8_/D4)4$21K35!=?:45MK M'G0-LY#Z2Y+>Y3A[I,*SGDWM(@?KYF*3#@7<@VP&M4E;E4TX#EQ'L\F%T+0& M6]A&I042QT1LT&[YCB]52@XUV=%`9\.HU57N2TZ5>1/=)]$J"FDQ8E^C?B5; M9=\$X2#NI@@*+@X[$.?1^@IGJS1;DW]@$K";C],\HDHYISQ358Y,Q^;EPIN$ MS86R#2G=G"SXD/3-+Y]E6EAW)!%8H1MC%3,,NDZ&!'Y8'BE\4[)$HGC)E-_) M(\0/T*2796T<2RHK=9&/A<8QC68%%GT(R=)^.3\'44)[/)XEM1;E2AQ2Q#/1 M.-!A=6*%J4J$)AD$M*)H0@FTP4_>GFF!Z&#H%1WN6WK;LAY1'0)]R3*=:;&) M8)1FSK6%B;[(*CDEQ.A^W:]1\>!Q)#M*BFA)[Y$2WFYH_LUR\H]/8;Q=XN4G MXL1TEW/+.T'T+[/RR*WX'2:B#1.Q)E6,&*4F(>P\,DW(=<^/1-JH(8XJZHC^ M,DB@3T-0_]+SHLPCH-*J.57$=_W3LOHA20L2DDOED-A["B\&$%&DG(>,W;BL^<"%354DD.<7MT%@5-$`DG4T)PV)GS@LB>X MT,6#:<5O1P"ZVLR:0\&.`S MOZ;9[V?)59:&.!_F-#I,8*\Q"R5U&S4:G-^8>-(Y#L6E:5J)[9OK#!:MDF>3 MI?>$-1_8^.DQ@]S$+)74?-1J<^YAXTKE/AUQ?*#3J]TEDWK60B^; M.\_Z'(0/48*S9U&VSYANCBDTHL6`\20+(40/TH`[]QPC+SV[JC$ZSO(;QP+R MD_GEN%3S(6U<2:&],?W9V'=8M[_- MDJC89KR.[(G^E6N-7H<`5$-O%*%5":^$=E_/;F"EOV51(;#`6:$`.\'<4KCS MA5_P0Q3&!OOO`L'8O)Q5T<[;$,YM6S9\SQ(J(&`+GH;7T>]]G1"`*`SB4[Q. M:2E:]9K0-9DA@EB?BHS`=__2UR@!JV>^!B&#O/$U@L-^;E#26*`6%;9TY'1< M)3TRIYY:RHZ01\Z%U#[J->?O.4A4=S/?.0YR_)#&R[/U)DL?^7T#[32HQ8"9 M$RV$$"=(#;CSV=+(B^3!^Q(#B2C`$^GL8CCT"!)Y]0X@``#9>X_%EGG7W[JW MYL[0_5^=3FO`IKH3C^[L\'@;Q;0N46N+72`8>Y2S*MID&\*Y7`J3PN.8\2?%;@]>!S8@'1LV.ZGDA6IW0UEC^'=!V6ACZ"1-$1P_?1 M\'[.TGRPT95(GAE<2Q0K8V,8_AB:P,[0XU*&ZMTC6W8";6J!<"/0O4P@AS<- MPW"[IF][XN4IWF0XY)TYR-\Q+E>Z1^LT*\KWJ)4:4&AL.O)`]PTG5D_KRN%$ MM-W?.IR4\?[%PX8\$NG3W9-R!.9$XAB+;N7:48J;(LBT]PYW MD.,.WT<)O2_L0!J++&B()(U!A95!!;RM#!$E%,PP\N'!PNH-.(7@S=K5B;8+8BCGOOT^-G/FUZ(#(2!XR&Y,'/NV?T.?A' MFJ&3.,AS^/MAU_21,LTM,.%[&*OK,2@:5?VE4VC!`]Y)DC+9N(HD` M[N\>]4?OW]+A,-"WBR;@U.6=NB>S?;9AH.[-21AMWY1[@K3/_NB26V1//MCG M!)PZO.VCSD^/GUE>R=)*33XWB`+0?:#A0K8N"-FCN[\Q-)0W:=>3`D4/^(XW>#E97:29KA\Y_P6AP])&J?WS\K[2;:([B\F#1.INI%DAP5R M%6D(:ST3JY%?(XJ,2FS4H,/N;!P-AD`'TO:$*&1T]?S9Q)WV:\2!/V:FR! MC^XSK+GO-@S5_10V5*QJ$K/%`YG&AC$GZ5E9H[,+EX0`*BF@A@3,9/8"1--. M:#O*-U`>AT6-V[Q(USB[QOS4.'^(-OHI38L!5.!H%J)5YJ@&=U_L:.*E7_)8 M8J`6"G3'H+G%<'CO)BB,M\0[,$"W:F2,MB[1B`#N[\ST1^_?*.$PP,8[!:=> M[!V>&ZXDVJ%ZMTO8$\MR:_`<[&*B/5-#-[+]N)NHD4]W.]&,YIWM*6\HFG!\ MLCG=I3[3!BSH-<61,ET6#R2QB)J4'?QRHD80X>:3>(%JN$:4A+QS*H/(EFZF MH.*3XVE9'.R*XAVY(\V5N-TDMK\2.)G@HF!^W/73B':!55>$34C>^:$@BJ7/ M$0R?_*MF9[`O$+6-SZ.5JJK? M#M4WA^F+9>DWUF- MKLS3%>(8J$*!O\LB$T13"JD&]\=\5$6.*E@OC$=3OJBT'>!"19D8YSA9XDQ; MF6A&\\>49.*83$K$\<*T^@S)3>RR;V(<%;B89^FZS,`DUNMKB2T*6I<=! M\OO%4;+\6WX7TK^_Y(&RQL*$X+ZRPDZ$JIY"#PU216'#4L]2&!*BD&3M]]W1 M=ZROT-]NCD_89^C+S1%,W<2.PJ`+5BY!$4M!\@"P2L+U3^.P3L(V>_(G;[++ MF#S(E:RS)-^RHS;CVHQ(#NJ#8:@S'QD>8"F-#,P[O""/'Y,X\S,W_4OM%4Y_-0E['=^)+"X?%RF(S-6J MQ?"JB`P4ZCD1-=OM=T3Z<``/B*B8D#RY04&%%2[TFR$#.<\M6'?X9ER0173; M\CHH=&UP^F!`[\8IV&V]'->!R8!&A>.S'3#N?K-%FFR5E")+P+DM\O5RM,HBUE[OSL^/):/X'; MX0+-Z$,$:TWQ-HCNYWQ[KOI3*<-%-3(JL;D-GJ,S=(PNT35T;C";A*\8@6\] M2""D._J&^G0#CD=G1KJ*="V"'Z=%AAITQ;&*)\7G,HG*5D3':9:E7^D2,]B0 M;XKG`4I1D_#'[DQBFLQ0A>^%5>J94W:?VF11$D:;(*[ZL=\Q`B0B9O7F0<@- M.:AN7OISR#E2Z+L*'H4E`IP_GN*[XHP^!7B;@3IW(I>W0? M,C&S>.K\3(T+G+69&#/GOM!14[9H&`L#^:<6=V4DK,GPC-BC0%7NK"GU,YGEP:^`Z;)R49RVO)*$G MW19Y$23L)?GNSHM?*><)2Y:IZ)^PV2T'4?`G!34(:4I%%>A>I*1:WNQ3TX8, M(G100\BG)'68K()(*XQS^BA>B5"[Z3;9YF29N*%WZ:G7KJ98'DHW6"ZV]*#I MWJ>0#/;$_;DI=*J99!@U3DJ MICNU.%TPB,H;.0^2[IWL6S'!B`GR`=TW0TNZ-.*O)'^8YY5DFPJ;@9*TV??# MQBV$\\&J3>8,:L?J,JKRYV8+>=9@!Z8AD`6SO/V/+Q9:OL?P:Y#1_.;Y*`RS M;:"23@4,U#)7RWJK=ZX4TGT370T;_1ZUY4,9%30JP>$>JA_$OL_/UN\BB'>/ MV,N%*?\9X?PLS[=X.4@3?62?'%PEFMGANYB>!``Y6]8!88$:`HA3@%J7["1? M+5?`T?@&A[\N=A4\LWX;443"43IH6U9/?>J(CS/AL7HF7"\*CZE&8[N$Q16@A<-"10L_['- M"VD<<^?T-^$#7FYC?+FZ>0@R?$QD6;)'DI*<<7E$-7'/GTHZ?FY@REAW]#7( MEKI&F!/2APD*DRM(#!*3$7<>-";FO.G<<%]O"L)`GC692EHNM3-5][XT$ODMP^!`FO_L]_IO-\?I;P.K&I?Y_!P^^9(XY4[R3N.G#L M_7'J48)-[_H+Q!D1ZBMSQ!_U*0@OJ&2&/DY$V2'+V;+8$N:P$5C=UYC@1R&] M%G13I.'OZ$L2%95RX';V@+5"OEREV9IMQ&>-AG*FH2W5$+J7*^CES2V_DH7@ M`WV*A[_8P+ZDMV$^!5'V2Q!OE0LH?_A[V;.3]0\$,7T9F7NQ\YNEY!Y-@`M4 M\5P_S\)`V+4\1/E&C/&7/5&._=V8?AXI`%WZ8_X31,)/D#8_`;^!JYQ$7MHL M.U:EH3S-NG90VZ`$:L0X_N5" MHX60IS7HV+`7?ESZ:@G8WM,37/6H[:J@/2U=*W&G`P5=P`-OLOEQO8G39XS9 M3@3/)+2--37P,,''*(`8093`SL.`@9.>&5;PY981QP!NBSE4!I'U?*>6E]*; MC2UVKHBT#\07J:]5?U_3U#97/OTT$-_]7',&AR4TJ3!YR MZW]EC!#,`U+NI+QV(*7V)N8DHMY<75F+Y-%*095_^+'?^R?9U?5@[_:E[]#Z MM@_KYT[KG!N#\VS_!:6.V'8I:ZF&5O5NZQ[&W5KPHSS?KKG*KJ/\]T\9QF*K MG:E_'?MQ]RRV#E7H)-'4=M#]B9_#))HC8C:A#PD\+!#E`E$VVIVR]BX^[JCA M7D3,".[!BNJEU0(/.";>F35S9Z.9CT\;3`LOZ`UG58_*.0<$C(*SJK`7_F89 M#2;NS2B*RX!7#0_8BMVY.FN9RP;5<;2B<6U\4W(S2:\T\UD@+M)8KQ6%W@K*P0U,:V`8!ZB$@8;/5%D#XWOU-_][@_2L;WA3N M697<^5$L9RYS`RY0LZJ*\J40;")FIZ\Y&5YEXF%=R*I M'./J/Z87QMU4HKKM4^/1]BKQ`G`3,E+>#<(QW^K9$NEZ3A5%.EP8Y MRO"F]#'`K8^65&S-DE=BV>BAB^&!$\F%4/I.&QS6962\&#V%(S6N`K4F'B[) MB7_NP)B_KCFYRM+[+%A?8YJ]1LE]]<9%*=Z6^'P6_1,O;]-CW&`I>Y1,1!QH M!V]2U;1VYR:A['[G;4*V%37[#1PJR2]0/0!JGE'A8Z!F$/HDX!T6\*%:?LRI MHZ/E,J+KDB"N8DCQ$!0H)/GJ'1;C2?D^!VW@&6PV6?I(&URPNU<-$-IPWB![ M>](W'$FX%"*H\"**:B5NPH+JTVDE3+L;IQ8%H.>F!3^2SIHE5GM^GOUM&_.6 MS8[BY%R=P=.$!?0B3*=:'HL=3'WL8AU;)K M:MVKQ]FSB&12V"1A237(_L0FO02J_3_N=\+>Q:"1AGTY9&H5,;^AYK'((IIEW?R$[.[D3,KO3_E?KFB#_=L?8V M#,D%T3RD?8/#;1:Q1[^:S=::#`M/G[;%-L-UE-J[.L2=5)2N4-ZH**M5%-0J MHD%KQ56T2^R2EOY<8_K\2T3?=VE+<;GB,93-)Z)(U:\D*978A9C[@J'=1:]J MB<93`BDSVI5=22_PDB"]=$7/!9+&M,L-SN:XGD_)+>.NK/H[IU5*,ZKA+$&W M1`U"$"RWK5>HG::UPB!4_//:)B:+=)^#)UK/W9;N9GOW#QP6MRF+XWG9#U:B MGT'8[F/9".&JX#4`%21:#>:O9XHEA;X%YIP*/=X-&)VJK[+;0#2=A+V`4U)! MMRG??A4)U)`@CF]B1Y-0M^:5 MTDA`7'NL#-U$``OM,,56?\$,;NR3Y$?H@ST,+RN M^L;98Q1B^=+P(DWH[C7FV^+Y;5H$L?@]K52]2(O_PL4U#M/[1+,K/.-XP!UM MYU*@M"/NU(/!==2=1Q+-/04^H+(S_@+5HY:IQ`*Q@=NG8:PXFXQ-'+E`S>A0 M6SJNU?DER6H0&@`;Q?`GL#,V:::RK;3)`F2I\19*(/3F?H&1D)\?DI5D M^1&%4YW@NV;BA<5,K:J=!%(I!R\GNFK$@PJYB[+"@.VF"&R]N%`\2/?53?^O MW89XO/R`II[;EQ?#1Y]LE&U9AA7.V=-:,MV='CK8*G+)-LW*P M_3ETM)-DUM;+PM@+5(^^W^V5A^KSZ/X^P_>T;7)4*Z!^J8YNZEO%O3TO;[^L M&LO@+(QR>D#1UMWD#48M!MRS`GAK%4Y2$6\<;7]*Y"U%F340"H/[%0A=*G2B M2(B;]8>8?;"ALX=5ZNA.#+U-FMVF&C(CHL*P=FC9GYX&5_YB[")0=D MC[F1[Q@C$-7`+]Y&?9XY*C)N?I=FM!3BOP+F5%\M%>X35U!075I?1YF$=]$46S_F)!@-E+M1!&W0/48SCI-,=H?-2]_F/ZJMQ]O-80ZFPF4I> M^"![=V"AD,!=B0L?=988PW?K/B9+1[4M6@7*I$=!@>C+:70FGV_CE).^*8*L M\%D1=_@^2E@+`J4Z]B= M'5]@]O3!IS1;X8AV!`%+"ITHLZT)\%;VM.4!7IYNFW.L,A]FR]+VB;BV;?U` M0H`MZD>)W&M'/X@*3.OY$2RZKAR9UM4_<,4DK`9#GYE-I9^><'N<6`@A>.;L M0CK2?J88&J5-F6=(AMF[9$,IPZQ11QC5@[CC3(5=^<$#4Z^TF0?;IN\E:^0I MQ%Y:8E/'7[:Q?DVU)-0YES+^6EY\.^+WWEHHPVXRN&+)I[L.;G\&\VT(-_QX M2Z(/Y!3GL'Q7OR,MR;Q*4_X&'^M&Q9-**Z81"67'5S`>F&_ M?IA>4MD<\57=9E+Y^0ETLCE2;55+GK[Z!LVC,XSN4U(ZFW+-B>KD0WN2O,XD ME]-0V[2GD@1=O_;27*G[LGW/@BG$=!X"'3I'G8;H9I?YSV+TH_L4.F=3[DPG MOKJA/0F=,\GE[G08(AMU?6P\0M\&M?PI#ID=J&V_CJ3S04=?<\Q*4W+@Z_?##6U;([/R"&FJBD.S&=7NS'JPI^R[ZJCWGUTB.@ZD(D]#;"C M5#UIC!W$P?Z%V1'BN>]E\5*#[13*-\;;?2B#,"E*DNB>- MNP-YV+_(.TI`]W49+S?Z3O,#&..O+]4>NS=@HIOV`-O;UJ-[&FVG5>X,3=E, M0_L76Z>4RUU;RWT-I+-JV[Q+Z__)8:]6Q;Y'J'J+NW[']B1-BBP(BVT0W^)L M_790U$;S\6Z4\>[!8 M_/C'-BJ>SQ(B'NLJE5\6#[S13AF%ZG=WYNEI,7S\/5LPCE7P)$O&H8/OSZ)Q MG&1SY"><$R2P@A@OO&=4G;W4_.QQ/XV)E"X/IB^P(LJMOO:K%&JTSGYA"IOK M9NW@X5_:="17KYO9J#WV"YJ,9((!SD6LG1U%;MJH"ZSZ?I]CE\9Y.6EH..JK[4V_Y.%;MGW)WR+\I>3!_+VU>'OD#06Q`_9EFZ%&2>[2%!3I; MSUFOY^B7LYU57OS>&*TL]V_:&,;<2YLSQOPT3C?;K#A[0;/%<+']VJ+[\\X6 M$_QRME/%B][U&UZ<.:P''QB/+VWNV.&'^YE)B,\2$0<14D#(*J M4>BKI?4X#$H<";&AT&]L,,`J]UIAQ\_UGW^+2+C(PH?G<_Q(+/HI4N59MLC` M+F(EFM3^M9APQFW!EM9R:R3T&\7PP?Q*KV$S8E^XTY1.7":UV-$`-L8A@DIM MTH8`G&G:Q4"12$1;`HN%R4D#WG:85=]&2=S%,8`!?/4LV)$=D`>>-]N:@ M%@/8#]5"2+VN#P[G8RI>=![%<1!'`KXM.%P0!H+4?,,ZP=O!3O#6/R=X.\P) MWGKD!&_'.,%;#YU`+PAW`C7?L$[P;K`3O///"=X-)N3H)'G M)^GZ+DK8<1D5EC!)F"-_Y=$29^SC*BP]*U0VBA*,U^X@M.BY(\@X]][1//:, MN:*$CL(_ME$>49P%:HBA%K4%+<6?J[[(_JK@#.('C?@H;*0/16(>Y+_"YN6O M4?'P)4GO MR(NCA8FDL-V31U_)>$@G*YL;;B[5>1R0?X:L M36WQ@*NK:/3/.:ZCR91AO)4&J([6]3&U4FPB>K9>LC!]^.'=(0O2Y(._*Z:? M9KU9"/-K1STC\-T&T]$"T@`Y&'F6H+=,0Y:8!U/H7V%RZJ1)6`01>Q0HS;(0 MD@7X%R.C.4F<2E0!`BUI=IGI\E8;Q=TBM: M'X.,AE#C!NK\X^]7,CE:P5,DF(,'WYNDBNCQT@2@WZ!7EYUM4<40+ M@"N>_*FI<:GRDP=:NLU>_!&B:B3H)]VP>,IVU<)TWF6^>HM607,T?%J7!9FD%LM887H-I", MET3%[^1+K_9>_VT6)'G,+XXL_['-BX'>;DG.FU`P2'S3.LV&ED]!9`##0U8X MW<,N@2X2"/L03EZ2!G9;\NV@B-Y!7R&(&ZC%=;?DHTE7+7@88>T]+!4PS&)* MS[JX\I%#.E^FZ-CHETX18-2"AK]^U!/@^/DBH%?I+U?-Q\^:*TA#"'AB5$81 MM8:FQ(8W/@-K-@9Y]XPX#;J=)5`!OZC4%K845'LM28OA@RE*A5#;7@LZTY]J*<$M< M&$<9))CH,E:(SIUG`%<]\ZMQT>4*B=CTWQP?N(A\%^F$=<7E71S=\[-=](70 MR=B>ZC9C+["FCU'.OH&O.^]-N^>&(G(=@@_SD$P$;0IT#E:K;6+%*N<^WZUV M6KKA1$P51VR+/+])X^5M>HZ#G'4*66^"A`S++/J4.,>G("0D:1UYTZM$LG3= ME:#[3:=I5%!M.^U?C:0J6)>\/U$113JC2ATUC3A>%%6&T9?$R0#3ZHE5% M'04-^>^<[D"!JT*M"/=[XAXKPYMMJN>C,,RV07Q4G!#VGLF'NG)42UP?)E># M8)KEGAP1>N&GX\J\!"RQH>YZ[")+G8S&=4%I1CZZ3Z)_0K:#[(AT33W[HO5V;:<2';X7[F064.-2:F1HMS)Q9K$KP4C0;;N*"*(P"U32 M\6*[9;"8Y;=HDQ9DNHJ"6*RQJST1SOU.<49FX2)ZQ+I3EAX4C"LIF!4=I@/B MW"VDX_>LHH&"/T%I>&EZ2EY'^>^:,Q,]"K1MJ,60&TH?'M!J5,SH3*C!010) M_*BC8>VDO(QZ2X;4GG7H4:`M2BV&W*+Z\(`6I6)&9U$5#J)(P`<>+B1QWG+@ MXU/(JD4K]O2];_0XH.T$]()(F@?($:!:!>BX49;.5$B-<0$WP=E!EEZ3`Q]. M*!K_-1U-2"&AIPOM880$#'!R,!T_B(GJCL<.DZ]7<+;FA2+4;,WI>`<B0*<05@*PEOB4ZY6J*4I8!]@SA('VCGD)_^8!X^*2CP5T@G4D4S8W17(PQ M"U1UG6"CHFK8!2VU52^TH76PITOL.)8W@M6 MNWLI@8.Q?"7#HL'W@)S;N8*#GF'P5_#*9KRP&Y"3LNS8@ODZJ[`U9"DXH#UK MV.^9M006QKJ5C"@LIH3WR-AGDL"Q[5\0(QMF_BH,0`_0"]%S`CDXC!_H>%$8 M4H/BD3?,*L?H*PVL.A(O/S[1UU6QW+@U<.XO(&@9KNX52(%`K@MH.)'TG6.P MJ`*>UVIECN8I3C0!Q0:0>0'%!($P`,*)3>V M>S3>'0;7`EVN.H<31F7H4*'MS"R6W-S4>(!69V+*7*,B;#=7C]#,U[E_^.'R M:`'UCVX$3%1OOIGU6PQ;7-Z\SO2`A.)K0]E/8-Y/*':'/\?,::V]Z0A2.[HRL[J&Y?<["[>C0_`]!N MX$K%IGLP\XSNQ:V:.46SNZ.3M_MG[U`I(=WU8MMKG0:1ISA)U_1-*;QDO2*# MD`FLW!$;0[MS?/S5I0.!DOL+K/H5Z=IZK-4P#`SMIYU<7:50SJ?"75L]$RI!$8" M-'CA55\`;=F5&MP7@U&77*E@/3`:;:&2U&Q`:ZUF%,"=Y5^DR;)D""^U!_12 M2!A[US`MFKH$S+F5*WF0W&`0((&/W>VY%DYPT$5:U-9-1#C*467SPO+$@]1` ML0C3Y`=:#!@?L!!"]`4-N'.?,/+2LS*.@6H4?TJV%;)HTP<#CE?VI$XDM`B^ MV)1V1M98%6AB,4:6C^M-G#YC(@W.'B-6T!UD^.`NR$DDIIT4,5F<\8LU1W%< MR9FN6!-AWJ2M?-F)0.<%>REXDV9$)_0D?I<\1;V-Q.4L2TDNL+Q+A1$::&M( MSWQK$T@."K?=H^-'L?(O7>55B?3M`M&S!;A-G/$BE#CS\V_>EQDNA%[MGAS; MG%L77^F1/3PNZ8EF?=1Q[D%=EIFM<4<,YWX5:Q$785?9SQ*\6N&0?D3[[5]J,$[0;C')P40'^=+\ M3/8$'-_;K[C\^$0?GB7C,U%DKT*.H.$^EQLM:)7A#28`DO>-Y+)?_\V[:]QA M6E:"BN!)VFCCGM#,T:N8D,5D@LAP$+,%1I`LT3:I_]GTAZ:O%Y/\IGRW&.75 MTF>!<,56EVB0YVD8L8TF]N@T49FLM,5M7_^IU"Q_-))3XK&,]3>NB?&H!_"> M[50"\Q1]I3L^+H3S1?`&BQJ!CYEOW`9/BGE@$`70YHM#A)2T8K1!AVK,:,_; M"-_D><:BBI*$U#R.F19!K,LX=I>5BQ.S-+\=K<>_,#^-']YL[W+\QY:$^(\D M>RIT)7YR4!C/TK$MNI`,SKFOJ)GH&4H#BA@L?(>>#O.F30DUN!>&HMUX4,%" M&XQI86)EDAV31]G^"6E[RN<)20OPGG! MH3*\5*AD+#&@[CT[B=[J[#.*DONN/SNPV>^E4Q)#`K4%:NC1M1*GB&J2J*() MM2TQJ0;:LJ;;@JSD$K9`R>EQ5(X"A;1@G2G.F\LW0]I32-"\Z%&A%$?3J**' M`]VM0L&0N=6#@.A7WXIA$IVGR?T!:VUL(Q!R')0'Y:MFLQ` MMBX%3PQD(O#%H3Y!L,#SQXRD`ID,JH7DA6E).+(SL@H3NBORA#(MS$*-KKHX MV6:L0.0S7D9A$-_B\"%)X_2>7AM7%L?:(+FOJ[`7I2JD,&.`5$[8LM4SG@H1 ME9BH0:6UJ##%L_LIC;8$P:E(Y=_GA`?R;_(O\@>ML2?_^/]02P,$%`````@` M18I;1[!3!8Y(.```-P<$`!0`'`!R;60M,C`Q-3`Y,S!?<')E+GAM;%54"0`# M$>HO5A'J+U9U>`L``00E#@``!#D!``#M?6USX[:2[O>MNO^!=_;#YE2M9R3+ MKZEDM_PZ<5V/Y;(]R>ZG4S0)23RA2(&/SZ:?AY\,D"@1.Z7C#]]5,:']BQXWF?_ON_ M_L^__?)_#P[^Y_+IWG)#)YV#(+&<"-@)<*T?7C*SKD"4H%_>!%=16%<3SQ(F`=?QZ./A\??QY8!P?Y>)=V#%N%@84'/OP\7/[E*A\[#'ZV MAH,OAZ,OAX/AL77\\V#X\^#4>ORV;/D-3G;BM3?UO>#/5_@]"U(/SQVOD?PZC*>PX&'TI&G[*6O[\$7N5UC]&1=OAE__Y=O_LS,#< M/O"".+$#9]4+#=/4;WA^?OX%_Q4VC;V?8]S_/G3L!,N@=5X6L07ZUT'1[`#] MZF!X>#`:?OZ(W4^0!Y;U2Q3ZX`E,+#R!GY/%&_CU4^S-WWPTA[+H+7I>TC MF3W/`$CB;K-G&5?^W!_M"/YY!A+/L7U9A*Q]1`I5RU_&XPE<2L(Y$$A-T^#2 MJ;@*YV\1F($@]MZ!5)(:OR2?/CN>W?KA#Y'Z0QB_+RW77NSX89Q&X#F=S^UH M,9X\>],`;A^.#=<=QPE3N/`$TTIY!=>U+ M07T\<7.]@S,)X$P$,+HRE+@9/D;A&S1K%H^^G6U+?Z7>&X)EW_E2!A8W^ZLP M3KZ!9!:Z=WAR6)_ZSIPPJ+A9?PU#]X?G^Y`K8[C71']/E8H\^B"Z9B%O@O/7V@)2!9"YKXVHKCYWMI>]+OMI^`; ML-&_A:PHA$$%ZA^8VOZ%@X070Y6'=@;:?>$I5P#,Z6.+H^$:1-X[Q!^RZ^(D MPN/=$Z"W'AT1:8Z\Q^"N%G[IY%P&I^GB;MASQ?_MK,]>W MY%F1+S;<&WM+A32J%(M2S)0;!MR`=2EF[JW#2[8TQ5!!'7JC5J<8>C@^),<" M%4-&TX@2K5%A&M$\[*8L4S%DL'U#II4JD([&<25;K&*F3QU:@>4GABKNS\FS M.AZ0GJ*97(/$]GSA]D=]?'FTH$LB-_7!>`(5UW,@0Z\]/TV@"J\UE$0K__>E M6&6K:91^*8ADYL]LP(*#N[@@JI@^(=F2$ZV(C!^13-4*)$_`">&)W??P!CJ> M7,V@20;BNZ"QGTPF])[31BWBU6Q7LX-27*!]8HX.J>-),8H@IDF:E"*N-;90 MP2GZ1.2<0T0O*O2QY="PXF#YMQ((:OF0Q).7N&V,,.ZFSEZB\<;[M4W1N8(* M5.-T_H9=T[=AM#RNC"=X@#'^"S(KD'G_F$;.#`[YY$UG2?P5"0FX&^&4C/G* M//M*P5'+%V324]H%,(?S$]Y"&GFM']P,M<5GD:D%#[J>@\-.8/OO@2=L%Q8P M`[R.E1N]3V&YF3I M4N9[$+[&('I'/I&[X"T5!J#-S'$S=ZVB["*63RCPOXG>&'I\6`'U2RW.#EE( M>?.(YO%D-7S#3EQVQ>N^>4\QZD3,7`^3\/W+R[P$,./T`]H\D<'@V&>./'O\%?+>;S` M8=>FN?[G?YZ,CL^&A\.3HY,3^#^GH^-1:89E-%Q$U=G:D5.,#7^L`*2>ZY&W M^/*&@_(/G)GG+P4]B<(Y#__R282,Q(01M&=__33\9*4QG&*(S?A51H!,.5S` MB;EH^/6T01.7OUXU7-DINE%I MM_6B8:'U,7C-$&U(=`F2E[Y*)T,D1TWB84H28Z&7[ZL^];$>MQ82CLP M^=N&`^1O6PX'?RZ/:.5#6OF8G6$ZL>-7+,XT/IC:]ANN@_(%^$E<_`;[Y4J@ MS7_]S^742K=PCV'L4;QS/%VA=(^&D`F#P]'@Y'1X=GH\Z*..W>G,;Q;I%%4; M::-\O1F^TDD.2HF^/DCY!,!-T[W/N$>D#).5@"@&N*5*P>>[/)/\U]I6F7,* MF7.B%@8,LB,)G(4TBMR],(*K.78ZJA`EJ@>"[GWA?U!(Q;OMXSNHI(CRQ!?A M!-$R]=54U"Q2JTN\.\42-'^%G6-%RT"6/(LB*("'(R$>0)(SEK0:4+H8A11N M0HEW#WP`>0?1:]@`D1,U$"DR1A:X"D@C),I-C()`*V'$NXRM%OEU/O<7^V,9 M'$]?%"@]C`($+YW$*Q01>\:I&G0\1N#-]MR;#Q2R#(I\B@I7"2AAZ&D46KK2 M2[S)$;.JG&EPY&`Y:AB%!6:IUR^-.->*,+']FLP5G4WR13(,'(Z39KVYIDCH M=-ADI(YB3"J6*2T#E[CPD[MH*EM&,34M^IRT"CI7DE9[12?+AOS*N\#Q4^3< M+G(QB<>)]JY53IY!3IYN-6HZTRSHT-EL88[T.7^L.,MQ!%EU,@TO':@5=%9M M1HHBF[)D4+<"I+&M:;A@)U+0T92T[2A:.ABQ8#H,>!#0]YBIX8&#*G5-9=WI M,"%UH==)KJ7,5VA3U].(6PZ6K-VUPX;`R^U>/)!@9BJ&$=O=-[F#=E#I)5\J M7%@HU_=^O+C'>[07Z!*/[7:SVEAG6;,(AWRYR4"GUI*-4N#6F4$6;G-[(^7+ M0:I4)X(B!U1Q0GX"[R!(6]2^N7&%5Z?0%#M1'.K6&Q8<=$IU%QPI73"RIZ!> M[`_&!:/>OLJQ$\BQXRU'!A^I4N^U%>TF)9<:\XY"[5/E'#RKGRB^V1"V?+"3 M*\K'H)/3D1D=NP`)/AP8=;E=(IWYAIO:1V=T"#Y2,A*O[RUX\U+([/#L-N8.1\.`D5^H!5AOO1OL].*6+D3#A)EAR++8BJ/`L)`Q*!2W^ M$WT\YMVW&&9*#3_.MB-!9_D+/JK2`&!4C`6J1^$E107;M:=[&P%!Z6$Z0'A) MEVIP*,H3Y`[#8>2Z@7#AI%RJVUQ9WD@^=1LBC[;GHW;HW#]I+)>:0CK6M M':M^C1_%FGB.1[)0VCN: MAYR.-`NR:'U-_.XO$7XK:-%JG=0;F@<)1AK[FJGG&00",$5@T^584\(_]BJC MU_DB,`-!C)]Y09Y#]'[+`TC&DQ?[@^Q:Y1G%/`R)8(`@/YMFNU.=M8_9RO-9/E4_\P]#RO(='@^.3T^'YV7!T=G*FRA+Q_?`'XOUM&%V'Z6LR M2?UZ6<*6&':>,:JJ,SP=G0Y4;R\=Q=5@C_1FA"!7G*\N_['J=(2*/(XPAUUL MXS^""!')#P,)DH&&3%YR_29`:WL[]7^P-5_.N==D?L3)1+ M>.1,K+COXCCE$G768=?$3*%:PO-H0NY3.%=UAIXF"[TK^1)>6Q,B?<;%G-)C M1Z3-LXR+?,A-H)2I:SBA]4Y)MWWU%OD$G$#)$A.T"53 M-G^66Z:LI$A%.OQ0-&35\^V#^(BP8Q8L7BM516+AQ"+0[6JQ\/E MACL7!NH,>>CJ*HSA\H1*Z,;/H4\VEBJM#!,W"W52(LA4"/QK%,;Q8Q1.B#$^ MI1:&";J-,@E9"TIR(=]`9*-X^_QEC;8'#(GM#1,_'YU:^:^>@>^C4N<@@"3X M%X%[X(M%DS==9.V'SB:MC%NY,M]B9+>2#%$Y0=Y#MZV.\: M6C5^B!]&7;Z8AU'B_8U%,)Y< M.'^E7H32>JNO*`S79,_1TQ@$]*59:C$%1;&^-5ZR&@[&H(*/0E')BSH%WRTI M7X6BMJ%@U5(['`@R'%LHE/!B@`K1/X1!6*6X>**/?HYH[6<8++K1J]6=V1UV MZB+:,P+@G@>@&&@OV38UUTZPW413%S$7P5)?P%;TFBE.32!RD[0C4#L9"Y8. M9$NM+*XH?8,7+;L'E$X8,:J6RLJ0NH4;G2QC"!M]-&C%#9+FTOB@$4 M0;"7=NPY!($WMC5,\.PT%J>DP?:F":T3>^WY:4*,-"6T-AP`-"H+"(@MVJ0X M,O7:>_=<$+@K#@#'A_]A"$`F=C4,(YU)+@"S[>\K_@&\Z0QJQ05$KCT%#^G\ M%43C22U2E[:;<(UA&(#ZTUX@2>1]G49(RE==UBAYSE%V`TUP.W*9Q2&<3>06]3>:;GW8NJYA:?1(PCQD5H%YQ`*XS$T)XIX M5Z/LDJ6E_M,C"E&!?$^2R'M-$U2+X27,2HVTA7>*&=T4;,ADAS%1XB0FW881 MW#2#K`J(LWB)[""&S$"\"ES\+S^#@/NO-+LW96`I)VZES$$[=,N$*;M2;([7 M4B_/%3TC0EFA^$T)[1#:#0;P_X\5O6T+D8HF]QB%R'WE7BZ^QRA0>!D@ M>`'7QO>L]%Y+K!SW0-KI/[?`&NUT$5S0RIC?_D.7(*D(/98ICUA963CQ2_@$ MG#!P/!]4*'H)Q:P-,CZU.R#;&/=T?GP9"M3QL#CASS[(#?9RG@L!>RQ=M1UMG?C&L=(I.+5]M+T`L&P>H#L)XQFI^1XE'7G4UXG4\FJ` MJJ+N>50(<-$!$)[^:*M0<^,]HCIQ2-`!NI:IJJCH\\V'`S7GQ?[(@PE1D&HS M-QJX3`K1Z3/F'I8R&=DWM[)E-5245@,E@2IZH:@7_-\2[_.'J=K+2#$.H!T\ MI5G^/7DB:YU49,;5N5&OYLX,KGI7[6#54_HL<&+D0M^KC)8E2Y'KL\X.E!P9 MP*^1]U5JGUU$4!OYDFU_;7:[QPB\V1YZ/P\35:31!=E36%F]#69,L0RVBV#K MS)>^.Z&>[]:1U_-'>X$6<^2V<9PHA5->/:'$O472!JMR^QAR^\AX%';FBV$/ M:+*;O4TIE[VO$9L&U0Z.,F^>1/-):M&?H588S:I@"+C>I@RD'1;E76_SY9RNND0>J@HB2+1]\.$KBZHT<&D(\58.O]=AA73*R0?`A5Y+^H\:*XA`-9/"V20%'ZD159E"%V&&2\ M7)%\W%3D]&C0O:*6&,?*M>RRPWAJXX+D*R)%%^:0L0X`+B["<^UAIB9I5`H> M(/HF&'KN$)HZ,D-4+4^=\A$*S;H-HPI;0.2]XYKH=P'D;9J5.ZPQOF71ZC;H M#@%1/)_Z/MI>7?A>M"HBR"R&_MXRQD%W!ZH2^&1(D3<"9_+GW?H[R"@#5=EZ M`MEZ;*J#C)<+FKTFO5K-<[9+%AS-V!DG@V22W9K.AJO&2;/H&W-')FD#M,BU9KQ]V!6D=> M2/9^':M%U'CR#413`#GBH^FAIQ9C]D6.[#8`K/ MM_"T_4J\EVSMN$/PZL8+J3XS16Y\N)0O=8T!1:3FNX,=+@Z(]6#I@IG5ZKPL M<]JZP2U;[@Y26(GOZSO2TT)B9VM_#R?CH%7NGT+NGQ@*/0E\ZOM^@28>SIO) M!#C)>`(/SC,[F((GJ#/C`-_A!R[Z#PI%>K=]RC4VSQ#:04Z`5[,W_6(CGY54 M/FLD]A'`1===#Q$GH(AG"!-1U)M^0UZC;.;#!5R_HV@!E^7?;3_EP]!:W]T! M#POA?2WR'#5O&*>0DDCE"*J>G3C$J0JDYB).Z7T M:LBH=-X7@0WC[5'(P1$#(O!0%NM"Z&(XJ;=(H/ MIW.-V6CN8FD.SD<#+$OXBS:L%S5$BBN;-=%V&,%028OBA.2+4>Y`R$;0%"DT M)>*RZY(IR%X]\-S\R@15(9P&WM^KJA^+!@CU&J_*QN'IZ&Q@"J#$\T7RE2KW M9L0.KSB!AE^^?-Y`'B2+QSS4[C'R''#SX?BIB\O7Q#-6B/&,N6LPZ\T;"?>B M#4"3_9C+M1<[?ABG$7A.YW,[6HPGSQ[4M(GGH`H-68TCM)>'ON>4`AJI3[H, M!_#_K`-K-3AZWR4;'[WA4OJ"M?J$M?R&BF<0:I2V/69`Z:#"8"U`?@UB)_(P M&+.25&NS?($RN_3)D<_6E3P MJ*Z"Q9#_:>%!+3BJM1I63?9(,XTM&LK03U$R3/.TV-679X@J\@\A\A4'PS"+ M%9Y0$5[6/[Y M"]_'M;#+OVK?BEDZJWENN$%DI?-:FZHS]]=.S_E$6GV-N`_-1FCZ\E(J+PR_ M7B.R%/?4HO6HUO91_X3PM]0N7E9>"N$[TBHF5!X!Q#Z1TM M;8IMBP/?(-JM$)U$W7AUVYU^(U:+IAS8EF7AM+XLH%$.T#`6'D>!4I3IN%Q< MI1%"$!0NNJ_-_T%7?)X!5&A]>7YMRMW85CL=YA=968'9:33CK.ZF3O*''47P M$,/N)CMK/*.CH:S26&I.LE6"5G-L,]G9NBHZGI=FQN%3:^^HG?+R"'#M--Z% M5`-T&)<,PF6J;N9O?K@`H.GEW!:%/F^X8$;C'N"!K6)DJS*TBB?+ES/$%9.6 MM!J@R;>V%^&4A6_`1O_F<.@/&\+4T'`6'L^J M#*A`#9:4L9\)Z%U4Z'*3>.Z"MY3'1\J<([16E!J@V$WO@B!^_`;<:6/IW!8M;PB`6WW"*GT#JWO^ M%:OT&1475R``D>VC2:=Q#%D[GC"SI>W:3LC02AP$K--D7UOZ#*G=2B,2-!4' M@6@F&;!(/:>O,?@KA8/>O',<)QHB`5=YTM=VK$7CR>/)1!DS,(XK2MKER&TTU^V1#-AI$K;5S== M'_I'B7%1&,`?GU176^IN91*-7E7DBH[IU+JJ]=B$RAW0+T;\\FX5/NXKMJ$Y$GE MV[.1692K+8HL2_9]G&&,JC(<0V50_*Y\]VS*_G0;<"G"D$_)M2":CUT&XQZ)TXR4NL1#-`%2YNO2RLBSE9S6MY)J)J[2_<+XE-P5A-$,2V$D[`L`J:-V^MXO6;7PM:DW^5+@W[+.":.M1R3B]^V)&+Q3C&^(Y1#DRFXNCYF>QW MG(N-B(]HMQ2)SQ'>`,/,6<(JN98\R]9P0%BVUE*'E:Y4YN00-V"ZK"UE3.!JPIR`A7D>.NRCN4PP4`?63-_GN"J$WD.7*XQI[X''ERAT5(K%(J< M7]D!7(K@B)2G/[7(FN?:S8;UW8R0.Z]T0S,BB;[D(R[FEC\2&KBE=QISIKMC M]%Y6&J$W^'"H.:\SOO\WM%M*>)/PY7/#F+UNR2`&OGP/PM<81.^(/;BF`7K8 M+7!@+[M2E;A-,P5^:NNANC&F&'##Q)SLRK45-D0;<^6@JXUFV">C,VVX^0Q+ MTWZ&R,PL''QW:T,]LOU'$.$W"@,'0+)6OPZSAP?OT9P+?V>'+5GF++1;"66E MO.O`5V.V__*59H-LOMI>@(JDW`5+AC;SD^>N6,AW=A#N,CEG@'6PGG3U@.[J M$+>N06)[/ILY<,3V)*+UTW+T?U@_Y1_8YQSR3OXB2#P7Y<1!/CXC4Q=K0_9Z M+W!OH7XA]T^:H:2>5GMT[M::-?2 M-=<;\JXGM:H53>M)\754R@)_'Y\V\ADT]-@O.WV*&"1W`00'0!LG8<:5-EN] M#+138HPU^P?PIC.H+Q=P*O84/*3S5Q#EMPGQ.$WBQ`["#4/IIY8.I(P"D"B&Z3@(8[` M$K[5B#2*>1#BI#6'SE'?/`%T.0M()\KVCMKI+VL!G8ZD&5(3<4G]'V'TYUWP M&(4.B/D@0>ZY_9C@I$W:380B4*"\X!BNOBC5F`\4Y)[;#PI.VOJ>"'4#1>GU M)Y:-BVOH:+2CTY.CL>'AR M?C(8'9Z>'JH.C*#7QF-)F:5TKVK'&=2.4^6ILATD1`M;Z,``BF'HP8-+LL#V M@59E]BX7+_#;%Q\>:5MGZ*D=&'H)L8Z)KBQ@@,-0,S@@>J[#N>T%O'!8]=0. M#EWEQX&$%NH-.3%^LR&7`Q`MRJ1_`\C?38`+I9=+[M:!##`T&WT%IM*_?`C@'*WK^;OT7A>Y9+0UTZ*#T,1$Y7 MJB5<7:O'BAVX=&@L&YB,!#J1N>!/31+\90KYZ@53JO"KC0P&``.A.0C.3`(! MD8'W\.A^EX`YMT=TV5$[L&S*(4KG`/$8JY7XOT;D[`IZ)^W$WE%.'`(GTRTE M.6.U:)RH0U:+G3XCTL4;R5V= M!ZJEN,:3JYD=3$%\%S3VXUT":BGDQ"6@'.E?G1/Z33XKV(4TPG[EV*\7\,*!%E&6`T1'`JV+08#@)M.8Q',9R\)P6V'`0:"@ M$T.V,-P$KB*C@N%5SM+KI4N3`IKY"Y1&CROTK)XPY+,J3NI6!<<+GF4[HVQ5 MY%.SLKFAOQ:#*K8L=N3=SV**+11HMWGT?HF12IE1=L225=E>Z5ZGJ$+P(YY; M&W`;NI@+!69JA?DK=8#%2V0'L9\);%EGA613T#N9"PT.>@69&NIMS>Y;@V*+ M4N;>,!06Y[=5MF1C"U[[L<\+\&7[D=!R;S!N@DSV%ZP)-+(/8-YVTI-V??,< MG]")CI+-N/R[=C+M*9*ZC.FD,HAPI%"$U,B\4@OMQ$CG.D%*%%I,R1R$F)ZG MP=)M])C2'4@RM9T MN?AF_RN,KGP[CBD;,,<(V@%#^!;=EQD45*G.[B13MJ+KP9[3BPUPCJ(=8/K* MEPLQS!Q1;E(TI@1>@W?@AV_`'4=7(2Y3Y*9.\@*<61#ZX71!S`5DZ[A-V&"6 MY`H?/1EAHB'R$MDN0`RDI_^M-S,<*%QDZU5WH''96+$$O5#U$`;XX>4$7$PC M0$G^Y.EJ.")ZLT)JT0%%]LM5&B?A'$1/(+MLB6?>&WT=H?0P'$!=.2"U3H&J MPEIVTIIP7FFS(]AHIUEJ,0)%:*#P\KXER92EJW;8V>0!F3+ODE-,C[=!32H8L)SWRXXDPT(XBC(<;DE-&]<,<.6F4WFE' ML42B7&KJJ':H^1Z#2>K?>Q-2,`9+U]U$4`O]@@Y1I#UO&0.PN7BP^S"8OH!H M?@U>DXZYQZ?UW&,TZ@$:UD+CZI-R7*;V/)%02BE]S:**LS6=#"LHCMJ_`?0?@?JE5_?M%5RFYQT6E@18:2`U.M MJ;>3BM;FICV)LKF2FFLG_[Y[+1>A#&%1&HGW'IUA(FH<5%NWK1`WQY[=B5[E M:WUC?,+W`,[BT@[^?(`G@]_B5P?]_#VVB5$)]`Y;(>E6456##SI0;&*\$O.B MOP/+/=]"W^1$51T_4B&`NK@W-:U2>P2I':D5:.>EG)DZY`_]=R^8 M5@FG'[=I?32'`D6B#6=Q;D(-0<4]2.`4BA6QY3F*>E.3,,!,GR$I,[_;D8=V MOB<[H;E)UYMI)_*^6SH3@93;+,4;>GGZU.V\WE`[43*)@BY!\S?R^S!PP^`N M@/-XA>>1\03.';B(]ON[R_$3?0UGZ:LU+/B6],[DFH*5ID-P2X`GM8]VV)#A MOZ-32XP'UD7`N8/Z,HRB\`>R:>TW^)=DP2%OTA!;(7ZZ^-@@P,4`J4Z?4S7` M0K$#=^CUOA2_P0.B.0$^]89&@H213*E7/]QU3PB.7R>'HOX5W@ M1.C9O2J+&GW`C'V-PD!_R@4%5?J:>(2;F'GS\>9E3WU>0_MJR+'9K/4T"CI] MZ98<1:DH'K>ZF%[:L1<_0X)L=QR4;7T2B%B[&XFD7L0+RF73[.VS*DOP<0_$ M">+"#3SQ.2B8]A%$#A+VE!3=R35&E;?'D+='I@&K"P>D/L6K:*EJXNP5M@00 MEVY!.[(X1C`25WWI%_3.K[`ML-&H?DB1*VD\^1Y_3>W(#F"O=?\*J9E10N1*':6R+KB4+E@L_5O^TS MAS9'8#X[!DKREOII?+]L(48*3;E0*><`+AG$(/U5XRI[3B![CDT!0`N1QCPR M5J:90?8&2YPF9Y$IY)O>S_,:A7^@9-P@\0#G4PYG]3S??$1K-:3:7;I.X7*V M;<^"LG55]*)X:6:+"\>)4IOT/DMS8^V4E4=0:X^&LY)GU&M>S72OV'<7Q^E* M99DPL=[9<(PPD6O,9M[,@^(%52Z<%)T,QP>5S+Z;?V/=(7UPD1E+SJ+TWEEQ M#WP-LO]R089A/,/1U)4#4JY&]0%:7Z-%<0DBZ5:+N,JTY"Y\]+"'/W M9O[FAPL`<)'C(,;?Z%AIZ+Q^`L'?.<`?LHHO6>5/Z5-\:#7O\:0\0US!%[CH M7>OX>09!^(JH*?:CEF-+WT&5/":'YH-%5I[Q!5*.*:Y_?;E8--,9*K,)2;:G`/\116G=VE[TN^VGQ+<;=9G?7J,4\UI:EJ`NALGJFO,B MCM-YQKG;,%JR93S!`V0\??2A=7\1N(]IY,S@D$^(IQFC@$0QS<12HYW/]?O++R\^7@##EQW4&`V*6]>W@=W7"$V MQU.I3UH?&[!-%"R\]MX]%P3NIK:)IN_NN%9LG+52W^TVP88J./E[B.(L46HO MXF7^6LTFM:1Q`GMU4<1CR55ACA1%+LQ"'](59]$>W<(HAP-"&&4^]G]8V>CZ M1$XV4!XFH.6^OZW3_CZ?V7-V!E7J5/&RQ02!#=S7Y[PP[HE('60L56)UA-`Y MH>\=?8\G)360,IWK!"E1:%%^]2A&J#V?E-1%L)2YU47;3H^)3T_U?%]R.R7= M2H\A#Y`4U^64#;C<1#O1;GH/;F4&P_.2B@PMIB`W6OB$!N)N93]98A2*E&_) M?-%`_/$_FJ[+#*)AC-4QW][:EH",ZG`WPLJ`I!&"ZQZ MF;O3^2OUHBPWX1M(9L0$5I:N^F%(CDSKX.G,':EG#465GBO,P/R-"VZP@*O: M8X\I5J9(CNU0!"9,_1-X*^R$*)Q&]OP)(&/#"Z9%B>2PXKQ#S:T3AZ3E!:.E:01Q!A M^I@00NJ\1TH'_NCV*HN\=:BE7BRIPQY5C#RAO`*CU=J3$3).DSBQ`Q>>$S@@ M4>JUQP4/8P2]%*.5L=,Y96#U8&1[T3X1X^\N5.6RL/">#LS:/#M+!__/[R!. MX"J0L8V:P23H$U71#$^/!H-=0K=,+A8`-^I^H#/72/Y$T1@G?6J']W?9\=)U]&T8X%UXRZ-<_M\?^1CA:J$#?>P^21<,=?MH8U?0$4&EY M#[TO4"42USV3&NPD0 M3GX4>##J!?MEX"J(WCT'-//](<3YM2`[XL4OZ.G%\M]1/-A#F/PO2)Z`$TX# MROE%VO=V#\)J6%IH@:R['44G&FE,S#PAT&#)?X7:D1Q8FYU$5;R'4+R*7X7: M?HUAYW.A1DT76[OHYCLVZ5B<*KM[5^<,"?>R.[` M\ND=5P\5W"T417)E:WVW#W<]65.`1LY-W%B8`.G M[R"Y3<%XLB0O@F>4BI?J/OR1O4B'*KQ]LZ,_09*_J59J-`Y09>GQI.EB3>:G M=A.8&^5F@619%VIB?-,26%(,LQDX%\/L$;T)AA:@EG5GIRA,N,2&Y0U4[$1> M9@,1#%=ZIRK[1I!]AX;CL0=?"EC)JE^Z9+W*^J6KNA*9;7WA)-X[_#UO.=/F MIU-KY4S+KZ7F+Z$67]P7.-7CU%SRPF77G/(=J-EW]%N<^`N>;H0G@JIDO.$# MSW-B1\DV%@%J?"9'$E:K']D#E84A4@IP**NYD26:7:9ERZI:CU M-;@&,@%I8HCN6P#C/$-3`*8H#W6+U[O;,)H`+TDC('O1:_B2"7C<$%?ZEM\P M!K`ZV9.JO2]:&I1#8;4_,HOR)E`.U]K5ZWK"S7=XC(U*NP^Z"%CN0-A7A0LL ME^YA_B+8)B<\CE;J0(-3BX52L`YC;T: MB&&9J#([6Z`(AEK]N^SGY&>5J$([VK@_^X?6([^``L0S?GT7%GJ)G))354V_@&A^*"F+KL-,3-$"#;@FI^J/3M&=193E>/($ M1X1+0Y+7R_T>>$G,&^TYXH_V+":`?EY-(>MHX4GL`T`%$;*5+]QOZ0(FE1?Z MOG"?31Q^A?+(;J5-E;YC2-^18EE+E5P=*>WU^^X<6E$=N$R/]"2,\0)V,,>5RVROY.??*=VD<[%&T,$74P\C/*$%3USU<3[3FY;TZ$ MTP&?&]YA);&0F,>P5?C+S-F[`.IMBCD^3F99^FU^E%X6+9,3I,O[??W0+`== M`F$LA,72V:%0;6HSV&N.*B9+R2XT6'GT/]VH#MG9?LUAXK&D3$># M;;4E6]=NV+%1C*ISH?I=4FJI"IS:?J?2CON"LBAWV-.@GT)RSF^OE7J*0$K6 MI\%J63WMZJ>6G//;JZ6>(A"4G[HS:EG*A=%/)WDFMU=(#?DO)6'68&TT]1RY M=]RH9K^HQ-T=S_8LX!DE\`=<5SW[U?"_Q`&?&S7`P7,^X0=^V M\,>M\M>MG_+OHSR;Y0RL;`H6G(-5FH3BC)LE^U:$Q2WY-O0N*M;HY8R:I)Q+ MQAT'3\!)(U3^%C:`^UU4_!/JHQ?3LFV$C:_=VL@B_O(2)Y<3^N;:+.F^7"Q_ M_,V#*W#DS!;WX!WXE"03OFD[C=M3G3QJ/@[7&/K"B%^L M%(QT9H4A21!+FN^"-V@<8CX.J8DUE![Z8J:SF"G08:3?8*`<<@/E<,>!0J-? M0MBQ+D`9<0-EM.-`H='?-]I6-Z#TL`OO6U+QA'Y#7S!NVK*6QDVM$O1NPPAX MT^`*SAX$SJ+PC&'B&PZ\)`CRC6(DR.A";P":`)X)LKM(+LIS-9B\3&/(RSB^ M"N>O7H!Q@+@#&0W%"'^*/4AU[A;-I+0@X++#2'ML"N1;7W.O)>S_7!,7.N1] M&#B0#?A#4+$;6WV'/)T^0Y7W)IYC!\GW('R-0?2.-J?,*N)ULM<>,24ZV:LS MM.`4B6WQ-*W2/*WR1*ULIGM/O!QWUQ]>,JOCHBJ]^&E-MW,-I,4B2/E65>5/ MH[[8T/B(/6&!7VT_R87S5^K%'OKM&LRX^V\M M=,10*F5?W*8UC*!`7VTON`_C^"YP_-1%\:'FZRCCF&'EN+DJZT]?7=B<"^,>3L-'Y:TA+RX"=ZGD#G>8 MWV$]S`\/;N6CX_B]ROAJW0;(8%E-9]'B,2"V5K'@5"<#.4F+P6MNK-U6U"*. MLK)S4*1O8%R-B,O%@XTR>L:3,AO(P7'L`V@N:ZH`&:3/1_>V("(GBAK?1NE1 MI?T,TGZJF_A40;G)\W?[`!.#3^2?@W1>POMHA#?[JXRI!H\%?T&U%_.=%%5G1<2>"%A M:5`>=+]NA#M.E,+C87)E1]$"_I+FF6#J:PZJ^I,M*/R5%*]SH@6$GI`.C2>/ M\+<>U#[TUV_VAS=/YVPP(O02F_]R)P M?P/N%"W/V9-LD,T/4--P.SY_U:CNKUI]TBI]$SNN\J]:J\]:/RT_K#@`YBL( M0&3[B)048B4,QA-FYK6XO<0,K6(=6DV3YAQ;:Z7=FB)2M.6EAH5N?3TE32QX M\N(_*=XR6A?MI,XB'9I,&4GJ+XS616,!,XJ*)FU&>@UQ9>3W MS32FFLL0M[3(!>)4IU11ZHA@9-='L*,IHMYF-;\G4Q]C`0'*YV2 MO4T*"E@Q'X261:TR]J"D*83:M=/4LMY4:31>CT(M!X?3HU`J?Y7--2MZE<\6 M_;HTX*I`5FGHO2M"/U?$,C@M7DTXOK1]*#WP/`,@*01\N6BV_2X7.477((9F M'6[+5'9+^`YB%!`X:E==%:XQ/PY$MP+WY0`6Z M0;-4B>VV7I9\E"G/<)6BSI52,^PZ7>NV]6#H1:CR+%G][^!UP(3R\R$WMRC; MAN(SHLSK?!VPPBVJ'M?YAEF,J)YP>NJY&#[NY%I'(ICA8:O>E.D>DH,II,UFK6%IKV/3]G"^)3&:18U_9;V MY1/(RGK%,^_M'(GH!V:ZC\!!\E+-4WGD6J MWU(#0"D6?!\_YA9A1X(?4U/L4$75QX\I[TQIH!]3*W`P2K:7'U,7=#1>A>-[ MO[7"I]<@".?H>0S@XAJH=E;UD'A-SCV&28`0QP`)L1+*K\OJ#EV*<=+<6&.P M:&*6P:EAW98T&[CX&4>CZM:"^!0MQ!JGRK]AY!^Q67D>67%+&T* MO__'@O9 MAYJ>"\J\/`5M-Q_H$3&HAY@!34\P<8]A)FK$L4*J$TU1($X[9R[!!+9YL3_H M[GF6$4Y?8_!7"@>]>>>/QCFJUYU=#6AE(ZH- MDEFGKR7PA=QH%`XYEGH=$?>^CFZA`/T:`OMRW]M-.U#SR8I-V M.[W*=;_Y?>TT>P3C&W`]Q_9?@#,+0C^<(L\I\8*AO=-62+Q=9E5W34>RE0M> MRK[?=LE`:JX=,L19]W0:M4J\;5"'1Q`YB/7HU:+?0_2,T5T`,0?B),XUQ65? M_QD&TQT(=&DR[0I=N2#Y+H#^'-0O7Q!IKW8,X#_^/U!+`P04````"`!%BEM' M3"4R`,`-``"%D```$``<`')M9"TR,#$U,#DS,"YXI;TK23()F!XS2=`$D< MI,G.O`UDB;8YE4@/225Q?_T>4A=+ED1)MMQDL7II'>FT>NF//F,.;Z0J-.1-B1CA&1[WA8>_HJ#=`W6Z( M=VX)D&(4:>"#WC!^,PZQ&3U!PT'_X+!_,!@>H:.3P?!D\`G=W<22-V#LC)2+ M"GN!/0M!?JDXZRRD7)[T^\_/S[WGPQ[C?(4?ROEPM<1\D,"=VK,!H!1U&NQMZ2LB1L5ZRX([Z MPK))>DS^SQ%2G$+W1I9=6XIY3 MK;S!Q1`ZM2AETI)0F?3?ZLER2>B,A7_"`\7I"6']5EL:P.S@$ MJ_I*O/\54M#1BLR+#'#PCE.@,0'T8 M0%U%,0S\3B*A$`H%6*?]38!-;!\J^X3^HG\O(7\`J8OJ&AZ$VJ&(2=.V7-MW MMU!<6U:L%SZ-Z-D[:_%#,9E!R\D\;*`N1]C,WX&9OS4>FLQ0@-BRN".+8^9! MJ2PP%>0)UZ(T3]/,[V$=?E/P+=L-L6V)Q:7+GDTM;KZ\F=D/M9@%4*116S[- M?%X08;M,^!Q_MCB%,:ZXP_SKPN)8C?H8&D1 M-^2[03R3/WR`EOP`?&"='/P1`2%`0AH*O8M255ZATT60,`I3SM'X";T+T_^I M=9VJKG,%TA2D"19KEA,/"SRDJIK9$0X'PTU'2&"D/2#QHB5Z"Z+O.%O"K'9U M!\-<"17I\]\^6:I6]Q;+`I*KJ)@)_I`E.`)]CS2LKM,Q\'L$T"V[]=G]PICS M3%P72G,B%YA?03G0.9FZ>"0$S&>@6-?U-%>BP`>:`S9[RL?!X::G1$EK%]'0 M:(V-`O#089(-18%DVVALX5;7C,X?L`JI3!,T)Y\6N$UU1;-;?,H.%11(5Z$@ M!9/F/OVNI7P+RB\P)T^0`35K$Y+KX*B`&O@;=N8PWAK9\`KLA'[?]SR+KR:S M+Q:AXII!+1-0U9A-U*C^=R(7:ZA+0BT*+]P$9H'G_/#TC0XX/,RV2VM8E(#3 MK51H)%I;"?X9V*G<4UN*W@6V_H36UB)E;A(X-CB91.O/U?TY#.M'_ZO1"Y5$ MKJ[HC'%/9RCTO"J2YOGMX%C-;R.`Y$\]N-%H*`'7DK=K2/@.IGL4^GE)((]5 MX\-II;)@\5'U8#%ZEX)N*V?ESB9NP[^2.24S*#VH@+;-?*@S='X'Y6U#&[K9 M1534,C$\!(8S4Y-$2YU`1FMH%&&W#&\;FBH+-96P=I!E+1L(:MG9(OICB/"4 M<&*.XK1D[!RAJ1R7*2&J;C2FI:XJ=6,FY`V6"^9<:3T]7-^D+5_(3-E1EC(% MTPUP4`*H):O!6-D64;`2(C]FB:P90I)E9#U*4M6.K+4,E*C4W-\ M6_YN<0[]2\XX(RM@YN;GW$Y,0:`U1LM/Y1F89/8WO7/QL[=TV0ICM;4"4Y$, MD525-C-WG#/C4GCAQLD($24A6R)K$;E@KH.Y4",XNGO%8U\]Y,7$ZH9(V``HB6G&;#_/K_[*BECJZ)5#`ONYF@ M>L@?O0O2:%=WMH[]/UA3-]O6%DB9J#P<'&27Y?.VD`98+67;+`CDLY45,!.5 MLW\BM<6S9:BI58)\OLK$S>Q]R+)G7#%H^6QFZ2"?2Y.HF<>C+(\%RP@M@_M8 M3\CGL[JBF=W=]LZV?.^PR)!/;(Z$F<%/608WM[FV-.VZ\E#80>:*F0G[.;=C MW%B%:$EK>#DBG\%*.F8ZC[-TEBY-M.PVL$9A8#1/SLCB<%#`XL9Z14M<,PL7 M^=R91,WT#;/T%2QBM`SN+Q2>SVI==3/3NQ^J:/G?,19WJT8IJK@K'@'/R)L8 M_E!MGRYZ%Z.V1UN:"AV4$5M-RVXS:Q"4ZCY/9>`%3 M?"RN:*Y>'8_8-8TR!\JLQ!0Z4/)\9]H6_;F0P!I0*4)H_6[?Y\G7'@%U?:6& M`YY:/9O,(I0FSI973L3L>1^SGK?E.?.DYX4FH<`F?=0S!&V];\<(6UE_9I0U M^T+I-M^V]VHX!%?\H9%\.3-_E;8"M[PU'84KJY$UM-"K=';#,4RHN5Z6ZDC#A(!H2)1WV(3KQUGF:6N"* MMQ['7V,*@@'0.U\3:TI<8IC3-(!H=I_J9WY2WZ!:?UDJ2%J/-1*)M^[3E/ND M@Y7)$6I2ZE$0.D_L/7^D;"HP?U(+7%=TZ1+?S_HDYY;IUSF@IG^:ON/>89K/7KX%%JI'KWBR:L16(F;VBREG/_RO2U#_J7J][/$/ZUJX3=:'464<0;^FJV[[TLP7' ML[,.]YQN=&W4GY#;WHOG1A(*WG!]F.9XLX#"=",(B]L9E,RE8@"BSR1!#>U' MMD<`DDBE?I=(!JETQ'MDN6!IOZF\`U]U\[Y!\9ZR/EZGLI^UUBE1+8 MU*I=`A6N7ZQG!Z.W39B2]`A9VQOD=IZ0N4ZR8EV(%%2J1]722UXN.;>L9>IN M29/GY2KVL2M%]*2[ADK9$M[XJ4=XT`#_&2VSZDAWM#:J5DO3*[LWV)MBWM%Y M..O452*NJT),9QT8K4/C$G0)P16@)P[S+$*O)/;4D`FR#6-$:'M]E>DOG/G+ MLXZ^7_6$@`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`:P*L8!=,3LM34_%ULSKR&)?D>[A:'_6;FTS2P/X?I MFYC,DNOCP7>.'_"+/(]PBU=`Q0````(`$6*6T>V=JGP MDZ```*`1#@`0`!@```````$```"D@0````!R;60M,C`Q-3`Y,S`N>&UL550% M``,1ZB]6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`18I;1U&ILLM_#P`` MU]<``!0`&````````0```*2!W:```')M9"TR,#$U,#DS,%]C86PN>&UL550% M``,1ZB]6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`18I;1PBU=/N]%P`` M4(0!`!0`&````````0```*2!JK```')M9"TR,#$U,#DS,%]D968N>&UL550% M``,1ZB]6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`18I;1WV6L9O(40`` MI=0$`!0`&````````0```*2!M<@``')M9"TR,#$U,#DS,%]L86(N>&UL550% M``,1ZB]6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`18I;1[!3!8Y(.``` M-P<$`!0`&````````0```*2!RQH!`')M9"TR,#$U,#DS,%]P&UL550% M``,1ZB]6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`18I;1TPE,@#`#0`` MA9```!``&````````0```*2!85,!`')M9"TR,#$U,#DS,"YX`L``00E#@``!#D!``!02P4&``````8`!@`4`@``:V$!```` ` end XML 48 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814

Legal Actions And Contingencies
3 Months Ended

Sep. 30, 2015

Legal Actions And Contingencies [Abstract]

Legal Actions And Contingencies

(12) Legal Actions and Contingencies

Litigation

In the normal course of business, we are subject to routine litigation incidental to our business. While the results of this litigation cannot be predicted with certainty, we believe that their final outcome will not, individually or in aggregate, have a material adverse effect on our consolidated financial statements taken as a whole.

Obligations Under Recourse Provisions

We use independent leasing companies to provide financing to certain customers for the purchase of our products. In some cases, we are liable in the event of a customer default, to the leasing companies, within certain limits, for unpaid installment receivables transferred to the leasing companies. The gross amount of receivables sold with recourse during the three months ended September 30, 2015 and 2014, amounted to $16.1 million and $2.0 million, respectively. The maximum potential amount of contingent liability under these arrangements at September 30, 2015 and June 30, 2015 were $9.1 million, and $7.2 million, respectively. The recourse liability recognized by us at September 30, 2015 and June 30, 2015, in relation to these arrangements was $0.5 million and $0.5 million, respectively.

XML 49 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Consolidated Statements Of Income [Abstract]

Net revenue $ 411,647 $ 380,399

Cost of sales (excluding amortization of acquired intangible assets) 173,028 143,086

Gross profit 238,619 237,313

Operating expenses:

Selling, general and administrative 111,095 110,520

Research and development 27,192 30,024

Amortization of acquired intangible assets 2,307 2,094

Total operating expenses 140,594 142,638

Income from operations 98,025 94,675

Other income, net:

Interest income, net 3,422 5,584

Other, net (2,003) 1,671

Total other income, net 1,419 7,255

Income before income taxes 99,444 101,930

Income taxes 19,041 18,670

Net income $ 80,403 $ 83,260

Basic earnings per share $ 0.57 $ 0.59

Diluted earnings per share (note 2) 0.57 0.58

Dividend declared per share $ 0.30 $ 0.28

Basic shares outstanding (000's) 140,309 140,127

Diluted shares outstanding (000's) 141,946 142,683

X

- Definition
The aggregate expense charged against earnings to allocate the cost of acquired intangible assets.
+ References
No definition available.
+ Details

Name: rmd_AmortizationOfAcquiredIntangibleAssets1

Namespace Prefix: rmd_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate dividends declared during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_CommonStockDividendsPerShareDeclared

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Total costs related to goods produced and sold during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 940

-SubTopic 20

-Section 25

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51673353&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 10

-Article 5

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(b))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51677171&loc=d3e3636-108311

+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 50 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814

Goodwill And Other Intangible Assets, Net
3 Months Ended

Sep. 30, 2015

Goodwill And Other Intangible Assets, Net [Abstract]

Goodwill And Other Intangible Assets, Net

(6)     Goodwill and Other Intangible Assets, net

Goodwill

Changes in the carrying amount of goodwill for the three months ended September 30, 2015, and 2014 were as follows (in thousands):

Three Months Ended September 30,

2015

2014

Balance at the beginning of the period

$

264,261
$

289,312

Business acquisition

-

6,454

Foreign currency translation adjustments

(1,443)

(18,502)

Balance at the end of the period

$

262,818
$

277,264

Other Intangible Assets

Other intangible assets were comprised of the following as of September 30, 2015, and June 30, 2015 (in thousands):

September 30, 2015

June 30, 2015

Developed/core product technology

$

66,104
$

67,548

Accumulated amortization

(51,144)

(50,373)

Developed/core product technology, net

14,960

17,175

Trade names

2,478

2,500

Accumulated amortization

(2,214)

(2,206)

Trade names, net

264

294

Non-compete agreements

1,590

1,747

Accumulated amortization

(1,590)

(1,704)

Non compete agreements, net

-

43

Customer relationships

29,102

30,538

Accumulated amortization

(19,532)

(19,308)

Customer relationships, net

9,570

11,230

Patents

63,533

66,585

Accumulated amortization

(45,727)

(48,185)

Patents, net

17,806

18,400

Total other intangibles, net

$

42,600
$

47,142

Intangible assets consist of patents, customer relationships, trade names, non-compete agreements and developed/core product technology.  We amortize intangible assets over the estimated useful life of the assets, generally between two and nine years. There are no expected residual values related to these intangible assets.

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814

Cost-Method Investments
3 Months Ended

Sep. 30, 2015

Cost-Method Investments [Abstract]

Cost-Method Investments

(5)      Cost-Method Investments

The aggregate carrying amount of our cost-method investments at September 30, 2015 and June 30, 2015, was $30.2 million and $25.6 million, respectively, and is included in the non-current balance of other assets on the condensed consolidated balance sheets.

We periodically evaluate the carrying value of our cost-method investments, when events and circumstances indicate that the carrying amount of an asset may not be recovered.  We estimate the fair value of our cost-method investments to assess whether impairment losses shall be recorded using Level 3 inputs. These investments include our holdings in privately held service and research companies that are not exchange traded and therefore not supported with observable market prices. However, these investments are valued by reference to their net asset values that can be market supported and unobservable inputs including future cash flows.  During the three months ended September 30, 2015 and 2014, we did not recognize any impairment losses related to our cost-method investments.  We have determined that the fair value of our investments exceed their carrying values.

The following table shows a reconciliation of the changes in our cost-method investments during the three months ended September 30, 2015 and 2014 (in thousands):

Three Months Ended September 30,

2015

2014

Balance at the beginning of the period

$

25,600
$

14,850

Investments

4,582

500

Balance at the end of the period

$

30,182
$

15,350

X

- Definition
The entire disclosure for investments accounted for under the cost-method. The carrying amount of such investments may be adjusted, for example, distributions in excess of cost (return of capital) or for other-than-temporary impairments. The cost method and lower-of-cost or market, an adaptation of the cost method, is generally followed for most investments in noncontrolled corporations, in some corporate joint ventures, and to a lesser extent in unconsolidated subsidiaries in which the entity does not have the ability to exercise significant influence.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

+ Details

Name: us-gaap_CostMethodInvestmentsDescriptionTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAllOtherInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 52 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories (Tables)
3 Months Ended

Sep. 30, 2015

Inventories [Abstract]

Schedule Of Inventories

September 30, 2015

June 30, 2015

Raw materials

$

75,490
$

74,416

Work in progress

2,215

2,550

Finished goods

180,904

169,893

Total inventories

$

258,609
$

246,859

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments And Hedging Activities
3 Months Ended

Sep. 30, 2015

Derivative Instruments And Hedging Activities [Abstract]

Derivative Instruments And Hedging Activities

(13)    Derivative Instruments and Hedging Activities

We transact business in various foreign currencies, including a number of major European currencies as well as the Australian and Singapore dollars. We have significant foreign currency exposure through both our Australian and Singaporean manufacturing activities, and international sales operations.  We have established a foreign currency hedging program using purchased currency options and forward contracts to hedge foreign-currency-denominated financial assets, liabilities and manufacturing cash flows.  The terms of such foreign currency hedging contracts generally do not exceed three years.  The goal of this hedging program is to economically manage the financial impact of foreign currency exposures denominated mainly in Euros, and Australian and Singapore dollars.  Under this program, increases or decreases in our foreign currency denominated financial assets, liabilities, and firm commitments are partially offset by gains and losses on the hedging instruments.

We do not designate these foreign currency contracts as hedges.  We have determined our hedge program to be a non-effective hedge as defined under the FASB issued authoritative guidance. All movements in the fair value of the foreign currency instruments are recorded within other income, net in our condensed consolidated statements of income.  We do not enter into financial instruments for trading or speculative purposes.

We held foreign currency instruments with notional amounts totaling $620.2 million and $576.5 million at September 30, 2015 and June 30, 2015, respectively, to hedge foreign currency fluctuations.  These contracts mature at various dates prior to September 30, 2018.

The following table summarizes the amount and location of our derivative financial instruments as of September 30, 2015 and June 30, 2015 (in thousands):

September 30, 2015

June 30, 2015

Balance Sheet Caption

Foreign currency hedging instruments

$

3,684
$

1,644

Other assets - current

Foreign currency hedging instruments

1,574

1,348

Other assets - non current

Foreign currency hedging instruments

(790)

(1,954)

Accrued expenses

Foreign currency hedging instruments

(2,804)

-

Other long-term liabilities

$

1,664
$

1,038

The following table summarizes the amount and location of gains (losses) associated with our derivative financial instruments for the three months ended September 30, 2015 and September 30, 2014, respectively (in thousands):

Gain /(Loss) Recognized

Income Statement Caption

Three Months Ended September 30,

2015

2014

Foreign currency hedging instruments

$

(39,353)
$

(11,054)

Other, net

Other foreign-currency-denominated transactions

37,081

12,148

Other, net

$

(2,272)
$

1,094

We are exposed to credit-related losses in the event of non-performance by counter parties to financial instruments.  We minimize counterparty credit risk by entering into derivative transactions with major financial institutions and we do not expect material losses as a result of default by our counterparties.

X

- Definition
The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4D

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4H

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4E

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 25

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(n))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_GeneralDiscussionOfDerivativeInstrumentsAndHedgingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 54 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stock-Based Employee Compensation
3 Months Ended

Sep. 30, 2015

Stock-Based Employee Compensation [Abstract]

Stock-Based Employee Compensation

(9)      Stock-Based Employee Compensation

We measure the compensation expense of all stock-based awards at fair value on the grant date.  We estimate the fair value of stock options and purchase rights granted under the employee stock purchase plan (the “ESPP”) using the Black-Scholes valuation model. The fair value of restricted stock units is equal to the market value of the underlying shares as determined at the grant date less the fair value of dividends that holders are not entitled to, during the vesting period.  The fair value of performance restricted stock units which contain a market condition, are estimated using a Monte-Carlo simulation model. We recognize the fair value as compensation expense using the straight-line method over the service period for awards expected to vest.

We estimate the fair value of purchase rights granted under the ESPP using the following assumptions:

Three Months Ended September 30,

2015

2014

Stock options:

Weighted average grant date fair value

$

-

$

-

Weighted average risk-free interest rate

-

-

Expected option life in years

-

-

Dividend yield

-

-

Expected volatility

-

-

ESPP purchase rights:

Weighted average risk-free interest rate

0.1%

0.1%

Expected option life in years

6 months

6 months

Dividend yield

1.73%

2.00%

Expected volatility

26%

24%

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814

Long-Term Debt
3 Months Ended

Sep. 30, 2015

Long-Term Debt [Abstract]

Long-Term Debt

(7)      Long-Term Debt

Long-term debt at September 30, 2015 and June 30, 2015 consisted of the following (in thousands):

September 30, 2015

June 30, 2015

Current long-term debt

$

-

$

-

Non-current long-term debt

500,587

300,594

Total long-term debt

$

500,587
$

300,594

Credit Facility

On October 31, 2013, we entered into a credit agreement, as borrower, with lenders, including Union Bank, N.A., as administrative agent, joint lead arranger, swing line lender and letters of credit issuer, and HSBC Bank USA, National Association, as syndication agent and joint lead arranger. Our obligations under the credit agreement are guaranteed by ResMed Corp. and ResMed Motor Technologies Inc., two of our U.S. subsidiaries.

The credit agreement provides a $700 million senior unsecured five-year revolving credit facility, with an uncommitted option to increase the credit facility by an additional $300 million. The credit facility also includes a $25 million sublimit for letters of credit. The credit facility terminates on October 31, 2018, when all unpaid principal and interest under the loans must be repaid. The outstanding principal amount due under the credit facility will bear interest at a rate equal to LIBOR plus 1.0% to 2.0% (depending on the then-applicable leverage ratio). At September 30, 2015, the interest rate that was being charged on the outstanding principal amount was 1.2%.  An applicable commitment fee of 0.15% to 0.25% (depending on the then-applicable leverage ratio) applies on the unused portion of the credit facility.

When we entered into the credit agreement, we used a portion of the proceeds from the initial funding of the credit facility to repay the outstanding balance under our previous revolving credit facility with Union Bank, N.A and other lenders. On that repayment, the previous credit agreement, dated as of February 10, 2011, between us and lenders (including Union Bank, N.A., as administrative agent, swing line lender and letter of credit issuer, HSBC Bank USA, National Association, as syndication agent and Union Bank, N.A., HSBC Bank USA, National Association, Commonwealth Bank of Australia and Wells Fargo Bank), was terminated and the commitments under the previous credit agreement were also terminated.

Our obligations under the current credit agreement are unsecured but are guaranteed by two of our U.S. subsidiaries. The credit agreement contains customary covenants, including certain financial covenants and an obligation that we maintain certain financial ratios, including a maximum leverage ratio of funded debt to EBITDA (as defined in the credit agreement) and an interest coverage ratio. The entire principal amount of the credit facility and any accrued but unpaid interest may be declared immediately due and payable if an event of default occurs, as defined in the credit agreement. Events of default under the credit agreement include failure to make payments when due, the occurrence of a default in the performance of any covenants in the credit agreement or related documents, or certain changes of control of ResMed Inc., ResMed Corp., ResMed Motor Technologies Inc., ResMed Limited, ResMed Holdings Ltd/LLC or ResMed EAP Holdings LLC.

At September 30, 2015, there was $500.0 million outstanding under the credit agreement.

X

- References
No definition available.
+ Details

Name: us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-term debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 56 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814

Product Warranties
3 Months Ended

Sep. 30, 2015

Product Warranties [Abstract]

Product Warranties

(8)      Product Warranties

Changes in the liability for warranty costs, which is included in accrued expenses in our condensed consolidated balance sheets, for the three months ended September 30, 2015 and 2014 are as follows (in thousands):

Three Months Ended September 30,

2015

2014

Balance at the beginning of the period

$

9,823
$

11,798

Warranty accruals for the period

1,790

3,376

Warranty costs incurred for the period

(2,039)

(1,567)

Foreign currency translation adjustments

(691)

(714)

Balance at the end of the period

$

8,883
$

12,893

X

- References
No definition available.
+ Details

Name: us-gaap_ProductWarrantiesDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

+ Details

Name: us-gaap_ProductWarrantyDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 57 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814

Stockholders' Equity
3 Months Ended

Sep. 30, 2015

Stockholders' Equity [Abstract]

Stockholders' Equity

(10)    Stockholders’ Equity

Common Stock.    During the three months ended September 30, 2015 and 2014 we repurchased 1.2 million and 0.8 million shares at a cost of $62.0 million and $42.9 million, respectively. Since the inception of our share repurchase programs and through September 30, 2015, we have repurchased a total of 40.4 million shares at a cost of $1.5 billion.  Shares that are repurchased are classified as treasury stock pending future use and reduce the number of shares outstanding used in calculating earnings per share.  At September 30, 2015, 14.3 million additional shares can be repurchased under the approved share repurchase program.

Preferred Stock.    In April 1997, the board of directors designated 2,000,000 shares of our $0.01 par value preferred stock as Series A Junior Participating Preferred Stock. No shares were issued or outstanding at September 30, 2015 and June 30, 2015.

Stock Options and Restricted Stock Units.    We have granted stock options and restricted stock units to personnel, including officers and directors, in accordance with the ResMed Inc. 2009 Incentive Award Plan (the “2009 Plan”).  These options and restricted stock units have expiration dates of seven years from the date of grant and vest over one to four years. We have granted the options with an exercise price equal to the market value as determined at the date of grant.

The maximum number of shares of our common stock authorized for issuance under the 2009 Plan is 43.7 million shares. The number of securities remaining available for future issuance under the 2009 Plan at September 30, 2015 is 13.8 million.  The number of shares of our common stock available for issuance under the 2009 Plan will be reduced by (i) 2.8 shares for each one share of common stock delivered in settlement of any “full-value award,” which is any award other than a stock option, stock appreciation right or other award for which the holder pays the intrinsic value and (ii) one share for each share of common stock delivered in settlement of all other awards.  The maximum number of shares, that may be subject to awards granted under the 2009 Plan to any individual during any calendar year, may not exceed 3 million shares of our common stock (except in a participant’s initial year of hiring, when up to 4.5 million shares of our common stock may be granted).

At September 30, 2015, there were $57.1 million in unrecognized compensation costs related to unvested stock-based compensation arrangements. This is expected to be recognized over a weighted average period of 2.0 years.  The aggregate intrinsic value of the stock-based compensation arrangements outstanding and exercisable at September 30, 2015 was $168.5 million and $46.3 million, respectively.  The aggregate intrinsic value of the options exercised during the three months ended September 30, 2015 and 2014, was $8.9 million and $9.7 million, respectively.

The following table summarizes option activity during the three months ended September 30, 2015:

Weighted Average Exercise Price

Weighted Average Remaining Contractual Term in Years

Outstanding at beginning of period

2,809,238
$

29.63
2.5

Granted

-

-

Exercised

(250,688)

18.34

Forfeited

(12,546)

44.32

Outstanding at end of period

2,546,004
$

30.65
2.5

Exercise price of granted options

$

-

Options exercisable at end of period

1,987,218
$

27.67

The following table summarizes the activity of restricted stock units during the three months ended September 30, 2015:

Weighted Average Grant-Date Fair Value

Weighted Average Remaining Contractual Term in Years

Outstanding at beginning of period

2,312,529
$

43.65
1.2

Granted

7,477

51.49

Vested

(25,245)

31.30

Forfeited

(5,839)

44.90

Outstanding at end of period

2,288,922
$

43.81
0.9

Employee Stock Purchase Plan (the “ESPP”).  Under the ESPP, we offer participants the right to purchase shares of our common stock at a discount during successive offering periods. Each offering period under the ESPP will be for a period of time determined by the board of directors’ compensation committee of no less than 3 months and no more than 27 months. The purchase price for our common stock under the ESPP will be the lower of 85% of the fair market value of our common stock on the date of grant or 85% of the fair market value of our common stock on the date of purchase. An individual participant cannot subscribe for more than $25,000 in common stock during any calendar year.  At September 30, 2015, the number of shares remaining available for future issuance under the ESPP is 1.5 million shares.

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 58 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814

Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Earnings Per Share [Abstract]

Net income $ 80,403 $ 83,260

Basic weighted-average common shares outstanding 140,309 140,127

Stock options and restricted stock units 1,637 2,556

Diluted weighted average shares 141,946 142,683

Basic earnings per share $ 0.57 $ 0.59

Diluted earnings per share $ 0.57 $ 0.58

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 59 R51.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments And Hedging Activities (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended

Sep. 30, 2015

Jun. 30, 2015

Derivative [Line Items]

Notional amount of foreign currency hedging contracts held $ 620.2 $ 576.5

Foreign Currency Contracts [Member]

Derivative [Line Items]

Terms of foreign currency hedging contracts, maximum 3 years

X

- Definition
Nominal or face amount used to calculate payments on the derivative asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Notional Amount

-URI http://asc.fasb.org/extlink&oid=6519104

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5580258-113959

+ Details

Name: us-gaap_DerivativeAssetNotionalAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeTermOfContract

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 60 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary Of Significant Accounting Policies (Policy)
3 Months Ended

Sep. 30, 2015

Summary Of Significant Accounting Policies [Abstract]

Organization And Basis Of Presentation

Organization and Basis of Presentation

ResMed Inc. (referred to herein as “we”, “us”, “our” or the “Company”) is a Delaware corporation formed in March 1994 as a holding company for the ResMed Group.  Through our subsidiaries, we design, manufacture and market equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea.  Our manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States.  Major distribution and sales sites are located in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway and Sweden.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all necessary adjustments, which consisted only of normal recurring items, have been included in the accompanying financial statements to present fairly the results of the interim periods.  The results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the year ending June 30, 2016.

The condensed consolidated financial statements for the three months ended September 30, 2015 and 2014 are unaudited and should be read in conjunction with the consolidated financial statements and notes thereto included in our Form 10-K for the year ended June 30, 2015.

New Accounting Pronouncements

New Accounting Pronouncements

In May, 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, “Revenue from Contracts with Customers”, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company beginning in the first quarter of fiscal year 2019. Early application is not permitted. We are currently assessing the impact of the adoption of ASU 2014-09 on our financial condition, results of operations and cash flows.

In April, 2015, the FASB issued ASU No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs". ASU 2015-03 will more closely align the presentation of debt issuance costs under U.S. GAAP with the presentation under comparable International Financial Reporting Standards (IFRS) by requiring that debt issuance costs be presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability. The new standard is effective for us beginning in the first quarter of fiscal 2017. We do not expect this updated standard to have a material impact on our consolidated financial statements and related disclosures.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory” which requires an entity to measure inventory within the scope of this ASU at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The amendments in this guidance more closely align the measurement of inventory in GAAP with the measurement of inventory in IFRS.  The new standard is effective for us beginning in the first quarter of fiscal 2018.  We do not expect this updated standard to have a material impact on our consolidated financial statements and related disclosures.

X

- Definition
Organization And Basis Of Presentation [Policy Text Bock]
+ References
No definition available.
+ Details

Name: rmd_OrganizationAndBasisOfPresentationPolicyTextBock

Namespace Prefix: rmd_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 61 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814

Goodwill And Other Intangible Assets, Net (Tables)
3 Months Ended

Sep. 30, 2015

Goodwill And Other Intangible Assets, Net [Abstract]

Schedule Of Changes In Carrying Amount Of Goodwill

Three Months Ended September 30,

2015

2014

Balance at the beginning of the period

$

264,261
$

289,312

Business acquisition

-

6,454

Foreign currency translation adjustments

(1,443)

(18,502)

Balance at the end of the period

$

262,818
$

277,264

Schedule Of Other Intangible Assets

September 30, 2015

June 30, 2015

Developed/core product technology

$

66,104
$

67,548

Accumulated amortization

(51,144)

(50,373)

Developed/core product technology, net

14,960

17,175

Trade names

2,478

2,500

Accumulated amortization

(2,214)

(2,206)

Trade names, net

264

294

Non-compete agreements

1,590

1,747

Accumulated amortization

(1,590)

(1,704)

Non compete agreements, net

-

43

Customer relationships

29,102

30,538

Accumulated amortization

(19,532)

(19,308)

Customer relationships, net

9,570

11,230

Patents

63,533

66,585

Accumulated amortization

(45,727)

(48,185)

Patents, net

17,806

18,400

Total other intangibles, net

$

42,600
$

47,142

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

+ Details

Name: us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

+ Details

Name: us-gaap_ScheduleOfGoodwillTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 62 R49.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details) - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Fair Value Measurements [Abstract]

Balance at the beginning of the period $ (1,584) $ (480)

Acquisition date fair value of contingent consideration (905)

Changes in fair value included in operating income 132

Payments 458

Foreign currency translation adjustments 70 (80)

Balance at the end of the period $ (1,514) $ (875)

X

- Definition
Contingent Consideration, Fair Value at Acquisition
+ References
No definition available.
+ Details

Name: rmd_ContingentConsiderationFairValueAtAcquisition

Namespace Prefix: rmd_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Contingent Consideration, Foreign Currency Translation Adjustments
+ References
No definition available.
+ Details

Name: rmd_ContingentConsiderationForeignCurrencyTranslationAdjustments

Namespace Prefix: rmd_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Business Acquisition, Contingent Consideration, at Fair Value, Paid During The Period
+ References
No definition available.
+ Details

Name: rmd_ContingentConsiderationPayments

Namespace Prefix: rmd_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 63 R41.htm IDEA: XBRL DOCUMENT v3.3.0.814

Long-Term Debt (Narrative) (Details)
3 Months Ended

Oct. 31, 2013

USD ($)

entity

Sep. 30, 2015

USD ($)

Line of Credit Facility [Line Items]

Amount outstanding under credit facility $ 500,000,000

Union Bank, N.A. and HSBC Bank USA [Member]

Line of Credit Facility [Line Items]

Credit facility termination date Oct. 31, 2018

Interest rate on outstanding principal amount 1.20%

Union Bank, N.A. and HSBC Bank USA [Member] | Revolving Credit Facility [Member]

Line of Credit Facility [Line Items]

Maximum borrowing capacity $ 700,000,000

Credit facility term, years 5 years

Uncommitted option to increase credit facility $ 300,000,000

Number of US guarantors | entity 2

Union Bank, N.A. and HSBC Bank USA [Member] | Letters Of Credit [Member]

Line of Credit Facility [Line Items]

Maximum borrowing capacity $ 25,000,000

Minimum [Member] | Union Bank, N.A. and HSBC Bank USA [Member]

Line of Credit Facility [Line Items]

Commitment fees percentage rate on unused portion of credit facility 0.15%

Minimum [Member] | Union Bank, N.A. and HSBC Bank USA [Member] | London Interbank Offered Rate (LIBOR) [Member]

Line of Credit Facility [Line Items]

Credit facility interest rate equal to reference rate plus 1.00%

Maximum [Member] | Union Bank, N.A. and HSBC Bank USA [Member]

Line of Credit Facility [Line Items]

Commitment fees percentage rate on unused portion of credit facility 0.25%

Maximum [Member] | Union Bank, N.A. and HSBC Bank USA [Member] | London Interbank Offered Rate (LIBOR) [Member]

Line of Credit Facility [Line Items]

Credit facility interest rate equal to reference rate plus 2.00%

X

- Definition
Represent the number Of US guarantors for credit facility
+ References
No definition available.
+ Details

Name: rmd_NumberOfUsGuarantors

Namespace Prefix: rmd_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Uncommitted option to increase credit facility
+ References
No definition available.
+ Details

Name: rmd_UncommittedOptionToIncreaseCreditFacility

Namespace Prefix: rmd_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentBasisSpreadOnVariableRate1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentInterestRateEffectivePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityCommitmentFeePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Date the credit facility terminates, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityExpirationDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=rmd_UnionBankNAndHsbcBankUsaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 64 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Statements Of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Consolidated Statements Of Comprehensive Income [Abstract]

Net income $ 80,403 $ 83,260

Other comprehensive income:

Foreign currency translation (loss) gain adjustments (122,108) (125,108)

Comprehensive (loss) income $ (41,705) $ (41,848)

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (c)(3)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569643-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 65 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814

Property, Plant And Equipment
3 Months Ended

Sep. 30, 2015

Property, Plant And Equipment, Net [Abstract]

Property, Plant And Equipment

(4)      Property, Plant and Equipment

Property, plant and equipment were comprised of the following as of September 30, 2015 and June 30, 2015 (in thousands):

September 30, 2015

June 30, 2015

Machinery and equipment

$

188,059
$

198,047

Computer equipment

126,928

125,423

Furniture and fixtures

37,396

38,511

Vehicles

5,680

5,371

Clinical, demonstration and rental equipment

81,174

80,911

Leasehold improvements

30,915

31,553

Land

51,905

54,915

Buildings

223,423

235,515

745,480

770,246

Accumulated depreciation and amortization

(376,496)

(382,488)

Property, plant and equipment, net

$

368,984
$

387,758

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13-14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2921-110230

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 66 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814

Long-Term Debt (Tables)
3 Months Ended

Sep. 30, 2015

Long-Term Debt [Abstract]

Schedule Of Long-Term Debt

September 30, 2015

June 30, 2015

Current long-term debt

$

-

$

-

Non-current long-term debt

500,587

300,594

Total long-term debt

$

500,587
$

300,594

X

- References
No definition available.
+ Details

Name: us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(e),(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

Name: us-gaap_ScheduleOfDebtInstrumentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 86 234 1 false 37 0 false 5 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://investor.resmed.com/2011-03-31/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://investor.resmed.com/2011-03-31/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://investor.resmed.com/2011-03-31/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statements Of Income Sheet http://investor.resmed.com/2011-03-31/role/StatementConsolidatedStatementsOfIncome Consolidated Statements Of Income Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements Of Comprehensive Income Sheet http://investor.resmed.com/2011-03-31/role/StatementConsolidatedStatementsOfComprehensiveIncome Consolidated Statements Of Comprehensive Income Statements 5 false false R6.htm 00400 - Statement - Consolidated Statements Of Cash Flows Sheet http://investor.resmed.com/2011-03-31/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements Of Cash Flows Statements 6 false false R7.htm 10101 - Disclosure - Summary Of Significant Accounting Policies Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPolicies Summary Of Significant Accounting Policies Notes 7 false false R8.htm 10201 - Disclosure - Earnings Per Share Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShare Earnings Per Share Notes 8 false false R9.htm 10301 - Disclosure - Inventories Sheet http://investor.resmed.com/2011-03-31/role/DisclosureInventories Inventories Notes 9 false false R10.htm 10401 - Disclosure - Property, Plant And Equipment Sheet http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipment Property, Plant And Equipment Notes 10 false false R11.htm 10501 - Disclosure - Cost-Method Investments Sheet http://investor.resmed.com/2011-03-31/role/DisclosureCostMethodInvestments Cost-Method Investments Notes 11 false false R12.htm 10601 - Disclosure - Goodwill And Other Intangible Assets, Net Sheet http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillAndOtherIntangibleAssetsNet Goodwill And Other Intangible Assets, Net Notes 12 false false R13.htm 10701 - Disclosure - Long-Term Debt Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLongTermDebt Long-Term Debt Notes 13 false false R14.htm 10801 - Disclosure - Product Warranties Sheet http://investor.resmed.com/2011-03-31/role/DisclosureProductWarranties Product Warranties Notes 14 false false R15.htm 10901 - Disclosure - Stock-Based Employee Compensation Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockBasedEmployeeCompensation Stock-Based Employee Compensation Notes 15 false false R16.htm 11001 - Disclosure - Stockholders' Equity Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 11101 - Disclosure - Fair Value Measurements Sheet http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 17 false false R18.htm 11201 - Disclosure - Legal Actions And Contingencies Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingencies Legal Actions And Contingencies Notes 18 false false R19.htm 11301 - Disclosure - Derivative Instruments And Hedging Activities Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivities Derivative Instruments And Hedging Activities Notes 19 false false R20.htm 11401 - Disclosure - Subsequent Events Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSubsequentEvents Subsequent Events Notes 20 false false R21.htm 20102 - Disclosure - Summary Of Significant Accounting Policies (Policy) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy Summary Of Significant Accounting Policies (Policy) Policies http://investor.resmed.com/2011-03-31/role/DisclosureSummaryOfSignificantAccountingPolicies 21 false false R22.htm 30203 - Disclosure - Earnings Per Share (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareTables Earnings Per Share (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShare 22 false false R23.htm 30303 - Disclosure - Inventories (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureInventoriesTables Inventories (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureInventories 23 false false R24.htm 30403 - Disclosure - Property, Plant And Equipment (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipmentTables Property, Plant And Equipment (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipment 24 false false R25.htm 30503 - Disclosure - Cost-Method Investments (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureCostMethodInvestmentsTables Cost-Method Investments (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureCostMethodInvestments 25 false false R26.htm 30603 - Disclosure - Goodwill And Other Intangible Assets, Net (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillAndOtherIntangibleAssetsNetTables Goodwill And Other Intangible Assets, Net (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillAndOtherIntangibleAssetsNet 26 false false R27.htm 30703 - Disclosure - Long-Term Debt (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLongTermDebtTables Long-Term Debt (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureLongTermDebt 27 false false R28.htm 30803 - Disclosure - Product Warranties (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureProductWarrantiesTables Product Warranties (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureProductWarranties 28 false false R29.htm 30903 - Disclosure - Stock-Based Employee Compensation (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockBasedEmployeeCompensationTables Stock-Based Employee Compensation (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureStockBasedEmployeeCompensation 29 false false R30.htm 31003 - Disclosure - Stockholders' Equity (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquity 30 false false R31.htm 31103 - Disclosure - Fair Value Measurements (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurements 31 false false R32.htm 31303 - Disclosure - Derivative Instruments And Hedging Activities (Tables) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables Derivative Instruments And Hedging Activities (Tables) Tables http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivities 32 false false R33.htm 40201 - Disclosure - Earnings Per Share (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareNarrativeDetails Earnings Per Share (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareTables 33 false false R34.htm 40202 - Disclosure - Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareScheduleOfBasicAndDilutedEarningsPerShareDetails Earnings Per Share (Schedule Of Basic And Diluted Earnings Per Share) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureEarningsPerShareTables 34 false false R35.htm 40301 - Disclosure - Inventories (Schedule Of Inventories) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureInventoriesScheduleOfInventoriesDetails Inventories (Schedule Of Inventories) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureInventoriesTables 35 false false R36.htm 40401 - Disclosure - Property, Plant And Equipment, Net (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipmentNetDetails Property, Plant And Equipment, Net (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosurePropertyPlantAndEquipmentTables 36 false false R37.htm 40501 - Disclosure - Cost-Method Investments (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureCostMethodInvestmentsNarrativeDetails Cost-Method Investments (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureCostMethodInvestmentsTables 37 false false R38.htm 40502 - Disclosure - Cost-Method Investments (Schedule Of Reconciliation Of Changes In Cost-Method Investments) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureCostMethodInvestmentsScheduleOfReconciliationOfChangesInCostMethodInvestmentsDetails Cost-Method Investments (Schedule Of Reconciliation Of Changes In Cost-Method Investments) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureCostMethodInvestmentsTables 38 false false R39.htm 40602 - Disclosure - Goodwill And Other Intangible Assets, Net (Schedule Of Changes In Carrying Amount Of Goodwill) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillAndOtherIntangibleAssetsNetScheduleOfChangesInCarryingAmountOfGoodwillDetails Goodwill And Other Intangible Assets, Net (Schedule Of Changes In Carrying Amount Of Goodwill) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillAndOtherIntangibleAssetsNetTables 39 false false R40.htm 40603 - Disclosure - Goodwill And Other Intangible Assets, Net (Schedule Of Other Intangible Assets) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillAndOtherIntangibleAssetsNetScheduleOfOtherIntangibleAssetsDetails Goodwill And Other Intangible Assets, Net (Schedule Of Other Intangible Assets) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureGoodwillAndOtherIntangibleAssetsNetTables 40 false false R41.htm 40701 - Disclosure - Long-Term Debt (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLongTermDebtNarrativeDetails Long-Term Debt (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureLongTermDebtTables 41 false false R42.htm 40702 - Disclosure - Long-Term Debt (Schedule Of Long-Term Debt) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLongTermDebtScheduleOfLongTermDebtDetails Long-Term Debt (Schedule Of Long-Term Debt) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureLongTermDebtTables 42 false false R43.htm 40801 - Disclosure - Product Warranties (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureProductWarrantiesDetails Product Warranties (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureProductWarrantiesTables 43 false false R44.htm 40902 - Disclosure - Stock-Based Employee Compensation (Schedule Of Assumptions For Fair Value Of Stock Option Plans And Purchase Rights Granted) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockBasedEmployeeCompensationScheduleOfAssumptionsForFairValueOfStockOptionPlansAndPurchaseRightsGrantedDetails Stock-Based Employee Compensation (Schedule Of Assumptions For Fair Value Of Stock Option Plans And Purchase Rights Granted) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureStockBasedEmployeeCompensationTables 44 false false R45.htm 41001 - Disclosure - Stockholders' Equity (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityNarrativeDetails Stockholders' Equity (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityTables 45 false false R46.htm 41002 - Disclosure - Stockholders' Equity (Schedule Of Option Activity) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityScheduleOfOptionActivityDetails Stockholders' Equity (Schedule Of Option Activity) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityTables 46 false false R47.htm 41003 - Disclosure - Stockholders' Equity (Schedule Of Activity Of Restricted Stock Units) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityScheduleOfActivityOfRestrictedStockUnitsDetails Stockholders' Equity (Schedule Of Activity Of Restricted Stock Units) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureStockholdersEquityTables 47 false false R48.htm 41101 - Disclosure - Fair Value Measurements (Summary Of Financial Assets And Liabilities) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesDetails Fair Value Measurements (Summary Of Financial Assets And Liabilities) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsTables 48 false false R49.htm 41102 - Disclosure - Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsReconciliationForFairValueMeasurementsUsingSignificantUnobservableInputsDetails Fair Value Measurements (Reconciliation For Fair Value Measurements Using Significant Unobservable Inputs) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureFairValueMeasurementsTables 49 false false R50.htm 41201 - Disclosure - Legal Actions And Contingencies (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingenciesDetails Legal Actions And Contingencies (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureLegalActionsAndContingencies 50 false false R51.htm 41301 - Disclosure - Derivative Instruments And Hedging Activities (Narrative) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesNarrativeDetails Derivative Instruments And Hedging Activities (Narrative) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables 51 false false R52.htm 41302 - Disclosure - Derivative Instruments And Hedging Activities (Summary Of Amount And Location Of Derivative Financial Instruments) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesSummaryOfAmountAndLocationOfDerivativeFinancialInstrumentsDetails Derivative Instruments And Hedging Activities (Summary Of Amount And Location Of Derivative Financial Instruments) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables 52 false false R53.htm 41303 - Disclosure - Derivative Instruments And Hedging Activities (Summary Of Gains (Losses) Associated With Derivative Financial Instruments) (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesSummaryOfGainsLossesAssociatedWithDerivativeFinancialInstrumentsDetails Derivative Instruments And Hedging Activities (Summary Of Gains (Losses) Associated With Derivative Financial Instruments) (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables 53 false false R54.htm 41401 - Disclosure - Subsequent Events (Details) Sheet http://investor.resmed.com/2011-03-31/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://investor.resmed.com/2011-03-31/role/DisclosureSubsequentEvents 54 false false All Reports Book All Reports In ''Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Balance Sheets (Parenthetical)'', column(s) 7 are contained in other reports, so were removed by flow through suppression. rmd-20150930.xml rmd-20150930_cal.xml rmd-20150930_def.xml rmd-20150930_lab.xml rmd-20150930_pre.xml rmd-20150930.xsd true true XML 68 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814

Cost-Method Investments (Schedule Of Reconciliation Of Changes In Cost-Method Investments) (Details) - USD ($)
$ in Thousands
3 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Cost-Method Investments [Abstract]

Balance at the beginning of the period $ 25,600 $ 14,850

Investments 4,582 500

Balance at the end of the period $ 30,182 $ 15,350

X

- Definition
Amount, after adjustment, of cost-method investment. Adjustments include, but are not limited to, dividends received in excess of earnings after date of investment that are considered a return of investment and other than temporary impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=29638308&loc=d3e40346-111594

+ Details

Name: us-gaap_CostMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAllOtherInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 69 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

Subsequent Events
3 Months Ended

Sep. 30, 2015

Subsequent Events [Abstract]

Subsequent Events

(14)    Subsequent Events

On October 2, 2015 we completed the acquisition of 100% of the shares in Curative Medical Technology Inc., a leading provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories in China. This acquisition will be accounted for as a business combination using purchase accounting and will be included in our condensed consolidated financial statements from the acquisition date.  The acquisition is not considered a material business combination and was funded through cash on-hand. We have not incurred any material acquisition-related costs.  The preliminary purchase price allocation will be completed during the quarter ending December 31, 2015.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company

Legal Actions And Contingencies	3 Months Ended
Legal Actions And Contingencies	Sep. 30, 2015
Legal Actions And Contingencies [Abstract]
Legal Actions And Contingencies	(12) Legal Actions and Contingencies Litigation In the normal course of business, we are subject to routine litigation incidental to our business. While the results of this litigation cannot be predicted with certainty, we believe that their final outcome will not, individually or in aggregate, have a material adverse effect on our consolidated financial statements taken as a whole. Obligations Under Recourse Provisions We use independent leasing companies to provide financing to certain customers for the purchase of our products. In some cases, we are liable in the event of a customer default, to the leasing companies, within certain limits, for unpaid installment receivables transferred to the leasing companies. The gross amount of receivables sold with recourse during the three months ended September 30, 2015 and 2014, amounted to $16.1 million and $2.0 million, respectively. The maximum potential amount of contingent liability under these arrangements at September 30, 2015 and June 30, 2015 were $9.1 million, and $7.2 million, respectively. The recourse liability recognized by us at September 30, 2015 and June 30, 2015, in relation to these arrangements was $0.5 million and $0.5 million, respectively.

Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Consolidated Statements Of Income [Abstract]
Net revenue	$ 411,647	$ 380,399
Cost of sales (excluding amortization of acquired intangible assets)	173,028	143,086
Gross profit	238,619	237,313
Operating expenses:
Selling, general and administrative	111,095	110,520
Research and development	27,192	30,024
Amortization of acquired intangible assets	2,307	2,094
Total operating expenses	140,594	142,638
Income from operations	98,025	94,675
Other income, net:
Interest income, net	3,422	5,584
Other, net	(2,003)	1,671
Total other income, net	1,419	7,255
Income before income taxes	99,444	101,930
Income taxes	19,041	18,670
Net income	$ 80,403	$ 83,260
Basic earnings per share	$ 0.57	$ 0.59
Diluted earnings per share (note 2)	0.57	0.58
Dividend declared per share	$ 0.30	$ 0.28
Basic shares outstanding (000's)	140,309	140,127
Diluted shares outstanding (000's)	141,946	142,683

Derivative Instruments And Hedging Activities (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2015	Jun. 30, 2015
Derivative [Line Items]
Notional amount of foreign currency hedging contracts held	$ 620.2	$ 576.5
Foreign Currency Contracts [Member]
Derivative [Line Items]
Terms of foreign currency hedging contracts, maximum	3 years

Long-Term Debt (Narrative) (Details)		3 Months Ended
Long-Term Debt (Narrative) (Details)	Oct. 31, 2013 USD ($) entity	Sep. 30, 2015 USD ($)
Line of Credit Facility [Line Items]
Amount outstanding under credit facility		$ 500,000,000
Union Bank, N.A. and HSBC Bank USA [Member]
Line of Credit Facility [Line Items]
Credit facility termination date		Oct. 31, 2018
Interest rate on outstanding principal amount		1.20%
Union Bank, N.A. and HSBC Bank USA [Member] \| Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 700,000,000
Credit facility term, years	5 years
Uncommitted option to increase credit facility	$ 300,000,000
Number of US guarantors \| entity	2
Union Bank, N.A. and HSBC Bank USA [Member] \| Letters Of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 25,000,000
Minimum [Member] \| Union Bank, N.A. and HSBC Bank USA [Member]
Line of Credit Facility [Line Items]
Commitment fees percentage rate on unused portion of credit facility		0.15%
Minimum [Member] \| Union Bank, N.A. and HSBC Bank USA [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Line Items]
Credit facility interest rate equal to reference rate plus		1.00%
Maximum [Member] \| Union Bank, N.A. and HSBC Bank USA [Member]
Line of Credit Facility [Line Items]
Commitment fees percentage rate on unused portion of credit facility		0.25%
Maximum [Member] \| Union Bank, N.A. and HSBC Bank USA [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Line Items]
Credit facility interest rate equal to reference rate plus		2.00%

Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Consolidated Statements Of Comprehensive Income [Abstract]
Net income	$ 80,403	$ 83,260
Other comprehensive income:
Foreign currency translation (loss) gain adjustments	(122,108)	(125,108)
Comprehensive (loss) income	$ (41,705)	$ (41,848)

Subsequent Events	3 Months Ended
Subsequent Events	Sep. 30, 2015
Subsequent Events [Abstract]
Subsequent Events	(14) Subsequent Events On October 2, 2015 we completed the acquisition of 100% of the shares in Curative Medical Technology Inc., a leading provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories in China. This acquisition will be accounted for as a business combination using purchase accounting and will be included in our condensed consolidated financial statements from the acquisition date. The acquisition is not considered a material business combination and was funded through cash on-hand. We have not incurred any material acquisition-related costs. The preliminary purchase price allocation will be completed during the quarter ending December 31, 2015.